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It is a great honor for me to be editor of the book Complementary Pediatrics. 
Currently; there is a lot of classical pediatric text books describing various topics. In 
these kinds of text books, there have always been similar topics with the same styles. 
In this book volume, beyond classical themes, a different approach was made to 
current pediatric issues and topics.  
This book volume covers complementary issues of pediatric subspecialties consisting 
of ophthalmologic, surgical, psychosocial and administrative issues of frequently used 
medications. Book consists of 16 chapters which will help get us and patients 
enlightened with the new developments on these subspecialties’ area.  
First section of the book is pediatric ophthalmology, which concisely explains most 
common eye disorders encountered during childhood until adolescence. Pediatric 
Surgery section discusses very classical but unsettled approaches for issues related to 
circumcision and cryptorchidism. An interesting approach also has been defined for 
the treatment of anal fissure. 
Section of special and interdisciplinary care entails pain management, snake bites, oral 
health, oxidative stress and a model of specialized interdisciplinary management. 
Oxidative stress of newborn is described in detail and therapeutic options are 
explained. In addition, the use of melatonin is mentioned as a useful tool to combat 
oxygen toxicity in newborns.  
Section on psychosocial issues is usually not mentioned in old pediatric textbooks, but 
it is not forgotten in this book volume. This section starts with adolescent psychosocial 
development and continues with commonly encountered problems such as alcohol 
intoxication and unwanted sexual experience. Moreover, as a paramedical issue, 
professional liability section describes liability in detail in this book.  
Frequently used medications section, lists the administration and dose of most 
frequently used pediatric drugs as a directory. This manual will help decrease 
administrative medication and calculation errors.  
X Preface 
 
In conclusion; with these 16 chapters, this book volume completes knowledge on 
pediatric subspecialties including psychosocial and special / interdisciplinary issues.  
Before I finish my last words, I feel obliged to my father Orhan and father-in-law 
Hasan Baş for their support during this period time. 
 
Öner Özdemir, MD  
Assoc. Prof. of Pediatrics 
İstanbul Medeniyet University 
Göztepe Research/Training Hospital  
3rd Clinic of Pediatrics, Division of Pediatric Allergy/Immunology 
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Pediatric Ophthalmology / Eye and Disorders 
Hikmet Basmak, Nilgun Yildirim, Seyhan Topbas,  
Ahmet Ozer, Nazmiye Erol, Huseyin Gursoy and Afsun Sahin 
Eskisehir Osmangazi University Medical Faculty,  
Department of Ophthalmology,   
Turkey 
1. Introduction 
1.1 Growth and development of child’s eye 
The growth and development of eye harbors many challenging anatomical and 
physiological alterations starting from the intrauterine life until the early puberty. After 
the early puberty, the axial length of eye, which is defined as the anterior posterior 
diameter of the eye, remains unaltered in healthy subjects. However, the refractive status 
of the eye may still change in adults due to aging processes. The eye development starts in 
the 3-week embryo, from the optic vesicles. The eye is an organ which derives from all 
three of the germ layers (ectoderm, endoderm and mesoderm). The initial 3 years of life is 
the critical period for eye development, and rapid increase in dimensions of the organ 
takes place in these years. Clear vision is mandatory for the development of visual cortex 
in this critical period. It is accepted that normal adult visual capacity develops at 3 years 
of age (Fredrick, 2004).  
The coordinated growth of eye’s refractive components to reach a plano refraction is called 
emmetropization. If any failure happens in this process, refractive errors develop. The axial 
length is either too short, causing hypermetropia, or too long, causing myopia. Astigmatism 
is due to abnormal shapes in cornea. Very high degrees of hypermetropia (>5D) is not 
normal in newborns. The cornea and lens may flatten normally within years, but the axial 
length often pauses behind. This causes permanent hyperopia, which is called 
nanophthalmos. Generally, eyes with hyperopia of greater than 5 diopters have little chance 
of emmetropization (Mutti, 1992).  
All anatomical alterations occur in order to achieve emmetropization. The corneal diameter 
at birth is about 9.5-10.5 mm. The average adult size is 12 mm. The corneal refractive power 
is 52 diopters at birth and 42-44 diopters in adulthood. Axial length is 17 mm at birth. It 
enlarges to 20 mm by the end of 12 months with continued rapid growth until 2 years old, 
then a slow increase to 24 mm by adulthood. The most rapid eye growth occurs within the 
first two years. At birth the power of the crystalline lens is 34 diopters. By 6 months of age 
power averages 28 diopters. By the adulthood the lens power reaches about 20 diopters. As 
cornea, lens, and axial length grow and change rapidly over the first months and years of 
life, the harmonization between these three components become crucial. 
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Normal infant eyes are 2 diopters hyperopic. This increases slightly to around age 7, then 
decreases to age 9-12 years when emmetropia is reached. Normal eyes have diminutive 
refractive changes after 13 years (Mutti, 1992). 
2. Congenital eye anomalies 
The congenital eye anomalies may appear in isolation or as part of a systemic syndrome. It 
may be genetically proven in some cases. Either germ line or somatic mutations can cause 
eye abnormalities. They may result from disruption, deformation, intrauterine infection or 
teratogenic exposure. Some anomalies significantly affect visual acuity. On the other hand, 
there are some anomalies which are noticed incidentally on routine eye check with no 
significance to the patient (Kherani & Robb, 2008).  
2.1 Infantile hemangiomas 
Infantile hemangiomas are the most common eyelid tumors in infancy. They have a bright 
red or purple appearance. Superficial ones typically blanch with pressure. At birth, they 
may be clinically undetected. However, they typically enlarge in the first 12 months 
followed by a slow involution during the first decade. Vision loss is related to amblyopia 
because of induced astigmatism or visual deprivation due to ptosis. Steroid treatment 
(intralesional and/or oral) is the first line of therapy (Levin, 2003).  
 
Fig. 1. Capillary hemangioma 
2.2 Epibulbar dermoids 
Choristomas (congenital dermoids) are masses of normal tissue found in an abnormal 
location. They induce astigmatism and cause refractive amblyopia. They may be excised to 
improve cosmetic appearance and avoid amblyopia. 
2.3 Microphthalmia 
A variety of disorders in which axial length is at least two standard deviations below normal 
is called microphthalmia. It is frequently associated with secondary orbital and ocular 
deformity including cataract and coloboma. It is frequently associated with various genetic 
conditions such as trisomy 13, Goldenhar’s syndrome (Kherani & Robb, 2008). 
 




It results from failure of the embryonic fissure to close along the inferonasal side of the optic 
cup during embryogenesis. It is frequently associated with microphthalmia. The visual 
prognosis is linked to the degree of optic nerve and macular involvement. 
2.5 Persistant fetal vasculature (persistant hyperplastic primary vitreus) 
It occurs sporadically and unilaterally in full-term health infants. The affected eye is 
microphthalmic with a shallow anterior chamber. A vascularized membrane behind the lens 
is typical. If the eye is not severely microphthalmic, surgical intervention may have a good 
prognosis (Levin, 2003). 
3. Optic nerve disease in children 
The optic nerve is approximately 50 mm long from the globe to the chiasm. It can be 
subdivided into four segments: Intraocular (optic disc, optic nerve head), intraorbital, 
intracanalicular and intracranial segment. Optic nerve is surrounded by the vascular pia, 
arachnoid and dura mater. The subarachnoid space is continuous with the cerebral 
subarachnoid space and contains the cerebrospinal fluid. The optic nerve carries 
approximately 1.2 million afferent nerve fibres which originate in the retinal ganglion cells 
(Kanski 2011).  
Common congenital optic disc anomalies are present as follows: Tilted disc, optic disc pit, 
optic disc drusen (hyaline bodies), optic disc coloboma, morning glory anomaly, 
hypoplastic optic nerve and myelinated nerve fibres (Nicholson et al., 2011). Optic disc 
drusen is a common anomaly with a prevalence of 0.3% of the population. In buried 
drusen which are the most commonly encountered type, they mimic papilloedema. 
Exposed optic disc drusen are rare types and more easily diagnosed. They are usually 
innocent, but rarely may lead to visual field defects or optic disc neovascularisation. 
Ultrasound is important for the differential diagnosis by showing calcific deposits 
associated with drusen (Kanski 2011).  
Optic neuritis is an inflammatory, infective or demyelinating process affecting the optic 
nerve. It can be classified both ophthalmoscopically and etiologically as follows. Papillitis is 
characterized by hyperemia and edema of the optic disc, associated with peripapillary 
flame-shaped hemorrhages. Neuroretinitis is characterized by papillitis in association with 
inflammation of the retinal nerve fibre layer and a macular star. The optic nerve head is 
normal in retrobulbar neuritis, because the optic nerve head is not involved. Optic neuritis 
may be seen due to demyelinating disease, parainfectious, infectious such as sinus-related, 
or associated with cat-scratch fever, syphilis, Lyme disease, cryptococcal meningitis and 
non-infectious such as sarcoidosis, systemic lupus erythematosus, polyarteritis nodosa and 
other vasculitides (Dale et al., 2009).  
Papilloedema is swelling of the optic nerve head secondary to raised intracranial 
pressure. It is nearly always bilateral, although it may be asymmetrical. Systemic findings 
such as headaches, deterioration of consciousness, nausea and vomiting, may be seen in 
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patients with papilloedema. Horizontal diplopia due to 6th nerve palsy may accompany 
the clinical picture. 
Optic nerve glioma is the most common primary neoplasm of the optic nerve. A low-grade 
form of this neoplasm, called benign optic glioma, occurs most often in the pediatric 
patients. On the other hand, the aggressive form of optic glioma, is most common in adults. 
Many children with optic nerve glioma are also known to have neurofibromatosis type 1. 
Another optic nerve tumor is meningioma. Meningiomas are believed to arise from 
arachnoid cap cells, and they are usually attached to the dura.  
Optic atrophy is the final common morphologic endpoint of any disease process that causes 
axonal degeneration in the optic nerve. There are two types; primary and secondary. 
Primary optic atrophy may be caused by lesions affecting the visual pathways from the 
retrolaminar portion of the optic nerve to the lateral geniculate body. Secondary optic 
atrophy is preceded by long-standing swelling of the optic nerve head. 
4. Retinitis pigmentosa 
Retinitis pigmentosa (RP) is a heterogeneous group of diffuse retinal dystrophies 
characterized by a progressive dysfunction affecting the rod more than the cone 
photoreceptors (a rod-cone dystrophy). It is the most common hereditary fundus distrophy 
with a prevalence of approximately 1:5000. All forms of RP can present in the first or second 
decade of life (Kanski, 2011). 
4.1 Inheritance and systemic associations 
RP can be inherited as an autosomal dominant (ADRP), autosomal recessive (ARRP) or X-
linked recessive (XLRP) pattern. RP can occur as an isolated sporadic disorder with no  
family history. The age of onset, rate of progression, eventual visual loss and associated 
ocular/systemic features are related to the type of inheritance (Khani, 2011). Approximately 
20% of these cases are ADRP, and 6% to 9% are XLRP. The remaining 71% to 84% are either 
ARRP or isolated simplex cases. Up to 40% of recessive cases are associated with other 
systemic pathologies or syndromes and 18% have associated hearing loss. The most 
common forms of ADRP appear to have a later onset and less severe clinical course than 
XLRP. Significantly reduced visual function usually occurs at a younger age in XLRP than in 
other forms of RP. Most patients with XLRP are legally blind by age 30. Important systemic 
associations are Basen-Kornzweig syndrome (abetalipoproteinaemia), Refsum disease, 
Bardet- Biedl syndrome and Usher syndrome (Drack, 2006). 
4.2 Symptoms and diagnosis  
Typically patients present with night blindness and visual field constriction. Central vision 
may or may not be involved. Classical retinal signs include bone-spicule pigmentation, 
arteriolar narrowing and disc pallor. Cystoid macular edema may occur. The fundus may be 
normal in the early stages of disease and this is often the case in young children. 
Electroretinography (ERG) is essential in the workup of inherited retinal dystrophies. Bright 
flash scotopic ERGs show a reduced a-wave, indicating rod photoreceptor dysfunction with 
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less severe photopic ERG abnormalities. Perimetry is useful in monitoring the progression 
of disease. Perimetry initially demonstrates small mid-peripheral scotomas that gradually 
coalesce to form the classical annular scooma that correlates in location and shape to the 
extent of fundus pathology (Kanski, 2011). 
4.3 Treatment 
Although the photoreceptor cell death of retinitis pigmentosa cannot at be arrested or 
reversed currently, some vision threatening complications (cataract and macular edema) can 
be successfully managed. Additional molecular and surgical therapies targeting various 
stages of the disease are under investigation. (gene and stem cell-based therapies, prosthetic 
retinal implants, germ and somatic cell gene replacement, allele-specific targeting strategies 
and retinal transplantation etc.) 
5. Retinopathy of prematurity 
Retinopathy of prematurity (ROP) is a disease of premature babies. The disease is a 
potentially blinding disorder affecting primarily the retinas of the premature infants. Three 
epidemics of ROP have been described. The first one was seen in the 1950s in the 
industrialized countries. The reason was uncontrolled oxygen therapy and inadequate 
neonatal intensive care. With developing technology in the western countries, the incidence 
of the surviving extremely low birth weight babies increased. This increase in survival 
resulted in another epidemic. This epidemic of ROP was the second epidemic, which was 
characterized by extremely low birth weight babies with ROP. Currently there is an ongoing 
epidemic in the third world countries. The characteristics of this third epidemic are the 
mixture of the first and second epidemics (Gilbert, 2008). 
5.1 Risk factors and pathogenesis 
Uncontrolled oxygen therapy and premature birth are the most important risk factors for 
ROP. Babies born at or before 31 weeks of gestational age, or weighing 1500 grams or less 
are under high risk for ROP. Systemic problems associated with prematurity may also be 
considered to be independent risk factors. Sepsis, anemia and growth retardation are the 
most significant of these systemic associations.  
The retina is not completely vascularized at birth. Especially the temporal quadrant of the 
retina lack blood vessels in the neonates and the retinal vessels development continues until 
the end of the first month of age. Vascular endothelial growth factor (VEGF) is very 
important for the retinal vasculature development. If uncontrolled and high oxygen therapy 
is applied in a premature infant, the production of VEGF may increase resulting in the 
development of ROP. Under physiological conditions, VEGF production is stimulated by 
hypoxia. Therefore, it is not exactly known why high oxygen levels lead to increased VEGF 
levels. The possible explanation for this inconsistency is the high variations encountered 
during uncontrolled oxygen supply. High oxygen levels suppress VEGF initially. This is 
followed by an exaggerated VEGF production, after cessation of the oxygen therapy. To 
prevent such variations in oxygen blood levels, oxygen supply should be given in a more 
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less severe photopic ERG abnormalities. Perimetry is useful in monitoring the progression 
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5.2 Clinical presentation 
The ROP can be categorized as active and chronic disease. Active disease is the ROP 
diagnosed at the early months of infancy. Most of the cases regress spontaneously. The role 
of an ophthalmologist is to recognize the more severe cases with the risk of progression and 
to apply treatment in the indicated cases. Ridge formation in the periphery of the retina is a 
feature of early ROP. Ridge is a fibrovascular tissue, developed as a response to hypoxia. 
Retinal bleeding and/or tractional retinal detachment may occur, if the disease progresses. 
In 20% of the babies with active ROP, chronic sequels of the disease may evolve. Most of 
these are innocuous, but fibrovascular tissues leading to macular distortion or retinal 
detachment may also develop. These may result in visual loss or even total blindness.  
5.3 Screening 
Screening by an ophthalmologist is recommended for infants with a birth-weight of ≤1500 
grams and/or ≤31 weeks of gestation. The time for screening is 4-7 weeks postnatally. There 
is inconsistency in the literature regarding the screening protocols. Protocols including more 
mature babies may be designed for developing countries (Basmak, 2009). 
5.4 Management 
Argon laser photocoagulation is performed in babies with threshold disease. Threshold 
disease is defined as 5 contiguous clock hours or 8 total clock hours of extraretinal 
neovascularisation located at or near the macula, which is the critical region of the retina for 
vision. Plus disease is also a feature of the threshold disease. It is defined as sausage like 
dilatations of the vessels around the optic disc, as a response to hypoxia. Posterior segment 
surgeries are indicated if retinal detachment occurs. The outcomes after laser therapy are 
successful in 85% of the cases, but they are not promising after surgery. Laser ablation of the 
avascular retina is applied to halt the progression of ROP. VEGF inhibitors alone or 
combined with laser therapy or surgery may be injected into the eyes to stop or slow the 
progression of the disease  (Erol, 2011). 
Pediatricians must be aware of the association between refractive disorders, amblyopia and 
strabismus in early or late childhood period and ROP. The risk of developing these 
disorders is correlated with the severity of ROP, but it still exists in regressed ROP cases 
with no sequel according to some literature. Therefore all ROP cases must be routinely 
referred to an ophthalmologist to screen for these possible associations.  
6. Lacrimal system disorders in children 
Unlike many insidious and asymptomatic ocular pathologies in children lacrimal system 
disorders alert parents immediately, because of an obvious watering eye with adherence of 
the lashes and with a mucoid discharge. Congenital nasolacrimal duct obstruction is the   
main etiology of epiphora in the pediatric age group. 
6.1 Congenital nasolacrimal duct obstruction 
The nasolacrimal duct is the continuation of the lacrimal sac. It opens into the nasal meatus. 
Its final end is partially covered by a mucosal fold called the valve of Hasner. This final 
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lower part of the canal at the level of the valve of Hasner, is not completely developed in 
some of the neonates. This developmental delay present in one fifth of the neonates. 
Spontaneous resolution of epiphora occurs in more than 90% of the cases within a year, after 
completion of the lower end of the canal (Ballard, 2000).  
6.2 Differential diagnosis of epiphora in children 
Amniontocele (congenital dacryocele), punctual atresia or fistulae between the sac and the 
skin are other rare etiologies for epiphora. Amniotecele is characterized by a blue-green 
distention of the lacrimal sac, observed externally at the level of inner canthus. It is due to an 
imperforate valve of Hasner. Amniontocele is mostly self limiting within a few days of birth, 
especially if massage is applied (Rose, 2000).  
 
Fig. 2. Left dacryocele  
6.3 Management of congenital nasolacrimal duct obstruction 
Spontaneous resolution is usual, so conservative treatments including antibiotic drops and 
massage of the lacrimal sac region is preferred within the first year of life. The index finger 
is put over the inner canthal region and the massage is applied firmly downwards. Three 
strokes of massage, 3-4 times per day are recommended. Early intervention is indicated if 
recurrent dacryocystitis occur before the first year of age.  
Probing of the nasolacrimal canal under general anesthesia is performed if epiphora persists 
beyond the first year of age. Probing is performed to disrupt the obstructive membrane at 
the level of valve of Hasner mechanically. The success rate of probing is very high. If it fails, 
the probing can be repeated once more. If epiphora persists after 2 technically satisfactory 
probing, more invasive procedures, including silicon tubes implantation, balloon dilatation 
of the nasolacrimal duct or dacryocystorhinostomy should be considered (Rose, 2000).  
Dacryocystorhinostomy is an invasive surgery, which involves anastomosing the lacrimal 
sac to the middle meatus by the removal of the lacrimal bone, is the gold standard treatment 
in adults, whereas it is usually the final treatment alternative in the pediatric age group.  
7. Childhood cataract 
The lens is a biconvex structure that hangs behind the iris. Its diameter is about 3.5 mm at 
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constitute the lens: capsule, epithelium and fibers. The crystalline lens is a transparent 
structure that helps to refract light to be focused on the retina, along with the cornea. The 
lens is capable of changing its shape in order to modify the focal distance of the eye, so that 
it can focus on objects at different distances, thus allowing a clear image of the object to be 
formed on the retina (Kanski, 2011).  
Cataract is the opacification of the crystalline lens. Cataracts result from protein 
denaturation, increased molecular weight of proteins, water vesicles between lens fibers, 
increasing proliferation and migration of the lens epithelium. Childhood cataract occurs 
worldwide and is an important cause of childhood blindness in many countries. Congenital 
cataracts occur in about 3 in 10 000 live births. Two-thirds of cases are bilateral. The cause of 
the cataract can be identified in about half of the cataractous eyes. Unilateral cataracts are 
usually isolated sporadic incidents, without a family history or systemic disease and 
effected infants are usually full-term and healthy. Cataract can be associated with ocular 
abnormalities, trauma, or an intrauterine infection such as rubella. Bilateral cataracts are 
often inherited and associated with other diseases. They require a full metabolic, infectious, 
systemic and genetic workup. The common causes are hypoglycemia, trisomy (eg, Down, 
Edward and Patau syndromes), myotonic dystrophy, infectious diseases (eg, toxoplasmosis, 
rubella, cytomegalovirus and herpes simplex [TORCH]) and prematurity. Isolated 
hereditary cataracts account for about 25% of the cases. The mode is most frequently 
autosomal dominant, but may be autosomal recessive or X-linked (Mickler, 2011).               
 
Fig. 3. Bilateral conjenital cataract  
Detailed eye examination is required for the density and morphology of the any lens 
opacity. Potential impact on visual function of cataract is assessed on the basis of the 
appearance of the red reflex and the quality of the fundus view on direct and indirect 
ophthalmoscopy. A very dense cataract occluding the pupil will preclude any view of the 
fundus. In case of pediatric cataract serology should be done for intrauterine infections. 
Urinalysis for reducing substance after drinking milk (galactosaemia) and chromatography 
for amino acids (Lowe syndrome) should be performed. Other investigations include fasting 
blood glucose, serum calcium and phosphorus and galactokinase levels. Children who have 
calcium and phosphorus anomalies severe enough to cause cataracts are usually having 
associated severe systemic problems. Referral to a pediatrician may be warranted for 
dysmorphic features or suspicion of other systemic diseases. Chromosome analysis may be 
useful in this context. It is important to examine parents and siblings to reveal a possible 
etiology (Krishnamurthy & Vanderveen, 2008).  
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Dense cataracts require early surgery when the child is 4–6 weeks of age to prevent the 
development of stimulus deprivation amblyopia. If the severity is asymmetrical in bilateral 
cataracts, the eye with the denser cataract should be addressed first. Surgery may not 
require in partial cataracts if opacity is not central. 
8. Childhood glaucoma 
The exact definition of glaucoma is still a subject of debate. What that did not change over 
years is that raised intraocular pressure is the most important risk factor for glaucoma 
development. Glaucoma is generally the disease of adults, occurring most frequently over 
40 years of age. However, it may also develop in children.  
Primary congenital glaucoma (PCG) is the most common reason for raised intraocular 
pressure in child. It occurs in 1:10000 births and more commonly in boys. 75% of the cases 
are bilateral. Although autosomal recessive cases have been described, most cases of PCG 
are sporadic. Glaucoma develops due to the anomalous development of the anterior 
chamber angle. Raised intraocular pressure, cloudy cornea, large appearance of the eye 
(buphthalmos), optic nerve alterations due to high intraocular pressure and special bio-
microscopic signs are diagnostic features of PCG.  
 
Fig. 4. Buphthalmos in PCG  
PCG has 3 subtypes; true, infantile and juvenile PCG. Intraocular pressure is elevated 
during intrauterine life in true PCG, whereas the disease started before 3 years of age in 
infantile PCG. Infantile cases are the most frequently encountered ones. Treatment is 
surgical in all cases of PCG. Medications may also be used concomitant with the surgery. 
The initial evaluation must be performed under general anaesthesia. Enlargement of the eye 
in pediatric age group should be referred to an ophthalmologist (Idrees, 2006).   
9. Pediatric eye examination 
There is no consensus on when the initial eye examination in a healthy child should be 
performed and how often the examinations should be repeated in the presence of normal 
eyes. Premature infants at risk of retinopathy of prematurity must be screened by an 
ophthalmologist. Many congenital ocular abnormalities may be diagnosed by simple 
observation by a pediatrician, if they are aware of the possible congenital ocular diseases.  
In developed countries, the initial eye examination by an ophthalmologist is commonly 
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of the infant can be checked. An infant should be able to fix and follow faces within 2-3 
weeks of age (Allen, 2000). The ability of the young children to fixate and follow a small 
target is an important gross evaluation of vision. Consistent objection from the child to 
having one eye occluded suggests that the un-occluded eye is amblyopic. Refraction 
examination and the red reflex test should be performed. The red reflex test is a screening 
test for retinal abnormalities and opacities in the visual axis such as congenital cataract and 
corneal opacities. It is performed by focusing an ophthalmoscope light from 30 cm away 
from the child’s eyes. If the red reflex of the 2 eyes is symmetrical, the test is normal. Dark 
spots in the red reflex or leukocoria (white reflex instead of red reflex) are indications for 
referral to an ophthalmologist.  
Special tests to confirm that, an infant sees, may be performed. Optokinetic drum test and 
the spinning test are the most popular simple methods to confirm visual response in an 
infant. Forced choice preferential looking is a popular way of quantifying infant vision. 
Portable cards; namely Teller or Keeler cards are used to quantify infant vision. Optotype 
tests to quantify visual acuity may be used in children between 1-3 years of age. Cardiff 
acuity cards at 1-2 years of age and Sheridan Gardner optotypes at 2-3 years of age are the 
most commonly preferred ones. In children over 3 years of age, Snellen acuity charts may be 
used. Eye movements and the position of the eyes should be simply observed. Hirschberg 
test, which is a light reflex test, is used to exclude manifest eye deviations. If an infant with 
manifest deviation fixates the penlight, the corneal reflex will be eccentric in the deviating 
eye. The reflex will be displaced nasally in the exotropia, and temporally in the esotropia.  
Pupils are smaller and poorly reacting in the newborns. Normal pupillary reactions should 
be documented by 3 months of age. Iris colour is permanent at 1 year of age. Colour vision 
assessment can be performed by the Hardy-Rand- Rittler plates in children as young as 3 
years of age (Mollon et al., 1991). If the child cannot tolerate ophthalmic examination and 
detailed examination is indicated, sedation can be required. Routine intraocular pressure 
measurement in cases with congenital glaucoma is an example for such conditions. 
Eye examinations after 3 years of age are more informative and more easily performed. 
Visual acuity assessment and the fundamental parts of eye examinations are similar with the 
adult patients. However, the physicians should keep in mind that, refractive status of the 
eye is very dynamic in preschool and school children, and preschool vision screening is 
recommended for all children.  
10. Refractive disorders 
10.1 Definitions 
Ametropia, which is defined as the presence of any of the refractive disorders, is the most 
commonly diagnosed disorder of the human eye. Ametropia includes the hyperopia, 
myopia and astigmatism. The most common refractive error in the pediatric population is 
myopia. The World Health Organisation estimates refractive disorders to be 2-10% 
worldwide. The prevalence is found to be much higher in the Far East. The prevalence of 
astigmatism of 1 diopter or more is 50% in infancy. The prevalence decreases rapidly during 
the process of emmetropization. Only few children develop astigmatism greater than 1 
diopter by 6 years of age (Maida et al., 2008).  
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10.2 Etiology  
The total refractive power of the human eye is approximately 60 diopters (D). The cornea 
provides two thirds of this total power and the lens provides the remaining 20 D. The 
normal eye creates clear images by focusing the images on the retina. If the un- 
accommodated eye focuses the images behind the retina, hperopia (farsightedness) 
develops. On the other hand myopia (nearsightedness) is the state in which the un-
accommodated eye focuses the images in front of the retina. The hyperopia and myopia may 
be due to altered total refractive power of the eye, but the axial length changes instead of 
that is the most common reason in most of the cases. Reduced axial length results in 
hyerpopia and the reverse in myopia (Riordan-Eva, 2004). 
The parental history of myopia, genetic predisposition and various environmental factors 
are associated with the development of myopia in a child. Familial predisposition also exists 
in hyperopia, which is much less common in the pediatric population. The children can 
tolerate low amounts of hyperopia by accommodation, so most of the low amounts of 
hyperopia are unrecognized in this population. However, higher degrees may result in 
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variations in the curvature of the cornea or lens at different meridians. Most of the 
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Anisometropia should be managed with caution, since it is the most important risk factor 
for amblyopia.  
11. Amblyopia 
11.1 Definition  
A physician must be aware of the definition of amblyopia properly to understand the 
importance of early diagnosis and management of amblyopia. Amblyopia is the 





of the infant can be checked. An infant should be able to fix and follow faces within 2-3 
weeks of age (Allen, 2000). The ability of the young children to fixate and follow a small 
target is an important gross evaluation of vision. Consistent objection from the child to 
having one eye occluded suggests that the un-occluded eye is amblyopic. Refraction 
examination and the red reflex test should be performed. The red reflex test is a screening 
test for retinal abnormalities and opacities in the visual axis such as congenital cataract and 
corneal opacities. It is performed by focusing an ophthalmoscope light from 30 cm away 
from the child’s eyes. If the red reflex of the 2 eyes is symmetrical, the test is normal. Dark 
spots in the red reflex or leukocoria (white reflex instead of red reflex) are indications for 
referral to an ophthalmologist.  
Special tests to confirm that, an infant sees, may be performed. Optokinetic drum test and 
the spinning test are the most popular simple methods to confirm visual response in an 
infant. Forced choice preferential looking is a popular way of quantifying infant vision. 
Portable cards; namely Teller or Keeler cards are used to quantify infant vision. Optotype 
tests to quantify visual acuity may be used in children between 1-3 years of age. Cardiff 
acuity cards at 1-2 years of age and Sheridan Gardner optotypes at 2-3 years of age are the 
most commonly preferred ones. In children over 3 years of age, Snellen acuity charts may be 
used. Eye movements and the position of the eyes should be simply observed. Hirschberg 
test, which is a light reflex test, is used to exclude manifest eye deviations. If an infant with 
manifest deviation fixates the penlight, the corneal reflex will be eccentric in the deviating 
eye. The reflex will be displaced nasally in the exotropia, and temporally in the esotropia.  
Pupils are smaller and poorly reacting in the newborns. Normal pupillary reactions should 
be documented by 3 months of age. Iris colour is permanent at 1 year of age. Colour vision 
assessment can be performed by the Hardy-Rand- Rittler plates in children as young as 3 
years of age (Mollon et al., 1991). If the child cannot tolerate ophthalmic examination and 
detailed examination is indicated, sedation can be required. Routine intraocular pressure 
measurement in cases with congenital glaucoma is an example for such conditions. 
Eye examinations after 3 years of age are more informative and more easily performed. 
Visual acuity assessment and the fundamental parts of eye examinations are similar with the 
adult patients. However, the physicians should keep in mind that, refractive status of the 
eye is very dynamic in preschool and school children, and preschool vision screening is 
recommended for all children.  
10. Refractive disorders 
10.1 Definitions 
Ametropia, which is defined as the presence of any of the refractive disorders, is the most 
commonly diagnosed disorder of the human eye. Ametropia includes the hyperopia, 
myopia and astigmatism. The most common refractive error in the pediatric population is 
myopia. The World Health Organisation estimates refractive disorders to be 2-10% 
worldwide. The prevalence is found to be much higher in the Far East. The prevalence of 
astigmatism of 1 diopter or more is 50% in infancy. The prevalence decreases rapidly during 
the process of emmetropization. Only few children develop astigmatism greater than 1 
diopter by 6 years of age (Maida et al., 2008).  
 
Pediatric Ophthalmology / Eye and Disorders 
 
13 
10.2 Etiology  
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use the lazy eye terminology instead of ambloypia. Due to the suppression of the blurred 
vision from the diseased eye, the risk of development of unilateral amblyopia is much 
higher than the risk of bilateral amblyopia. However, it may also develop bilaterally, if 
severe visual deprivation occurs in both eyes. A same ocular pathology that develops in a 
child may be an important etiology for a severe amblyopia, while the same pathology in the 
elderly decreases the visual acuity, but does not result in an amblyopia. This is very typical 
for the lens pathologies. Congenital cataracts are one of the important etiologies for 
amblyopia, while senile cataracts are the most common treatable cause of vision loss among 
the elderly. Any pathology that results in abnormal visual experience in one or two eyes 
before the critical period of visual development may result in amblyopia. The critical period 
usually ends at 6-8 years of age (Morishita, & Hensch, 2008). The amblyopia is the disease of 
the visual cortex and it only develops in children younger than 6-8 years old. The critical 
period is the time of maximum neurological plasticity of the visual cortex cells. The visual 
acuity and binocular vision improves depending on the visual inputs until the end of the 
critical period. There is no consensus on which visual acuity should be adopted for the 
clinical definition of amblyopia. The cut-off level varies between 20/40 and 20/30 and the 
prevalence also varies accordingly. The prevalence of the disease may be considered 
approximately 2% in the general population (Webber & Wood, 2005).  
11.2 Etiology  
There are many treatable and untreatable causes of amblyopia. The most common etiologies 
are eye deviations and refractive errors. Anisometropia is a significant difference in the 
refractive status between the two eyes. The eye with more hypermetropia or more 
astigmatism is chronically blurred, so the risk of the development of amblyopia is high in 
that eye. Congenital cataracts, retinoblastoma, nystagmus, corneal opacities and any ocular 
media opacities including vitreous hemorrhages may end up with amblyopia, if they occur 
before the critical period of visual development (Carlton & Kaltenthaler, 2011). 
11.3 Management  
The severity of the amblyopia depends on the severity of the blur, the duration of the 
abnormal vision and the age of onset of the visual impairment. The pediatrician plays a 
crucial role in the early diagnosis of possible causes of amblyopia. The major determinants 
of success in amblyopia treatment are early recognition by the pediatrician, early referral to 
the pediatric ophthalmologist and prompt treatment. 
The initial step in the management is the correction of the underlying etiology, if possible. 
Surgical treatment of the strabismus, or the congenital cataract, correction of the refractive 
errors by glasses or contact lenses are the main treatment modalities for the correction of the 
most common causes of amblyopia. In some pathologies, such as nystagmus, 
retinoblastoma, it is not possible to eliminate the underlying cause of blurred vision totally. 
Therefore, the management of amblyopia due to such untreatable diseases is very difficult. 
After the correction of the underlying organic pathology, the most difficult aspect of the 
management starts; the occlusion of the sound eye in most cases or the alternate occlusion if 
the condition is bilateral. The aim of the patching the diseased eye is to improve the visual 
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cortex which receives the inputs from the bad eye. This is possible if the neurological 
plasticity of the visual cortex remains. The best outcomes are achieved if the management 
starts before 5 years of age, but the patching may be tried up to 22 years of age (Matta et al., 
2010). If children cannot tolerate patching, the penalization, which is the impairment of 
vision in the sound eye by eye drops, can be preferred. There is no consensus on the 
duration of patching per day and the total duration of the treatment. However, it is known 
that, it is long treatment frequently lasting more than years. Well cooperation with the 
parents is crucial to obtain successful outcomes. It is commonly accepted that amblyopia 
cannot be treated beyond a certain age. However, some trials to manage amblyopia in adults 
gave promising results. Perceptual visual learning and levodepo are the possible new 
treatment modalities for amblyopia in the elderly. These may also be tried in elder children, 
if conventional treatments fail (Astle et al., 2011). 
12. Pediatric eye deviations 
Under normal physiological conditions, the image of an object falls simultaneously on the 
fovea of each. This is possible if the eyes are properly aligned. This straight position of the 
eyes is called orthophoria. Any misalignment of the either eye is called strabismus or eye 
deviation in other words. There are 2 benefits of treating strabismus. The initial one is 
functional gain including the improvement of visual acuity and stereopsis. The second one 
is the cosmetic improvement. 
12.1 Types of eye deviations  
Tropia defines manifest deviation of eyes and phoria implies latent deviation. Phoria is 
detected by the simple cover-uncover test. The test is performed while the patient fixates a 
distant object. The physician covers one eye for 2-3 seconds and then the other eye. If 
orthophoria is present, no movement is detected. If latent deviation exists movement of eyes 
towards the opposite of the deviation is observed. For example in a patient with inward 
latent deviation, the uncovered eye move from inwards to outwards. Latent deviations may 
become manifest temporarily, when the child is tired or ill. It can also become permanently 
manifest during the follow-up.  
Horizontal deviations are the most commonly observed types of strabismus. Esotropia is the 
manifest inward deviation of eyes, while esophoria is the latent inward deviation of eyes. 
Exotropia is the manifest outward deviation of eyes, while exophoria is the latent outward 
deviation of eyes. Esotropia is by far the most common form of strabismus. Infantile 
esotropia constitutes almost half of all cases of esotropia. Infantile esotropia is the inward 
deviation of eyes, which is diagnosed at 6 months of age. The angle of deviation is usually 
large and surgery is usually indicated. Pseudo-strabismus is the illusion of deviation in a 
child with orthophoria. It is most commonly in the form of pseudo-esotropia. The most 
common reason for this false appearance of inward deviation is broad nasal bridge with 
prominent epicanthal folds. This appearance usually resolves spontaneously and requires 
no treatment (Fredrick, & Asbury, 2004).  
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The most common one is the sixth cranial nerve palsy (abducens palsy), which is 
characterized by loss of abduction. Cranial imaging must be ordered in all forms of acquired 
paralytic strabismus to exclude cranial masses (Harley, 1980).  
The angle of deviation in eyes with all types of deviations is measured objectively by using 
special prisms. The prism cover test is preferred if the child cooperates. In severe amblyopia 
and in very young children prism reflex test (Krimsky test) is performed. The patient fixates 
a light and the prism is placed in front of the deviating or bad eye to center the corneal 
reflex.  
12.2 Management 
Associated amblyopia and refractive errors must be addressed initially in all cases of 
strabismus. Abnormal eye movements are frequently associated with pediatric eye 
deviations and they can influence the management of the cases. Accommodative types of 
esotropias may be completely cured with spectacles. Surgical correction is decided 
according to the angle of deviation, if the deviation is not corrected by the spectacles during 
follow-up. All types of strabismus must be referred to an ophthalmologist, since early 
treatment by spectacles or surgery is important for normal binocular visual development. 
13. Common eyelid and orbital diseases in children 
The most important issue in pediatric eyelid disorders is to identify whether the lesions 
affect the visual development or not. If it occludes the visual axis, the pathology must be 
treated promptly to prevent the development of amblyopia. Entropion, ectropion, 
distichiasis, epicanthal folds, and telecanthus (increased distance between the medial 
canthus of each eye) are common congenital anomalies of the eyelids. Although they are 
solely cosmetic problems in most cases, they may result in corneal changes secondary to 
corneal irritation and exposure due to mal-position of the eyelids. 
Congenital ptosis is the most important disease of the eyelids in a child. It is usually 
unilateral and occurs sporadically in most cases. The underlying pathology is the dysplasia 
of the levator palpebralis muscle. Surgical correction during the preschool years must be 
performed. If the disease is severe, early surgery to prevent amblyopia may be performed. 
 
Fig. 5. Stye at lower eyelid 
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Chalazion (Chronic inflammation of the meibomian glands), blepharitis (effects base of the 
eyelashes) and acute infection of the eye lash follicle (stye) are very frequent infections of the 
eyelids in children. The infections are mostly innocent and respond well to conservative 
therapies (Hughes, 2000). 
13.1 Orbital infections 
The bacterial infections of the soft tissue anterior or posterior to the orbital septum are the 
most common diseases of the orbit in the pediatric age group. The infections occur in two 
clinical forms; preseptal cellulitis or orbital cellulitis. Orbital cellulitis is the most common 
cause of protrusion of the eyeball in children. It is a life-threatening disease of the tissues 
behind the orbital septum. On the other hand, preseptal cellulits involves tissues anterior to 
the orbital septum. Preseptal cellulitis usually responds to ampiric antibiotic treatment, 
whereas orbital cellulitis may be associated with serious complications requiring longer 
periods of treatment and surgical interventions (Kanski, 2011).  
Protrusion of the eyeball, limitations of the eye movements and decreased visual acuity are 
signs of orbital cellulitis. Skin trauma, sinusitis, lacrimal sac infections and rarely remote 
infections may be the source of preseptal or orbital cellulitis. Preseptal cellulitis rarely 
progresses to orbital cellulitis.  
 
Fig. 6. Left orbital cellulitis  
Subperiosteal and orbital abscesses, intracranial complications (meningitis, brain abscess) 
and ocular complications such as optic neuropathy and endophthalmitis may complicate 
orbital cellulitis. Hospitalization and aggressive medical treatment to prevent life-
threatening complications is indicated in orbital cellulitis (Sullivan, 2004). Any painful 
periorbital edema or pain associated with eye movements should raise the suspicion of 
serious orbital cellulitis and referral to an ophthalmologist is indicated.  
14. Conjunctival diseases in children 
14.1 Ophthalmia neonatarum 
Ophthalmia neonataurum means, conjunctivitis occurring in the first month of life. It is still 
a significant cause of blindness in underdeveloped countries. It can be bacterial, viral and 
chemical. The most serious form is caused by Neisseria gonorrhoeae. Onset is typically within 
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ceftriaxone and topical penicillin as well. Infection with herpes is rarer but requires prompt 
therapy with acyclovir. Chemical cases are caused by silver nitrate and occur within 24 
hours life. Tetracyclin, erythromyicin ointments or povidone-ioidine drops can be used for 
prophylaxis.  
14.1.1 Conjunctivitis 
Conjunctivitis in children is one of the most common reasons to visit a pediatrician. Majority 
of these infections are self-limited and does not require therapy. This section covers a variety 
of infectious conjunctival diseases that might be confronted in routine pediatrics practice.  
Red eye is one of the most important ophthalmological emergencies. There are several 
causes such as conjunctivitis, keratitis, uveitis etc. Fortunately, majority of the red eye occurs 
due to conjunctivitis. The underlying etiology is almost always bacterial in children. 
However, it can be viral or allergic. During examination there are some key points that will 
help to differentiate the etiology: 
Symptoms: Allergic cases will always have prominent itching. Bacterial cases will always 
have discharge.  
Presence and nature of discharge: Bacterial infections will have a purulent, yellow-green 
discharge. Viral cases will have a serous or mucoid discharge. Allergic cases will have 
serous discharge with excessive tearing. 
Laterality: Bacterial cases can be either unilateral or bilateral. Viral and allergic conjunctivitis 
occur almost always bilateral. 
Cul-de-sac: Always pull the lower eyelid away from the globe to examine the cul-de-sac. 
Bacterial conjunctivitis will have tarsal papillae. Viral and allergic conjunctivitis will have 
tarsal follicles.  
Systemic associations: Viral conjunctivitis might be associated with upper respiratory 
infections. Allergic conjunctivitis might be seen with upper respiratory allergic symptoms. 
First-line therapy for bacterial conjunctivitis is topical flouroquinolone. In many cases 
polysporin, erythromycin or trimethoprim/sulfa is effective. Viral conjunctivitis is self-
limited. For allergic cases topical antihistaminic drops are effective.  
15. Corneal diseases in children 
The cornea is the anterior transparent, avascular anatomical structure of the human eye. It 
constitutes 2/3 of the total refractive capacity. There are many congenital and acquired 
corneal diseases, which may lead to blindness if left untreated. Corneal dystrophies, 
congenital anomalies, corneal ectasias, metabolic keratopathies and infectious diseases are 
the main corneal diseases that may be diagnosed in a child. Most of the corneal pathologies 
disturb the transparency of the organ and should be referred to an ophthalmologist 
immediately. Microcornea, megalocornea, anophthalmos and microphthalmos are rare 
congenital anomalies that affect cornea. Microphthalmos is defined as the developmental 
arrest of all ocular structures, while anophthalmos is the complete failure of the eye 
development. 
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Corneal involvement (corneal edema, infiltrations or erosions) may be seen in cystinosis, 
mucopolysaccharidoses, Wilson disease, Fabry disease and tyrosinaemia type 2. The 
treatment of the systemic disease is the mainstay treatment of these metabolic keratopathies. 
Corneal dystrophies and corneal ectasias are frequently diagnosed during puberty or later. 
They are structural diseases of the cornea and mostly genetically determined, but the clinical 
picture rarely occurs in childhood. Keratoconus is the most common corneal ectasia of the 
human eye. It is typically diagnosed during puberty with unilateral impairment of vision. 
Corneal thinning and irregular astigmatism are the main features of the keratoconus. Hard 
contact lenses and corneal transplantation are treatment options based on the severity of the 
disease (Ciralsky & Colby, 2007).  
15.1 Keratitis 
Staphylococcus aeurus, staphylococcus epidermidis, and streptococcus pneumonia are the 
most common organisms that cause infectious keratitis. Bacterial keratitis usually occurs in 
patients with damaged corneal epithelial integrity. However, Neisseria gonorrhoeae, 
Corynebacterium diphteriae, Listeria and Haemophilus species may lead to keratitis in the 
presence of intact epithelium. Bacterial keratitis is characterized by oval shaped corneal 
infiltrations surrounded by corneal edema, conjunctival hyperemia (injection), ocular pain 
and photophobia.  
 
Fig. 7. Gonococcal keratoconjunctivitis 
Pseudomonas aeruginosa keratitis tend be very severe and typically produces stromal 
necrosis with a shaggy surface and adherent mucopurulent exudates. It is an infection 
usually seen in contact lens users with a damaged corneal epithelial surface. The infection 
may progress rapidly ending with corneal perforation. In the management of keratitis, 
ampiric broad-spectrum therapy is recommended until the offending microorganism is 
identified in the culture. If the type of bacteria is identified from the stained diagnostic 
smear, then appropriate single drug therapy may be considered.  
Herpes simplex virus (HSV) infection is more commonly acquired in adolescence than in 
childhood. It can be transmitted to neonates as they pass through the birth canal of a mother 
with genital infection that can lead to serious systemic disorders in the newborns. Primary 
ocular HSV infection is a form of HSV infection that typically manifests in children aged 
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as cutaneous or eyelid marginal vesicles, or ulcers on the bulbar conjunctiva that can be 
rarely accompanied by dendritic epithelial keratitis. Primary ocular HSV infection is a self 
limited disease that usually resolves spontaneously. Oral antiviral therapy can speed up the 
resolution. 
Dendritic ulcers, stromal necrotizing keratitis and disciform keratitis are forms of recurrent 
ocular infection of HSV. These may also occur in this age group. Topical and oral antiviral 
therapy can be used in the management of recurrent HSV keratitis. 
Adenoviruses are the most common viral pathogens that may cause viral keratitis in a child. 
Pharyngoconjunctival fever (PCF) and epidemic keratoconjunctivitis (EPC) are 2 different 
clinical pictures that are caused by different serotypes of adenoviruses. PCF is caused by 
types 3, 4 and 7, while EPC is caused by types 8, 19 and 37. Corneal involvement is much 
more common and severe in EPC. Keratitis may persist for years in some cases. PCF is the 
less severe form of the disease. Keratitis is usually mild and self limiting. Mild to moderate 
fever may accompany PCF. The management of adenoviral keratitis is usually conservative. 
Topical steroids and cyclosporine may be tried to reduce inflammation. Reduction of 
transmission risk by avoiding contact with infected patients during the initial 7-10 days of 
the active disease and by good hygiene is much more important than its management. 
Ophthalmologists are well experienced about EKC, because unfortunately the eye clinics are 
usually the most common places to come in contact with the adenovirus and many 
ophthalmologists are infected once or more with adenoviruses. Many outbreaks occur due 
to improperly disinfected diagnostic instruments (Kanski, 2011).  
15.2 Allergic diseases affecting the cornea 
Vernal keratoconjunctivitis is an allergic eye disease that is mainly seen in male children. 
Symptoms include itching, photophobia, and mucoid discharge. Corneal findings consist of 
Horner-Trantas dots (degenerated eosinophils and epithelial cells) in the limbal area, 
punctate epithelial erosions and shield ulcer (an oval noninfectious epithelial ulcer). Corneal 
findings are generally accompanied by conjunctival ones which are hyperemia, conjunctival 
edema (chemosis) and papillary hypertrophy. Topical antihistamines and mast-cell 
stabilizers can be used in the management of vernal conjunctivitis. Severe cases may require 
topical corticosteroid or topical immune-modulating agents such as cyclosporine.  
Atopic keratoconjunctivitis is a rare bilateral allergic eye disease that is most commonly 
diagnosed in young men, but also in children. Clinical picture is similar to vernal 
keratoconjunctivitis, but more severe. The papillary hypertrophy are less developed 
compared to vernal keratoconjunctivitis. The history of allergy such as allergic asthma or 
atopic dermatitis is commonly associated. Keratopathy leading to total corneal 
neovascularization may occur. Management is similar to vernalis keratoconjunctivitis, but 
the disease is less responsive.  
15.3 Reiter syndrome  
It is characterized by the ocular triad (conjunctivitis/ episcleritis, iridocyclitis, or keratitis), 
urethritis and arthritis. It is usually associated with gram-negative bacterial ( Salmonella, 
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Shigella and Yersinia) dysentery. Corneal diseases usually respond to topical corticosteroids 
(Kanski, 2011). 
16. Pediatric uveitis 
The uvea is a pigmented structure that primarily lies between the retina and the sclera and 
constitutes the vascular portion of the eye. It comprises the iris, ciliary body and choroid. 
Uveitis, by strict definition implies an inflammation of the uveal tract. Uveitis is named 
according to the anatomical location of inflammation in the uvea. Anterior uveitis may be 
subdivided into: Iritis and iridocyclitis. Iritis is primarily the inflammation of the iris tissue. 
On the other hand, iridocyclitis involves both the iris and the pars plicata of the ciliary body. 
Intermediate uveitis is defined as inflammation predominantly involving the pars plana, the 
peripheral retina and the vitreous. Posterior uveitis involves the fundus posterior to the 
vitreous base. Panuveitis implies involvement of the entire uveal tract without a 
predominant site of inflammation (Kanski, 2011). 
Pediatric uveitis may be categorized into 4 types of uveitis based on the anatomical location 
of the inflammatory process. These are anterior (non-granulomatous and granulomatous), 
intermediate and posterior uveitis. Etiologic factors associated with these uvetis in children 
are as follows.  
Anterior non-granulomatous uveitis: Idiopathic, HLA-B27 associated, juvenile rheumatoid 
arthritis (JRA), ankylosing spondylitis, Reiter's disease, psoriasis, inflammatory bowel 
disease, nephritis, systemic lupus erythematosus, Herpes Simplex virus (HSV), Lyme 
disease, leukemia, drug-induced.  
Anterior granulomatous uveitis: Sarcoidosis, inflammatory bowel disease, syphilis, Herpes 
simplex virus, tuberculosis, Behcet's disease, multiple sclerosis, fungal disease, Whipple's 
disease, leprosy.  
Intermediate uveitis: JRA, Pars Planitis, Multiple Sclerosis, Lyme disease, Sarcoidosis.  
Posterior Uveitis: Toxocariasis, Toxoplasmosis, Leukemia, Tuberculosis, Intraocular Foreign 
Body, Vogt-Koyanagi Harada Syndrome (VKH), Cytomegalovirus, HSV/VZV, inflammatory 
bowel disease, syphilis, Behcet's disease, systemic lupus erythematosus, Kawasaki's disease, 
sarcoidosis, polyarteritis nodosa, Wegener's granulomatosis (Kanski, 2011).  
Anterior uveitis is the most common form of uveitis. Features are typically with sudden 
onset of unilateral pain, photophobia and redness, which may be associated with 
lacrimation. Occasionally patients may notice mild ocular discomfort a few days before the 
acute attack when clinical signs are absent. Visual acuity is usually good. The presence of 
vitreal cells in an active vitritis are the main signs of pars planitis. Posterior uveitis 
encompasses retinitis, choroiditis and retinal vasculitis. Some lesions may originate 
primarily in the retina or choroid but often there is involvement of both (Sauberan, 2010).  
Special investigations such as skin tests, serology and radiology are indicated in posterior 
uveitis, granulomatous inflammation, recurrent uveitis and bilateral uveitis.  
Treatment of the majority of uveitis involves predominantly the use of anti-inflammatory 
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necessary. Topical steroids are the mainstay treatment for anterior uveitis, while systemic 
steroids are indicated in most cases of intermediate and posterior uveitis. If the disease is 
unresponsive to systemic steroids and/or the patient cannot tolerate systemic steroids, other 
immunosuppressive agents including azathioprine, methotrexate and ciclosporin may be 
used (Jancevski ,2010).  
17. Retinal detachment in children 
Retinal detachment is not common in infants and children. While the incidence of retinal 
detachment is 12 in 100000 in all age groups, only between 1.7% and 5.7% are diagnosed 
during childhood. The association of retinal detachment with complex intraocular 
pathologies in young children often presents a challenge to treatment. 
There are 3 types of retinal detachment: Rhegmatogenous retinal detachment develops 
when there is a hole or tear in the retina, which transmits intraocular fluid underneath the 
retina and subsequent separation of the retina from the underlying pigment epithelium 
occurs. The second most common form is tractional, where the retina is pulled away from 
the underlying tissues. Exudative detachment develops when subretinal fluid accumulates 
under the retina such as in Coat’s disease or vasoproliferative disorders (Yokoyama et al., 
2004).  
17.1 Clinic and diagnosis 
Symptoms of retinal detachment are sudden onset of floaters, light flashes, appearance of 
black veil and loss of visual acuity. It is important to recognize that most of the small 
children cannot express loss of visual acuity and often vision may already be low due to 
concomitant ocular pathologies. Therefore the delay in diagnosis is more common in the 
pediatric retinal detachments compared to that in the adult retinal detachments. In a 
significant proportion of the patients, the diagnosis is made by chance during a routine eye 
examination or by noticing leukocoria. It is important to realize that retinal detachment in 
children may occur in both eyes frequently.  
17.2 Etiology 
Trauma has been reported to be the cause in 27–51% of cases of childhood retinal 
detachment. Ocular trauma is an important cause of retinal abnormalities in children and it 
is more common in boys. Retinal dialyses may be found in the superonasal or 
inferotemporal quadrant. Traumatic retinal detachment is seen most commonly in older 
children and is usually caused by blunt trauma (Sarrazin et al., 2004). The second frequent 
etiological factor is high myopia in children and if it is congenital may indicate an 
underlying abnormality. Retinal detachment may also result from intraocular infection or 
inflammation. The existence of systemic or hereditary diseases such as Trisomy 13 (Patau 
syndrome), Walker Warburg syndrome, Meckel syndrome, Norrie disease and incontinentia 
pigmenti should be investigated in retinal detachments of early childhood (0-1 year). In such 
cases, central nervous system imaging and detailed neurological examination should be 
requested. Also it is important to rule out retinoblastoma. Some of these children do not live 
very long due to these systemic or hereditary diseases. Retinal detachment in infants and 
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children should lead the physician to suspect a systemic disease, a syndrome, trauma, or a 
tumor in the eye. That should be ruled out with ultrasound or CT scan. Other causes of 
congenital or infantile retinal detachment should also be considered, including Stickler’s 
syndrome, retinopathy of prematurity, persistent hyperplastic primary vitreous (PHPV), 
also called persistent fetal vasculature (PFV), may also present with a retinal detachment at 
birth; however, the associated microphthalmos and cataract often makes the diagnosis 
easier. Stickler’s syndrome combines ocular, orthopedic and midfacial anomalies in an 
autosomal dominant inheritance pattern. Ocular abnormalities include high myopia, empty 
vitreous with membranes and bands.  
17.3 Management 
Prediction, prophylaxis and timely surgical treatment of retinal detachment may prevent 
visual loss. Retinal detachment in childhood and adolescence is different from adult cases 
due to higher rate of complicating predisposing factors such as trauma and high myopia 
and also due to the delay in the diagnosis that is mostly made after macular involvement. By 
appropriate surgical treatment the anatomic success rate may be as high as adult cases, 
however lower functional results are usually achieved because of higher rate of macular 
involvement (Butler et al., 2001; Topbas et al., 2003). It is important for the pediatrician to 
refer the children with signs and symptoms of retinal detachment, children with systemic 
disorders associated with retinal detachment and also children with ocular trauma history 
to an ophthalmologist. 
18. Retinoblastoma 
Retinoblastoma (RB) is the most common intraocular malignancy of the childhood, 
occurring in about in 1/15.000 to 20.000 live births. The tumor develops from the immature 
retina. 
18.1 Inheritance  
RB occurs in hereditary and nonhereditary forms. It can be unilateral or bilateral. The 
hereditary form is usually bilateral and multifocal, whereas the nonhereditary form is 
unilateral and unifocal. The RB gene is recognized to be a recessive suppresser gene located 
on chromosome 13 at the 13q14 segment and some affected children have other systemic 
features of the 13 q deletion syndrome. It is accepted that all bilateral and familial cases of 
RB will manifest a germline mutation, whereas only 10–15% of unilateral sporadic cases will 
show germline mutation (Shields, 2006). 
18.2 Symptoms and diagnosis 
RB usually diagnosed between 3 months and 3 years of age, but it can be congenital or it can 
occur in older children. The affected child usually presents with leukocoria and/or 
strabismus. More advanced tumors can cause painful secondary glaucoma or signs of orbital 
cellulitis. The diagnosis of RB is best made by slit lamp bio-microscopy and indirect 
ophthalmoscopy. Ancillary studies are ultrasonography and computed tomography. The 
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ophthalmoscopy. Ancillary studies are ultrasonography and computed tomography. The 






Fig. 8. Leukocoria due to RB 
18.3 Metastatic spread and second primary malignancies  
Metastatic spread is to regional nodes, lung, brain and bone. Second non-ocular cancers are 
leading cause of death in patients with the familial form of RB. Most common second 
tumors are soft tissue sarcoma, osteogenic sarcoma of the skull or the long bones, primitive 
neuroectodermal brain tumor and cutaneous melanoma. Trilateral RB refers to bilateral 
retinoblastoma associated with an intracranial primitive neuroectodermal tumor in the 
pineal or supraseller region (Murphree, 2006). 
18.4 Current management of RB  
Goals of treatment from most to least important ranking are: saving life, maintaining the eye 
and vision, and preserving cosmetic appearance. RB treatment typically requires the 
cooperation of an ophthalmic oncologist, pediatric oncologist and radiation therapist. 
Treatment varies depending on the number, size, and location of the tumors. Protocols are 
currently being evaluated to use chemoreduction therapy to shrink the RB in order to treat 
them with thermotherapy, laser therapy, cryotherapy, and local episcleral plaque radiation. 
More advanced tumors are managed by enucleation. External beam radiotherapy is 
typically reserved for eyes that fail the above methods, especially if retinoblastoma is 
bilateral. Lifelong monitoring is important to diagnose second primary tumor in the healthy 
eye as early as possible (Valenzuela, 2011). 
19. Systemic disease and eye in children 
19.1 Intrauterine infections 
Congenital toxoplasmosis, cytomegalovirus, herpes simplex, lymphocytic choriomeningitis 
virus, varicella–zoster virus, West Nile virus infections are main intrauterine infections that 
may result in ocular pathologies. The principal ophthalmic manifestations are chorioretinal 
scar or an active chorioretinitis, and congenital cataract. When they are present in congenital 
toxoplasmosis, herpes simplex, and cytomegalovirus, they are associated with extensive eye 
involvement (Mets, MB. & Kumar, 2006). 
19.2 Metabolic disease 
Disorders of copper metabolism: Wilson’s disease. The principal ophthalmic manifestations 
are Kayser-Fleischer ring, due to copper deposition in Descemet’s membrane and sun-
flower cataract. 
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The mucopolysaaharidoses (Hurler syndrome, Schie syndrome, Hunter’s syndrome, 
Sanfippo’s syndrome): The principal ophthalmic manifestations are progressive corneal 
clouding, pigmentary retinal degeneration, optic atrophy, sometimes papilloedema and in 
certain cases glaucoma. 
The gangliosidoses: Defects in lysosomal degradation of gangliosides can result in abnormal 
accumulation of these lipids. (Infantile, late infantile/Juvenile GM, Tay-Sachs disease) The 
principal ophthalmic manifestations are macular cherry red spot, tortiosity of retinal vessels, 
retinal hemorrhages and optic atrophy. Strabismus, nystagmus and mild corneal cloudy can 
be seen.  
Niemann-Pick disease: The principal ophthalmic manifestations are macular cherry red 
spot, mild corneal haze and fine lens opacities. 
Gaucher’s disease: The principal ophthalmic manifestations are ocular lesions resembling 
pinguecula, paralytic strabismus and corneal opacities 
Albinism: Genetic disorders of melanin synthesis. The principal ophthalmic manifestations 
are retinal hypopigmentation, foveal hypoplasia, misrouting of optic nerve fibers at the 
chiasm with altered visual function, iris hypopigmentation, photophobia, nystagmus, 
strabismus and high refractive errors. 
Galactosemia: The principal ophthalmic manifestation is cataract (Martyn, 2006). 
19.3 Connective tissue disorders 
Angioid streaks (blood vessel-like) and visual loss may occur in pseudoxantoma elasticum 
 
Fig. 9. Blue sclera in a case of EDS 
Stretchable lids, retinal detachment and blue sclera have been reported in Ehler Danlos 
syndrome (EDS). Subluxation of crystalline lens, strabismus and retinal detachment may be 
seen in Marfan syndrome (Traboulski, 2006) 
20. Ocular trauma in children 
Ocular traumas in childhood are frequent and major causes of visual impairment, especially 
of unilateral non-congenital blindness in this age group. The frequency of eye traumas is 
almost double in boys especially in older age groups. This may be due to boys being more 
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Evaluation starts with a detailed history of the trauma, from the child if possible and also 
from the parents. Examination of the traumatized eye may be difficult in children. It is 
important to be patient and gentle. A mild sedative may sometimes be helpful. Visual 
function should be estimated in the beginning of the examination. Literate or illiterate 
Snellen charts may be used if possible. Otherwise reading any material or finger counting  
may help to determine the approximate level of visual acuity. Afterwards lids, conjunctivas 
and orbit are examined externally to reveal any lid lacerations or orbital rim fractures. The 
globe is examined carefully and gently. Irregular pupils, edema of the conjunctiva and blood 
in the anterior chamber and in the vitreous cavity are signs of severe ocular injury. 
20.2 Common eye injuries and management 
An external examination should be performed to look for eyelid lacerations which are seen 
as distortion of eyelids. A good functional and cosmetic result may only be obtained by 
appropriate suturing technique. Lacerations of the medial part of the lower lid may include 
lacrimal canaliculi. Tear drainage may be impaired leading to watering of the eye if not 
repaired properly. 
Blunt ocular trauma may lead to traumatic hyphema, ruptured globe, retinal dialysis, retinal 
tears, macular hole and commosio retina. Hyphema is the collection of blood in the anterior 
chamber due to rupture of an iris or ciliary body vessel. Hyphema may be noticed as a red 
collection in the lower part of the anterior chamber or may fill the anterior chamber totally. 
Treatment includes bed rest, elevation of the head for approximately 45 degrees, cycloplegic 
and steroid eye drops. Blunt trauma may also rupture the eyeball. Conjunctival edema, soft 
eye and deep anterior chamber are signs of a posteriorly ruptured eye. Retinal tears and 
dialysis are severe consequences of blunt trauma which may lead to retinal detachment and 
therefore a detailed fundus examination is mandatory. Subretinal and intraocular 
hemorrhages may be highly associated with the shaken baby syndrome. Diffuse 
involvement of fundus with intravitreal and large subhyaloid hemorrhage are associated 
with more severe neurological injuries (MacEwen et al., 1999).  
Corneal injuries may be in a spectrum from minor abrasions to serious penetrating wounds 
extending to the sclera. Abrasions are common and present with foreign body sensation, 
lacrimation and photophobia. It is important to look for a foreign body, which may be 
embedded at the upper tarsal conjunctiva, by everting the upper lid. Abrasions are treated 
by topical antibiotics and patching the eye. Irregular pupil due to iris prolapsus from the 
wound is a general finding of the penetrating injuries. If such an open globe injury is 
suspected, extreme care should be taken not to exert pressure to the globe and an eye shield 
should be placed over the eye. Systemic antibiotics, pain relievers and tetanus prophylaxis 
should be taken into consideration. 
Chemical injuries may give damage to the eyelids, cornea and conjunctiva. Burns that 
penetrate deeper than the cornea are more serious and may lead to cataracts and glaucoma. 
Chemical injuries in children mostly occur at home from cleaning products or other regular 
household products. These injuries are dangerous and the treatment must be started    
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immediately by irrigation with copious amounts of water as soon as possible. The type of 
injury, severity and the initial visual acuity are important prognostic factors for the final 
visual outcome. The visual prognosis is better if immediate diagnosis and treatment is 
provided and therefore it is important for the general physicians to recognize the severity of 
the trauma, provide suitable medical management and refer to the ophthalmologist as soon 
as possible (Moreira et al., 1988; Serrano et al., 2003).  
20.3 Prevention of eye injuries 
Most eye injuries can be avoided by simple measures, but still many children face serious 
visual impairment due to trauma. Most of the eye injuries occur at homes, in streets and 
roads, in schools and in other child care facilities. Adult supervision is an important factor  
for the prevention especially for the younger age groups. More than half of the injuries are 
without adult supervision at the time of event. Trauma is one of the most important 
preventable causes of blindness in children. Important points in prevention include parental 
supervision, education of children and protective eye-wears when necessary. Protective eye 
wears such as polycarbonate goggles should especially be recommended to functionally one 
eyed children (Mulvihill et al., 1997).  
Recognition of eye injuries, taking immediate measures and referral to an ophthalmologist 
are key components in the management of eye injuries for general practitioners. 
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1. Introduction 
Cryptorchidism or undescended testis (UDT) is the most common genital abnormality seen 
at term in boys (Meij-de Vries A et al 2010, Topari & Kalieva 1999 ). Traditionally  UDT was 
thought to be a congenital disease, with a prevalence of about 0.8-1% by 1 year of age 
(Berkowitz G Set al 1993). The term acquired UDT was introduced the last few decades, after 
well documented clinical observations in individuals and groups of patients that many boys 
continue to be diagnosed and treated later in childhood (Myers NA & Officer CB 1975, 
Atwell JD 1985, Clarnette TD et al 1977, Schiffer KA et al 1987, Robertson JF & Azmy AF 
1988, Wright JE 1989, Fenton EJM et al 1990,Mayr J et al 1995) despite the recommendations 
for early surgical treatment by orchidopexy (Ritzén M et al 2007). Today, acquired UDT is a 
recognized separate entity, and after a new clinical classification in 2003, UDT is categorized 
into two forms:  congenital UDT  and acquired UDT (Hack WW  et al 2003a). 
Although the pathogenesis of congenital UDT is considered multifactorial including 
hormonal, genetic, and environmental influences (Ghacko JK & Barthold JS 2009, Barthold JS 
2008 ), the exact etiology of acquired UDT remains unclear  (Meijer RW 2004). Furthermore, 
while surgical treatment is recommended for congenital UDT patients as young as 6 months 
(Ritzén M, 2007), to reduce the increased risks of progressive infertility, testicular 
malignancy, torsion, associated inguinal hernia, and because of cosmetic and psychological 
aspects (Ashley RA et al 2010, Lamah M et al 2001) there is much controversy in the 
management of acquired UDT (Hack WW  et al 2010).  
In this article, we present the current data of the literature of this distinct entity in a concise 
but comprehensive review.  
2. Patients and methods  
A systematic review of the literature was performed focusing on the diverse aspects of the 
epidemiology, pathogenesis, diagnosis and management of acquired UDT.  Data were 
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extracted from Medline database form inception to October 2011. A UDT was defined as a 
non-palpable testis inside the scrotum and for which further traction on cord traction was 
painful (Meij-de Vries A et al 2010). A congenital UDT was defined as a testis which had not 
previously descended (Meij-de Vries A et al 2010, Hack WW et al 2003b), whereas an 
acquired UDT was defined as an UDT in which a previous scrotal position was documented 
on at least one occasion (Barthold JS & González R 2003). This does not include testes 
identified as being cryptorchid after inguinal surgery. 
3. Epidemiology 
Although the incidence of congenital UDT in full term males remains constant in the last 
few decades (Barthold JS & González R  2003), the true incidence of acquired UDT remains 
unknown, because of the lack of studies documenting the prevalence of this condition (Hack 
et al 2010) First Villumsen  et al (Villumsen AL & Zachau-Christianssen B 1966) in 1966, 
reported that 69/4300 boys, (84 testes), had 2%, either unilateral or bilateral ascending testes 
from a normal position at birth to a higher position by the age of 3 years. In 1975, Myers et al 
(Myers NA & Officer CB 1975) reported a study of two families in whom all nine boys had 
normal descended testes documented as infants, but four in one family and three in the 
other required surgery for UDT before their teenage years. Wyllie in 1984, (Willye GG 1984) 
reported a study of 100 boys with retractile testes in whom 42% had testes at a higher level 
after a 5-year observation. Atwell in his paper, (Atwell JD 1985) reported an incidence of 1% 
acquired UDTs of all orhiopexies undertaken in his unit. In a study from Oxford (John 
Radcliffe Hospital Cryptorchidism Study Group 1986)) was found that 40% of boys whose 
testicles had not descent at birth but had done so by 3 months became undescended by the 
age of 1 year. Since then, others have given various  rates, with ascending testes comprise 
16% (Fenton EJM et al 1990), 2.3% (Gracia J et al. 1997), 5% (Eardley I et al 1994), 20% 
(Rabinowitz R & Hulbert WC, Jr 1997 ), and 73% (Hack WW et al 2003b) of all orcidopexies. 
In a cross sectional Dutch study, Hack et al (Hack et al 2007a) found a prevalence of 
acquired UDT up to 2.2% among 6-13 year old boys. Acerini et al (Acerini CL et al 2009), in a 
UK infant cohort study observed a cumulative incidence up to 7% at the age of 24 months  
(0.7%, 4%, 1.3% , and 1% at ages 3 months, 12 months, 18 months , and 24 months 
respectively). More recently, Wohlfahrt-Veje et al (Wohlfahrt-Veje C et al 2009) reported that 
acquired UDTs account for 58% of all cases of cryptorchidism (congenital and acquired) at 
18 months, 71% at 36 months and 69% thereafter. 
Although estimates regarding the true incidence of testicular ascent vary considerably, 
orchidopexy rates and higher than expected mean age of orchidopexy suggest that acquired 
UDT is more common than indicated by the number of detailed case reports. Most authors 
agree that acquired UDTs is a common phenomenon outnumbering congenitalUDTs by a 
factor of two to three (Hack WW et al 2003b, Hack WW et al 2007a) 1, Agarwal PK et al 2006. 
This could mean that the pathogenesis of AUDTs, as in congenital forms, is multifactorial 
also. 
3.1 Pathogenesis   
The pathogenesis of acquired UDT is not fully clarified, since several mechanisms have been 
proposed to elucidate the testicular ascent. Essentially, 4 major theories have been descrived 
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to explain the process of secondary ascent (excluding that for iatrogenic reasons). The first 
theory is based on surgical findings during orchidopexies. Atwell (Atwell JD 1985) noted the 
presence of a persistent processus vaginalis (PV) in 9/10 of his patients. He proposed that 
the acquired malposition of the testis is due to partial absorption of the PV into the parietal 
peritoneum, and this alteration in the distribution of the peritoneal lining of the abdominal 
cavity leads to traction of the spermatic cord and ascent of the testis. Clarnette et al 
(Clarnette et al 1977, Clarnette et al 1997) reported the presence of a fibrous structure 
extending with the cord structures, which on immunohistochemistry showed the 
characteristics of a remnant of the PV. Other studies found the presence of PV or hernia sac 
in 23%-76% of orchiopexies for acquired UDT (Robertson JF & Azmy AF 1988, Wright JE 
1989, Meijer RW 2004, Gracia J et al 1997 , Eardley I  et al 1994, Hack WW 2003b, Redman JF 
2005). Based on these findings, it was suggested that the persistence of a patent PV or its 
remnants is responsible for tethering the testis in a static  position during a period of somatic 
growth. However, recently Meij-De Vries et al (Meij-de Vries A et al 2010), studying the 
perioperative surgical findings in congenital UDTs and acquired UDTs, found that acquired 
UDTs are more likely to have a closed PV, and a normal insertion of the gubernaculum. The 
conflicts seems to be continued, after the current findings of Mirillas et al (Mirilas et al 2010) 
who studied the sonographic pattern of the PV in children with acquired UDTs and found 
that PV is  patent in a manner similar to the inguinal hernia and hydrocele . They suggested 
that a scrotal testis could be retracted through the PV to a higher position with contraction 
of the cremaster muscle. 
The second theory speculates an association between retractile testes and acquired UDTs. 
Agarwal et al (Agarwal PK et al 2006) reported an incidence of 32% of retractile testes which 
became ascending during of about 3-year follow-up period. Willie (Willye GG 1984) 
reported an incidence of 42% of retractile testis to become ascending. Stec et al (Stec AA et al 
1987) noted an incidence of 3.2% (21 of 666 retractile testes) underwent secondary ascent and 
orchidopexy. They stated that the majority of retractile testes resolve without surgical 
intervention. Eardlay et al (Eardley I  et al 1994) found that 27% of ascending testes were 
previously retractile. Smith et al (Smith JA et al 1989) reported  an increased secondary 
ascent of the testes in boys with cerebral palsy, where an increased cremasteric muscle 
hypertonicity is noted. These findings show that about a third of ascended testes may be 
passing through a retractile phase through the transition from the scrotum to an extrascotal 
position (Hack ww et al 2003c). Natural course of acquired undescended testis in boys. Brit J 
Surg, 90, pp.728-31). The following mechanisms have been proposed to clarify the possible 
causes of retractile testes to become ascended: a) Smith et al (Smith JA et al 1989), speculated 
that cremaster muscle spasticity may be a possible cause of acquired UDT in patients with 
cerebral palsy. However, the proposed etiology in otherwise normal boys is not clear 
(Barthold JS & González R. 2003), b) The cremaster muscle is androgen sensitive and 
exhibits decreased activity, resulting in decreased testicular retractility, during periods of 
high androgen production, specifically in infancy and puberty. It has been shown, that 
target disruption of estrogen receptors in mice produces cremasteric hypertrophy and 
testicular retraction (Bartlett JE et al 2008). Theoretically, environmental chemicals that 
influence sex steroid production or action could exaggerate the physiological hyperactivity 
of the cremaster muscle in young boys and increase the risk o testicular ascent (Gray LE & 
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the association between ascent testis and these substances is theoretical, and c)  Robertson et 
al (Robertson JF & Azmy AF 1988) suggested that peri-testicular adhesions might be 
responsible for retaining the retractile testis in an inguinal position but this association has 
not been proved yet.  
A third hypothesis proposed by Rusnack et al (Rusnack SL et al 2002) who found that 
primary undescended testes, ascending testes and the contralateral descended testes share 
the same histopathology concerning the total and differential germ cell counts per tubule. 
These findings suggest that an endocrine defect could be the cause of acquired UDT, since 
no thermal effect can be blamed for the decreased germ cell count in the descent testes. A 
further implication of an endocrine defect in the pathogenesis of acquired UDT is derived 
from recent reports which found an increased risk of AUDTs with proximal hypospadias 
(Tasian GE et al 2010, Itesako T  et al 2011). The authors suggest that the role of prenatal and 
postnatal androgen disruption may link these conditions. 
Finally, the fourth theory speculates the role of genitofemoral nerve (GFN) as a factor in 
testicular ascent. Hutson et al (Hutson JM & Hasthorpe S 2005) found that the GFN acts as 
second messenger for androgen by release calcitonin gene related peptide (CGRP) to control 
descent of the testis. They proposed the following mechanism by which the influence of the 
GFN is implicated: at birth the spermatic cord is 4 to 5 cm in length, but by the 10th year, it is 
8-10 cm. This doubling in length is inhibited if there is a residual fibrous remnant of the PV, 
which may caused by deficient CGRP release from the GFN postnatally. Shono et al (Shono 
T et al 1999) reported that the proximal division of the GFN in neonatal rats causes testicular 
maldescent and may also induce testicular ascent in adulthood. They proposed that some 
intrauterine disorders of the GFN may cause testicular ascent.  
The perception of acquired UDT has not been widely accepted. Rabinowitz et al 
(Rabinowitz R & Hulbert WC, Jr. et al 1997) studied 21 patients (23 undescended testis) and 
found that the gubernaculum attachment in half of the cases was abnormal. They stated that 
“this condition is ought to a missed diagnosis at a younger age. The testis is undescended, 
bur almost completely descended. With somatic growth the distance between the terminal 
portion of the gubernaculum and the scrotum increases, making the diagnosis more 
obvious”. Furthermore, Redman in his paper (Redman JF 2005) challenged the concept of 
acquired UDT, arguing for “abandoning the concept and diagnosis of the ascending testis 
and embracing the phenomenon that the examination of the testis in infants and boys is an 
inexact process”.  
3.2 Natural history 
The assessment  of the natural history of acquired UDT is complicated by the difficulty in 
differentiating between “high retractile” testes and testes that have ascended from a normal 
descended position in the scrotum (Taghizadeh AK & Thomas DF 2008). However, some 
conclusions concerning the natural history are extracted by three long-term prospective 
studies performed by Eisjbouts et al, Sijstermans et al,  and Hack et al. Eisjbouts et al 
(Eijsbouts SW et al 2007) evaluated prospectively 107 patients (132 acquired UDT) with a 
mean age 8.9±2.9 years. The mean follow-up was 4.5 years (range 0.3-12.1 years). The results 
showed that 75/132 (56.8%) testes descended spontaneously at puberty. Orchidopexy was 
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performed in 57/132 (43.2%) testes. They noted that acquired UDT showed an increasing 
chance of descending spontaneously with increasing age, and an appropriate for the age 
testicle volume. Sijsterman et al (Sijsterman K et al 2006) reported that among 129 acquired 
UDTs, (mean follow-up 2.5 years, range: 0.2-8.5 years), 98 (76%) descended spontaneously at 
puberty with appropriate testicular growth; in the remaining 31 (24%) orchidopexy was 
performed at puberty, due to non-descent. Hack et al (Hack WW et al 2010) assessed 
prospectively the natural history and long-term testicular growth of acquired UDT after 
spontaneous descent or pubertal orchidopexy in case of non-descent, in 391 boys with 464 
acquired UDT. At the time of referral the median age was 7.1 years. The mean follow-up 
was 4.7 years (range 0.1-12.0 years). They found that a 77.7% has a tendency of spontaneous 
descent at puberty, and in nearly all cases, after spontaneous descent or after pubertal 
orchidopexy, with long-term testicular volumes appropriate for age. Pubertal surges in 
luteinizing hormone and testosterone, as also is seen in the first 3 months after birth (Hamza 
AF et al 2001) when spontaneous descent of congenital UDT can still occur, are 
hypothesized to be responsible for pubertal spontaneous descent (Sijsterman K et al 2006).   
3.3 Acquired UDT and fertility  
There is limited evidence from the available data of the literature about the impact of 
acquired UDT in the fertility. As mentioned above, biopsies taken from ascending testes 
showed comparable histological findings to biopsies taken from the contra lateral descended 
testes and primary undescended testes (Rusnack SL et al 2002). Gracia et al (Gracia J et al. 
1997) reported an impaired spermatogenic potential in 25/ 35 (71.4%) biopsied ascending 
testes. Meijer et al (Meijer RW et al 2004) reported that 24 / 30 acquired UDTs (80%) were 
small for the children’s age and 1 (3%) was atrophic. These findings imply that acquired 
UDTs might  influence  fertility.  
3.4 Acquired UDT and cancer 
It is generally accepted that UDT is a risk factor for testicular cancer (Pettersson A et al 
2007). Among men who have had UDTs the risk of cancer is increased two to eight times, 
and among all men with testicular cancer have a history of cryptorchidism (Topari J & 
Kalieva M 1999, Dieckemman KP et al 2004). However, orchidopexy does not reduce the 
risk of cancer but renders the retained testis amenable to self-estimation later in adulthood 
(Hack WW et al 2010). It remains unknown whether the risk of malignancy in acquired UDT 
and congenital UDT is the same. Nevertheless, the risk of cancer in acquired UDT might be 
lower than in congenital UDT, since neonatal gonocytes have transformed normally before 
the abnormality develops (Hutson JM &Clarke MC 2007 ). 
4. Diagnosis 
Past history and clinical examination are essential for the correct diagnosis of an acquired 
UDT. Commonly, acquired UDT is seen after the age of 4-5 years ((Myers NA & Officer 
CB 1975), and peaks around age 8 (Wohlfahrt-Veje C et al 2009). Clinically, acquired UDTs 
may be distinguished from retractile testis because they have a smaller size, immediate 
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However, early forms, even in boys less than 1 year, have also been recognized (Hack 
WW 2007b). Wright (Wright JE 1989) proposed the following criteria that have to be 
satisfied for the diagnosis of acquired UDT: a) it must be recorded by an experienced 
observer that the testis once had reached the bottom of the scrotum, b) the same or an 
equally experienced observer must later be unable to manipulate it into the scrotum, and 
the testis must remain above the scrotum when the child squats or sits bolt upright with 
the thighs abducted. c) there must have been no surgery or inflammatory episode to have 
caused the ascent, and d) the testis must remain above the scrotum when the child is 
anesthetized.  
Potential impediments that may interfere in the correct diagnosis an ascending testis 
include: a) obesity, b) a small contracted scrotum, and c) an uncooperative or fretful patient 
(Redman JF 2005). The contractions of the cramasteric muscles, hydroceles, thick walled 
hernia sacs, and long looping vasa are further possible factors to a correct diagnosis 
(Redman JF 2005) 
5. Management  
The proper management of acquired UDT  remains controversial mainly due to a lack of 
longitudinal follow up data ((Hack WW et al 2010). Currently  two main polices have been 
proposed : a) the policy of prompt surgical correction (Taghizadeh AK & Thomas DF 2008, 
Bonney T et al 2008) and b) consrvative policy either of ”wait and see“(Meij-de Vries A et al 
2010) or hormonal treatment (Meijer RW et al 2001). The target of the first policy is to 
achieve normal or at least improved fertility, and to prevent malignancy (Hack WW et al 
2010). However, it is still unknown whether the risks of infertility and cancer migh benefit at 
all from surgery as in congenital UDT (Hack WW et al 2010). In addition, it must be noted 
that there is no evidence that the ascended testis has a higher malignancy rate compared 
with the normal descended testis (Ong C et al 2005). Τhe second policy is based on studies 
which showed a spontaneous descent of acquired UDTs at the beginning of puberty in 57% 
to 77.5% of the cases, with normal testicular growth ( Hack WW et al 2010, Acerini CL et al 
2009). This policy is supported by the following: 1) surgery itself can lead to complications 
such as direct injury to the vas deferens or testicular vessels (Mouriquand PDE 2008), 2) 
Meijer et al (Meijer RW et al 2001) treated successfully  with human chorionic gonadotropin 
(HCG) 14/ 15 acquired UDTs (93.3%) (54). In addition, Hutson et al (Hutson JM & Basley 
SW 1991 ) predicted acquired UDTs to respond well to HCG therapy. These findings 
suggest that surgery should be reserved for those testes which fail to respond to hormonal 
therapy and those with anatomical abnormalities; 3) there is no strong evidence that early 
operation in boys 4-14 years has any effect on subsequent fertility (Chilvers C et al 1986). 
Although these results seem promising of a conservative approach to acquired UDTs, more 
long term follow-up studies are necessary to determine the consequences in fertility 
potential of boys with a history of acquired UDTs.  
6. Conclusions 
This study showed, that there is an ongoing interest for the exact pathogenesis and the 
optimal mode of treatment of acquired UDTs. However, the data are inconclusive, as there 
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are no available studies reaching a worldwide consensus. Large series, randomized-
controlled studies and close follow-up beyond the puberty are recommended to further 
elucidate acquired UDT.  
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1. Introduction 
Christians and no believers perform Circumcision for health and hygienic reasons especially 
in U.S.A. and some countries of the Middle East. It is uncommon in Northern Europe, 
Central and South America and Asia (Leitch, 1970). It is one of the" oldest operations but it 
has not received enough consideration or progress in the Middle East. It is always regarded 
as a minor outpatient procedure often performed by primitive clamps by barbers, Mohels, 
medical students and house officers (Kaplan, 1977).In hospitals, male circumcision is 
performed by junior gynecologists, urologists, or surgeons. The objective of this article is to 
perform a review of the literature regarding the different aspects of male circumcision and 
discussing the following points; history of circumcision, urgent indications of circumcision, 
merits and arguments related to circumcision, religious factors, contraindications of 
circumcision, timing of circumcision, different techniques of circumcision , complications 
after circumcision and relation to STDs or UTI. 
2. History of circumcision 
Circumcision is one of the oldest operation in the history and the first unequivocal 
description of circumcision is found in the forth dynasty Egyptian toombs (3000 BC). 
According to Herodotus, it was practiced at puberty. It is carved on portraits in the Karnak 
temple of Mount Saini Statues of Pharaohs. Its technique is seen in a bas brief on Mastaba of 
Sakkarah in the fifty dynasty (Bistschai& Brodnay, 1956; Arnaout et al., 1962 and Badr, 
1963). Whether it had a religious or hygienic in purpose in Ancient Egypt, it is unknown. 
According to Herodotus, the Egyptians taught the procedure to Jews, Syrians and 
Phoenicians. Later, the custom spread to Ethiopians but Herodotus did not know that 
Columbus would find the natives of the West Indias circumcised. Captain Cook found the 
practice used by natives of Australia, Fijt, New Caledonia, New Hebrides and Madagascar 
(Blandy, 1968).It is a religious ritual practiced by Jews and Muslims. Jews practice it on the 
eighth day after birth. From Jews, it passes to the Christians who performed it for hygienic 
purposes then passed to Muslims as an important ritual of cleanliness for males. It was 
introduced to the western cultures by Biblical injunctions (Arnaout et al., 1962).Circumcision 
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in the-one continent of Africa, only certain tribes circumcise e.g., Zulo, Xahsa, Bechuana and 
Falasha while among its many Christian communities; circumcision has a religious 
significance only in Ethiopia (Blandy et al., 1968). 
3. The prepuce (what is removed during circumcision?) 
The glans is covered by the prepuce which is formed of two layers of skin reflected at the 
neck of the penis behind the corona glandis; the inner layer of the prepuce is confluent along 
the line of the neck with thin skin-which covers and adheres firmy to the glans on the 
undersurface of the glans penis, a small median fold passes to the deep surface of the 
prepuce (frenulurn). The prepuce is separated from the glans by a potential space (preputial 
sac) which presents two shallow fossae on either side of the frenulum. On the corona 
glandis and on the neck of the penis, there are numerous small preputial sebaceous glands 
which secrete smegma beneath the foreskin (a mixture of sebaceous material and shed 
keratin). It has a peculiar odor, and may be seen exiting from the foreskin tip or accumulate 
in clumps beneath the foreskin (Gray's Anatomy, 1950). 
4. Indications of circumcision 
4.1 Phimosis 
It is a condition in which the contracted foreskin cannot be retracted over the glans and the 
commonest cause is chronic infection from poor local hygiene. In diabetic older men, 
balanoposthitis may lead to phimosis (Eiger, 1972). Congenital narrowing of the preputial 
orifice associated with long foreskin leads to ballooning out of the prepuce on micturition 
with a thin weak stream of urine leading to difficult micturition with residual urine, 
hydroureter and hydronephrosis but more often occurs as a result of atresia meati which 
may lie hidden by phimosis (Blandy et al, 1968, Bailey & Love's, 1992). It is reported that 
most cases of phimosis occur in uncircumcised males although excessive skin left, which 
may become stenotic lead to phimosis. 
Circumcision has been the traditional treatment for phimosis but  not the only management 
option; the best of which appears to be gentle physical retraction combined with topical 
steroid treatment of the unretractable foreskin (Dewan et al., 1996).  
Circumcision for phimosis in infant and young boys is done due to a request by the patients 
(religious and personal), or due to recurrent balanitis with inability to retract the prepuce 
and rarely due to a very long prepuce. In adults, it is done due to inability to retract for 
intercourse, tight frenum, balanitis and sometimes, prior to radiotherapy for penile 
carcinoma.(Bailey& Love's, 1992). 
4.2 Paraphimosis 
Tight prepuce has been retracted and cannot be returned to its normal position. This is due 
to chronic infection under the redundant foreskin which leads to contracture of the preputial 
opening (phimosis) and formation of a tight ring of skin when the foreskin is retracted over 
the glans. The skin ring leads to venous congestion which leads to engorged oedematous 
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glans making the condition worse. As the condition progresses, arterial occlusion and 
necrosis of the glans may occur. Treatment can be done by firm squeezing of the glans for 
five minutes to reduce tissue oedema and to decrease the glans size then the skin can be 
drawn forwards over the glans. If this is unsuccessful, general anaesthesia must be given 
and the constricting band is incised and circumcision is done to trim the redundant skin 
later on and antibiotics should be given (Bailey & Love's, 1992). 
4.3 Trauma 
It is a rare indication for circumcision (Blandy et al., 1968). 
4.4 Balanoposthitis  
Inflammation of the glans penis is known as balanitis while the inflammation of the prepuce 
is known as posthitis. Frequently, the opposing surfaces of the prepuce and glans are 
implicated in the inflammation process (Balanoposthitis).  
The immediate cause of acute balanoposthitis is the multiplication within the preputial sac 
of pyogenic organisms as  Streptococcal pneumococci and coliform bacilli. A contributing 
cause of balanoposthitis is diabetes (Manson, 1966 and Ross, 1941). 
4.5 Prophylactic neonatal circumcision 
Circumcision is done as prophylactic reasons to reduce the incidence of: urinary tract 
infection, penile carcinoma and carcinoma of the cervix "and sexually transmitted diseases. 
4.6 Religious reasons  
Circumcision is a religious rite among Muslims and Jews (Arnaout et al., 1962). 
5. Circumcision/sexually transmitted diseases (STDs) &HIV 
Donovan et al. in 1994,stated that the uncircumcised penis is hypothetically at increased risk 
of STDs especially-genital herpes, gonorrhea, syphilis, immunodeficiency virus type 1 (HIV-
1) infection, candidiasis and chancroid due to larger surface area, thinner epidermal barrier, 
more liability for epithelial microtrauma and the moist warm neck under the foreskin  
favoring the persistence of fastidious microorganisms. However, none of these hypotheses 
has been proven. Moses et al. in 1994, in eighteen cross sectional studies from six countries 
reported a statistically significant association between male circumcision and the risk for 
HIV infection. Male circumcision should be considered as an essential strategy for AIDs-
control (Tyndall et al., 1996). Caldwell in 1996 reported that in parts of subsaharan Africa, 
nearly 25% of the population is HIV positive as a result of heterosexual transmission of the 
virus. Lack of circumcision makes men in this region particularly susceptible. Taylor and 
Rodin in 1975, reported that there was a positive relationship between lack of circumcision 
and genital herpes simplex virus infection (HSV). Simonsen et al. in 1988, reported that in a 
controlled study of Human Immunodeficiency Disease (HIV), they found that men who 





in the-one continent of Africa, only certain tribes circumcise e.g., Zulo, Xahsa, Bechuana and 
Falasha while among its many Christian communities; circumcision has a religious 
significance only in Ethiopia (Blandy et al., 1968). 
3. The prepuce (what is removed during circumcision?) 
The glans is covered by the prepuce which is formed of two layers of skin reflected at the 
neck of the penis behind the corona glandis; the inner layer of the prepuce is confluent along 
the line of the neck with thin skin-which covers and adheres firmy to the glans on the 
undersurface of the glans penis, a small median fold passes to the deep surface of the 
prepuce (frenulurn). The prepuce is separated from the glans by a potential space (preputial 
sac) which presents two shallow fossae on either side of the frenulum. On the corona 
glandis and on the neck of the penis, there are numerous small preputial sebaceous glands 
which secrete smegma beneath the foreskin (a mixture of sebaceous material and shed 
keratin). It has a peculiar odor, and may be seen exiting from the foreskin tip or accumulate 
in clumps beneath the foreskin (Gray's Anatomy, 1950). 
4. Indications of circumcision 
4.1 Phimosis 
It is a condition in which the contracted foreskin cannot be retracted over the glans and the 
commonest cause is chronic infection from poor local hygiene. In diabetic older men, 
balanoposthitis may lead to phimosis (Eiger, 1972). Congenital narrowing of the preputial 
orifice associated with long foreskin leads to ballooning out of the prepuce on micturition 
with a thin weak stream of urine leading to difficult micturition with residual urine, 
hydroureter and hydronephrosis but more often occurs as a result of atresia meati which 
may lie hidden by phimosis (Blandy et al, 1968, Bailey & Love's, 1992). It is reported that 
most cases of phimosis occur in uncircumcised males although excessive skin left, which 
may become stenotic lead to phimosis. 
Circumcision has been the traditional treatment for phimosis but  not the only management 
option; the best of which appears to be gentle physical retraction combined with topical 
steroid treatment of the unretractable foreskin (Dewan et al., 1996).  
Circumcision for phimosis in infant and young boys is done due to a request by the patients 
(religious and personal), or due to recurrent balanitis with inability to retract the prepuce 
and rarely due to a very long prepuce. In adults, it is done due to inability to retract for 
intercourse, tight frenum, balanitis and sometimes, prior to radiotherapy for penile 
carcinoma.(Bailey& Love's, 1992). 
4.2 Paraphimosis 
Tight prepuce has been retracted and cannot be returned to its normal position. This is due 
to chronic infection under the redundant foreskin which leads to contracture of the preputial 
opening (phimosis) and formation of a tight ring of skin when the foreskin is retracted over 
the glans. The skin ring leads to venous congestion which leads to engorged oedematous 
 
Merits and Arguments Related to Circumcision 
 
45 
glans making the condition worse. As the condition progresses, arterial occlusion and 
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6. Circumcision/urinary tract infections 
Winberg's study in Scandinavia 1975, where circumcision is uncommon showed that in male 
infants with pyelonephritis, the prepuce is colonized with the offending organism. This only 
occurs during the first months of life where boys have a urinary tract infection more 
frequently than girls.  
Ginsburg and McCracken in 1982, like Winberg found that early in life, the number of boys 
with acute pyelonephritis was greater than girls and 95% of all boys with urinary tract 
infection were uncircumcised. The association between circumcision and infection has since 
been confirmed by Wiswell and Roscelle  in two epidemiologic studies, the latest involving 
over 400,000 infants. That study showed that the incidence of urinary tract infection was 
only 0.1% when circumcision was performed. Finally, taking into consideration the fact that 
most males in these Scandinavian studies are uncircumcised, it may consider the prepuce as 
a risk factor. Wiswell and Roscelle in 1986 and Horzog 1989, stated that the infection rate in 
uncircumcised infants was ten times greater than in circumcised males. So, prophylactic 
neonatal circumcision is mandatory to reduce the incidence of UTI.  
7. Circumcision/carcinoma of the penis 
KuroviUa et al. in 1971 Stated that, Jews do not have cancers of the penis because they 
perform ritualistic circumcision upon their male children on the 8th day of life. Muslims also 
perform ritualistic circumcision. Compared with Hindus, who live in a similar environment 
but who do not circumcise, Muslims are relatively free from penile cancers while those who 
delay circumcision till boys are about 10 years of age; by that time, occult cancerous changes 
have become so well established beneath the prepuce that the disease can not be prevented. 
Study of men with cancers of the penis shows a high proportion with conditions of the 
prepuce that make its retraction difficult or impossible. Difficulty in retracting the prepuce 
especially in a man careless of hygiene is likely to result in accumulation and retention of 
the smegma, probably the exciting agent in the production of penile cancer. It is evident that 
the complete prophylaxis conferred by a well performed circumcision early in infancy is not 
produced by the circumcision of adults. When an infant is circumcised and the glans is no 
longer protected by the prepuce, a dense, thicker epidermis develops that-resists formation 
of cancer by chronic irritation. An association has been reported between cancer of the 
cervix and penis (Smith et al., 1980) . It has long been known that carcinoma of the cervix is 
rare in nuns and that the incidence of such cancer is low in populations in whom most males 
are circumcised (Blandy et al., 1968). 
8. Contraindications of circumcision  
Any penile abnormality in which the foreskin may be used in later reconstruction e.g., 
Hypospadias or Epispadias. Epispadius is a contraindicatios for circumcision. 
1. In doubtful sex as male and female pseudo-hermaphrodism or true hermaphrodism 
where both ovaries and testes are present. 
2. In anemic, marasmic or weak children as well as in the presence of acute disease or 
active infections. 
3. Unfavorable general conditions, e.g., prematurity, uncorrected bleeding diathesis 
(Grimes, 1978). 
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9. The optimum age for circumcision 
The third week is the best time for circumcision because pain is minimal, bleeding is 
minimal, wound healing is perfect, and the risk of infection and psychological effects are 
minimal because the blood is still loaded with maternal antibodies with the near sterility of 
the skin of the neonate. 
Circumcision can be done at any later healthy period preferably before school age. 
If it is confirmed that the uncircumcised male neonate is at a higher risk of serious urinary 
tract infection than the circumcised one and therefore, the operation should be done shortly 
after birth. 
 Jewish ritual of circumcision on the eighth day is known to be more effective prophylaxis 
than procedures performed at the age between 4-14 years (Blandy, 1968). 
However, operations performed at adolescence or later in life are completely attended with 
undesirable erections, protracted healing and infection (Arnaout et al., 1962). 
In Muslim areas, circumcision is usually performed in the first few months of life. In 
Uganda and similarly in Kenya, circumcision age is 12-20 years. 
Also, circumcision can be done in the first day of life provided no hypospadius, bleeding 
tendency or intersex is present. 
10. Different opinions & arguments in neonatal circumcision 
It is a custom: The most important, arguments are those of custom and tradition.  
It confers beauty: It is difficult to evaluate the consideration of beauty since these are 
subjective. In cultures where circumcision is norm, young women find the uncircumcised 
penis radiculously ugly. Young ladies refuse intercourse without wearing an appropriate 
brooch through his penis. 
It promotes health: through the prevention of venereal diseases, cancer of the penis and 
cervix uteri. Hutchinsons in 1891, the greatest syphilologist suggested that, the presence of 
the foreskin constitutes a constant source of irritation leading to high risk of syphilis in early 
life and cancer in the aged. Penile cancer is never seen in a Jew and chancres are rare. 
In some countries, insurance excluded infants under the age of 15 years. The reason was that 
the money used to pay for the possible unnecessary circumcisions would cover much of the 
cost of emerging neonatal and premature intensive care units. Circumcision is done when 
the boy is more than one day old and after he has been checked for bleeding tendency 
(Blandy et al, in 1968). 
There   are children who are brought in by their parents for circumcision for ethnic or social 
reasons (Shanon et al., 1979).  
On the other hand, the risk cost- effectiveness and medical resources should probably be 
allocated to health measures of demonstrated value. Laumann et al. in 1997, in The National 
Health and Social life survey, indicated that there are no significant differences between 
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Also, uncircumcised men appear slightly more likely to experience sexual dysfunction 
especially later in life. Their results support the view that physicians and parents must be 
informed about potential benefits and risks of circumcision. 
Tran and Giacomantanio in 1996, reported that the increased rate of penile cancer among 
uncircumcised men appears to justify the procedure but that alone is not sufficient 
justification. The final decision in neonatal circumcision should be made by parents with 
balanced counsel from the attending physicians. The Infectious Disease Committee of the 
Canadian of Society in 1996, stated that circumcision of newborns should not be routinely 
performed.  
11. Anaesthetic techniques during circumcision 
Circumcision may be conducted using a wide variety of general, regional and local 
anaesthetic techniques. The choice of an ideal anaesthetic technique depends upon surgical 
and patients factors. In addition, sedation is commonly used to supplement local anaesthetic 
based techniques as part of a so-called monitored anaesthesia care (MAC) technique. 
12. Methods of circumcision 
Circumcision is one of the oldest and commonest operations in medicine. There are several, 
methods aiming for completely exposure of the glans and complete excision of the prepuce. 
In infants and neonates:  
Primitive methods: Bamboo - Lazem - shield (Ritual Jewish Circumcision). 
Standard methods: Bone forceps, surgical dissection - circumcision by the use of special 
instruments (Gomco clamp- plastibell device- Mogen clamp) (Holman et al,1990). 
In older children and adults:  
Dorsal slit and dissection technique-sleeve resection method. 
In Sudan, Bamboo size of the glans is applied over the glans down to the corona to protect 
the glans inside it while the prepuce is pulled out over the outer surface of the bamboo and 
cut off at the appropriate level. 
Blunt circumcision on clamps (lazem or kalloba) (Arnaout et al., 1962), made of non-cutting 
blades articulating at one end are widely used by village barbers in rural areas.  
Ritual Jewish Circumcision: The Jewish ritual operation is usually done by a professional 
circumciser who is trained to do the operation as well as to observe the rituals. Circumcision 
is usually done in a Synagogue but now is done in hospitals. 
13. Complications of circumcision 
The common complications due to circumcision are not usually serious. These include: 
1. Asymmetrical removal of the foreskin which may require recircumcision for cosmetic 
purposes. 
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2. The suture line may become infected specially by Staphylococcal infection. (Annunziato 
and Goldbum in 1978). 
3. Meatal stenosis is probably the most common potentially adverse result of neonatal 
circumcision. Lacking of the foreskin coverage leads to irritation and inflammation of 
the meatal tissues by the very alkaline urine formed after meals. This leads to stenosis 
or meatal adhesions. Formal meatotomy is required  when the stream is very fine in 
calibre (Blandy et al., 1968). 
4. Bleeding from an artery or vein. Shulman et al. in 1964, reported that the most common 
complication in 800 infants undergoing ritual circumcision by Mohels on the 8th day of 
life in Jews is haemorrhage which occurs in ten patients. 
5. Removal of excessive skin of the penile shaft along with the prepuce. On healing of the 
wound, the penis sets buried in the scrotum. This results in a concealed or denuded 
penis. Repair is complicated by the lack of the available skin to cover the shaft of the 
penis. (Radhakrishnan & Reges, 1984).  
6. If the urethra is grapsed in the circumcision clamp or from stitches placed in the 
urethra, the injury is usually a fistula at the corona (Shulman et al., 1964). 
7. Penile glans amputation during circumcision. Sherman et al. in 1996, reported seven 
cases of traumatic amputation of the glans penis and/or urethra during circumcision 
due to errors in the circumcision technique. The excised glandular tissue remains viable 
up to eight hours after injury. Reanastomosis of the glans and/or urethra following 
distal amputation even when there is a delay in the surgical repair of up to eight hours 
is usually successful. 
8. Gangrene of the penis and scrotum (Du-Toit & Villet in 1979). 
9. Complete avulsion of the skin of the penis and scrotum (Malherbe, 1975). Shulman et al. 
in 1964, reported that 1:800 would develop complications requiring admission to the 
hospital, e.g., necrosis of the glans, laceration of the scrotum and removal of the entire 
penile skin. 
14. Laser circumcision 
The laser beam cuts as well as controls bleeding from the skin, resulting in a very tidy wound. 
This technique allows exact proportions of skin and mucous membrane to be removed. Laser 
circumcision is the technique of choice for children circumcision and can also be applied to 
adult patients. Clinical comparative studies between the Neodymium:yttriumaluminum- 
garnet (Nd:YAG) laser and conventional circumcision in boys are very few. Vaos compared 
the clinical effects of the Nd:YAG laser contact technique with those of a conventional 
technique on the grounds of certain perioperative parameters, including operative time, length 
of hospital stay, postoperative complications and morbidity. Seventy-five patients undergoing 
circumcision were reviewed retrospectively. Operative time, length of hospital stay, and 
postoperative morbidity were analyzed. The study concluded the Nd:YAG laser contact 
technique is an effective laser-assisted procedure alternative to the conventional technique in 
circumcision with virtually no significant postoperative morbidity (Vaos,2004). 
Similar study using Carbon dioxide laser circumcision found this technique to reduce 
operative time translating into cost effectiveness. Morbidity rates of laser circumcision 
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15. Psychological effect of circumcision 
An early operation minimizes the potential psychological damage caused by genital surgery 
(Manley, 1982). Also, avoids sensitive phases of psychosocial development (maternal 
bonding, separation anxiety, development of genital body image, gender identity, and 
phallic awareness), the disruption of which is thought to predispose to psychological 
problems in later life. The age at which surgery took place was not associated with abnormal 
psychological adjustment later in life (Freud 1955). 
16. Conclusions 
The advantages of male circumcision are much more than the disadvantages and this 
explains the increased number of parents asking for circumcision for their male infants. 
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15. Psychological effect of circumcision 
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1. Introduction 
Anal fissures are common in infancy and represent the most common cause of bright rectal 
bleeding at any age. Delayed diagnosis and treatment can lead to a disturbing cycle of 
constipation, repeat rectal bleeding, and crying, due to increasing pain during and after 
defecation. In spite of its high frequency, the problem remains underrated by most 
clinicians, with only a paucity of data on the management of anal fissures in children being 
found in the literature. The objective of this work is to bring this common and distressing 
problem into a more positive light, based on our good results achieved by the nifedipine gel 
with lidocaine treatment.  
2. History 
The first description of anal sphincterotomy in the world literature is found in Alexis Boyer's 
11-volume Traite des Maladies Chirurgicales published between 1818 and 1826 (DeMoulin, 
1977). His descriptions of the condition are dramatic, detailing the severe suffering patients 
endured. Louis Lemmonier, in 1869, gave the world the first anatomic description of an anal 
fissure. Boyer established the relationship between anal sphincter spasm and no healing of 
anal fissures, as well as the association between constipation and anal fissure. He was the 
first to divide the sphincter to cure the problem. This procedure, routine and quite safe 
today, caused deaths and pelvic abscesses in four patients, as reported by Velpeau in 1832. 
During the 1950s, fissure excision, anal sphincter stretching, injection therapy (local 
anesthetic and sclerotherapy) and sphincterotomy were performed for chronic anal fissures. 
Later, in the late 1960s and early 1970s, cutaneous island advancement flaps were added to 
this group (Ruiz-Moreno, 1968; Samson & Stewart, 1970). The modern reintroduction of 
sphincterotomy for anal fissure can be attributed to Eisenhammer (1951). In 1953, Inburg 
published his technique of partial internal sphincterotomy, cutting the sphincter through the 
bed of the fissure. It was not until the mid to late 1970s that lateral internal sphincterotomy 
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An anal fissure is a linear, longitudinal split in the lining of the distal anal canal, extending 
from below the dentate line to the anal verge. They are usually very painful because of their 
somatic innervations, the pain resulting from spasm of the anal sphincter in response to 
stretching and tearing during passage of stool. A well developed anal fissure rests directly 
over the internal sphincter and the circular fibers of this sphincter are visible on the floor of 
the fissure on naked eye inspection.  
4. Anatomy 
ANAL FISSURE - ANATOMY
 
Fig. 1. Anal fissure anatomy. 
5. Incidence and etiology 
Anal fissures presents mostly in children aged 6-24 months. The overall incidence in 
children is not well described. Anal fissures are located in the posterior midline in 90% of 
the cases, although 10-20% in women and 1-10% in men are located in the anterior midline 
(Notaras, 1988). The posterior commissure of the anoderm is less well perfused than other 
anodermal regions (Schouten et al., 1994). Pressure over the branches of the inferior rectal 
artery (increased tone at the internal sphincter and high canal pressures) causes relative 
ischemia (Klosterhalfen et al., 1989). First described as a disease entity in 1934, the cause of 
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anal fissures is still unknown. Constipation and passage of hard stool were traditionally 
blamed and believed to be the causative factor of anal fissure, but a history of constipation is 
elicited in only approximately 20% of the patients (McCallion & Gardiner, 2001). Trauma, 
usually because of passage of a large or hard stool, is believed to be a common initiating 
factor. Ball suggested that passage of hard stool tore down the anal valve, leaving the coiled-
up skin at the anal verge as the "sentinel pile" (Lund & Scholefield, 1996). The remaining 
fissures are associated with chronic diarrhea, food allergy, Crohn's disease, syphilis, human 
immunodeficiency virus (HIV), or tuberculosis.  
6. Pathophysiology 
The pathophysiology is fairly complex and multifactorial, with anodermal ischemia, 
infection, chronic constipation, hypertonicity of the smooth muscle of the internal anal 
sphincter (IAS) and elevated maximal anal resting pressure (MARP) being involved (Gillet 
& Padias, 2006; Schouten et al., 1996). The exact mechanism surrounding the 
pathophysiology of anal fissures has not been clearly established, but current theories 
involve the tonicity of the anal sphincter and anal blood flow. A relative lack of nitrate oxide 
synthase, as found in other spasmodic states of the gastrointestinal tract, has been suggested 
as a possible mechanism for IAS hypertonia (Lund, 2006). As fissures are most commonly 
seen in the posterior midline, inadequate blood flow to this region has been hypothesized to 
play a role in the development of fissures. End arterioles from the inferior rectal artery 
pierce both sphincters to reach the submucosa of the anal canal and travel cephalad in this 
plane. Klosterhalfen et al. (1989) suggested that hypertonic sphincter decreases blood flow in 
these terminal vessels as they pass through the IAS fibers. Recognized features common to 
most chronic anal fissures are a high resting anal canal pressure due to hypertonicity of the 
internal anal sphincter, reduced vascular perfusion index at the site of the fissure, and the 
presence of "ultraslow" pressure wave activity in the internal anal sphincter (Hancok, 1977, 
Schouten & Blankensteijn, 1992).  
7. Classification 
Anal fissures may be classified as acute or chronic and typical or atypical. Acute fissures 
cause bright red bleeding with bowel movements and anal pain or spasm that can last for 
hours after the bowel movement. They have the appearance of a simple tear, superficial or 
deep in the anoderm. Chronic anal fissures present with induration at the edges, a sentinel 
pile, visible fibers of the internal anal sphincter, chronic granulation tissue in the base of the 
fissure and a hypertrophied anal papilla. They are acute fissures that fail to heal following 6 
to 8 weeks of intensive treatment. Typical fissures are usually in the posterior or anterior 
midline, and are not associated with other diseases. Atypical fissures can occur anywhere in 
the anal canal, and tend to be associated with other diseases.  
8. Differential diagnosis 
Pruritus ani, inflammatory bowel disease (mostly Crohn's disease), tuberculosis, immune 
system diseases, acquired immunodeficiency syndrome (AIDS), Chlamydia, venereal 
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9. Innervation and pharmacology of the internal sphincter 
The enteric nervous system consists of two major plexuses of interconnecting ganglia, the 
myenteric (Auerbach's) plexus and the submucous (Meissner's) plexus. The enteric nervous 
system contains entire reflex pathways that permit peristaltic contractions independent of 
extrinsic innervations. The internal anal sphincter receives its sympathetic innervations from 
the hypogastric pelvic plexuses. Parasympathetic innervation is from the first, second, and 
third sacral segments via the pelvic plexus. Internal anal smooth muscle relaxation can be 
inhibited by stimulation of nonadrenergic noncholinergic enteric neurons, parasympathetic 
muscarinic receptors, or sympathetic beta adrenoceptors, and by inhibition of calcium entry 
into the cell. Sphincter contraction depends on an increase in cytoplasmic calcium and is 
enhanced by sympathetic alpha adrenergic stimulation (Bhardwaj et al., 2000). A number of 
putative nonadrenergic transmitters have been suggested, the work being concentrated on the 
function of adenosine triphosphate (ATP), vasoactive intestinal peptide (VIP), and nitric oxide 
(NO) and their role in mediating the rectoanal inhibitory reflex (RAIR), as they are known to 
act together in mediating enteric inhibitory cotransmission in other areas of the gut. NO 
activates soluble guanylate monophosphate (cGMP) and relaxation of smooth muscle. NO has 
been widely demonstrated to be the main chemical neurotransmitting agent in the 
nonadrenergic neurons mediating relaxation of the internal anal sphincter. Working on the 
opposum internal anal sphincter, Rattan and Chakder suggested that NO was a nonadrenergic 
noncholinergic inhibitory neurotransmitter (Rattan & Chakder, 1992). NO caused 
tetrodotoxin-resistant relaxations of internal anal sphincter strips. The internal anal sphincter 
generates a high degree of tone in the resting state and is responsible for 50-85% of overall 
resting anal tone. This is due to both intrinsic myogenic activity and extrinsic adrenergic 
innervations. The effects of adrenergic agonists are well documented. Parks et al demonstrated 
that internal anal sphincter strips contracted to noradrenaline, had a variable response to 
adrenaline and relaxed in response to isoprenaline (Parks et al., 1969). Analysis of these 
responses using appropriate adrenoceptor antagonists has shown that contractions were 
mediated via alpha-receptors and relaxations via beta-receptors. Contractions to noradrenaline 
and adrenaline can be converted to relaxations by the addition of an alpha-receptor antagonist. 
Burleigh et al. (1979) have shown that acetylcholine has a predominantly inhibitory effect on 
internal anal sphincter smooth muscle acting through muscarinic receptors. Furthermore, 
electrical field stimulation of internal anal sphincter strips resulted in relaxation of the smooth 
muscle. These relaxations are abolished by tetrodotoxin, indicating that they are nerve 
mediated. Transient internal anal sphincter relaxation in response to rectal distension was first 
described by Gowers in 1877. O'Kelly et al. (1994) suggested that NO might be important in 
mediating the rectoanal inhibitory reflex. A review on the pharmacology of the internal anal 
sphincter was reported by Cook et al. (2001).  
10. Clinical picture 
The clinical picture involves a history of constipation in 20% of the cases, intense crying with 
bowel movements, streaks of bright red blood on the surface of hard stool, on the diaper, or 
on the toilet paper, following bowel movements, discharge and pruritus. The clinical 
hallmark of anal fissure is pain during, and especially some time after defecation. Inspection 
of the anal region reveals a posterior midline laceration, a sentinel skin tag, and signs of 
inflammation.  
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11. Medical treatment 
Acute fissures often resolve within 10-14 days of conservative management. However, as 
long as 6-8 weeks may be necessary for the fissure to heal. Recurrence after conservative 
management can be observed in 27% of the cases. Dietary modification (increased fluid and 
fiber intake), stool softeners (lactulose) and warm baths are all part of the conservative 
treatment (Shafik, 1993). Conservative treatment is safe, has few side effects, and should 
usually be the first step in therapy. Shub et al. (1978) reported that 44% of fissure patients 
healed with sitz baths, a psyllium fiber supplement, and emollient suppositories. In 27% of 
these "healed" patients, the fissures recurred over a 5-year follow-up period.  
The optimal treatment for an anal fissure is to induce a temporary reduction of anal canal 
resting pressure to allow healing of the fissure without permanently disrupting normal 
sphincter function. Internal anal smooth muscle relaxation can be inhibited by stimulation of 
non-adrenergic non-cholinergic enteric neurons, parasympathetic muscarinic receptors, or 
sympathetic beta adrenoceptors, and by inhibition of calcium entry into the cell.  
11.1 Glyceryl trinitrate 
Glyceryl trinitrate (GTN) is a vasodilator and causes relaxation of smooth muscle. 
Relaxation of the internal sphincter tone is achieved by the reduction of intracellular calcium 
in the smooth muscle cells by nitric oxide donation. Topical GTN heals anal fissures better 
than a placebo, irrespective of dose, but is associated with headache in around 25% of the 
patients. During the late 90's, GTN ointment was the best one could offer for a child with 
anal fissure. Exogenous nitrates release nitric oxide in vivo and have been used clinically as 
nitric oxide donors. Loder et al. (1994) demonstrated that topical application of 0.2% GTN 
led to decreased resting anal pressure. Chemical sphincterotomy using GTN with adjunctive 
stool softeners has been demonstrated to be quite effective at relieving symptoms and 
promoting healing. They significantly decrease pain during the therapy period. A study of 
80 patients reported in the Lancet in 1997 showed healing in 26/38 (68%) after GTN, 
compared with 3/30 (8%) after placebo (Lund & Scholefield, 1997). Another study 
comparing GTN, lidocaine and placebo, was reported in the Journal of Pediatric Surgery in 
1999. Complete healing was observed in 26/31 (83.9%) after GTN, 7/14 (50%) after 
lidocaine, and 6/11 (35.3%) after placebo (Tander et al., 1999). Kenny et al. (2001) questioned 
the healing power of GTN, reporting 31 children with an overall fissure healing rate of 84%, 
but with no differences being observed between GTN and placebo. Bacher et al. (1997) 
conducted a randomized trial of 0.2% GTN vs. 2% lidocaine gel, each applied 3 times daily, 
in a mixed group of acute and chronic fissure patients. After 1 month, healing rates were 
higher with GTN in both the acute (91.6%, GTN vs. 50%, lidocaine) and chronic (62.5%, GTN 
vs. 20%, lidocaine) fissure groups. A randomized, placebo-controlled treatment of anal 
fissure by lidocaine, EMLA, and GTN in 102 children, showed faster response rates by GTN 
application, and similar and high success rates by 8 weeks of EMLA treatment (Sönmez et 
al., 2002). The average age of patients was 3 years (range, 2.5 months to 15 years). Symptoms 
at admission consisted of hard stools in 90% of patients, pain or crying during defecation in 
87%, bleeding in 84%, excessive straining at defecation in 35%, and mucosal prolapse in 9%. 
Despite the encouraging results reported with topical nitrates, severe headaches and noted 
relapse rates are major drawbacks. Dorfman et al. (1999) reported a 27% symptomatic 
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11. Medical treatment 
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1999. Complete healing was observed in 26/31 (83.9%) after GTN, 7/14 (50%) after 
lidocaine, and 6/11 (35.3%) after placebo (Tander et al., 1999). Kenny et al. (2001) questioned 
the healing power of GTN, reporting 31 children with an overall fissure healing rate of 84%, 
but with no differences being observed between GTN and placebo. Bacher et al. (1997) 
conducted a randomized trial of 0.2% GTN vs. 2% lidocaine gel, each applied 3 times daily, 
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Despite the encouraging results reported with topical nitrates, severe headaches and noted 
relapse rates are major drawbacks. Dorfman et al. (1999) reported a 27% symptomatic 





patients, including headaches in 63% and light-headedness in 52%. Carapeti et al. (1999) 
noted relapse rates of 33% with 0.2% GNT and 25% with escalating-dose GTN (mean follow-
up, 9 months). Headaches were observed in 72% of the patients. More recent studies have 
shown lower healing rates with GTN than were initially reported. Patient non-compliance 
and tachyphylaxis are also major drawnbacks to this treatment. Local application of another 
precursor of nitric oxide, L-arginine, has been reported as effective in promoting fissure 
healing without headache as a side effect (Gosselink et al., 2005).  
11.2 Calcium channel blockers 
They improve fissure healing by inhibiting calcium ion entry through voltage-sensitive 
areas of vascular smooth muscle, causing muscle relaxation and vascular dilatation. Topical 
diltiazem (Cardizem) has similar efficacy to GNT, with fewer side effects, but the experience 
with children is small. 
11.3 Nifedipine  
NIFEDIPINE CHEMICAL STRUCTURE
 
Fig. 2. Nifedipine chemical structure. 
Nifedipine (Adalat) has a modulating effect on the microcirculation (Oshiro et al., 1995). The 
advent of this calcium channel blocker as nifedipine gel was a turning point and a major 
contribution to the healing of posterior anal fissures. Used to treat hypertension, angina 
pectoris, Raynaud's syndrome, congestive heart failure, and cardiomyopathies, it may cause 
side effects like headache, upset stomach, dizziness, tiredness, flushing, heartburn, 
tachycardia, muscle cramps, enlargement of gum tissue around teeth, constipation, nasal 
congestion, and cough. The first clinical study on the effects of calcium antagonists on resting 
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anal pressure showed that pressures were reduced with sublingual nifedipine in both healthy 
volunteers and patients with hypertonic sphincters (Chrysos et al., 1996). A medline database 
literature search concerning the non-surgical treatment of chronic anal fissures, including 282 
patients, called the attention to nifedipine gel. The study compared nifedipine with lidocaine 
with hydrocortisone acetate, showing 98% complete healing after nifedipine and 61% complete 
healing in the control group. Nifedipine reduced MRAP by 30% and maximum squeeze 
pressure by 16.8% (McCallion & Gardiner, 2001). Another large study by Perroti et al. (2002) 
comparing nifedipine and lidocaine with hydrocortisone and lidocaine, showed complete 
healing in 94.5% of the nifedipine treated patients and only 16.4% of the control patients.  
Preliminary results of a multicenter study on nifedipine for local use in conservative 
treatment of anal fissures was reported by Antropoli in 1999. Total remission from acute 
anal fissure was achieved after 21 days of therapy in 95% of the nifedipine-treated patients, 
with a mean reduction of 30% in maximum resting anal pressures. A randomized controlled 
double-blind trial comparing nifedipine gel plus lidocaine, topical lidocaine alone and 
hydrocortisone acetate ointment, showed topical nifedipine plus lidocaine gel to be effective 
and well tolerated in the treatment of chronic anal fissures (Perroti et al., 2002). In other 
studies reported by Merenstein & Rosenbaum (2003) and Slawson (2003), remarkable 
improvement in healing was observed when 1.5% lidocaine and 0.3% nifedipine were 
applied twice daily for 6 weeks. Ezra & Susmalliam (2003) showed a better healing rate with 
topical nifedipine than with GTN. Katsinelos et al. (2006) reported that aggressive treatment 
of acute anal fissure with 0.5% nifedipine gel ointment prevents its evolution to chronicity. 
Twenty-seven of their 31 patients achieved complete remission and healing of the anal 
fissure following an 8-week treatment course (85.2%). Recurrence was observed in 16% of 
their patients. A systematic review of medical therapy for anal fissure including 31 trials 
from 1966 to 2002 returned the black shadow of pessimism to most physicians' minds. Nine 
agents were studied: GTN, isosorbide dinitrate, botulinum toxin, diltiazem, nifedipine, 
hydrocortisone, lidocaine, bran, and placebo. The results were only marginally better than 
placebo (R. Nelson, 2004)! A Cochrane Collaboration Review from 2009, by the same author, 
showed no better results. GNT was found to be marginally, but significantly, better than 
placebo in healing anal fissure (48.6% vs. 37%, p < 0.004), but late recurrence of the fissure 
was common, in the range of 50% of those initially cured!  Botox and calcium channel 
blockers were equivalent to GNT in efficacy, with fewer adverse effects. No medical therapy 
was found to come close to the efficacy of surgical sphincterotomy (R.L. Nelson, 2006). 
Combined treatments have also been reported. The combination of nifedipine and 
botulinum toxin was superior to nitroglycerin and pneumatic dilatation with respect to both 
healing (94% v. 71%) and recurrence rate (2% v. 27%) (Tranqui et al., 2006). Headache is the 
most common complication of administering topical nifedipine in adults, but not in 
children. Nifedipine gel in the treatment of anal fissure has now been accepted even in 
China, with good results (Hong-yu et al., 2004). Reversible chemical sphincterotomy with 
nifedipine gel looks now as the most promising development in the treatment of anal 
fissures in children. The outcome is extremely good and side effects almost nonexistent.  
11.4 Botulinum toxin (Botox)  
Botulinum neurotoxin is a lethal biological substance produced by the anaerobic bacterium 
Clostridium botulinum. Serotype A is commercially available and has proven to be of 





patients, including headaches in 63% and light-headedness in 52%. Carapeti et al. (1999) 
noted relapse rates of 33% with 0.2% GNT and 25% with escalating-dose GTN (mean follow-
up, 9 months). Headaches were observed in 72% of the patients. More recent studies have 
shown lower healing rates with GTN than were initially reported. Patient non-compliance 
and tachyphylaxis are also major drawnbacks to this treatment. Local application of another 
precursor of nitric oxide, L-arginine, has been reported as effective in promoting fissure 
healing without headache as a side effect (Gosselink et al., 2005).  
11.2 Calcium channel blockers 
They improve fissure healing by inhibiting calcium ion entry through voltage-sensitive 
areas of vascular smooth muscle, causing muscle relaxation and vascular dilatation. Topical 
diltiazem (Cardizem) has similar efficacy to GNT, with fewer side effects, but the experience 
with children is small. 
11.3 Nifedipine  
NIFEDIPINE CHEMICAL STRUCTURE
 
Fig. 2. Nifedipine chemical structure. 
Nifedipine (Adalat) has a modulating effect on the microcirculation (Oshiro et al., 1995). The 
advent of this calcium channel blocker as nifedipine gel was a turning point and a major 
contribution to the healing of posterior anal fissures. Used to treat hypertension, angina 
pectoris, Raynaud's syndrome, congestive heart failure, and cardiomyopathies, it may cause 
side effects like headache, upset stomach, dizziness, tiredness, flushing, heartburn, 
tachycardia, muscle cramps, enlargement of gum tissue around teeth, constipation, nasal 
congestion, and cough. The first clinical study on the effects of calcium antagonists on resting 
Nifedipine Gel with Lidocaine in the Treatment 
of Anal Fissure in Children: A Pilot Study and Review of the Literature 
 
59 
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Clostridium botulinum. Serotype A is commercially available and has proven to be of 





hyperhidrosis, achalasia and chronic anal fissure (Jankovic & Brin, 1991). Botulinum toxin 
(Botox) is associated with a similar rate of healing of anal fissure as GTN, but is more 
expensive. The technique, dose and site of injection do not affect the rate of healing. The 
experience in children is very small. Jost & Schimrig (1993) first reported the use of botulin 
toxin (BT) for anal fissure in 1933. The commercially available agent prevents neural 
transmission by preventing acetylcholine release from presynaptic nerve terminals. BT 
exerts its effects on the acetylcholine releasing parasympathetic peripheral nerve endings as 
well as the ganglionic nerve endings, leading to flaccid paralysis of the internal anal 
sphincter (IAS). This effect stays for about 3 months, a period sufficient for most non-
complicated anal fissures to heal. Jost (1997) subsequently reported on a series of 100 
patients treated with BT injection. In all, 78 patients became pain-free within 3 days, and 
healing rates at 3 and 6 months were 82% and 79%. BT injection was compared with topical 
GTN (0.2% twice daily) in a randomized trial of 50 chronic anal fissure patients (Brisinda et 
al., 1999). Resting anal pressure decreased in both groups, but did so to a greater extent in 
the BT group (29% with BT vs. 14% with GTN at 2 months). Healing rates were 96% in the 
BT group and 60% in the GTN group. No adverse effects were seen in the BT group.  
11.5 Hyperbaric oxygen 
Hyperbaric oxygen therapy provides a significant increase in tissue oxygenation in 
hypoperfused wounds. This increase in oxygen tension induces positive changes in the wound 
repair process by enhancing fibroblast replication, collagen synthesis and neovascularization. 
Cundall et al. (2003) reported a small series of adult patients with chronic anal fissure treated 
by hyperbaric oxygen. They found the procedure safe and appropriate in patients who have 
failed medical treatment, in those at risk of fecal incontinence, and in patients who are unfit for 
operation or in whom surgery has failed (Cundall et al., 2003).  
11.6 Naturopathic treatment 
Homeopathic medicines are excellent to alleviate the pain and spasm. Some of the more often 
indicated medicines are Chamomilla, Graphites, Nitric acid, Ratanhia, Sepia, Silicea and Thuja. 
Aesculus and Paeonia may be indicated if keynote symptoms are present. Homeopathic 
medicines often work faster and provide greater pain relief than analgesics and narcotics. In 
order to facilitate healing of the fissure, a topical cream consisting of Vitamins A and E, 
panthenol, calendula, goldenseal and Emu oil , can be used (Kruzel, 2006).  
11.7 Iontophoresis 
Iontophoresis using a zinc or copper electrode and applying a positive current will help to 
facilitate healing by hardening the underlying fissure, decreasing bleeding and affording 
pain relief.  
11.8 Nd:YAG or CO2 laser 
Contact Nd:YAG laser therapy appears to be efficient and safe in the treatment of anorectal 
lesions, including anal fissures (Sankar & Joffe, 1988; Walfisch et al., 1994). With the advent 
of the CO2 laser, a laser sphincterotomy and fissurectomy have proved to be very effective, 
with good results, prompt rehabilitation, reduced amount of complications and fewer 
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recurrences (Ali, 1988; Skobelkin et al., 1989). It involves laser vaporization of the fissure 
locally. Patient acceptance is remarkable, and the treatment can be carried out at a fraction 
of the cost of hospital surgical treatment. There are no reports of laser treatment for anal 
fissures in children.  
11.9 Wonder remedies 
 
Fig. 3a. Anal Fissures DX: a unique formula with anti-inflammatory properties, providing 
immediate soothing relief. 
 
Fig. 3b. H-Fissures: healing natural oil with anti-inflammatory properties, specially 
formulated to provide instant relief from the pain and discomfort of fissures, reducing the 
swelling without skin irritation. 
 
Fig. 3c. Fissure Control: a breakthrough topical homeopathic treatment made of a blend of 
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recurrences (Ali, 1988; Skobelkin et al., 1989). It involves laser vaporization of the fissure 
locally. Patient acceptance is remarkable, and the treatment can be carried out at a fraction 
of the cost of hospital surgical treatment. There are no reports of laser treatment for anal 
fissures in children.  
11.9 Wonder remedies 
 
Fig. 3a. Anal Fissures DX: a unique formula with anti-inflammatory properties, providing 
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formulated to provide instant relief from the pain and discomfort of fissures, reducing the 
swelling without skin irritation. 
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Fig. 3d. Paeonia-Heel: a homeopathic medicine containing Paeonia officinalis (Peony), 
Graphites (graphite), Nux vomica (vomit nut), Sulfur (sulphur), Acidum nitricum (nitric 
acid), and Hamamelis (witch-hazel). 
 
Fig. 3e. Dr Wheatgrass's cream: enriched with highly bioactive wheatgrass-derived 
antioxidants, containing vitamins A,C and E, phytosterols, aminoacids and minerals. The 
Figure shows Dr Wheatgrass's antioxidant skin recovery cream.  
 
Fig. 3f. Nature's Wonderland Stone Root Herbal Supplement: Collinsonia Canadensis, sour 
and spicy in taste, and warming in action. It relaxes constriction and clears venous 
congestion and inflammation. The Figure shows the Collinsonia Canadensis flowers.  
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12. Surgical treatment 
Surgical treatment is rarely needed for infants and children. Open or closed lateral internal 
sphincterotomy (healing rates of 93% to 100%, recurrence rates of 0% to 25%), internal 
sphincterotomy (for chronic anal fissures), and posterior midline sphincterotomy are all part 
of the surgical arsenal. The open lateral sphincterotomy is the procedure of choice for 
children. Relative contraindications to operative treatment include inflammatory bowel 
disease and profound immunosupression.  
12.1 Anal dilatation 
First described in 1829 by Recamier and popularized by Lord in the treatment of 
hemorrhoids, anal stretching has been used in the past based on the concept of loosening the 
sphincter muscle and increasing the blood flow to the anoderm. Anal dilatation was 
reintroduced for anal fissure therapy in 1964, with success rates of 87% to 100% (Watts et al., 
1964), but are not recommended in children because of the very high rate of recurrence (10% 
- 30%) , risk of sphincter damage and incontinence after excessive stretching.  
12.2 Fissurectomy 
Fissurectomy as a treatment for anal fissures in children was found successful only when 
combined with postoperative laxative therapy (Lambe et al., 2000a). An important part of 
their technique was the use of stay sutures to avoid the need for an anal retractor, thereby 
preventing stretching of the internal anal sphincter. A triangular part of the anoderm is 
excised along with the fissure itself. A good and reliable operation, but leaves behind a large 
and uncomfortable external wound, which takes a long time to heal. Application of a split 
thickness graft to the wound has been advocated, in order to improve healing.  
12.3 Internal anal sphincterotomy 
Internal anal sphincterotomy (IAS) was popularized for the treatment of anal fissure during 
the 1950s by Eisenhammer (1951). Lateral internal sphincterotomy (LIS) has been found to 
be the preferred operation. LIS can be performed using either the open or closed technique , 
the method of Notaras, dividing the IAS via a small stab wound (Notaras, 1971). Equal 
success has been reported with open or closed lateral sphincterotomy for acute and chronic 
anal fissures in children. A systematic review on the treatment of anal fissure was published 
by Steele & Madoff in 2006. Current concepts in anal fissures were reported by Ayantude et 
al. (2006) in the same year, involving a literature search from 1970 to 2004.  
Chronic anal fissures tend to be refractory and are usually reluctant to heal with 
conservative treatment. Chronicity is defined by chronology (6-8 weeks) and morphologic 
features (visible transverse internal anal sphincter fibers, chronic granulation tissue, 
indurated edge, a sentinel pile, and a hypertrophic anal papilla). A very large series of adult 
patients was published by Lysy et al. in 2006. Prolonged periods of treatment were 
necessary and 384 patients were healed (84.4%) by the end of four months. Older age and 
longer time interval between symptom appearance and treatment negatively affected fissure 






Fig. 3d. Paeonia-Heel: a homeopathic medicine containing Paeonia officinalis (Peony), 
Graphites (graphite), Nux vomica (vomit nut), Sulfur (sulphur), Acidum nitricum (nitric 
acid), and Hamamelis (witch-hazel). 
 
Fig. 3e. Dr Wheatgrass's cream: enriched with highly bioactive wheatgrass-derived 
antioxidants, containing vitamins A,C and E, phytosterols, aminoacids and minerals. The 
Figure shows Dr Wheatgrass's antioxidant skin recovery cream.  
 
Fig. 3f. Nature's Wonderland Stone Root Herbal Supplement: Collinsonia Canadensis, sour 
and spicy in taste, and warming in action. It relaxes constriction and clears venous 
congestion and inflammation. The Figure shows the Collinsonia Canadensis flowers.  
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inflammation and ischemia and subsequent fibrosis may compromise the healing process. 
After recurrence, patient education for self and prompt retreatment was found to improve 
outcome. Chronic anal fissures are caused by internal sphincter hypertonia, which leads to 
reduced blood flow and tissue hypoxia, with consequent healing failure. A cautious surgical 
approach is required to treat those who do not respond to medical treatment, and should 
include excision of the fissure along with its sentinel tag and internal sphincterotomy at the 
base of the ulcer (Cohen & Dehn, 1995; Lambe et al., 2000b). The wound is left open and 
should heal in 7-14 days without scarring. Local reconstruction with advancement flaps is a 
relatively new and effective adjunct to chronic fissure excision. Practice parameters for the 
management of anal fissures from the American Society of Colon and Rectal Surgeons were 
reported by Orsay et al. (2004) and a very extensive review on the diagnosis and care of 
patients with anal fissure was reported by the American Gastroenterological Association 
(Madoff & Fleshman, 2003).  
13. Our experience: Nifedipine gel 0.2% with lidocaine 
13.1 Subjects  
Seventy children suffering from acute and chronic anal fissures treated by us between 2004 
and 2010 comprised the study population. They were all treated topically with nifedipine 
gel 0.2% with lidocaine for 4 weeks and followed up for as long as possible in our outpatient 
clinic (a maximum of 5 years).  
13.2 Methods 
Because anal fissure has such a distinctive appearance, its healing is the most objective 
measure of treatment efficacy available that can be standardized. Combining all analyses in 
which a placebo was used as the comparison group, the healing rate in the placebo group is 
35.5 percent, a level of response that is fairly uniform across studies (standard deviation, 
11.8 percent). For these reasons we did not find necessary to use a control group in the 
present pilot study.  
13.3 Results 
There were 28 males and 42 females. Their clinical presentation consisted of constipation, 
rectal bleeding, anal and abdominal pain, perianal itching and rectal prolapse (58, 50, 33, 6, 
4, and 1 cases, respectively). Posterior, anterior, multiple, both posterior and anterior, and 
both posterior and lateral fissures were the main physical findings (44, 16, 5, 4, and 1 cases, 
respectively). Fifty eight patients completed the 4-week treatment course, with another 7 
patients requiring a second 4-week treatment course in order to achieve complete remission, 
indicated by resolution of symptoms and complete healing of the fissure (65 patients 
altogether). The remaining 5 patients had recurrence of symptoms in 2, 4, 11, 18 and 19 
months, respectively, treated successfully by an additional 4-week course of nifedipine. The 
recurrence rate observed was very low (7.14%). All the 70 patients had a mean follow-up of 
1.88 years, ranging from 6 months to 5.2 years. Problems with compliance were not 
observed, one of the main reasons for treatment failure in adults. No side effects of 
nifedipine were observed.  
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Fig. 4. Clinical presentation (percentage) 
14. Special situations 
1. Crohn's disease: Platell et al. (1996) noted symptomatic anal pathology in 42.4% of 
Crohn's disease patients, 27.6% of them presenting anal fissures. Frequently, they are 
multiple or off the midline, and often coexist with other pathology (Sangwan et al., 
1996). They can be locally aggressive, progressing to form deep ulcers with granulating 
bases and overlapping skin edges.  
2. HIV/AIDS: Anal fissures maintain their typical appearance, but have poor wound 
healing (Lord, 1997). Barrett et al. (1998) reported their experience with perianal disease 
in 260 HIV-positive patients, 32% of them with anal fissures (Barrett et al., 1998). 
Eighteen patients underwent sphincterotomies. Viamonte et al. (1993) reviewed the 
treatment of 33 HIV-positive fissure patients. Thirteen underwent LIS, with excellent 
results (12 improved).  
15. Conclusions 
Topical 0.2% nifedipine with lidocaine appears today as the most efficient mode of 
treatment for anal fissures in children, with a significant healing rate and no side effects. It is 
safe and effective, prevents the evolution of acute anal fissures in children to chronicity, 
avoids surgical procedures in the great majority of cases, avoids complications and does not 
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Free radicals are highly reactive molecules containing one or more unpaired electrons. They 
donate or abstract electrons from other molecules in an attempt to pair their electrons and 
generate a more stable species. Oxygen-derived reactants collectively termed reactive 
oxygen species (ROS) as well as reactive nitrogen species (RNS) are normally produced in 
living organisms. When produced in excess, they are important mediators of cell and tissue 
injury [Halliwell, B. (1999), Fridovich, I. (1998), Gitto, E. et al. (2002)]. The resulting damage 
is referred to as oxidative stress. Free radicals are highly unstable and several enzymes and 
small-molecular-weight molecules with antioxidant capabilities protect against them 
[Halliwell, B. (1992)]; these protective molecules are part of the antioxidative defence 
system. There is a critical balance between free radical generation and antioxidant defences. 
Free radical reactions lead to the oxidation of lipids, proteins, polysaccharides and to DNA 
damage (fragmentation, base modifications and strand breaks); as a consequence, radicals 
have a wide range of biologically toxic effects [Saugstad, OD. (1996), Sarker, AH. et al. 
(1995)]. The generation of both ROS and RNS are summarised in figure 1. 
Newborns and especially pre-term infants are probably more prone to oxidative stress than 
are children and young adults. There are some special reasons for this. These infants very 
often 1) are exposed to high oxygen concentrations, 2) have infections or inflammation, 3) 
have reduced antioxidant defence, and 4) have free iron which enhances the Fenton reaction 
leading to production of highly toxic hydroxyl radicals [Saugstad, OD. (2003, 2005)]. The 
Fenton reaction describes the interaction of hydrogen peroxide with a transition metal 
resulting in the generation of the highly toxic hydroxyl radical. Oxidative stress has been 
postulated to be implicated in several newborn conditions and, in 1988, SAUGSTAD 
[Saugstad, OD. (1988)] coined the phrase ‘‘oxygen radical diseases of neonatology’’. The 
idea contends that oxidative stress affects different organs, often simultaneously, giving rise 
to different signs according to the organ most affected. He included bronchopulmonary 
dysplasia/chronic lung disease, retinopathy of prematurity and necrotising enterocolitis in 
this category. Later, it became clear that free radicals are also involved in periventricular 
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leukomalacia [Haynes, RL. et al. (2003)] as well as in regulating the ductus arteriosus and 
pulmonary circulation [Clyman, RI. et al. (1989), Archer, SL. et al. (1989), Sanderud, J. et al.  
(1993)]. If the concept of ‘‘oxygen radical diseases in neonatology’’ is correct, it means that 
the conditions mentioned are not different diseases but belong to the same frequently have 
higher plasma levels of non-transferrin-bound iron and higher erythrocyte free iron than 
adults [Ogihara, T. et al. (1996)]. 
 
Fig. 1. Summary of the production of reactive oxygen species (ROS) and reactive nitrogen 
species (RNS). 
2. Oxidative stress in pregnancy, in pre-eclampsia and at parturition 
Pregnancy is a physiological state accompanied by a high metabolic demand and elevated 
requirements for tissue oxygen. This increased oxygen demand augments the rate of 
production of ROS and even women with normal pregnancies experience increased 
oxidative stress and lipid peroxidation relative to age-matched, non pregnant women. 
Several studies have shown that the antioxidative defense system is altered during 
pregnancy. Circulating levels of lipid peroxides increase significantly in the maternal 
circulation when a woman becomes pregnant. Various antioxidants, however, including 
vitamin E, ceruloplasmin, erythrocyte thiols and iron-binding capacity also increase. Several 
of these elevate progressively with advancing gestation, while serum iron concentrations 
progressively decrease. While there is a gradual favoring of antioxidant activity over 
oxidation during normal pregnancy, there is an insufficient increase in antioxidants to offset 
the rise in free radical generation. In contrast to the low-molecular weight antioxidants, the 
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activity of an important family of antioxidative enzymes, the superoxide dismutases (SOD), 
are depressed in the blood of pregnant women [Wisdom, SJ. et al. (1991)]. In addition, 
Walsh and Wang [Walsh, SW. & Wang, Y. (1993)] reported a deficiency in another 
antioxidative enzyme, glutathione peroxidase (GPx), during pregnancy. GPx is an 
important antioxidant enzyme present in virtually all tissues. The enzyme limits the 
accumulation of lipid peroxides and utilizes reduced glutathione (GSH) as its cofactor to 
convert lipid peroxides into relatively harmless hydroxylated fatty acids, water and 
glutathione disulfide. Given these actions, it might be expected that a deficiency in this 
enzyme may lead to elevated oxidative stress during pregnancy. The placenta is a major 
source of oxidative stress during pregnancy. It is rich in polyunsaturated fatty acids, and 
the placenta is an abundant source of lipid peroxides which are secreted into the maternal 
circulation. In normal pregnancy, placental lipid production is believed to be kept under 
control by placental antioxidant enzymes [Walsh, SW. et al. (1993)]. Major antioxidant 
enzymes such as SOD, catalase (CAT), GPx, glutathione reductase, glutathione S-
transferase and glucose-6-phosphate dehydrogenase are all present in the placenta. In the 
normal placenta, the activities of SOD and CAT increase as gestation progresses, while the 
activity of GPx is diminished. On the other hand, placental production of lipid peroxides 
progressively drop as normal gestation advances, most likely because of the elevated 
activities of SOD and CAT. Thus, in normal pregnancy, placental antioxidant defenses are 
considered sufficient to control lipid peroxidation. Pre-eclampsia is a multisystem 
disorder unique to human pregnancy. It is a complication in 5–10% of pregnancies and 
remains a leading cause of maternal and neonatal mortality and morbidity. This human 
disorder is a leading cause of premature delivery and intrauterine fetal growth 
retardation (IUGR). Pre-eclampsia is usually diagnosed in late pregnancy because of 
increased blood pressure and proteinuria with the symptoms of pre-eclampsia typically 
disappearing shortly after delivery of the placenta. A significant rise in lipid peroxidation 
levels in the placenta of pre-eclampsia has been suggested [Walsh, SW. et al. (2000), 
Hubel, CA. (1999), Gupta, S. et al. (2005), Vanderlelie, J. et al. (2005), Atamer, Y. et al. 
(2005)]. Several lines of evidence support this assumption, including increased lipid 
peroxidation products, elevated nitrotyrosine immunostaining and reduced antioxidant 
enzyme activities in preeclamptic placentas. In a case control study, Vanderlelie et al. 
[Vanderlelie, J. et al. (2005)] measured tissue levels of SOD, GPx and lipid peroxidation in 
placental samples from women with normal pregnancies (18 women) and with pre-
eclampsia (20 women). Placental tissue homogenates from pre-eclamptic patients 
contained significantly higher levels of lipid peroxides [malondialdehyde (MDA) and 4-
hydroxy-2 (E)- nonenal; 20.68 versus 5.33 mm/mg protein], whereas there were 
significantly lower levels of SOD (2.02 versus 2.48 U/ mg protein) and of GPx (11.50 
versus 17.33 mmol/min/mg) than in control placentas. These finding are consistent with 
a limited enzymatic antioxidant capacity and elevated breakdown of lipids in placental 
tissue of women suffering from pre-eclampsia. Increased levels of thromboxane and lipid 
peroxides associated with a loss of GPx activity was also reported in placentas from pre-
eclamptic patients compared with those from normal pregnancies [Walsh, SW. & Wang, 
Y. (1993)]. In parallel, the in vitro production of lipid peroxides and thromboxane is 
augmented in both trophoblast cells and villous tissues from women with pre-eclampsia 
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lipid peroxide metabolite), as measured by levels in the medium, is higher for pre-
eclamptic placental tissue explants than for normal placental explants [Walsh, SW. et al. 
(2000)]. Collectively, the data provide convincing evidence that oxidative stress and 
especially lipid peroxidation are abnormally increased in the placentas of pre eclamptic 
women. Many et al. [Many, A. et al. (2000)] found particularly intensive immunoreactivity 
for nitrotyrosine in invasive cytotrophoblasts in placental biopsies and vascular 
endothelium in the floating villi obtained from women with pre-eclampsia. The presence 
of nitrotyrosine is suggestive of damage caused by peroxynitrite, a potent nitrosative 
agent [Beckman, JS. & Koppenol, WH. (1996)]. Overall, the findings of nitrotyrosine 
residues in the cellular components of pre-eclamptic placentas may reflect increased 
production of the superoxide anion radical, as it couples with nitric oxide to generate 
peroxynitrite. Placental generation of ROS and reactive nitrogen species (RNS) in pre-
eclampsia might be facilitated by a reduction in local antioxidant defense, although it is 
not clear whether this reduced antioxidant defense is part of the problem or secondary to 
free radical damage. The activities of placental SOD and glucose 6 phosphate-
dehydrogenase are reduced in pre-eclampsia compared to placentas from normal 
pregnancy [Poranen, AK. et al. (1996)]. Moreover, the activities and mRNA expression of 
Cu/ZnSOD and GPx, and tissue levels of vitamin E are significantly lower in placental 
tissues from pre-eclampsia than from normal pregnancy [Wang, Y. & Walsh, SW. (1996)]. 
In summary, there appears to be an increment in ROS generation in the placenta of pre-
eclamptic women. There is also evidence for increased nitrotyrosine residue formation in 
the pre eclamptic placenta suggestive of peroxynitrite formation, perhaps arising from 
local NO production coupled with increased generation of superoxide anion radical and 
either regionally decreased or inadequate SOD. The transition from fetal to neonatal life at 
birth includes acute and complex physiologic changes. The delivery of the fetus from an 
intrauterine relatively hypoxic environment with a PO2 of 20–25 mmHg to an extrauterine 
normoxic environment with a PO2 of 100 mmHg increases oxidative stress. This four to 
fivefold rise in oxygen tension is believed to induce a greater production of ROS [Shoji, H. 
& Koletzko, B. (2007)]. In addition, labor and childbirth may be associated with periods of 
both hypoxia and oxidative stress for the newborn, while neonatal plasma is relatively 
deficient in antioxidants. Several investigators studied the relationship between the 
oxidative state of the mother and the newborn at the moment of birth. Arguelles et al. 
[Auguelles, S. et al. (2006)] measured oxidative stress markers [carbonyl groups, lipid 
peroxides and total antioxidant capacity (TAC)] and found a good correlation between the 
oxidative status of the mother and of the neonate, with higher oxidative stress correlating 
with an even higher oxidative stress of the newborn based on measurements in umbilical 
cord blood. They also report that smoking mothers and their newborns had a higher 
concentration of the carbonyl groups, lipid peroxides and a lower TAC. Term labor is 
typically associated with oxidative stress for the neonate, but there is no difference 
between the degree of fetal oxidative stress in vaginal delivery and cesarean section 
[Fogel, I. et al. (2005), Hracsko, Z. et al. (2007)]. It is unclear, however, whether oxidative 
stress is related to the delivery itself or whether it reflects a pre-existing fetal oxidative 
status. Lauries et al. [Laurie, S. et al. (2007)] demonstrated that distressed fetuses 
delivered by emergency cesarean exhibited increased MDA concentrations, a parameter 
indicative of oxidative damage, and an enhanced GPx activity in amniotic fluid and 
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umbilical cord blood compared to non distressed fetuses delivered by elective cesarean 
section. This is probably an indication of higher fetal oxidative stress. 
2.1. Oxidative stress in neonatal diseases  
Perinatal asphyxia is an insult to the fetus or newborn resulting from a lack of oxygen 
(hypoxia) or a reduced perfusion (ischemia) in various organs. While virtually every organ 
of the body is affected by asphyxia leading to multiorgan failure, the most severe insult 
occurs in the central nervous system, which also lacks many repair processes [Scher, M. 
(2001)]. The mechanism of cellular injury after hypoxia or ischemia is poorly understood, 
but is probably mediated by an excess release of neurotransmitters, generation of ROS/RNS 
and the initiation of lipid peroxidation which, in turn, leads to a cascade of damaging events 
[Harris, ED. (1992)]. 
At the cellular level, cerebral hypoxia–ischemia sets in motion a series of biochemical events 
commencing in a shift from oxidative to anaerobic metabolism; this leads to an 
accumulation of NADH, FADH, lactic acid and H+ ions [Palmer, C. et al. (1990)]. If the 
asphyxic insult persists, the fetus is unable to maintain circulatory centralization, cardiac 
output and cerebral perfusion falls. Owing to the acute reduction in its oxygen supply, 
oxidative phosphorylation and ATP production in the brain are diminished [Yager, JY. et al. 
(1992), Berger, R. et al. (1994)]. As a result, the Na+/K+ pump in cell membranes are 
deprived of the required energy to maintain ionic gradients. With a reduced membrane 
potential, increased numbers of calcium ions flow through voltage-dependent ion channels, 
down an extreme extra-intracellular concentration gradient, into the cell. Intracellular 
accumulation of Na+ and Cl) ions leads to swelling of the cells as water enters by osmosis 
(cytotoxic cell edema) [Vannucci, RC. et al. (1993)]. This damage is thought to be caused by 
the post ischemic production of oxygen radicals, synthesis of NO, inflammatory reactions 
and an imbalance between excitatory and inhibitory neurotransmitter systems. Part of the 
secondary neuronal cell damage may be caused by induction of a well-known cellular 
suicide program referred to as apoptosis [Berger, R. & Garnier, J. (2000)]. Production of 
reactive species in the early reperfusion phase plays a substantial role in the resulting brain 
cell damage. Among the toxicants generated are the superoxide anion radical (O2 •)) and 
hydrogen peroxide (H2O2). The latter agent can be converted to the highly reactive 
hydroxyl radical by transition metals, in particular free iron, ultimately leading to lipid 
peroxidation of the brain cell membranes as well as damage to other macromolecules 
[Halliwell, B. & Gutteridge, JC. (1990)]. 
Recent studies reported increased intra-erythrocyte free iron levels in infants with asphyxia 
[Buonocore, G. et al. (1998)]. Iron may be released from hemoglobin in erythrocytes as result 
of oxidative stress [Ferrali, M. et al. (1992)]. As the erythrocyte is a target of extracellular free 
radicals, free iron release may be followed by extracellular oxidative stress caused by O2 •) 
generation because of phagocyte activation [Buonocore, G. et al. (1994)]. Intra-erythrocyte 
free iron concentrations appear to be a reliable marker of cell oxidative stress and an 
indicator of the risk of oxidative injury in other tissues. Increased production of free radicals 
including the O2 •) and NO induces oxidative stress in the placenta by formation of the pro-
oxidant ONOO); this reactant is formed when O2 •) couples with NO• [Crow, JP. & 
Beckman, JS. (1996), Szabo, C. & Oshima, H. (1997)]. ONOO) is cytotoxic due to a number of 
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variety of enzymes (most notably, mitochondrial respiratory enzymes) and membrane 
pumps [Crow, JP. & Beckman, JS. (1995)] and depletion of GSH [Phelps, DT. et al. (1995)]. 
Moreover, ONOO) causes DNA damage [Inoue, S. & Kawanishi, S. (1995), Salgo, MG. et al. 
(1995)] resulting in the activation of the nuclear enzyme poly (ADP-ribose) synthetase, 
depletion of NAD and ATP, and ultimately leading to cell death [Szabo, C. et al. (1997)]. The 
higher levels of free radical production associated with repetitive ischemia likely reflect 
differences in oxygen availability during these events. During repetitive ischemia, the 
availability of oxygen to the fetus for intermittent periods of reperfusion facilitates free 
radical production. With the increased availability of oxygen, oxidative reactions rather than 
reductive reactions are favored. Hyperoxic exposure itself, although essential for promoting 
survival of infants with RDS, induces excessive production of ROS in the respiratory system. 
There exist, however, several potential causes of intracellular and extracellular oxidant 
stress in the preterm newborns with RDS. The high inspiratory concentrations of oxygen 
required to achieve adequate arterial oxygenation, pro-oxidant drugs and infections or 
extrapulmonary inflammation can all promote ROS accumulation and the utilization and 
depletion of antioxidative agents [Kothecha, S. (2000)]. 
In experimental models of respiratory distress, the specific targets of a hyperoxic insult to 
the lung are the vascular endothelial cells and the epithelial cells of the alveoli. ROS induce 
ultrastructural changes in the cytoplasm of pulmonary capillary endothelial cells and cause 
focal hypertrophy and altered metabolic activity. Thus, increased oxidative stress 
accompanied by reduced endogenous antioxidant defenses may play a role in the 
pathogenesis of a number of inflammatory pulmonary diseases including respiratory 
distress in the newborn [Bhandari, V. et al. (2000), Ikegami, M. et al.  (2000)]. A deficit in the 
precise balance between exposure to oxidants and endogenous antioxidants obviously leads 
to elevated oxidative damage. The molecular damage caused by free radicals and related 
reactants appear to be involved in the pathogenesis of a growing number of diseases, 
including RDS of the newborn [Lamb, NJ. et al. (1999), Huertas, JR. et al. (1998)]. When 
phagocytes such as neutrophils are stimulated by microorganisms or other means, they are 
activated and increase their oxidative metabolism; as a result, toxic oxygen derivatives, i.e. 
ROS, are formed. If these oxygen based products are not inactivated, their high chemical 
reactivity leads to damage to a variety of cellular macromolecules including proteins, 
carbohydrates, lipids and nucleic acid. This results in cell injury and may induce respiratory 
cell death [Esteban, J. et al. (1999)]. Under these conditions, a surfactant deficiency may be 
aggravated by the inactivation of the small amount of endogenous surfactant that is 
produced [Boda, D. et al. (1998)]. Furthermore, if exogenous surfactant is given, it may also 
be destroyed [Ikegami, M. et al. (2000), Huertas, JR. et al. (1998)]. Reactive oxygen species 
also have been implicated in the molecular damage seen in the bronchoalveolar lavage 
(BAL) fluid of patients with RDS [Banks, BA. et al. (1998), Dellinger, RP. (1999)]. This 
assertion is supported by several findings; H2O2 is detected in the expired air of RDS 
patients, and myeloperoxidase (MPO) and oxidized-1-antitrypsin have been found in BAL 
fluid. Moreover, increased plasma lipid peroxidation products have been measured in 
critically ill patients and in patients with sepsis and at risk of developing RDS. Also, 
evidence of augmented levels of oxidized lipids and proteins have been found in the plasma 
of patients with RDS. Elevated levels of ROS also have been implicated in the molecular 
damage seen in the BAL fluid of patients with RDS. BAL fluid normally contains a large 
amount of the antioxidant GSH; however, in patients with RDS this is mostly in the oxidized 
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form [Janssen, YMW. et al. (1998)]. Consistent with this, oxidative inactivation of 1-
antiprotease also has been observed in RDS. Elevated concentrations of xanthine and 
hypoxanthine are present in the plasma and BAL fluid of patients with RDS and are a 
potential source of ROS in the presence of exogenously added xanthine oxidase. Also, 
elevated concentrations of orthotyrosine and metatyrosine in BAL fluid protein imply the 
formation of the damaging •OH in the lungs of these patients, as orthotyrosine and 
metatyrosine are isomers of tyrosine thought to be formed exclusively by aromatic 
hydroxylation of phenylalanine by •OH [Kim, K. et al. (1999)]. Chlorotyrosine and 
nitrotyrosine also have been found in BAL fluid from patients with RDS. Increased 
concentrations of chlorotyrosine residues in BAL fluid proteins from patients with RDS 
indicate hypochlorous acid (HClO) production by the activated inflammatory cells in the 
lungs of these patients. Chlorotyrosine is formed by HClO-dependent chlorination of 
paratyrosine. HClO is a damaging oxidant formed from H2O2 and chloride ions by the 
enzyme MPO, present in activated inflammatory cells. HClO has been implicated as the 
major damaging species produced by activated neutrophils. While HClO itself is a 
destructive oxidant, it also may interact with low molecular mass iron or O2 •) to produce 
the •OH. Nitrotyrosine concentrations also are significantly elevated in the BAL fluid 
protein of patients with RDS [Ogihara, T. et al. (1999)]. Nitration of tyrosine residues is an in 
vivo marker of the formation of ONOO). Earlier studies reported increased nitrotyrosine 
concentrations in the lungs of patients with RDS. Additionally, under acidic conditions 
ONOO) decomposes to form a powerful oxidant with properties similar to •OH. There is, 
however, another possible explanation for the formation of nitrotyrosine. Recent work 
shows that nitrotyrosine can arise from the reaction of tyrosine with nitroxyl chloride, an 
intermediate formed by the interaction of nitrite (the auto-oxidation product of nitric oxide) 
with HClO. Interestingly, nitrotyrosine concentrations in BAL fluid protein from patients 
with RDS treated with NO were elevated compared with those found in lung-injured 
patients not receiving this therapy [Metnitz, PGH. et al. (1999)]. Increased nitrotyrosine 
concentrations may reflect augmented ONOO) formation in patients receiving NO. As the 
patients receiving inhaled NO are no sicker, in terms of Acute Physiology and Chronic 
Health Evaluation II score or FIO2 requirements, than those patients not receiving this 
therapy, it implies that inhaled NO may react with O2 •) in these circumstances to form the 
nitrating agent [Vento, G. et al. (2000)]. Finally, MPO concentrations are significantly 
elevated in the BAL fluid from patients with RDS, suggesting lung neutrophil recruitment 
and activation [Yitig, S. et al. (1998)]. Collectively, the data are compelling that RDS is 
associated with elevated ROS/RNS generation and the consequential increased oxidative 
damage to the respiratory tree. 
Sepsis represents a serious problem in newborns with an incidence of one to 10 cases per 
1000 live births, with even higher rates in low-birth-weight neonates. Hospital acquired 
infections in neonatal intensive care units may also occur as frequently as 30 infections per 
100 patients. Mortality rates resulting from sepsis in newborns are 30– 50% [Perez, EM. & 
Weisman, LE. (1997)]. Sepsis is characterized by alterations in body temperature, 
hypotension, hypoperfusion with cellular damage which culminates in multiple organ 
failure [Antonielli, M. (1999)]. The initiating event in sepsis is the result of release of 
endotoxins [i.e. bacterial cell wall lipopolysaccharides (LPS)] from gram-negative and gram-
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(1995)] resulting in the activation of the nuclear enzyme poly (ADP-ribose) synthetase, 
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survival of infants with RDS, induces excessive production of ROS in the respiratory system. 
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patients, and myeloperoxidase (MPO) and oxidized-1-antitrypsin have been found in BAL 
fluid. Moreover, increased plasma lipid peroxidation products have been measured in 
critically ill patients and in patients with sepsis and at risk of developing RDS. Also, 
evidence of augmented levels of oxidized lipids and proteins have been found in the plasma 
of patients with RDS. Elevated levels of ROS also have been implicated in the molecular 
damage seen in the BAL fluid of patients with RDS. BAL fluid normally contains a large 
amount of the antioxidant GSH; however, in patients with RDS this is mostly in the oxidized 
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form [Janssen, YMW. et al. (1998)]. Consistent with this, oxidative inactivation of 1-
antiprotease also has been observed in RDS. Elevated concentrations of xanthine and 
hypoxanthine are present in the plasma and BAL fluid of patients with RDS and are a 
potential source of ROS in the presence of exogenously added xanthine oxidase. Also, 
elevated concentrations of orthotyrosine and metatyrosine in BAL fluid protein imply the 
formation of the damaging •OH in the lungs of these patients, as orthotyrosine and 
metatyrosine are isomers of tyrosine thought to be formed exclusively by aromatic 
hydroxylation of phenylalanine by •OH [Kim, K. et al. (1999)]. Chlorotyrosine and 
nitrotyrosine also have been found in BAL fluid from patients with RDS. Increased 
concentrations of chlorotyrosine residues in BAL fluid proteins from patients with RDS 
indicate hypochlorous acid (HClO) production by the activated inflammatory cells in the 
lungs of these patients. Chlorotyrosine is formed by HClO-dependent chlorination of 
paratyrosine. HClO is a damaging oxidant formed from H2O2 and chloride ions by the 
enzyme MPO, present in activated inflammatory cells. HClO has been implicated as the 
major damaging species produced by activated neutrophils. While HClO itself is a 
destructive oxidant, it also may interact with low molecular mass iron or O2 •) to produce 
the •OH. Nitrotyrosine concentrations also are significantly elevated in the BAL fluid 
protein of patients with RDS [Ogihara, T. et al. (1999)]. Nitration of tyrosine residues is an in 
vivo marker of the formation of ONOO). Earlier studies reported increased nitrotyrosine 
concentrations in the lungs of patients with RDS. Additionally, under acidic conditions 
ONOO) decomposes to form a powerful oxidant with properties similar to •OH. There is, 
however, another possible explanation for the formation of nitrotyrosine. Recent work 
shows that nitrotyrosine can arise from the reaction of tyrosine with nitroxyl chloride, an 
intermediate formed by the interaction of nitrite (the auto-oxidation product of nitric oxide) 
with HClO. Interestingly, nitrotyrosine concentrations in BAL fluid protein from patients 
with RDS treated with NO were elevated compared with those found in lung-injured 
patients not receiving this therapy [Metnitz, PGH. et al. (1999)]. Increased nitrotyrosine 
concentrations may reflect augmented ONOO) formation in patients receiving NO. As the 
patients receiving inhaled NO are no sicker, in terms of Acute Physiology and Chronic 
Health Evaluation II score or FIO2 requirements, than those patients not receiving this 
therapy, it implies that inhaled NO may react with O2 •) in these circumstances to form the 
nitrating agent [Vento, G. et al. (2000)]. Finally, MPO concentrations are significantly 
elevated in the BAL fluid from patients with RDS, suggesting lung neutrophil recruitment 
and activation [Yitig, S. et al. (1998)]. Collectively, the data are compelling that RDS is 
associated with elevated ROS/RNS generation and the consequential increased oxidative 
damage to the respiratory tree. 
Sepsis represents a serious problem in newborns with an incidence of one to 10 cases per 
1000 live births, with even higher rates in low-birth-weight neonates. Hospital acquired 
infections in neonatal intensive care units may also occur as frequently as 30 infections per 
100 patients. Mortality rates resulting from sepsis in newborns are 30– 50% [Perez, EM. & 
Weisman, LE. (1997)]. Sepsis is characterized by alterations in body temperature, 
hypotension, hypoperfusion with cellular damage which culminates in multiple organ 
failure [Antonielli, M. (1999)]. The initiating event in sepsis is the result of release of 
endotoxins [i.e. bacterial cell wall lipopolysaccharides (LPS)] from gram-negative and gram-





inflammatory cells, including polymorphonuclear leukocytes (neutrophils; PMN), 
monocytes/macrophages and lymphocytes. LPS also initiates cellular and humoral aspects of 
the inflammatory immune response. The inflammatory response that occurs as the result of 
infection is the predominant determinant of outcome in sepsis [Cohen, J. (2002), Abraham, E. 
& Singer, M. (2007)]. A major feature of sepsis is tissue infiltration by phagocytic cells [Basit, A. 
et al. (2006), Cepinskas, G. et al. (2003), Ley, K. & Reutershan, J. (2006), Rawlingson, A. (2003), 
Razavi, HM. et al. (2005)]. When this occurs, PMN and monocytes/macrophages respond to 
septic stimulation by producing ROS and RNS [Mochida, S. et al. (2007)]. In addition, PMN 
release enzymes (e.g. elastase, cathepsin, etc.) and the MPO-derived oxidant, HOCl. These 
reactants contribute to PMN/macrophage-mediated killing of bacteria. However, if produced 
in excess during sepsis, the ROS/RNS and proteolytic enzymes cause microvascular 
dysfunction followed by organ shutdown. An inflammatory response to septic stimuli is 
crucial for host defense, because it up-regulates anti-inflammatory mediators (e.g. IL-1 
receptor antagonist, IL-4, IL-10) and antioxidant enzymes (e.g. CAT, GPx and SOD). However, 
the excessive production of pro-inflammatory mediators in sepsis overwhelms the anti-
inflammatory signaling processes leading to a suppression of innate immune functions 
(especially those of PMN) and causing immunoparalysis and subsequently an increased 
susceptibility to infection [Riedemann, NC. et al. (2003)]. It is important to note that, besides 
immune cells, microvascular endothelial cells also become activated in sepsis which 
contributes to amplification of the inflammatory response [Lush, CW. & Kvietys, PR. (2000), 
Ley, K. & Reutershan, J. (2006), Liu, L. & Kubes, P. (2003)]. It is known that septic stimuli (e.g. 
LPS, TNF-a) initiate activation of transcription factors including NFjB and AP-1, resulting in 
transcriptional activation of multiple genes. This leads to the release of pro-inflammatory 
cytokines (e.g. TNF-a, IL-1b, etc), and elevates the expression of adhesion molecules (e.g. E-
selectin, ICAM-1, VCAM-1) and chemokines by endothelial cells [Ley, K. & Reutershan, J. 
(2006), Liu, SF. & Malik, AB. (2006), Abraham, E. (2003), Rao, RM. et al. (2007)]. The central role 
of ROS/RNS in modulation of the endothelial cell proinflammatory phenotype is well 
documented [Janssen-Heininger, YM. et al. (2000)]. Despite a large amount of research, little 
progress has been made in improving the outcome of septic newborns [Riedemann, NC. et al. 
(2003)]. Efforts to block one or more aspects of the sepsis-associated inflammatory pathways 
have had little impact on patient survival. Of many drugs tested, few have demonstrated 
efficacy [Panacek, EA. et al. (2004), Bernard, GR. et al. (2001), Abraham, E. (2005), Ely, EW. et 
al. (2002)]. Clinical reports are consistent with the involvement of ROS/RNS in neonatal sepsis 
and its complications. Batra et al. [Batra, S. et al. (2000)] documented increased production of 
oxygenderived reactants in septic neonates. Also, Seema et al. [Seema, KR. et al. (1999)] found 
newborns with sepsis have significantly higher levels of TNF-a and increased activity of 
antioxidative enzymes, SOD and GPx. Finally, Kurt et al. [Nese Citak, KA. et al. (2007)] 
demonstrated that serum IL-1b, IL 6, IL-8, and TNF-a are mediators of inflammation and can 
be used at the diagnosis and at the evaluation of the therapeutic efficiency of drugs used to 
treat neonatal sepsis. 
2.2 Oxidative stress and resuscitation with ambient air VS pure oxygen 
The traditional method of resuscitation of newly born infants is with pure oxygen 
[Kattwinkel, J. et al. (1999), Niermeyer, S. et al. (2000)]. However, this therapy was 
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introduced without any preceding randomised trials being conducted. It was assumed, 
without any supporting data, that 100% O2 would be the optimal oxygen concentration 
[Lefkowitz, W. (2002)]. There is, however, reason to believe that oxidative stress is elevated 
when resuscitation is performed with pure oxygen compared with ambient air. For this 
reason, SAUGSTAD and AASEN [Saugstad, OD. & Aansen, AO. (1980)] warned that the use 
of high concentrations of supplemental O2 might be detrimental for resuscitation. Several 
experimental as well as clinical studies seem to confirm this [Armstead, WM. et al. (1988), 
Bagenholm, R. et al. (1998), Kondo, M. et al. (2000),  Kutzsche, S. et al. (2002), Vento, M. et al. 
(2001), Saugstad, OD. (2001)]. In addition to animal studies, clinical trials have importantly 
shown that ambient air is at least as efficient as pure O2 for resuscitation of the newly born 
[Ramji, A. et al. (1993), Saugstad, OD. et al. (1998), Vento, M. et al. (2001, 2003), Ramji, S. et 
al. (2003)]. 
In 1993, RAMJI et al. [Ramji, A. et al. (1993)] published a single-centre study from New Dehli 
with the aim of investigating the feasibility of using 21% O2 for resuscitation. A total of 42 
infants resuscitated with 21% and 42 with 100% O2 were enrolled with the following 
inclusion criteria: cardiac frequency, 80 bpm and or apnoea/ poor response. Birth weight 
,1,000 g and or lethal congenital anomalies were exclusion criteria. Restoration of cardiac 
frequency, Apgar score, acid base and blood gases were not different between the two 
groups. A second investigation in this area was the Resair 2 study [Saugstad, OD. et al. 
(1998)], a multicentre study comprising ,600 infants from Egypt, Estonia, India, Norway, 
Philippines and Spain recruited from 10 centres. The study was pseudo-randomised and not 
blinded. No significant differences in the primary outcome measure, which was early 
neonatal death and/or hypoxic ischaemic encephalopathy grade 2 or 3, were found. 
However, there was a statistically insignificant tendency to higher neonatal survival in the 
infants resuscitated with 21% versus 100% O2. Time to first breath and first cry was 
significantly delayed in those reoxygenated with pure oxygen. Since then, three more 
studies by Resair 2 collaborators have been published, two from Spain [Vento, M. et al. 
(2001, 2003)] and one from India [Ramji, S. et al. (2003)]. When the results of these five 
studies were combined, a significant reduction in neonatal mortality (from 13 to 8%) in those 
resuscitated with ambient air compared with 100% O2 was found. Most of the 1,737 children 
were enrolled from developing countries; SAUGSTAD et al. [Saugstad, OD. et al. (2005)], 
therefore, separately analysed the Spanish babies. In this material, a 3% reduced mortality 
was found in favour of room-air infants (from 3.5 to 0.5%), indicating that, also in 
industrialised countries, a significant reduction in neonatal mortality can be achieved by not 
using pure oxygen for resuscitation. One surprising finding of these studies is that time to 
first breath and first cry is significantly reduced by 24 s; moreover, the 5-min Apgar score, as 
well as cardiac frequency at 90 bpm is also significantly higher in room-air-resuscitated 
infants compared with those resuscitated with pure oxygen. 
For babies born at term, the Guidelines of 2005 recommend use of 100% supplemental O2 
when a baby is cyanotic or when positive pressure ventilation (PPV) is required during 
neonatal resuscitation. However, research suggests that resuscitation with ,100% may be just 
as successful. If resuscitation is started with ,100% oxygen, supplemental oxygen up to 100% 
should be administered if there is no appreciable improvement within 90 s following birth. 
If supplemental oxygen is unavailable, the use of room air to deliver PPV is suggested. To 
reduce excessive tissue oxygenation in a very pre-term baby (less than ,32 weeks), use of an 
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PPV with an oxygen concentration between room air and 100%. No studies justify starting at 
any particular concentration. Adjust O2 concentration up or down to achieve an 
oxyhaemoglobin concentration that gradually increases toward 90%, and reduce the oxygen 
concentration as saturations rise over 95%. If the cardiac frequency does not respond by 
increasing rapidly to .100 bpm, correct any ventilation problem and use 100% oxygen. If the 
facility does not have use of an oxygen blender and pulse oximeter in the delivery room, and 
there is insufficient time to transfer the mother to another facility, the resources and oxygen 
management described for a term baby are appropriate. There is no convincing evidence that a 
brief period of 100% oxygen during resuscitation is detrimental to the pre-term infant. In 2007, 
a summary of the results of three systematic reviews [Saugstad, OD. et al. (2005), Tan, A. et al. 
(2005), Raby, Y. et al. (2007)] of five trials and seven individual studies, including up to 2,011 
newborn infants, indicated that neonatal mortality was reduced by 30–40% if resuscitation is 
carried out with 21% instead of 100% O2 [Saugstad, OD. (2007)]. Room-air resuscitation also 
leads to faster early recovery and a shorter duration of resuscitation. To date, there are 
sufficient data available to recommend that newborn resuscitation should generally not be 
carried out using 100% O2. In extremely low-birth-weight (ELBW) infants, arterial oxygen 
saturation (Sa,O2) levels should be kept between 85 and 93% or possibly between 88 and 95%, 
but should definitely not exceed 95%. Fluctuations should be avoided [Saugstad, OD. (2007)]. 
A recent prospective, randomised, clinical trial included infants of f28 weeks of gestation who 
required active resuscitation and were randomly assigned to a low-oxygen group (fraction of 
inspired oxygen: 30%) or a high-oxygen group (fraction of inspired oxygen: 90%) [Escrig, R. et 
al. (2008)]. The fraction of inspired oxygen in the low-oxygen group was increased stepwise to 
45% and that in the high-oxygen group was reduced to 45% to reach a stable pulse oxygen 
saturation of approximately 85% at 5–7 mins in both groups. No differences in oxygen 
saturation in minute-to-minute registers were found, independent of the initial fraction of 
inspired oxygen used 4 mins after cord clamping. Likewise, no differences in mortality rates in 
the early neonatal period were detected. The authors concluded that resuscitation can be safely 
initiated for ELBW neonates with a low fraction of inspired oxygen (30%), which then should 
be adjusted to the infant’s needs, reducing the oxygen load to the neonate [Saugstad, OD. 
(2003)]. 
New Guidelines for Neonatal Resuscitation give reason to Saugstad, who had long been 
considered a historical mistake and an anachronism to continue to resuscitate infants with 
100% O2. For term infants it's recommended to use oxygen blenders and pulse oximeters 
during resuscitation; it’s recommended the use of O2 100% only when a child is cyanotic or 
when is required positive pressure ventilation, but it can be successful resuscitation with 
concentrations of O2 <100%; it’s recommended to start with 21% oxygen; if there is not an 
adequate response regarding heart rate within 90 s, add oxygen according to pulse oximetry if 
possible [Vento, M. & Saugstad, OD. (2010)]. For preterm infants (<32 wk.) it’s recommended 
to begin PPV with O2 concentrations in a range between 21% and 30%. If Sa O2 is < 70% at 5 
min of age, give oxygen. If heart rate is not increasing satisfactorily, oxygen should be given at 
any time to both groups. Babies with abnormal lungs, for instance after meconium aspiration, 
may need supplemental oxygen from early on [Vento, M. & Saugstad, OD. (2010)]. 
2.3 Oxidative stress and lung injury 
Chronic lung disease (CLD) of the newborn is one of the definitive factors influencing the 
mortality and morbidity of VLBW infants [Banks, BA. et al. (1998)]. The aetiology of CLD is 
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unknown, but many investigators have suggested that free radicals may have a key role in 
its development. The exposure of immature lungs to prolonged periods of high levels of 
inspired oxygen is accepted as an important contributor to the development of CLD through 
both free radical effects on endothelial and epithelial cell barriers that induce pulmonary 
oedema and trigger mechanisms that lead to activation and accumulation of inflammatory 
cells [Saugstad, OD. (1998)]. Unfortunately, CLD still develops in extremely premature 
infants that do not have significant ventilatory or supplemental oxygen needs in the acute 
course of prematurity. A new form of CLD is less fibrotic than its earlier counterpart, and 
there is a significant component of delayed alveolar development and perhaps permanent 
alveolar underdevelopment [Coalson, JJ. et al. (1999), Margraf, LR. et al. (1991)]. Currently, 
the mechanisms for the development of the new form of CLD have not been fully elucidated 
and the contribution of oxygen toxicity is debatable. The fact that premature infants develop 
CLD without being exposed to high concentrations of supplemental oxygen raises the 
question as to whether oxidative stress in fact contributes to the development of CLD. It is 
plausible, however, that even low concentrations of supplemental oxygen in premature 
patients with developmentally poorly prepared antioxidant defense mechanisms may 
generate significant oxidant stresses and lung injury secondary to oxidation of specific 
macromolecules [Welty, SE. (2000)]. In addition, inflammatory cell accumulation and 
activation in the lung may generate oxidants and oxidant stresses that also oxidise 
macromolecules which leads to CLD [Welty, SE. (2000)]. The literature provides evidence 
that premature infants who develop CLD have both qualitative and quantitative differences 
in oxidation of lipids and proteins when compared with infants who do not develop CLD. 
Such differences in oxidation patterns are the most obvious in the first few days of life 
[Welty, SE. (2001)]. In a study by OGIHARA et al. [Ogihara, T. et al. (1999)], plasma levels of 
lipid aldehydes were measured in the first week of life in premature infants. Plasma 
concentrations of heptanal, 2-nonenal and 4 hydroxynonenal were higher in the first 24 h of 
life in infants who develop CLD than in those that did not. In another study, elevated 
exhaled pentane levels were strongly associated with several adverse outcomes in 
premature infants. In fact, infants who developed CLD had higher exhaled pentane on the 
first day of life than did patients who did not develop CLD [Nycyk, JA. et al. (1998)]. Protein 
oxidation was also previously assessed in premature infants and correlated with the 
development of CLD. There is also an association between higher protein carbonyl contents 
in tracheal aspirates in the first week of life and the development of CLD [Varsila, E. et al. 
(1995)]. Moreover, RAMSAY et al. [Ramsay, PL. et al. (2001)] demonstrated that there were 
no differences in oxygen requirements of tracheal aspirate contents of total 2,4-
dinitrophenylhydrazine reactive proteins between premature infants who did or did not 
develop CLD; however, infants who developed CLD did have more frequent oxidation of 
specific proteins than did infants who did not develop CLD. These results suggest that 
identifying specific proteins that are more frequently oxidised in infants who develop CLD 
may be important in determining specific mechanisms for the development of CLD. Other 
pathways of ROS generation include metabolism of catecholamines, the arachidonic acid 
cascade, and mitochondrial metabolism [Bracci, R. (1997)]. However, the main source of free 
radicals in the lungs seems to be phagocyte activation [Delacourt, C. et al. (1996), Pittet, JF. et 
al. (1997)]. The increase in phagocyte number and interleukin concentrations in BAL fluid 
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unknown, but many investigators have suggested that free radicals may have a key role in 
its development. The exposure of immature lungs to prolonged periods of high levels of 
inspired oxygen is accepted as an important contributor to the development of CLD through 
both free radical effects on endothelial and epithelial cell barriers that induce pulmonary 
oedema and trigger mechanisms that lead to activation and accumulation of inflammatory 
cells [Saugstad, OD. (1998)]. Unfortunately, CLD still develops in extremely premature 
infants that do not have significant ventilatory or supplemental oxygen needs in the acute 
course of prematurity. A new form of CLD is less fibrotic than its earlier counterpart, and 
there is a significant component of delayed alveolar development and perhaps permanent 
alveolar underdevelopment [Coalson, JJ. et al. (1999), Margraf, LR. et al. (1991)]. Currently, 
the mechanisms for the development of the new form of CLD have not been fully elucidated 
and the contribution of oxygen toxicity is debatable. The fact that premature infants develop 
CLD without being exposed to high concentrations of supplemental oxygen raises the 
question as to whether oxidative stress in fact contributes to the development of CLD. It is 
plausible, however, that even low concentrations of supplemental oxygen in premature 
patients with developmentally poorly prepared antioxidant defense mechanisms may 
generate significant oxidant stresses and lung injury secondary to oxidation of specific 
macromolecules [Welty, SE. (2000)]. In addition, inflammatory cell accumulation and 
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macromolecules which leads to CLD [Welty, SE. (2000)]. The literature provides evidence 
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dinitrophenylhydrazine reactive proteins between premature infants who did or did not 
develop CLD; however, infants who developed CLD did have more frequent oxidation of 
specific proteins than did infants who did not develop CLD. These results suggest that 
identifying specific proteins that are more frequently oxidised in infants who develop CLD 
may be important in determining specific mechanisms for the development of CLD. Other 
pathways of ROS generation include metabolism of catecholamines, the arachidonic acid 
cascade, and mitochondrial metabolism [Bracci, R. (1997)]. However, the main source of free 
radicals in the lungs seems to be phagocyte activation [Delacourt, C. et al. (1996), Pittet, JF. et 
al. (1997)]. The increase in phagocyte number and interleukin concentrations in BAL fluid 





are involved in the development of lung injury [Groneck, P. et al. (1993)]. Infants destined to 
develop CLD have increased pro-inflammatory cytokine levels in airway samples 
[Bancalari, E. & Gonzales, A. (2000), Speer, CP. & Groneck, P. (1998)]; however, there is little 
information on when the pro-inflammatory indicators appear or how they progress in the 
pre-term lung subjected to mechanical ventilation. Moreover, in those infants, a large 
number of activated neutrophils are found in the air spaces within hours after birth 
[Arnoon, S. et al. (1993)].The contribution of airway inflammation to the development of 
CLD of prematurity has been extensively studied [Jonsson, B. et al. (1997), An, H. et al. 
(2004), Bancalari, E. (2000), Groneck, P. & Speer, CP. (1995), McColm, JR. & McIntosh, N. 
(1994)]. There is a dynamic and complex balance between pro- and anti-inflammatory 
cytokines in the human immune system. Previous studies on premature infants have shown 
that an increase of tumour necrosis factor (TNF)-a in tracheal secretions, among other pro-
inflammatory cytokines, was associated with the duration of mechanical ventilation 
[Schultz, C. et al. (2003)] and the development of CLD [Deng, H. et al. (2000), Kotecha, S. 
(1996), Kotecha, S. et al. (1995)]. The role of the anti-inflammatory cytokines is less clear. 
Recent studies have demonstrated that pre-term infants with respiratory distress do 
produce significant amounts of IL-10 in the lower airways and the presence of this anti-
inflammatory cytokine prevents the development of CLD of prematurity [McColm, JR. et al. 
(2000)]. JONES et al. [Jones, CA. et al. (1996)] were unable to detect interleukin (IL)-10 in 
most of the airway samples from pre-term infants. This observation agrees with a study 
showing that the control of airway inflammation by this cytokine is limited in infants 
[Dudley, DJ. et al. (1997)]. Of interest is that SAUGSTAD [Saugstad, OD. (2003)] claims that 
these changes are seen very early and are present only a few hours or days after birth in 
those infants who go on to develop CLD. This may support the suggestion that pre-natal 
factors, such as inflammation, are important for its development and that the changes 
leading to CLD are triggered before birth. If this is the case, it holds important implications 
for future therapeutic approaches [Saugstad, OD. (2003)]. The most common reason for 
neonates requiring respiratory support is RDS. In this disease, the pathophysiology is one of 
progressive loss of lung volume, intrapulmonary shunt and deflation instability. Animal 
and human models of RDS have clearly shown that ventilator strategies alter the clinical and 
pathological evolution of RDS. In addition, it is claimed that neonates with RDS are 
susceptible to lung injury and the subsequent development of related conditions. It is being 
increasingly realised that modes of mechanical ventilation that result in end-inspiratory 
alveolar over-stretching and/or repeated alveolar collapse and re-expansion disturb the 
normal fluid balance across the alveolo-capillary membrane. The effects of this include 
disturbance in the integrity of the endothelium and epithelium and impairment of the 
surfactant system; these changes are similar to those seen in acute RDS. Mechanical 
ventilation can injure pre-term lungs and multiple ventilation strategies have been 
attempted to reduce injury and improve outcomes. In 1999, CLARK et al. [Clark, RH. et al. 
(1999)] proclaimed that, ‘‘the concept of ventilator-induced lung injury has come of age’’. 
There are many data which suggest that ventilation can cause biotrauma associated with a 
‘‘mediator storm’’ (perhaps cytokines) and that it is responsible for distal organ dysfunction, 
subsequent multiorgan failure and death. Although it has been shown that pulmonary 
cytokine levels also appear to be elevated in some neonates on assisted ventilation, the exact 
relationship to neonatal lung injury has yet to be defined. Pro-inflammatory mediators may 
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be elevated because of fetal exposure to maternal inflammatory mediators, post-natal 
infections or due to release of mediators from the pre-term lung attributable to ventilator-
induced injury. The pre-term lung is susceptible to injury with the initiation of ventilation 
because potential lung volumes are small, surfactant may be deficient, the lung matrix is not 
fully developed and the air spaces contain residual fetal lung fluid. Tidal volume (VT) 
during the resuscitation of pre-term infants is not monitored, and easily visible chest 
movements will result in VT in excess of that routinely needed to ventilate infants [Ikegami, 
M. et al. (2000)]. Preterm infants are often hyperventilated and low carbon dioxide tension 
(PCO2) values after birth correlate with an increased incidence of CLD [Gannon, M. et al. 
(1998)]. The most effective strategy is the avoidance of mechanical ventilation with the use 
of nasopharyngeal continuous positive airway pressure whenever possible. Barotrauma, 
volutrauma and oxygen toxicity, during intermittent positive pressure ventilation, are 
assumed to be important factors in the pathogenesis of CLD as they cause pulmonary 
damage, resulting in a release of multiple proinflammatory cytokines and production of 
extracellular matrix components and growth factors [Ehrenkranz, RA. & Mercurio, MR. 
(1992)]. The current orientation in the clinical practice is to emphasise the potential 
importance of reducing mechanical insults on acutely diseased lungs by using special 
modes of ventilation, e.g. high frequency oscillatory ventilation (HFOV), that limit the 
pressure and volume of gas delivered to the lungs [Zoban, P. & C  erny, M. (2003)]. HFOV 
may reduce volutrauma by using a small tidal volume (VT), maintaining almost constant 
alveolar pressure, and optimising lung volume through the regulation of mean airway 
pressure [Bohn, DJ. et al. (1980), Gerstmann, DR. et al. (1990)]. Reducing volutrauma is 
important since damaged tissue generates free radicals and may become inflamed, a process 
that further contributes to the production of toxic oxygen derivatives. The results of 
randomised trials to date, conducted on human neonates comparing HFOV with 
conventional mechanical ventilation (CMV), have been inconclusive and the results are 
conflicting. Therefore, it remains an open question whether HFOV is more beneficial in 
preventing CLD than a high-rate, minimal-pressure, low VT, CMV strategy [Bollen, CW. et 
al. (2003)]. Also, in the Cochrane Database of 2007, the authors conclude that there is no 
clear evidence that elective HFOV offers important advantages over CMV when used as the 
initial ventilation strategy to treat pre-term infants with acute pulmonary dysfunction. There 
may be a small reduction in the rate of CLD with HFOV use, but the evidence is weakened 
by the inconsistency of this effect across trials and the overall borderline significance [Cools, 
F. et al. (2007)]. To develop less traumatic mechanical ventilation, with the aim of limiting 
lung volutrauma, guaranteed volume (GV) integrates various modalities to trigger 
ventilation with pressure control including assisted/controlled (A/C), synchronised 
intermittent mandatory ventilation (SIMV) and pressure support ventilation (PSV). GV is an 
uncommon ventilation method which controls pressure but provides a fixed current volume 
according to compliance variations, to resistance and to spontaneous activity. The ventilator 
corrects inspiratory pressure giving a current volume that tends to be the same as the set 
volume. The gradual improvement in compliance of a pulmonary pathology ventilated with 
GV follows a reduction of peak inspiratory pressure [Donn, SM. & Sinha, SK. (2003), 
Herrera, CM. et al. (2003)]. LISTA et al. [Lista, G. et al. (2004)] evaluated the lung 
inflammatory response in pre-term infants with RDS mechanically ventilated with or 
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tracheobronchial aspirate (TA) fluid. Their data suggest that a volume-targeted ventilatory 
strategy may play a role in reducing the acute inflammatory response, and thereby also 
limiting oxidative stress in pre-term infants with RDS. The outcome of this clinical trial 
shows that there are lower pro inflammatory cytokine levels (IL-6, IL-8, and TNF-a) in BAL 
of infants with severe RDS supported with PSV with GV compared with PSV only. The 
study of DANI et al. [Dani, C. et al. (2006)] was the first clinical trial demonstrating that the 
early treatment of RDS with HFOV is associated with the reduction of pulmonary 
inflammatory reaction in pre-term infants in comparison with the early application of 
another potentially lung-protective ventilations strategy such as PSV plus GV. While there 
are obviously conflicting findings in this field, it is generally accepted that antecedent lung 
inflammation or injury makes the lungs more susceptible to volutrauma and oxidant 
induced injury by the reactive species shown in figure 1. The resulting damage promotes 
inflammation that is not limited to the lung but that may also affect distant organs, and 
oxygen, when used at high concentration, can be toxic. Although there are a variety of 
modalities of ventilation that are non invasive, each ventilatory strategy has a potentially 
negative consequence in terms of tissue damage resulting from the production of both ROS 
and RNS. Small VT ventilation is associated with progressive low volume and surfactant 
dysfunction. Limiting VT requires higher levels of end-expiratory pressure and/or FI,O2 to 
maintain adequate oxygenation. Higher levels of FI,O2 can contribute to oxidant-induced 
lung injury. Thus, the use of lung protective strategies in the neonate requires proactive 
decisions that must be specific for disease pathophysiology and lung maturity, and that 
involve compromises between gas exchange goals and potential toxicities of the treatments. 
Besides the ventilatory strategies in common use to treat brochopulmonary dysfunction in 
newborns and because optimal oxygen saturation for use in these cases is difficult to 
achieve, other treatments have also been attempted. For example, inhalation of nitric oxide, 
administration of caffeine or surfactant and intramuscular injection of high doses of vitamin 
A have been used in infants with the hope of improving pulmonary physiology. 
Additionally, the utility of two antioxidants, i.e. Nacetylcysteine and superoxide dismutase, 
have been tested. None of these extra-ventilatory procedures has generally provided 
substantial benefit [Thomas, W. & Speer, CP. (2008)]. 
3. Melatonin and oxidative stress 
Melatonin, an endogenously produced indoleamine, is a highly effective antioxidant, free 
radical scavenger, and a primary circadian regulator. Melatonin has important antioxidant 
properties owing to direct and indirect effects. It directly scavenges reactive oxygen and 
reactive nitrogen species, prevents molecular oxidation, improves mitochondrial 
physiology, and restores glutathione homeostasis. Its indirect antioxidant effects stem from 
its ability to stimulate the activities of the enzymes involved in the glutathione cycling and 
production. Melatonin, by reducing free radical damage, may be an effective protective 
agent for the fetus as it is in adults. Several clinical studies on melatonin have shown that it 
reduces oxidative stress in human newborns with sepsis, hypoxic distress, or other 
conditions, where there is excessive free radical generation. Several clinical studies that used 
melatonin showed that it reduces oxidative stress in newborns with sepsis, distress, or other 
conditions, where there is excessive ROS/RNS production [Gitto, E. et al. (2009)]. In one of 
these studies, the level of lipid peroxidation products and the nitrite + nitrate levels were 
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measured in the serum of asphyxiated newborns before and after treatment with melatonin 
given within the first 6 hr of life [Fulia, F. et al. (2001)]. Serum levels of these measures in 
newborns with asphyxia were found to be significantly higher than those in normal infants; 
these levels were significantly reduced by melatonin treatment [Fulia, F. et al. (2001)]. The 
protective actions of melatonin in these situations likely relate to the antioxidant properties 
of the indole and its metabolites as well as to the ability of melatonin to increase the 
efficiency of mitochondrial electron transport, thereby reducing electron leakage and free 
radical generation [Hardeland, R. (2005),  Leon, J.; Acun˜a-Castroviejo, D. et al. (2004), 
Leo´n, J. et al. (2005), Reiter, RJ. et al. (2008)]. 
A seminal study examined the changes in the clinical status and serum levels of lipid 
peroxidation products [MDA and 4-hydroxylalkenals (4-HDA)] in septic newborns treated 
with melatonin given within the first 12 hr after diagnosis [Gitto, E. et al. (2001)]. Ten other 
septic newborns in a comparable state were used as _septic_ controls, while 10 healthy 
newborns served as normal controls. Serum MDA + 4-HDA concentrations in newborns with 
sepsis were significantly higher than those in healthy infants without sepsis; in contrast, in 
septic newborns treated with melatonin, there was a significant reduction of MDA + 4- HDA 
levels compared to the values measured in the normal controls at both 1 and 4 hr after the 
initiation of melatonin treatment. Melatonin also improved the clinical outcome of the septic 
newborns as judged by measurement of sepsis related serum parameters after 24 and 48 hr. 
We have also tested whether melatonin treatment would lower IL-6, IL-8, TNFa, and 
nitrite/nitrate levels in 24 newborns with respiratory distress syndrome (RDS) of III or IV 
grade (radiographically confirmed) diagnosed within the first 6 hr of life [Gitto, E. et al. 
(2004)]. Compared with the melatonin treated RDS newborns, in the untreated infants, the 
concentrations of IL-6, IL-8, and TNFa were significantly higher at 24, 72 hr, and at 7 days after 
onset of the study. In addition, nitrite/nitrate levels at all time points were higher in the 
untreated RDS newborns than in the melatonin treated babies. Following melatonin 
administration, nitrite/ nitrate levels decreased significantly, whereas they remained high and 
became further elevated in the RDS infants not given melatonin. In a clinical trial, the levels of 
proinflammatory cytokines (IL6, IL-8, and TNFa) and the clinical status of 110 preterm 
newborns with RDS ventilated with different modalities [conventional ventilation, pressure-
support ventilation (PSV) and with guaranteed volumes (GV), and high-frequency oscillatory 
ventilation] were evaluated before and after treatment with the antioxidant melatonin [Gitto, 
E. et al. (2005)]. Compared with the melatonin-treated RDS newborns, the concentrations of 
inflammatory cytokines were significantly elevated in the newborns given only the diluent. 
When serum levels of IL-6, IL-8, and TNFa for the two groups were compared, melatonin 
treatment clearly had anti-inflammatory effects. In particular, it was noted that newborns 
mechanically ventilated in PSV mode with GV presented a greater reduction of serum levels of 
inflammatory cytokines than did newborns ventilated in conventional mode or with 
oscillatory ventilation. The measured inflammatory cytokines were most markedly elevated in 
infants mechanically ventilated but not given melatonin. Newborns not treated with 
melatonin, who developed chronic lung disease (CLD), have much higher concentrations of 
proinflammatory cytokines than infants without CLD [Gitto, E. et al. (2004)]. It was also found 
that melatonin lowered interleukin IL-6, IL-8, TNF-a, and nitrite/nitrate levels and modified 
serum inflammatory parameters in surgical neonates, thereby improving their clinical course 
[Gitto, E.; Romeo, C. et al. (2004)]. In animals, the anti-inflammatory actions are thoroughly 
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lung injury. Thus, the use of lung protective strategies in the neonate requires proactive 
decisions that must be specific for disease pathophysiology and lung maturity, and that 
involve compromises between gas exchange goals and potential toxicities of the treatments. 
Besides the ventilatory strategies in common use to treat brochopulmonary dysfunction in 
newborns and because optimal oxygen saturation for use in these cases is difficult to 
achieve, other treatments have also been attempted. For example, inhalation of nitric oxide, 
administration of caffeine or surfactant and intramuscular injection of high doses of vitamin 
A have been used in infants with the hope of improving pulmonary physiology. 
Additionally, the utility of two antioxidants, i.e. Nacetylcysteine and superoxide dismutase, 
have been tested. None of these extra-ventilatory procedures has generally provided 
substantial benefit [Thomas, W. & Speer, CP. (2008)]. 
3. Melatonin and oxidative stress 
Melatonin, an endogenously produced indoleamine, is a highly effective antioxidant, free 
radical scavenger, and a primary circadian regulator. Melatonin has important antioxidant 
properties owing to direct and indirect effects. It directly scavenges reactive oxygen and 
reactive nitrogen species, prevents molecular oxidation, improves mitochondrial 
physiology, and restores glutathione homeostasis. Its indirect antioxidant effects stem from 
its ability to stimulate the activities of the enzymes involved in the glutathione cycling and 
production. Melatonin, by reducing free radical damage, may be an effective protective 
agent for the fetus as it is in adults. Several clinical studies on melatonin have shown that it 
reduces oxidative stress in human newborns with sepsis, hypoxic distress, or other 
conditions, where there is excessive free radical generation. Several clinical studies that used 
melatonin showed that it reduces oxidative stress in newborns with sepsis, distress, or other 
conditions, where there is excessive ROS/RNS production [Gitto, E. et al. (2009)]. In one of 
these studies, the level of lipid peroxidation products and the nitrite + nitrate levels were 
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measured in the serum of asphyxiated newborns before and after treatment with melatonin 
given within the first 6 hr of life [Fulia, F. et al. (2001)]. Serum levels of these measures in 
newborns with asphyxia were found to be significantly higher than those in normal infants; 
these levels were significantly reduced by melatonin treatment [Fulia, F. et al. (2001)]. The 
protective actions of melatonin in these situations likely relate to the antioxidant properties 
of the indole and its metabolites as well as to the ability of melatonin to increase the 
efficiency of mitochondrial electron transport, thereby reducing electron leakage and free 
radical generation [Hardeland, R. (2005),  Leon, J.; Acun˜a-Castroviejo, D. et al. (2004), 
Leo´n, J. et al. (2005), Reiter, RJ. et al. (2008)]. 
A seminal study examined the changes in the clinical status and serum levels of lipid 
peroxidation products [MDA and 4-hydroxylalkenals (4-HDA)] in septic newborns treated 
with melatonin given within the first 12 hr after diagnosis [Gitto, E. et al. (2001)]. Ten other 
septic newborns in a comparable state were used as _septic_ controls, while 10 healthy 
newborns served as normal controls. Serum MDA + 4-HDA concentrations in newborns with 
sepsis were significantly higher than those in healthy infants without sepsis; in contrast, in 
septic newborns treated with melatonin, there was a significant reduction of MDA + 4- HDA 
levels compared to the values measured in the normal controls at both 1 and 4 hr after the 
initiation of melatonin treatment. Melatonin also improved the clinical outcome of the septic 
newborns as judged by measurement of sepsis related serum parameters after 24 and 48 hr. 
We have also tested whether melatonin treatment would lower IL-6, IL-8, TNFa, and 
nitrite/nitrate levels in 24 newborns with respiratory distress syndrome (RDS) of III or IV 
grade (radiographically confirmed) diagnosed within the first 6 hr of life [Gitto, E. et al. 
(2004)]. Compared with the melatonin treated RDS newborns, in the untreated infants, the 
concentrations of IL-6, IL-8, and TNFa were significantly higher at 24, 72 hr, and at 7 days after 
onset of the study. In addition, nitrite/nitrate levels at all time points were higher in the 
untreated RDS newborns than in the melatonin treated babies. Following melatonin 
administration, nitrite/ nitrate levels decreased significantly, whereas they remained high and 
became further elevated in the RDS infants not given melatonin. In a clinical trial, the levels of 
proinflammatory cytokines (IL6, IL-8, and TNFa) and the clinical status of 110 preterm 
newborns with RDS ventilated with different modalities [conventional ventilation, pressure-
support ventilation (PSV) and with guaranteed volumes (GV), and high-frequency oscillatory 
ventilation] were evaluated before and after treatment with the antioxidant melatonin [Gitto, 
E. et al. (2005)]. Compared with the melatonin-treated RDS newborns, the concentrations of 
inflammatory cytokines were significantly elevated in the newborns given only the diluent. 
When serum levels of IL-6, IL-8, and TNFa for the two groups were compared, melatonin 
treatment clearly had anti-inflammatory effects. In particular, it was noted that newborns 
mechanically ventilated in PSV mode with GV presented a greater reduction of serum levels of 
inflammatory cytokines than did newborns ventilated in conventional mode or with 
oscillatory ventilation. The measured inflammatory cytokines were most markedly elevated in 
infants mechanically ventilated but not given melatonin. Newborns not treated with 
melatonin, who developed chronic lung disease (CLD), have much higher concentrations of 
proinflammatory cytokines than infants without CLD [Gitto, E. et al. (2004)]. It was also found 
that melatonin lowered interleukin IL-6, IL-8, TNF-a, and nitrite/nitrate levels and modified 
serum inflammatory parameters in surgical neonates, thereby improving their clinical course 
[Gitto, E.; Romeo, C. et al. (2004)]. In animals, the anti-inflammatory actions are thoroughly 






Toxic derivatives of oxygen are referred to as free radicals and are either oxygen (ROS) or 
nitrogen-based (RNS) reactants. ROS/RNS are destructive to all key molecules, i.e. lipids, 
proteins and DNA, within all cells. Since the lungs of newborn infants are highly susceptible 
to oxidative damage by ROS/ RNS, care should be taken in the use of pure oxygen during 
resuscitation of infants. Also, avoidance of mechanical ventilation with the use of 
nasopharyngeal continuous positive air pressure may reduce respiratory tissue damage 
resulting from ROS/RNS. 
Oxygen, which is obviously vital to survival, can obviously be highly damaging to tissues 
such as the lungs of newborns which are known to be poorly equipped to neutralise its toxic 
derivatives. Thus, the exposure of the newly born infant respiratory tree to oxygen at a 
higher percentage than exists in normal ambient air, i.e. 20%, or at a positive pressure 
should be performed with caution especially since it may be minimally or no better than 
using ambient air. Also, the use of antioxidants to quell molecular damage by ROS/RNS 
could be considered in situations in which pure oxygen or positive pressure are used. One 
antioxidant that may be useful in these situations is melatonin; this indoleamine has been 
shown to be useful to combat oxygen toxic in newborns [Gitto, E. et al. (2009)]. 
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1. Introduction 
Pain is defined as “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage 
(Higginson&Murtagh 2010). Defining “pain” in a succinct manner is a great challenge. 
What is pain? It has been described as an emotional state, a physical experience, a 
spiritual sacrament, and a complex set of interconnected subcellular signals (Mirchandani 
et al., 2011). According to the International Association for the Study of Pain (IASP), pain 
is defined as "an unpleasant sensory and emotional experience which we primarily 
associate with tissue damage or describe in terms of such damage, or both 
(Portenoy&Kanner 1996). In different places and in different points over time, both 
Eastern and Western medical traditions have included a concept of imbalance as an 
important etiology of painful symptoms (Helms, 1998) ... the difference between the body 
of a living man and that of a dead man is just like the difference between (Bias&Cope, 
2011). Cancer pain may be either acute or chronic. Acute pain; acute pain is initially 
treated with short-acting non-opioid pharmacologic agents or combination opioid drugs. 
Acute versus chronic pain is important to clearly differentiate. Acute pain is rapid in 
onset, self-limiting, a symptom of the disease, and the patient often presents in acute 
distress. Examples of acute pain include postoperative pain, obstetrical labor pain, and 
trauma or injury-related pain and characteristically is described as sudden, sharp, and 
localized pain. It is usually self-limited and may be associated with physiologic changes 
such as diaphoresis and increases in heart rate and blood pressure (Mirchandani et al 
2011). Chronic pain; chronic pain is long-term pain classified as acute, moderate, and 
severe. It is often differentiated as malignant or non-malignant pain. Chronic pain is often 
described as gnawing, aching, and diffuse and is more gradual in onset and cessation than 
acute pain, which can also be simultaneously superimposed on top of the former. It can 
vary in intensity, may remit briefly, and has definite impact psychologically and socially. 
Pain characteristics: Acute and chronic was given Table 1. The treatment for such pain is 
often successful with traditional pharmacologic measures; however, often less traditional 
drugs and even non-pharmacologic therapies are necessary to achieve relief (Mirchandani 
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drugs and even non-pharmacologic therapies are necessary to achieve relief (Mirchandani 





Acute pain                                                          Chronic pain 
1. Usually obvious tissue damage 
2. Distinct onset                       
3. Short, well-characterized duration 
4. Resolves with healing               
5. Serves a protective function        
6. Effective therapy is available                           
1. Multiple causes (malignancy, benign) 
2. Gradual or distinct onset 
3. Persists after 3–6 months of healing 
4. Can be a symptom or diagnosis 
5. Serves no adaptive purpose 
6. May be refractory to treatment 
Table 1. Pain characteristics: acute and chronic (Mirchandani et al., 2011) 
Over time and across cultures, the understanding and expression of pain reflects the 
contemporary spirit of the age. Universally, the human experience begins through the 
painful process of birth, and throughout our lifetimes (Dedeli&Karadeniz, 2009). Factors 
mediating children’s pain was given Fig. 1. 
 
 
Fig. 1. Situational factors mediating children’s pain (McGrath&Crawford, 2010) 
 
Pain Management and Nursing Approaches in Pediatric Oncology 
 
99 
Physiologic pain is defined as rapidly perceived non-traumatic discomfort of very short 
duration, alerting the individual of a dangerous stimulus. This is adaptive and initiates the 
withdrawal reflex that prevents and/or minimizes tissue injury. Physiologic pain can be 
divided into neuropathic pain and nociceptive pain (Mirchandani et al., 2011). Physiologic 
pain types of pain was given Table 2. 
 
Two Major Types of Pain 
I. Nociceptive Pain II. Neuropathic Pain 
A. Somatic Pain              
 B. Visceral Pain 
A. Centrally Generated Pain                 
 B. Peripherally Generated Pain 
I. Nociceptive Pain: Normal 
process of stimuli that damages 
normal tissues or has the 
potential to do so if prolonged; 
usually responsive to non-
opioids and/or opioids. 
A. Somatic Pain: Arises from 
bone, joint, muscle, skin, or 
connective tissue. It is usually 
aching or throbbing in quality 
and is well localized. 
B. Visceral Pain: Arises from 
visceral organs, such as the GI 
tract and pancreas. This may be 
subdivided: 
1. Tumor involvement of the 
organ capsule that causes 
aching and fairly well-localized 
pain. 
2. Obstruction of hollow viscus, 
which causes intermittent 
cramping and poorly localized 
pain. 
II. Neuropathic Pain: Abnormal processing of sensory 
input by the peripheral or central nervous system; 
treatment usually includes adjuvant analgesics. 
A. Centrally Generated Pain 
1. Deafferentation pain: Injury to either the peripheral 
or central nervous system. Examples: Phantom pain 
may reflect injury to the peripheral nervous system; 
burning pain below the level of a spinal cord lesion 
reflects injury to the central nervous system. 
2. Sympathetically maintained pain: Associated with 
dysregulation of the autonomic nervous system. 
Examples: May include some of the pain associated 
with reflect sympathetic dystrophy/causalgia 
(complex regional pain syndrome, type I, type II). 
B. Peripherally Generated Pain 
1. Painful polyneuropathies: Pain is felt along the 
distribution of many peripheral nerves. Examples: 
diabetic neuropathy, alcohol-nutritional neuropathy, 
and those associated with Guillain-Barre syndrome. 
2. Painful mononeuropathies: Usually associated with 
a known peripheral nerve injury, and pain is felt at 
least partly along the distribution of the damaged 
nerve. Examples: nerve root compression, nerve 
entrapment, trigeminal neuralgia. 
Table 2. Physiologic pain types  
The four predominant etiologies of cancer pain are: (1) that directly produced by the tumor; 
(2) that due to the various modalities of cancer therapy; (3) that related to chronic debility; 
and (4) that due to an unrelated, concurrent disease process (Eidelman&Carr, 2006). Tumor-
Related Pain; Most cancer-related pain is directly produced by the malignancy itself. The 
neoplasm may extend into surrounding tissue and exert pressure on nociceptors in diverse 
organs, as well as nerves. Furthermore, recent studies have found evidence that pain-gene 
rating mediators are directly released from certain tumors or from surrounding tissue in 
response to tumor invasion or metastasis such as to bone (Eidelman&Carr, 2006; Unuvar, 
1999). Treatment-Related Pain; The various modalities of cancer therapy may paradoxically 
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and (4) that due to an unrelated, concurrent disease process (Eidelman&Carr, 2006). Tumor-
Related Pain; Most cancer-related pain is directly produced by the malignancy itself. The 
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organs, as well as nerves. Furthermore, recent studies have found evidence that pain-gene 
rating mediators are directly released from certain tumors or from surrounding tissue in 
response to tumor invasion or metastasis such as to bone (Eidelman&Carr, 2006; Unuvar, 
1999). Treatment-Related Pain; The various modalities of cancer therapy may paradoxically 





invasive procedures. Also, there are numerous postsurgical chronic pain syndromes. The 
administration of chemotherapy itself may cause immediate acute pain (e.g., intravenous 
infusion pain, abdominal discomfort during intraperitoneal infusion) or painful sequelae 
such as mucositis, arthralgias, and headaches. Moreover, chemotherapeutic agents, 
including vinca alkaloids, cisplatin, and paclitaxel, are associated with peripheral 
neuropathies. Radiation therapy may injure soft tissue or neuronal structures, resulting in 
mucositis, proctitis, enteritis, osteonecrosis, peripheral neuro pathies, or plexo pathies. 
Furthermore, novel anti cancer agents such as hormonal or immunotherapy may produce 
pain (Eidelman&Carr, 2006; Unuvar, 1999). Debility-Related Pain; Many cancer patients 
may be inactive or suffer debilities that are associated with painful conditions. Many cancer 
patients may be inactive or suffer debilities that are associated with painful conditions. For 
instance, patients who have received immunosuppressive therapy or have hematologic 
malignancies are at increased risk for developing postherpetic neuralgia. Also, many 
malignancies are associated with an increased incidence of thrombosis, which may present 
as pain and swelling in the affected site (Eidelman&Carr, 2006). Non-Malignant Concurrent 
Disease; Patients with cancer may experience discomfort as a direct consequence of a 
concurrent, benign disease process (e.g., degenerative joint disease or diabetic neuropathy). 
Therefore, it is important to review patients’ past medical histories and to consider any 
coexisting nonmalignant condition as a potential source of symptoms (Eidelman&Carr 2006). 
2. Epidemiology 
2.1 Frequency  
World Health Organization (WHO ) states that 25% of cancer patients suffer pain, 33% of 
such patients suffer pain during treatment of the diseases, the rate of pain is between 75-90% 
in advanced and terminal period of the disease, 70% of such pain is directly associated with 
cancer, 20% of such pain is also based on cancer treatment (Aslan, 2006). 
When pain reasons of the patients consulted with a algology clinic in Turkey were analyzed, 
it was found that cancer pain ranked the first (Aslan, 2006). The prevalence of cancer pain in 
patients with advanced or terminal disease was given Table 3. 
Even when WHO guidelines are followed, failure to achieve satisfactory pain relief occurs in 
10%–20% of patients. For these instances, some authors have proposed descriptors such as 
“opioid–poorly responsive pain” or “opioid-irrelevant pain.” Therefore, there is a need both 
in clinical practice and in the standardized comparison of research findings for a systematic 
approach to identify and categorize factors associated with a poor prognosis (O’ leary et al., 
2010). 
2.2 Pain assessment methods 
Pain assessment and pain measurement in children is challenging. These challenges depend 
on permanent changes in process of child’s perception, interpretation and expression with 
regards to age, growth phase, previous pain experience and other environmental factors 
(Manworren&Hynan, 2003; Unuvar, 1999). Pain assessment in children is given in the fig. 2 
(Ramamurthy, 2006) 
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Fig. 2. Pain assesment stages (Hockenberry-Eaton et al., 1999) 
The “ABCs” of pain assessment in children are: 
• Assess: Always evaluate a child with cancer for potential pain. Children may 
experience pain, even though ther may be unable to expree the fact in words. Infans 
and toddlers can show their pain only by how they look and act: older children may 
deny their pain for fear of more painful treatment. 
• Body: Be careful to consider pain as an integral part of the physical examination. 
Physical examination should include a comprehensive check of all body areas for 
potential pain sites. The child’s reactions during the examination-grimacing, 
contracture, rigidity, etc.- may indicate pain.  
• Context: Consider the impact of family, health-care, and environmental factors on the 
child’s pain. 
• Document: Record the severity of a child’s pain on a regular basis. Use a pain scale that 
is simple and appropriate both for the developmental level of the child and fort he 
cultural context in which it is used. 
• Evaluate: Assess the effectiveness of pain interventions regularly and modify the 
treatment plan as necessary, until the child’s pain is alleviated or minimized. 
Selection of method to be used for pain assessment in children should be made considering 
child's age, general status, pain recognition (Manworren&Hynan, 2003; Unuvar, 1999). 
Children show their pains in different ways according to age group. Newborn children 
move less than normal, cry more frequently and are highly restless, may look pale and 
sweaty when they have pain. They do not eat as much as they eat normally. They cry if they 
are touched or moved (Manworren&Hynan, 2003). Toddler; painful toddler may cry more 
than normal, is restless and moves less than normal like newborn children. Toddler may 
show location of the pain even though it may not state explicitly when she/he has pain. 
When toddlers are spoken about the pain, they may understand this. Do not think that you 
have known your child's pain location. In a study carried out, it is claimed that "FLACC" 
(Face ,Legs, Activity, Cry, Consolability) pain assessment scale which is conducted by 
assessing child's facial express, position of legs, movements, crying and being relieved is 
quite useful in paediatric nurse's assessing pain and pain approach in preverbal patients. In 
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this study, patient’s pains were graded with scores ranging between 0 to 10 by using 
“FLACC” score and the effects of oral and IV analgesics were evaluated. FLACC scores 
prior to use of analgesic drug were found significantly higher as compared to an assessment 
carried out subsequent to use of analgesic drug (Manworren&Hynan, 2003). Young 
children; young children think of their pains until they are able to speak. Child may be 
asked about the location of the pain. Child should be given help to find the location of the 
pain. Child might be asked to paint the location of the pain by showing him a picture as 
indicated below (Fig. 3). 
 
Fig. 3. Location of the pain in children 
After determination of presence and location of the pain, it is required to determine the level 
of the pain. Pain might be measured with 3 different methods since it is subjective and 
individual (Fig. 2) (Unuvar, 1999). First of these methods is personal expressions. This 
method is the most important one in pain assessment which attempts to assess the cognitive 
component of the pain. It is necessary to know well the words which children use in 
describing the pain. The most frequently used method is face scale (Fig. 4) (Hockenberry-
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for “worst pain”  
Recommended age 
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The other methods depend on behaviour pattern (such as tone of voice, facial expression 
and gestures) and biological parameters (such as heart rate, falling of peripheral oxygen 
saturation). Personal expression is the best measurement method if can be obtained and is 
accepted as "golden rule" in pain measurement (Unuvar, 1999). Behavioral pain assessment 
scale for young children was given in the Table 4. 
 
FLACC Scale Scoring 
Categories  0 1 2 
Face  No particular 
expression or smile 
Occasional grimace or 
frown, withdrawn, 
disinterested 
Frequent to constant 
quivering chin, 
clenched jaw 
Legs  Normal position or 
relaxed 
Uneasy, restless, tense Kicking, or legs 
drawn up 
Activity  Lying quietly, normal 
position, moves easily 
Squirming, shifting back 
and forth, tense 
Arched, rigid or 
jerking 
Cry  No cry (awake or 
asleep) 
Moans or whinpers; 
occasional complaint 
Crying steadily, 
screams or sobs, 
frequent complaints 
Consolability  Content, relaxed Reassured by occasional 
touching, hugging or 
being talked to, 
distractible 
Difficult to console or 
comfort 
Total is scored from 0-10.  
Table 4. Behavioral pain assessment scales for young children (Hockenberry-Eaton et al., 1999) 
Adolescents; adolescents give reactions similar to adults. They may look calm, have sleeping 
problems, loss of appetite, avoid from friends or family, be nervous or angry. They may not 
say when they have pain since they are afraid of getting addicted to narcotics. The best 
method determine the pain of adolescent patients is scales which have assessment criteria 
ranging 0 to 5 (0= presence of no pain, 5= presence of intense unbearable pain). Expression 
of pain according to age groups was given Table 5. 
3. Pain control methods 
The necessary nature of pain treatment has long been categorized among other basic human 
rights, and in 1999 the Joint Commission on Accreditation of Healthcare Organizations 
formalized pain standards to ensure to all patients their right to appropriate assessment and 
management of their pain, describing pain as the “fifth vital sign” (Lanser, 2001). Intrinsic to 
our capacity to treat pain is possession of perspective of themany cultural beliefs, 
philosophical ideologies, and scientific discoveries that have influenced and evolved into 
the modern Western conceptualization of pain. Cancer pain can not be treated sufficiently. 
In analysis of 11 reports including 2000 cancer patients in 1986, it was found that pains 
could not be healed in 50-80% of the patients in developed country. Pain may be healed with 
simple methods in 90% of cancer patients. However, it was also detected that pains could 
not be healed with acceptable methods in 10% of these patients. American National Cancer 
Institute attracted attention to be importance of issue with message that “being unable to 
treat cancer pain is a serious and unacceptable community health problem” (Aslan, 2006).  
 





Expressions of pain 
Infants  May: 
- Exhibit body rigidity or thrashing may include arching 
- Exhibit facial expression of pain (brows lowered and drawn together, 
eyes, tightly closed, mouth open ans squarish) 
- Cry intensely/loudly 
- Be inconsolable 
- Draw knees to chest 
- Exhibit hypersensitivity or irritability 
- Have poor oral intake 
- Be unable to sleep 
Toddlers  May: 
- Be verbally aggressive, cry intensely 
- Exhibit regressive behavior or withdraw 
- Exhibit physical resistance by pushing painful stimulus away after it is 
applied 
- Guard painful area of body 








- Verbalize intensity of pain  
- See pain as punishment 
- Exhibit thrashing of arms and legs 
- Attempt to push stimulus away before it is applied 
- Be uncooperative 
- Need physical restrain 
- Cling to parent, nurse, or significant other 
- Request emotional support (e.g. hugs, kisses) 
- Understand that there can be secondary gains associated with pain 




- Verbalize pain 
- Use an objective measurement of pain 
- Be influenced by cultural belief 
- Experience nightmares related to pain 
- Exhibit stalling behaviors (e.g., “Wait a minute” or “ I’m not ready”) 
- Have muscular rigidity such as clenched first, white knuckles, gritted 
teeth, contracted limbs, body stiffness, closed eyes, or wrinkled forehead 
- Include all behaviors of preschoolers/young children 
- Be unable to sleep 
Adolescents May:   
- Localize and verbalize pain 
- Deny pain in presence of peers 
- Have changes in sleep patterns or appetite 
- Be influenced by cultural beliefs 
- Exhibit muscle tension and body control  
- Display regressive behavior in presence of family 
- Be unable to sleep 
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The WHO Analgesic Stepladder is a multi-step approach to treating pain, and is a guide for 
initiating analgesic drugs and dosages that correspond to the patient’s reported level of pain 
(Fig. 5). The ladder starts with non-opioid oral drugs for mild pain and progresses to strong 
opioids, adjuvants and invasive therapies for severe and/or intractable pain (Hockenberry-
Eaton et al., 1999). 
 
Fig. 5. Therpeutic ladder for pain management (Hockenberry-Eaton et al., 1999) 
3.1 Pharmacological pain management 
Western oncology group states that although cancer patients have taken analgesic, 67% of 
them have pain, 36% of them have so severe pains as to deteriorate their daily functions, 
42% of them have not taken sufficient analgesic treatment. Tolerance and fear of addiction 
prevents cancer treatment (Aslan, 2006). While planning pain treatment, location, level, 
quality of pain, presence and features of the diseases causing pain, age of patient, present 
clinical facilities should be taken into consideration. In the light of all these features, 
treatment method is decided (Bedre& Sethna, 2002; Krauss& Gren, 2000). Drug treatment is 
the most frequently used method in treatment of acute and chronic pains in children. 
Analgesic drugs can be used singly or in a drug combination way (Golianu et al., 2000). For 
this purpose, non-opioid analgesics, opioid analgesics and adjuvant analgesics are used. In 
recent years, significant developments have been made in this field by adjustment of doses 
of these drugs and knowing their efficiency and pharmacologic differences in children. The 
most significant steps in this field have been taken by WHO. In consequence of studies 
concerning drug use especially in children with cancer pain, WHO published a guide book 
titled cancer pain treatment and palliative care (WHO, 1998). Medical management of cancer 
pain was given Fig. 6. 
 




Fig. 6. Medical management of cancer pain (Gindrich, 2006)   
3.1.1 Opioid (narcotic) analgesics  
The word "opioid" contains all components associated with opium. Use of pure alkaloids 
has become widespread in whole world since second half of 19th century after Serturner 
isolated morphine from opium for the first time in 1806 (Cizmeci& Babacan, 2007). The first 
preference should be oral route in implementation of analgesic drugs, which is the first pain 
control method in algorithms used in treatment of chronic pains. Where oral intake is not 
possible, intravenous, intramuscular, subcutaneous, transdermal, intrathecal, or epidural 
route might be used (Golianu et al., 2000). Opioids are used for removal of severe pains. 
Opioids such as morphine, meperidine, methadone, fentanyl, codeine and hydromorphone 





The WHO Analgesic Stepladder is a multi-step approach to treating pain, and is a guide for 
initiating analgesic drugs and dosages that correspond to the patient’s reported level of pain 
(Fig. 5). The ladder starts with non-opioid oral drugs for mild pain and progresses to strong 
opioids, adjuvants and invasive therapies for severe and/or intractable pain (Hockenberry-
Eaton et al., 1999). 
 
Fig. 5. Therpeutic ladder for pain management (Hockenberry-Eaton et al., 1999) 
3.1 Pharmacological pain management 
Western oncology group states that although cancer patients have taken analgesic, 67% of 
them have pain, 36% of them have so severe pains as to deteriorate their daily functions, 
42% of them have not taken sufficient analgesic treatment. Tolerance and fear of addiction 
prevents cancer treatment (Aslan, 2006). While planning pain treatment, location, level, 
quality of pain, presence and features of the diseases causing pain, age of patient, present 
clinical facilities should be taken into consideration. In the light of all these features, 
treatment method is decided (Bedre& Sethna, 2002; Krauss& Gren, 2000). Drug treatment is 
the most frequently used method in treatment of acute and chronic pains in children. 
Analgesic drugs can be used singly or in a drug combination way (Golianu et al., 2000). For 
this purpose, non-opioid analgesics, opioid analgesics and adjuvant analgesics are used. In 
recent years, significant developments have been made in this field by adjustment of doses 
of these drugs and knowing their efficiency and pharmacologic differences in children. The 
most significant steps in this field have been taken by WHO. In consequence of studies 
concerning drug use especially in children with cancer pain, WHO published a guide book 
titled cancer pain treatment and palliative care (WHO, 1998). Medical management of cancer 
pain was given Fig. 6. 
 




Fig. 6. Medical management of cancer pain (Gindrich, 2006)   
3.1.1 Opioid (narcotic) analgesics  
The word "opioid" contains all components associated with opium. Use of pure alkaloids 
has become widespread in whole world since second half of 19th century after Serturner 
isolated morphine from opium for the first time in 1806 (Cizmeci& Babacan, 2007). The first 
preference should be oral route in implementation of analgesic drugs, which is the first pain 
control method in algorithms used in treatment of chronic pains. Where oral intake is not 
possible, intravenous, intramuscular, subcutaneous, transdermal, intrathecal, or epidural 
route might be used (Golianu et al., 2000). Opioids are used for removal of severe pains. 
Opioids such as morphine, meperidine, methadone, fentanyl, codeine and hydromorphone 





doses might be needed in order to prevent pain due to tolerance occurring against opioids. 
Tolerance and development of addiction dependent on morphine use occur in children less 
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intratecal are used with epidural route (Bedre& Sethna 2002).  
The most commonly used 2 drugs; 
• Morphine, given at 0,1 mg/kg IV 5-10 minutes before the procedure or 0,3 mg/kg 
orally 1 hour before the procedure. 
• Fentanyl, 0.5-2 µg/kg given 5-10 minutes before the procedure. 
The combined use of opioids and benzodiazepines should be evaluated for for efficacy and 
for any potential adverse effects at the peak of their action to guide subsequent titration 
(WHO, 1998). Schema related to using opiods was given Fig. 7. 
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3.1.2 Non-opioid analgesics 
Non-opioid analgesics are used singly in light pains or by combining with opioids in mild 
pains. The most frequent used non-opioids are paracetamol, aspirin and nonsteroid anti-
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inflammatory (Bedre&Sethna, 2002; Golianu et al., 2000). Pharmacodynamic and 
pharmacokinetic features of paracetamol, salicylates and nonsteroid anti-inflammatory drug 
(NSAID) in children are not different from adults except for neonatal period. Drug selection 
changes depending on various factors such as action time of drug, whether asked for anti-
inflammatory effect or not, oral or IV route preference and adverse effects of drug. While 
majority of drugs in this group have both three of analgesic, antipyretic, anti-inflammatory 
effects, the others have just analgesic and antipyretic effects. Selections of analgesic are 
made in line with pain level according to step principle. According to WHO’s three steps 
principle, nonsteroid anti-inflammatory drugs are given in light pains, weak opioids in 
addition to NSAIDs are given in mild pains, strong opioids are also given additionally in 
severe pains. Moreover, adjuvant drugs can be added in all steps (Eyigor et al., 2007). 
Schema related to using NSAIDs was given Fig. 8. 
 
 
Fig. 8. Scheme of using nonsteroidal antiinflamatory drugs  (Alanmanou, 2006b) 
3.1.3 Adjuvant agents 
Adjuvant analgesics are used for potantializing analgesic effects and improving symptoms 
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anesthetics, neuroleptics, myorelaxants,  ntihistaminics, psychostimulants, corticosteroids 
and calcium channel blockers are used (Bedre&Sethna, 2002, Eyigör et al., 2007). Unless 
drugs are useful in removing pain in children, invasive attempts might be applied. The 
fundamental reason for childhood regional anaesthesia and analgesia implementations' not 
attracting attention might be listed as lack of experience in this field, adverse effect fear and 
not establishing dialog with the patient during attempt. Anatomical differences such as 
being different heights and anatomical structures of children during adolescence, extension 
of dura and spinal cord to lower segments in newborn children, being tight of epidural field, 
not yet completing of myelination following the birth, being thin of ligaments and fascias 
might lead to technical difficulties in regional implementations (Yaster&Hardart 2002; 
Desparment-Sheridan, 2000). Schema related to using steroids was given Fig. 9. 
 
Fig. 9. Scheme of using steroids (Ramamurthy&Alanmanou, 2006) 
In general, pain assessment and treatment steps were given in fig. 10. 
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3.2 Nonpharmacologic pain management  
Nonpharmacologic methods must be integral part of the management of children’s cancer 
pain, beginning at the time of diagnosis and continuing throughout treatment (WHO, 1998). 
Nonpharmacologic methods in the management of pain have been found to be highly 
effective for some children and for some procedures. These techniques are easy to learn and 
should be used when possible to give the child some control in the management of pain. The 
examples given for distraction, muscle relaxation, and guided imagery are easy techniques 
to learn and can be used with young children (Hockenberry-Eaton, M et al; 1999). Non-drug 
approaches should supplement, but not replace, appropriate drug treatment (Hockenberry-
Eaton et al., 1999; WHO, 1998). In selection of nonpharmacologic method use, child’s age, 
behavioral factors, coping ability, fear/anxiety and type of pain experience play role. 
Nonpharmacologic pain management implementations are divided into 4 groups as 
supportive, cognitive, behavioral and physical methods. In Table 6, non-pharmacologic 
methods used in relieving pain are summarized (WHO, 1998). 
 
Supportive Cognitive Behavioral Physical 
Family-centre 
care 
Distraction Deep breathing Touch 
Information Music Relaxation Heat and cold* 
Empathy Imagery  Transcutaneous electrical 
nerve stimulation (TENS) 
Choices Hypnosis   
Play    
*Heat and cold should not be used with infants because of the risk of injury 
Table 6. Nonpharmacologic methods of pain relief (WHO 1998) 
3.2.1 Supportive methods 
Supportive methods are intended to promote the good psychosocial care of children. The 
first principle is that care is family-centered, that is, it is based on the needs of both family 
and child. Parental involvement in decision-making, and in providing comfort to children, is 
particularly important. Parents need a perceptive environment and they may require 
instruction in how best to help their child. The family includes everyone who is intimately 
associated with the child. In most cases it is the parents who know their children best and 
can therefore become allies in treatment, but they may need to be taught how they can help 
manage their children’s pain and anxiety. Family centered care encourages them to choose 
how to participate in treatment, giving them culturally appropriate information and 
teaching them coping techniques. It also helps family members to understand the cultural, 
spiritual, financial, social, interpersonal, and emotional impact of the diagnosis of cancer in a 
child.Making the clinic or hospital environment friendly to families is another important 
aspect of family-centre care, and liberal visiting arrangements and a physical atmosphere 
conducive to family participation in treatment should be encouraged. It is essential that a 
child’s family and friends are made to feel welcome. Both children and families need 
information to prepare them for what will happen during the course of the disease end its 
treatment. If families are not accurately informed about the diagnosis and the treatment 
plan, they cannot participate. Information is accepted best if it is tailored to the needs of the 
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child and family. Some children and families seek out information; others may find that too 
much information increases their anxiety. Health care provides should therefore try to 
individualize their dealings with families. An empathic approach is essential, and 
information should be given a little at a time, repeated as frequently as needed. Booklets, 
videos, drawings, and dolls can be useful tools in this process. Children should never be lied 
to about painful procedures; they will distrust and fear what will be done to them in the 
future. Health-care workers must be genuinely fond of children and know how to deal with 
them. Ideally, children should be given choices about which techniques to use to control 
pain. They should be given choices about which techniques to use to control pain. They 
should also be allowed to make decisions that do not interfere with treatment, such as which 
finger to prick for blood samples. Play is an essential part of every child’s daily life and even 
the sickest child can be helped to play. Playing enables children to understand their world 
and to relax and forget their worries. All children must therefore have the time and place to 
play, and painful procedures must not be carried out in play areas. Normal activities such as 
school, hobbies, and visits by friends should be encouraged. Psychosocial treatment is an 
integral part of cancer pain treatment. It should be used in all painful or potentially painful 
situations, often combined with analgesic drug therapy (WHO, 1998).  
3.2.2 Cognitive methods 
Cognitive treatment methods are intended to influence a child’s thoughts and images. 
Parents are often very skilled at using these methods because they know their children’s 
preferences (WHO, 1998). Distraction is used to focus the child’s attention away from the 
pain (Hockenberry-Eaton, 1999). Active distraction of children’s attention is important: the 
more involved a child becomes in an activity, the greater the distraction from pain (WHO, 
1998). For children, simple distraction techniques can be very effective in decreasing pain 
(Hockenberry-Eaton, M 1999). Infants and young children require concrete events or objects 
to attract their attention; interesting toys that provide something to see, hear, and do are 
best. Older children benefit from concentrating on a game, conversation, or special story 
(WHO 1998). In studies conducted, it was reported virtual reality was useful in distracting 
attention in painful medical interventions and decreasing pain and distress and child's 
selection should be attached importance in implementation ( Gershon et al., 2004, Nilsson  et 
al., 2009). Music, even as simple as a mother’s lullaby, is a universal soother and distractor 
(WHO, 1998). Listening to music is an important tool which decreases heart rate, body 
temperature, blood pressure and breathing rate, distracts patient’s attention, lowers the 
nausea depending on chemotherapy and especially increases the life quality of the patients 
in terminal period (Chase, 2003; Deng et al., 2004; Halstead&Roscoe, 2002; Hiilliard, 2003; 
Kaminski&Hall, 1996; Mccaffery, 2000). In a study performed by Burns et al. (2001) on 
cancer patients, it was reported that well-being and relaxion increased in the patients in 
music listening process, and tension decreased. In the study carried out by Chan et al. (2003) 
on the patients to whom colposcopy was applied, pain and anxiety level of the group 
listening to music was found lower. Nguyen et al. (2010) found that pain score, heart and 
breathing rate were lower in the group listening to music during and after lumbar puncture 
implementation in children with cancer. Listening to music was found to increase 
endorphin secretion by inducing alpha wands and to play a role in not only decreasing the 
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other physiological responses (Henry, 1995). It is also quite important that child selects 
his/her own music (Nilsson S et al. 2009). Moreover, there are studies concerning influence 
of the music belonging to children’s own culture (Balan et al., 2009; Ngyen et al. 2010). 
Imagery is the process in which a child concentrates on the image of a pleasant and 
interesting experience instead of on the pain. A child can be helped by an adult to become 
absorbed in a previous positive experience or an imaginary situation or adventure. Colors, 
sounds, tastes, smells and atmosphere can all be experienced in imagination (WHO, 1998; 
Hockenberry-Eaton, 1999). Storytelling is a powerful way to engage the imagination and 
provide distraction; children may enjoy old favorites or new stories told from books or from 
memory (WHO, 1998). What should be taken into account in assisted imagining is not to use 
images causing fear and anxiety in patient (such as water, forest) (Black&Matassarin Jacobs, 
1997). Children should be encouraged to use their imagination by their parents. In their 
studies in which Kuttner et al. (1988) compared medical treatment, occupation and 
imagination techniques under hypnosis during bone marrow aspiration, they found 
imagination method was more useful in children between 3-6, both occupation and 
imagination method was more effective in 7-10 group. Besides, it was determined that one 
or more sessions were required in order to learn coping abilities of the group to which 
occupation method was applied. Occupation methods which children may like according to 
their age groups are given in Table 7. 
 
Age  Methods 
0-2 years Touching, stroking, patting, rocking, playing music, using mobiles over 
the crib 
2-4 years Puppet play, storytelling, reading books, breathing, blowing bubbles 
4-6 years Breathing, storytelling, puppet play, talking about favorite places, TV 
shows, activities 
6-11 years  Music, breathing, counting, eye fixation, thumb squeezing, talking about 
favorite places, activities on TV shows, humor 
Table 7. Distraction techniques in children (Hockenberry-Eaton, M 1999) 
True hypnosis requires specialized training, but pain can be modified by words of comfort 
and relief spoken in a particular way. Firstly, a child should be encouraged to relax and 
focus attention on a favorite activity, on deep breathing, or on a pain-free part of the body. 
Children can also imagine they are closing pain “switches” or “gates” or that they have the 
“magical” powers of their popular heroes to make their pain become less (WHO, 1998). 
Hypnotic ability is limited in children younger than 3, they begin at 5-6 and climb up to the 
highest level at 7-14. In the study conducted by Liossi et al (2006) on pediatric cancer 
patients, it was found that hypnosis decreased pain and anxiety level of the patients (Liossi 
et al., 2006). However, there are many clinic researches and systemic reviews concerning 
efficiency of hypnosis in decreasing distress related to chemotherapy and interventions 
(lumbar puncture, bone marrow aspiration, venepuncture etc.) which cause pain in 
especially pediatric cancer patients (Accardi&Milling, 2009; Liossi et al., 2006, Liossi et al. 
2009; Richardson et al., 2006; Rogovik&Goldman, 2007; Tsao&Zeltzer 2005; Zelter et al. 
2001). Also, it was found that distress management implementations had useful and positive 
effect in coping with pain in the future (Rocha et al., 2009). Imagination scenes which 
children like are given in Table 8.  
 
Pain Management and Nursing Approaches in Pediatric Oncology 
 
115 
Visual Imagery Auditory Imagery Movement Imagery 
Favorite places Conversations with significant 
others 
Flying 
Animals Favorite song Swimming 
Flower gardens Playing a musical instrument Skating 
TV or movies Listening to music Amusement rides 
Favorite room Environmental sounds 
(waves, etc.) 
Any activity 
Favorite sport   
Table 8. Favorite imagery scenes for children (Hockenberry-Eaton, M 1999) 
3.2.3 Behavioral methods 
Deep breathing is a simple way to help a child to reduce pain and gain self-control. It 
focuses the attention, reduces muscular tension, relaxes the diaphragm, and oxygenates the 
body. It is best to start teaching this technique by asking the child to breathe out, and tol et 
go of the tension, or “scary” feelings, with each breath. Deep breathing is the easiest 
technique to use with young children. Younger children can be taught to breathe deeply by 
blowing bubbles from soap solution or by using party blowers (WHO, 1998). For school age 
children, asking them to hold their breath during a painful procedure transfers their focus to 
their breathing and not on the procedure (Hockenberry-Eaton, 1999). Older children can use 
more sophisticated breathing techniques such as breathing in and out, each fort he count of 
three (WHO, 1998). Muscle relaxation Muscle relaxation is used to decrease mental and 
physical tension. It is used most effectively in older children and adolescents because it 
involves the relaxation of voluntary skeletal muscles. Slowly each muscle is tensed and then 
relaxed in a systematic way. Attention is placed on breathing which causes the individual to 
be aware of the feelings of tension and relaxation (Hockenberry-Eaton, 1999). Relaxation is 
often combined with suggestion and deep breathing, and these methods can reduce 
anticipatory anxiety and help to reduce nausea and vomiting (Hockenberry-Eaton, 1999; 
WHO, 1998). In the study Anderson et al. (2006) carried out on cancer patients, it was found 
that less pain was suffered in the group to which relaxion technique was applied. Walco et 
al (2005) reported significant decrease in heart rate using cognitive-behavioral method in 
preventing procedural distress in children with cancer. In systemic reviews of Ellis&Spanos 
(1994), it was reported that cognitive-behavioral methods had critical importance in 
decreasing pain during painful procedures such as bone marrow aspiration and lumbar 
puncture. Cognitive-behavioral methods are the most frequently used methods to increase 
coping ability of the child and decrease children’s distress in medical procedures (Collins et 
al., 2008). 
3.2.4 Physical methods 
Touch is important for all children, particularly the pre-verbal child, who understands the 
world to a large extent through touching and feeling. Touch must be appropriate for the 
child’s needs, that is, not too invasive either physically or psychologically. Touching 
includes stroking, holding and rocking, caressing, massaging hands, back, feet, head, and 
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puncture. Cognitive-behavioral methods are the most frequently used methods to increase 
coping ability of the child and decrease children’s distress in medical procedures (Collins et 
al., 2008). 
3.2.4 Physical methods 
Touch is important for all children, particularly the pre-verbal child, who understands the 
world to a large extent through touching and feeling. Touch must be appropriate for the 
child’s needs, that is, not too invasive either physically or psychologically. Touching 
includes stroking, holding and rocking, caressing, massaging hands, back, feet, head, and 





is too much effort for the child, touch can be the best form of communication. When a child 
must be touched for medical purposes, e.g. palpation of the abdomen, care must be taken to 
use warm hands, to proceed gently, and to talk quietly with the child about what is being 
done. Sources of heat and cold are often easily available. Ice wrapped in a cloth can be used 
to soothe disease pain or inflammation, or to reduce the pain of a procedure such as 
intramuscular injection. Heat is useful for muscle pain. However, neither cold nor heat 
should be used on infants because there is a risk of injury. The physical methods applied in 
removal of pain and their definitions are given in Table 9. Transcutaneous electrical nerve 
stimulation (TENS) is achieved with a battery-operated device that delivers electrical 
stimulation through electrodes placed on the skin. It possibly acts by cutaneous stimulation 
of large-diameter nerve fibres, reducing pain transmission at the spinal level. Children often 
experience TENS as tingling or tickling; it must not become painful. The technique is simple 
to use, is effective, and requires little preparation (WHO, 1998). Acupuncture has been used 
therapeutically in China for thousands of year, its importance in Europe and USA increases 
gradually. It was reported to be especially efficient in decreasing chemotherapy-related 
nausea/vomiting and cancer-related pain in the patients. However, number of studies 
carried out on pediatric patients is low (Hockenberry-Eaton, 1999; Jindal et al., 2008). In their 
study, Reindl et al. (2006) reported that acupuncture decreased the need of antiemetic 
treatment in preventing chemotherapy-related nausea in pediatric patients.. It is 
recommended to apply acupuncture with methods such as hypnosis and massage (Jindal et 
al 2008). Zelter et al (2002) applied hypnotherapy with acupuncture to children with chronic 
pain their study and reported no adverse effect, on the contrary parents and children 
reported significant improvements concerning pain and treatment. However, since there 
was no control group available in the study, efficiency of acupuncture / hypnotherapy was 





Massage Includes stroking, rubbing or deep manipulation of muscles. 
Music Can help to provide the child with a familiar environment; children often 
come to the hospital or hospice with their own music. 
Heat Warm compress or use of a heating pad, to the painful site (moist or dry 
heat). 
Cold/Ice Cold compress or ice pack. Precaution: assure ice pack is wrapped allowing 
comfortable sensation of cold without damaging the skin by freezing tissue. 
Limit ice application to10 minutes, then rotate site. If skin becomes blanched, 
discontinue cold treatment. 
Table 9. Comfort measures (Hockenberry-Eaton, M 1999) 
4. Nursing approach 
As in all the other fields of pediatrics, supportive methods have indisputable importance in 
pediatric oncology. Family-centered care which is the fundamental element of supportive 
methods forms the integrative role of pediatric nursing. Parents should be encouraged to 
participate in care of their children at hospital in accordance with their readiness so that 
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family-centered care implementations can be carried out and the care given should be 
controlled. Nurse training and consultancy roles should be used effectively. Parents should 
be allowed to ask question so that they could understand the diagnosis and treatment 
methods applied to their children and parents’ opinion should be asked in decisions related 
to child’s treatment. In this regard, nurse should encourage the parents to ask question and 
be open in communication with them. Pediatric nurse is responsible for training the parents 
about the care of the child. It is important that such training continues until child is 
discharged from the hospital. Nurse should make sure that family has gained the 
knowledge and skills required in respect of child’s care and do these correctly. Nurse should 
prepare the parents about care of child at home by ensuring parents’ participation in care 
and controlling the care they give at hospital (Boztepe, 2009). Nurses should conduct proper 
assessment and treatment of the pain which is a necessary part of children’s care for optimal 
treatment of the child with pain. The pain which is not treated or taken under control might 
lead to long-term chronic pain. Having limited knowledge about effective assessment and 
treatment options might be a reason for being unable to take the pain under control. 
However, attitude, belief and previous experiences may affect their decisions. Nurses 
should spare time for themselves in order to equip themselves with up-to-date knowledge 
concerning assessment and treatment of the pain (Clark, 2011). Nurses play a critical role in 
efficient pain management of the patient. Nurse should permanently inform the patient and 
patient's family about pain management methods. They should be encouraged to participate 
in efficient pain management and trained about how pain management and methods to 
increase their life qualities will be (Williams, 2011). Also, nurses should ensure inclusion of 
effective behavioral methods in routine care of the children with cancer (McCarthy et al., 
1996). Pain is a subjective experience and each and every child should be treated as an 
individual. Multimodal approach (together with pharmacologic and nonpharmacologic pain 
management) is the best way to optimize pain control with least negative effects. Even the 
smallest children deserve ensuring the best pain control in a safe manner (Clark, 2011). 
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1. Introduction 
It has been estimated that worldwide about 5 million people (adults and children) are bitten 
by snakes every year (Kalantri et al., 2006), and 50,000 die according to data from the World 
Health Organization (Schaper, de Haro, Desel, Ebbecke, & Langer, 2004). However, it is well 
known that events related to snake bites are under-reported, especially in the author's 
country possibly because snakebites are not a very relevant cause of mortality. Nevertheless,  
they are a serious cause of morbidity, especially in children. Under-reporting of this 
important health issue can be blamed on the fact that the population is not well informed 
about snake classification causing them to not provide accurate information to healthcare 
personnel when a patient is taken for medical care after a snake attack. Children do not react 
to snake bites in the same way as adults. In children, this event is always more severe since 
they are exposed to a larger amount of venom per m2 of body surface (De la O Cavazos 
2006). A small child is more vulnerable to a given volume of venom than a larger individual 
(Hodge III & Tecklenburg, 2006) Also, there will be different presentations including 
neurotoxicity, myotoxicity, renal failure, edema, bleeding due to activation of clotting 
proteins, and intravascular hemolysis, because different kinds of snakes have different types 
of venom that cause different symptomatology. (Jeng & Glader, 2004). 
On the other hand, there is very little information for primary care physicians and 
pediatricians and most of the time it is outdated. Hence, the need for a reliable source of 
information in the event of a snake bite in pediatric patients that is updated, easy to find and 
well-structured in a way physicians find it easy to read and to easily and rapidly translate it 
into clinical practice to assure a fact-based, accurate treatment and prompt recovery with the 
least possible amount of sequels. 
2. Epidemiology 
Snakebites are seriously under-reported all over the world. We currently do not have 
trustworthy studies or statistics to asses this problem. What we do have is information that 
can guide us and inform us about the most affected areas and the most common 
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Snakebites are seriously under-reported all over the world. We currently do not have 
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presentation. For example, studies such as the one by Ruiz Molina and cols. show not only a 
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higher incidence in men (2.5:1) but also a reasonably high incidence in pediatric population 
between the ages of 11 and 16 (39.3%), followed closely by even younger children ages of 6-
10 (32.1%). This may be related to the fact that in several under-developed tropical countries 
where snakebites represent a major health issue children take part in agricultural activities 
or are attacked due to their innate curiosity, which in turn, makes them victims more easily 
than adults. Snake bites remain a public health problem in most countries. This is especially 
true in countries where agricultural activities are predominant, since this is one of the 
occupations more often affected by snakebites (Chippaux, 1998). Once we get hold of he few 
statistics we have, we face a new problem: the disparity in the epidemiological data. This 
reflects different grades of reporting. The more industrialized the country, the more reliable 
the statistics are. Sadly, snake bites are a problem related to low-income countries that have 
frail health systems and a lower rate of reporting. Also, morbidity and mortality have low 
rates and are well documented in first-world countries, probably because of the health 
facilities and availability of newer and better treatments. This is yet another argument to 
sustain that snake envenoming is a disease of the underdeveloped countries. In the few 
studies we can relate to, a negative association between snakebite deaths and government 
expenditure on health services has been found. Because of this, mortality is highest in these 
countries, since the population has no access to proper and adequate treatment and the 
government is not able to provide it because they are just not capable of dealing with the 
financial burden of snakebites (Harrison, Hargreaves, Wagstaff, Faragher, & Lalloo, 2009). 
In México, an average of 20 deaths per year are reported. However, very few accidents are 
reported in communities most at risk. These communities also have little access to health 
services. In fact, about 27 000 cases of snake envenomation and more than 100 deaths per 
year occur in México. Between 1994 and 1996, the Mexican Social Security Institute (IMSS) 
reported 1 961 venomous snake bites; thirty percent of patients were children. In the IMSS 
report, the age group most affected was 15 to 44 years, with 51.4% of cases. The immense 
majority of poisonings occurred between June and October and 70-90% of these bites were 
located in the legs. 
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Table 1. Areas most commonly involved in snakebites. 
For years, it has been accepted that snake attacks occur in the field and men are the most 
affected, but in the study by Sotelo-Cruz it was found that there is no predominance in 
gender and while it is true that most of the children attacked were from rural areas, these 
attacks occured nearby their living places in some cases even within their home. The seasons 
of the year when more attacks were reported were summer and autumn. This is because the 
summer season in these countries lasts nearly six months. The time of day when most of the 
attacks happened ranges from 2:00 and 7:00 p.m., although 12.7% of the attacks happened 
during the night, the injury site was located in the legs in 78.1% of cases (Sotelo 2004). 
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3. Snake identification 
In the world there are over 2,500 snake species described, of these, only about 350 are 
considered poisonous and dangerous for humans. These 2,500 snake species are divided 
into 15 families and the following have enough species to be relevant or dangerous 
(Government of Canada, n.d.): Colubridae, Boidae, Viperidae, and Elapidae or 
Hydrophiidae. Just as we have countries where venemous snakes are a major health issue 
because of the large number of species they harbor, we also have countries where venemous 
snakes are virtually non-existent (except for imported snakes), such as New Zealand, Cuba, 
Haiti, Jamaica, Puerto Rico, Ireland, Polynesia, Hawaii and the polar regions. 
In this chapter, we are going to be focusing on the snakes most commonly found in the 
Americas, more specifically in North America (the United States and Northern México), 
These snakes are from the Elapidae and the Viperidae families such as the pit viper, the 
rattlesnake, the water moccasin, and the copperhead, since they are responsible for about 
99% of the cases reported. The coral snake, which can also be found in North America, is 
responsible for only 1% of the cases, along with the exotic imported species.  
 
Fig. 1. Diagram that shows the fifteen families of snakes in the world. The families marked 
in red contain the most important and dangerous snakes in America. 
A very important part of the process of providing the best medical care available resides in 
the identification of the snake. Important as this is, it is recommended not to go after the 
snake to try to identify it or kill it. We need to remember that most snakes only attack when 
they feel menaced in the first place, thus, going after a snake after it has already attacked 
would put us in more danger, risking a second bite or a first bite in a different person. If we 
are in an advantageous situation (adequate lighting, such as broad sunlight, regular, flat 
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because of the large number of species they harbor, we also have countries where venemous 
snakes are virtually non-existent (except for imported snakes), such as New Zealand, Cuba, 
Haiti, Jamaica, Puerto Rico, Ireland, Polynesia, Hawaii and the polar regions. 
In this chapter, we are going to be focusing on the snakes most commonly found in the 
Americas, more specifically in North America (the United States and Northern México), 
These snakes are from the Elapidae and the Viperidae families such as the pit viper, the 
rattlesnake, the water moccasin, and the copperhead, since they are responsible for about 
99% of the cases reported. The coral snake, which can also be found in North America, is 
responsible for only 1% of the cases, along with the exotic imported species.  
 
Fig. 1. Diagram that shows the fifteen families of snakes in the world. The families marked 
in red contain the most important and dangerous snakes in America. 
A very important part of the process of providing the best medical care available resides in 
the identification of the snake. Important as this is, it is recommended not to go after the 
snake to try to identify it or kill it. We need to remember that most snakes only attack when 
they feel menaced in the first place, thus, going after a snake after it has already attacked 
would put us in more danger, risking a second bite or a first bite in a different person. If we 
are in an advantageous situation (adequate lighting, such as broad sunlight, regular, flat 
 
Complementary Pediatrics 126 
surface with minimal plant growth, etc.) there are several bits of information we should 
recall if we clearly see the snake: 
3.1 Pit viper 
These snakes have pits, one in each side of the face, located between the eye and the nostril. 
These pits, not found in the non-venomous species, contain heat-sensing organs, very 
important for these venomous snakes, since they have a very poor vision. If we have a good 
view of the snake, we can observe its pupils, which are different from non-poisonous 
snakes. Pupils in the pit viper are elliptical and vertically oriented. The fangs in venomous 
snakes are only superior, two in number and hollow. These are usually 5 to 20 mm long. 
These fangs are folded posteriorly in the palate and are shown only when the snake attacks. 
Regarding the head, in most poisonous snakes it is more triangular than in non-poisonous 
snakes. Last, if the snake is captured or killed, we can examine the anal plate. In poisonous 
snakes the scales are in a single row after the anal plate. In non-harmful snakes the anal 
plate ends in a cleft or a double row of scales. These snakes produce an hemotoxic venom. 
3.1.1 Rattlesnakes 
There are four kinds of rattlesnakes (Crotalus) in North America, this is the reason why this 
species is very heterogeneous regarding its colors and length. We have: the Eastern 
Diamondback, the Western Diamondback, the Mojave Rattlesnake and the Tropical 
Rattlesnake. The Eastern Diamondback is the most common. We can find it in the Southeast 
Coastal area of the United States (North Carolina, South Carolina, Louisiana and Florida). 
This snake can be up to two meters long and has a characteristic pattern of bright lines that 
form a symmetric diamond pattern. The Western Diamondback lives in the Southeast of the 
United States, mainly southeast California, Oklahoma, Arizona, New Mexico and Texas. It is 
a little shorter than the Eastern Diamondback measuring only up to 1.5 meters. The Mojave 
Rattlesnake can be found in the Southwestern United States, principally in the Mojave 
Desert in California, Nevada, Southeast Arizona, Texas and the north portion of Mexico. It 
prefers rocky desert areas and this species is only about 75 cm. Last, we have the Tropical 
Rattlesnake, which lives in crops and sandy areas in the Southern of Mexico, Central 
America and South America (except Chile). These can measure up to two meters long, even 
though it usually is 1.5 meters long. These snakes are responsible for approximately 60% of 
all pit viper attacks and for this reason emergency staff need to be familiar with the general 
characteristics of these snakes and always take into consideration the possibility of a 
rattlesnake attack when treating a patient that has been bitten by an unidentified snake in 
the United States and Northern Mexico (Hodge III & Tecklenburg, 2006). Rattlesnakes 
attract children because of the sound the rattle makes when the snake is ready to attack. 
3.1.2 Copperheads  
The copperhead (Agkistrodon contortrix) is a common poisonous snake that lives in the 
Southeast United States (from Florida to Massachusetts) and much of the Northeast 
(Oklahoma, Illinois, Kansas, Ohio) but it can reach westward to states such as Texas and 
Nebraska. This reptile accounts for approximately 30% of venomous snake bites but, luckily, 
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it is seldom a serious threat to life or limb. Copperheads are usually 60 cm to 1 m in length 
and have a light pink to red–brown body with darker brown crossbands shaped like 
hourglasses. The head has a coppery tinge (Hodge III & Tecklenburg, 2006). 
3.1.3 Water moccasin  
The water moccasin, also known as the cottonmouth (Agkistrodon piscivorus), is a 
semiaquatic pit viper found in the Southeastern of the United States, including Southeast 
Virginia, West and Central Alabama, South Georgia, Illinois, East and central Kentucky, 
South and Central Oklahoma, Texas, North Carolina, South Carolina and Florida. These are 
larger and more belligerent snakes, often traveling with their heads in an aggressive 45-
degree angle from the horizontal. Their body is olive brown to black, with darker markings 
on the sides that often fade over the dorsum. The ventral surface is lighter in color. The oral 
mucosa is distinctively white, hence the name cottonmouth. Like the copperhead, bites from 
this species are, in general, less serious than Crotalus species (Hodge III & Tecklenburg, 
2006). The cottonmouth may alert the future victim of the imminent attack by mouth gaping 
and tail vibrations (Glaudas & Winne, 2007). 
3.2 Coral snake  
Coral snakes belong to the Elapidae family. This is a relatively shy and passive snake. It can 
be found in Southeast United States as far as west Texas, as well as in countries from Central 
and South America. Unlike the pit viper, coral snakes have round pupils, not so triangular 
heads and do not have pits with heat sensing organs between the eye and the nostril. They 
can measure approximately 60 cm. and are described as a brightly colored snake. They can 
attract young children, who end up being victims of this venomous snake. It can be easily 
confused with non-poisonous snakes because of their bright colors. If the snake is presented 
in a safe way we can observe red and black bands that alternate with narrow yellow rings. 
Whenever we see yellow rings next to red bands we should think of a coral snake. Non-
poisonous similar snakes have yellow rings directly in touch with black (and not red) bands.  
3.3 Snakes outside america 
In Europe, Africa and Oceania, we have an enormous number of species as dangerous as the 
ones living in America. In Europe, the Common adder is distributed widely across the 
continent, even reaching the northern part of Morocco. Has a variable color, ranging from 
completely black specimens to different dark zigzag patterns, measuring around 45 
centimeters. Inoculates hemotoxic venom, its victims usually are campers, hikers and field 
workers. Another hemotoxic venom inoculating snake in Europe, although not as common 
(found only in Italy, Yugoslavia, northern Albania, and Romania) is the Long-nosed adder, 
which is gray, brown, or reddish with a dark brown or black zigzag pattern running the 
length of its back. A dark stripe is usually found behind each eye. In the southeast Europe 
area we can find the Pallas' viper with hemotoxic venom that is rarely fatal.  
Regarding Africa, the Boomslang a 60-centimeter green or brown snake with hemotoxic 
venom inhabits the sub-Saharan Africa. Through most of the African territory particularly 
Angola, Cameroon, Uganda, Kenya, and the Congo we can find the Bush viper, often called 
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surface with minimal plant growth, etc.) there are several bits of information we should 
recall if we clearly see the snake: 
3.1 Pit viper 
These snakes have pits, one in each side of the face, located between the eye and the nostril. 
These pits, not found in the non-venomous species, contain heat-sensing organs, very 
important for these venomous snakes, since they have a very poor vision. If we have a good 
view of the snake, we can observe its pupils, which are different from non-poisonous 
snakes. Pupils in the pit viper are elliptical and vertically oriented. The fangs in venomous 
snakes are only superior, two in number and hollow. These are usually 5 to 20 mm long. 
These fangs are folded posteriorly in the palate and are shown only when the snake attacks. 
Regarding the head, in most poisonous snakes it is more triangular than in non-poisonous 
snakes. Last, if the snake is captured or killed, we can examine the anal plate. In poisonous 
snakes the scales are in a single row after the anal plate. In non-harmful snakes the anal 
plate ends in a cleft or a double row of scales. These snakes produce an hemotoxic venom. 
3.1.1 Rattlesnakes 
There are four kinds of rattlesnakes (Crotalus) in North America, this is the reason why this 
species is very heterogeneous regarding its colors and length. We have: the Eastern 
Diamondback, the Western Diamondback, the Mojave Rattlesnake and the Tropical 
Rattlesnake. The Eastern Diamondback is the most common. We can find it in the Southeast 
Coastal area of the United States (North Carolina, South Carolina, Louisiana and Florida). 
This snake can be up to two meters long and has a characteristic pattern of bright lines that 
form a symmetric diamond pattern. The Western Diamondback lives in the Southeast of the 
United States, mainly southeast California, Oklahoma, Arizona, New Mexico and Texas. It is 
a little shorter than the Eastern Diamondback measuring only up to 1.5 meters. The Mojave 
Rattlesnake can be found in the Southwestern United States, principally in the Mojave 
Desert in California, Nevada, Southeast Arizona, Texas and the north portion of Mexico. It 
prefers rocky desert areas and this species is only about 75 cm. Last, we have the Tropical 
Rattlesnake, which lives in crops and sandy areas in the Southern of Mexico, Central 
America and South America (except Chile). These can measure up to two meters long, even 
though it usually is 1.5 meters long. These snakes are responsible for approximately 60% of 
all pit viper attacks and for this reason emergency staff need to be familiar with the general 
characteristics of these snakes and always take into consideration the possibility of a 
rattlesnake attack when treating a patient that has been bitten by an unidentified snake in 
the United States and Northern Mexico (Hodge III & Tecklenburg, 2006). Rattlesnakes 
attract children because of the sound the rattle makes when the snake is ready to attack. 
3.1.2 Copperheads  
The copperhead (Agkistrodon contortrix) is a common poisonous snake that lives in the 
Southeast United States (from Florida to Massachusetts) and much of the Northeast 
(Oklahoma, Illinois, Kansas, Ohio) but it can reach westward to states such as Texas and 
Nebraska. This reptile accounts for approximately 30% of venomous snake bites but, luckily, 
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it is seldom a serious threat to life or limb. Copperheads are usually 60 cm to 1 m in length 
and have a light pink to red–brown body with darker brown crossbands shaped like 
hourglasses. The head has a coppery tinge (Hodge III & Tecklenburg, 2006). 
3.1.3 Water moccasin  
The water moccasin, also known as the cottonmouth (Agkistrodon piscivorus), is a 
semiaquatic pit viper found in the Southeastern of the United States, including Southeast 
Virginia, West and Central Alabama, South Georgia, Illinois, East and central Kentucky, 
South and Central Oklahoma, Texas, North Carolina, South Carolina and Florida. These are 
larger and more belligerent snakes, often traveling with their heads in an aggressive 45-
degree angle from the horizontal. Their body is olive brown to black, with darker markings 
on the sides that often fade over the dorsum. The ventral surface is lighter in color. The oral 
mucosa is distinctively white, hence the name cottonmouth. Like the copperhead, bites from 
this species are, in general, less serious than Crotalus species (Hodge III & Tecklenburg, 
2006). The cottonmouth may alert the future victim of the imminent attack by mouth gaping 
and tail vibrations (Glaudas & Winne, 2007). 
3.2 Coral snake  
Coral snakes belong to the Elapidae family. This is a relatively shy and passive snake. It can 
be found in Southeast United States as far as west Texas, as well as in countries from Central 
and South America. Unlike the pit viper, coral snakes have round pupils, not so triangular 
heads and do not have pits with heat sensing organs between the eye and the nostril. They 
can measure approximately 60 cm. and are described as a brightly colored snake. They can 
attract young children, who end up being victims of this venomous snake. It can be easily 
confused with non-poisonous snakes because of their bright colors. If the snake is presented 
in a safe way we can observe red and black bands that alternate with narrow yellow rings. 
Whenever we see yellow rings next to red bands we should think of a coral snake. Non-
poisonous similar snakes have yellow rings directly in touch with black (and not red) bands.  
3.3 Snakes outside america 
In Europe, Africa and Oceania, we have an enormous number of species as dangerous as the 
ones living in America. In Europe, the Common adder is distributed widely across the 
continent, even reaching the northern part of Morocco. Has a variable color, ranging from 
completely black specimens to different dark zigzag patterns, measuring around 45 
centimeters. Inoculates hemotoxic venom, its victims usually are campers, hikers and field 
workers. Another hemotoxic venom inoculating snake in Europe, although not as common 
(found only in Italy, Yugoslavia, northern Albania, and Romania) is the Long-nosed adder, 
which is gray, brown, or reddish with a dark brown or black zigzag pattern running the 
length of its back. A dark stripe is usually found behind each eye. In the southeast Europe 
area we can find the Pallas' viper with hemotoxic venom that is rarely fatal.  
Regarding Africa, the Boomslang a 60-centimeter green or brown snake with hemotoxic 
venom inhabits the sub-Saharan Africa. Through most of the African territory particularly 
Angola, Cameroon, Uganda, Kenya, and the Congo we can find the Bush viper, often called 
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leaf viper because of its color and because it uses its prehensile tail to secure itself to 
branches. Its venom is hemotoxic and healthy adults rarely die from its bite. The feared 
Asiatic cobra is distributed from southeast to southwest Asia, including Indonesia. Its 
venom is highly neurotoxic, causing respiratory paralysis with some tissue damage. With 
even stronger neurotoxic venom and wider distribution (From southeast to southwest Asia, 
including Indonesia) we have the Egyptian cobra 
4. Pathophysiology 
In the pathophysiology of envenomation we can consider different factors that can be 
divided into human factors, which include the size of the victim, general health and wound 
characteristics, such as depth of fang penetration and location of the wound and snake 
factors which include the size of the snake, the amount of venom injected, and the strength 
of the particular species venom. Healthy, angered and hungry snakes unload more venom 
than a recently satiated and surprised snake (Hodge III and Tecklenburg 2006). Snake 
venom is a complex mixture of proteolytic enzymes, peptidases, proteinases, 
phospholipases and neurotoxins that are able to cause serious damage to the 
musculoskeletal, blood clotting, cardiopulmonary, renal and central nervous systems. Due 
to the venom, there is cell function degeneration and the final outcome depends on the type 
of venom injected. Generally, envenomation increases capillary permeability that results in 
blood and plasma loss from the intravascular to the extracellular space, creating edema, 
which, in case of being sufficiently important, may cause circulatory compromise and 
hypovolemic shock. Also, snake venom has citolytic properties, which cause local necrosis 
and secondary infection, which could result in sepsis and death (De la O Cavazos 2006). 
Venoms with neurotoxic activity produce paralysis and respiratory distress by binding the 
nicotinic acetylcholine receptors, and preventing the depolarizing action of acetylcholine. 
Hemotoxic effects induce hemolysis, fibrinogen proteolysis, and thrombocytopenia, which, 
along with activation of plasminogen, can lead to a bleeding diathesis in severe 
envenomation  (Hodge III & Tecklenburg, 2006). Cardiotoxic effects lead to heart failure as 
well as myotoxicity and nephrotoxicity. Some are known poisons and it is important to 
know their mechanism of action for diagnosing anding accidents caused by these reptiles. It 
is also helped to unveil a number of physiological distrurbances caused by these venoms 
regarding neurotransmission, coagulation processes and mechanisms of inflammation. The 
most important effect of neurotoxins is to prevent the transmission of nerve impulses in 
cholinergic synapses. ALFA neurotoxins interfere with neurotransmitter release and cause 
muscle paralysis, respiratory failure and death by asphyxiation. Phospholipase A2 catalyzes 
the hydrolysis of phosphoglycerides creating phospholipids, which have detergent 
properties with a highly polar hydrophilic head and a hydrophobic tail and therefore they 
are capable of damaging cell membranes by breaking the continuity of its bilayer lipid . 
They have an important action in the phenomena of hemolysis, myonecrosis, neurotoxicity 
and anticoagulantion. The myotoxin-type crotalin protein acts through activation of 
sarcolemmal channels, inhibiting the activity of sarcoplasmic reticulum ATPase with 
significant depolarization and changes in the osmolarity of muscle fibers with vacuolization 
and lysis of myocytes and, local necrosis of skeletal muscle. The coagulants and 
anticoagulants such as the crotaline venoms cause a syndrome similar to disseminated 
intravascular coagulation (DIC) through an enzyme protein similar to thrombin, which 
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prompts the formation of fibrin monomers, generating an abnormal mesh of fibrin, upon 
which the factor XIII can not act being lysed by the mechanisms of fibrinolysis as 
degradation products of fibrin D-dimer. It also contains inhibitors of factor X activation of 
prothrombin and thrombin and fibrinogenases. 
5. Clinical manifestations 
We can have diverse clinical manifestations when it comes to snakebites. The inapparent 
bites occur mainly when dealing with non-venomous snakes or when we have a bite by a 
venemous snake which did not cause symptoms. Due to the low frequency of poisoning by 
snake bites, it has been suggested that snakes who bite as a defensive move against humans 
do not inject enough venom to cause systemic symptoms, these are called dry bites.  
Generally, local events occur in the time span of the first 10 to 30 minutes. Local pain is 
perceived along with the presence of edema, exudate and presence of bullae, accompanied 
by numbness of the tongue, jaw and scalp. There may be numbness around the bite with  
bleeding or a purpuric rash and/or necrosis or gangrene. As for the systemic manifestations, 
they start with the onset of fear and impending death feeling, which accelerates absorption 
of the venom. Other symptoms depend on the pathophysiological changes of the venom of 
certain species; neurotoxic venoms manifest as neuromuscular blockade resulting in flaccid 
paralysis, ptosis, and difficulty breathing; cardiotoxic venoms manifest as tachycardia, 
hypotension and ECG abnormalities, there may be fluctuations in heart rate, blood pressure 
and even heart failure in severe cases. There may be muscle necrosis resulting in 
myoglobinuria. 
Different poisons trigger different clinical manifestations and it is important for healthcare 
staff to learn to recognize the general characteristics of every single of them or at least the 
more common, depending on their geographical localization. 
5.1 Pit vipers 
Pit viper snakes (rattlesnakes, copperheads, and water moccasins) produce hemotoxic 
venom. Local pain is typically intense, and a sensation of burning occurs within five to ten 
minutes. The pain is greater with ensuing edema and presumably increases with a larger 
inoculation of venom. Only in rare occasions the venom will sediment in the muscule 
compartment, in which cases the amount of edema will be minimal. In Diamondback 
rattlesnake bites, the limb may swell completely in just one hour. There can be local 
echymmosis and vesicles in the first hours. Lymphadenitis and some adenomegalies may 
become apparent. Victims of a significant rattlesnake bite often complain within minutes of 
perioral numbness, extending to the scalp and periphery. This parenthesis may be 
accompanied by a metallic taste in the mouth. 
These patients also may have nausea, vomiting, weakness, chills, sweating, syncope, and 
other more ominous symptoms of systemic venom absorption. A copperhead envenomation 
produces less local symptoms, and systemic consequences are often minimal or nonexistent 
unless a small child, multiple bites, or a larger than average snake is involved. The water 
moccasin's effects are more variable. 
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leaf viper because of its color and because it uses its prehensile tail to secure itself to 
branches. Its venom is hemotoxic and healthy adults rarely die from its bite. The feared 
Asiatic cobra is distributed from southeast to southwest Asia, including Indonesia. Its 
venom is highly neurotoxic, causing respiratory paralysis with some tissue damage. With 
even stronger neurotoxic venom and wider distribution (From southeast to southwest Asia, 
including Indonesia) we have the Egyptian cobra 
4. Pathophysiology 
In the pathophysiology of envenomation we can consider different factors that can be 
divided into human factors, which include the size of the victim, general health and wound 
characteristics, such as depth of fang penetration and location of the wound and snake 
factors which include the size of the snake, the amount of venom injected, and the strength 
of the particular species venom. Healthy, angered and hungry snakes unload more venom 
than a recently satiated and surprised snake (Hodge III and Tecklenburg 2006). Snake 
venom is a complex mixture of proteolytic enzymes, peptidases, proteinases, 
phospholipases and neurotoxins that are able to cause serious damage to the 
musculoskeletal, blood clotting, cardiopulmonary, renal and central nervous systems. Due 
to the venom, there is cell function degeneration and the final outcome depends on the type 
of venom injected. Generally, envenomation increases capillary permeability that results in 
blood and plasma loss from the intravascular to the extracellular space, creating edema, 
which, in case of being sufficiently important, may cause circulatory compromise and 
hypovolemic shock. Also, snake venom has citolytic properties, which cause local necrosis 
and secondary infection, which could result in sepsis and death (De la O Cavazos 2006). 
Venoms with neurotoxic activity produce paralysis and respiratory distress by binding the 
nicotinic acetylcholine receptors, and preventing the depolarizing action of acetylcholine. 
Hemotoxic effects induce hemolysis, fibrinogen proteolysis, and thrombocytopenia, which, 
along with activation of plasminogen, can lead to a bleeding diathesis in severe 
envenomation  (Hodge III & Tecklenburg, 2006). Cardiotoxic effects lead to heart failure as 
well as myotoxicity and nephrotoxicity. Some are known poisons and it is important to 
know their mechanism of action for diagnosing anding accidents caused by these reptiles. It 
is also helped to unveil a number of physiological distrurbances caused by these venoms 
regarding neurotransmission, coagulation processes and mechanisms of inflammation. The 
most important effect of neurotoxins is to prevent the transmission of nerve impulses in 
cholinergic synapses. ALFA neurotoxins interfere with neurotransmitter release and cause 
muscle paralysis, respiratory failure and death by asphyxiation. Phospholipase A2 catalyzes 
the hydrolysis of phosphoglycerides creating phospholipids, which have detergent 
properties with a highly polar hydrophilic head and a hydrophobic tail and therefore they 
are capable of damaging cell membranes by breaking the continuity of its bilayer lipid . 
They have an important action in the phenomena of hemolysis, myonecrosis, neurotoxicity 
and anticoagulantion. The myotoxin-type crotalin protein acts through activation of 
sarcolemmal channels, inhibiting the activity of sarcoplasmic reticulum ATPase with 
significant depolarization and changes in the osmolarity of muscle fibers with vacuolization 
and lysis of myocytes and, local necrosis of skeletal muscle. The coagulants and 
anticoagulants such as the crotaline venoms cause a syndrome similar to disseminated 
intravascular coagulation (DIC) through an enzyme protein similar to thrombin, which 
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prompts the formation of fibrin monomers, generating an abnormal mesh of fibrin, upon 
which the factor XIII can not act being lysed by the mechanisms of fibrinolysis as 
degradation products of fibrin D-dimer. It also contains inhibitors of factor X activation of 
prothrombin and thrombin and fibrinogenases. 
5. Clinical manifestations 
We can have diverse clinical manifestations when it comes to snakebites. The inapparent 
bites occur mainly when dealing with non-venomous snakes or when we have a bite by a 
venemous snake which did not cause symptoms. Due to the low frequency of poisoning by 
snake bites, it has been suggested that snakes who bite as a defensive move against humans 
do not inject enough venom to cause systemic symptoms, these are called dry bites.  
Generally, local events occur in the time span of the first 10 to 30 minutes. Local pain is 
perceived along with the presence of edema, exudate and presence of bullae, accompanied 
by numbness of the tongue, jaw and scalp. There may be numbness around the bite with  
bleeding or a purpuric rash and/or necrosis or gangrene. As for the systemic manifestations, 
they start with the onset of fear and impending death feeling, which accelerates absorption 
of the venom. Other symptoms depend on the pathophysiological changes of the venom of 
certain species; neurotoxic venoms manifest as neuromuscular blockade resulting in flaccid 
paralysis, ptosis, and difficulty breathing; cardiotoxic venoms manifest as tachycardia, 
hypotension and ECG abnormalities, there may be fluctuations in heart rate, blood pressure 
and even heart failure in severe cases. There may be muscle necrosis resulting in 
myoglobinuria. 
Different poisons trigger different clinical manifestations and it is important for healthcare 
staff to learn to recognize the general characteristics of every single of them or at least the 
more common, depending on their geographical localization. 
5.1 Pit vipers 
Pit viper snakes (rattlesnakes, copperheads, and water moccasins) produce hemotoxic 
venom. Local pain is typically intense, and a sensation of burning occurs within five to ten 
minutes. The pain is greater with ensuing edema and presumably increases with a larger 
inoculation of venom. Only in rare occasions the venom will sediment in the muscule 
compartment, in which cases the amount of edema will be minimal. In Diamondback 
rattlesnake bites, the limb may swell completely in just one hour. There can be local 
echymmosis and vesicles in the first hours. Lymphadenitis and some adenomegalies may 
become apparent. Victims of a significant rattlesnake bite often complain within minutes of 
perioral numbness, extending to the scalp and periphery. This parenthesis may be 
accompanied by a metallic taste in the mouth. 
These patients also may have nausea, vomiting, weakness, chills, sweating, syncope, and 
other more ominous symptoms of systemic venom absorption. A copperhead envenomation 
produces less local symptoms, and systemic consequences are often minimal or nonexistent 
unless a small child, multiple bites, or a larger than average snake is involved. The water 
moccasin's effects are more variable. 
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5.2 Coral snakes 
In Coral Snake bites, the inoculation of venom is neurotoxic. Clinical manifestations from a 
coral snake envenomation are mild pain (against intense pain from a pit viper snakebite), 
swelling, erythema and paresthesis in the area of the wound. The wound is represented by 
puncture marks, abrasions or scratches (D. L. Morgan, Borys, Stanford, Kjar, & Tobleman, 
2007). Most snake bites do not leave important local signs other than one or two punctures 
and sometimes small teeth marks. Systemic effects appearing after several hours include 
nausea, vomiting, dizziness, malaise, slurred speech, muscle weakness, respiratory 
depression, or seizures (Hodge III & Tecklenburg, 2006).  
6. Laboratory  
The laboratory tests are of little importance to diagnose a snakebite, with the exception of 
the  ELISA test, which is available to identify the species involved, based on venom 
antigens. These studies are expensive and are not fully available and are of no value except 
for epidemiological studies. In a hospital setting , laboratory studies are important to 
monitor poisoning victims, as well as when determining stages of treatment. 
Changes in the blood include anemia, leukocytosis and thrombocytopenia, the blood smear 
may show evidence  of hemolysis. Also, prolonged clotting times and decreased fibrinogen 
may be present. Among the metabolic changes we can find hypokalemia and respiratory 
acidosis if neuroparalysis occurs. 
Urinalysis may reveal hematuria, proteinuria and hemoglobinuria. Electrocardiographic  
changes are usually nonspecific and may include rhythm disturbances, mainly bradycardia, 
AV block with ST segment elevation or depression. Cholesterol lowering has been 
documented and can be explained by transcapillary lipoprotein loss. There have been 
reports of changes in the electroencephalogram in up to 96% of patients with snake bites, 
but none showed clinical changes or encephalopathy. In 62% of the patients, the 
electroencephalogram showed grade I changes, 31% showed grade II changes. (Avila-
Aguero: ML199). 
7. Management and treatment 
Science has made enormous advances regarding the pharmacologic treatment of children 
and adults who have been victims of snake bites. Successful treatment will always depend 
on the rapidness with which management begins, even at the scene of the attack, and, of 
course, once the patient arrives for appropriate management to a hospital.  
7.1 Prehospital care 
As we mentioned before, efforts should not be made to catch the snake, since this might 
result in wasted time and further bites. The basis in prehospital care is to limit the spread of 
venom throughout the body. Compressive bandages might be of help. These can be done 
with elastic bandages, if available, or torn clothing after removing clothes and jewelry. The 
extremity should be kept below the level of the heart. The bandage should be tight enough 
to help delay systemic absorption of the venom. Please be aware that incisions and suction 
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are not indicated and could actually promote the development of further infections (D. L. 
Morgan et al., 2007). Remember that all bite wound are already considered contaminated 
wounds and that these invasive measures might actually worsen the problem unless 
performed in the first 30 minutes after the attack has taken place and in a sterile 
environment (Robert L Norris & Adler, 2011). Tourniquets that completely occlude vascular 
irrigation have created more problems than those solved, therefore, they are not 
recommended for their prehospitalary care. 
7.2 Emergency room care 
As soon as the patient reaches the hospital it is important to asses the CAB (circulation, 
airway and breathing) before starting any kind of treatment, this includes appropriate 
management of any active bleeding and of the airway to avoid respiratory failure or 
aspiration. Monitoring of vital signs can be useful to forecast complications and most of the 
times this can be done in the emergency room without sending the patient to the ICU. After 
these measures have been taken care of, hydration is next, since one of the effects of snake 
venoms is to mobilize intravascular fluid to the interstitial space, leaving the patient 
dehydrated. For this, normal saline or Ringer´s lactate is used. Laboratory tests that are 
useful in these settings are CBC, PT/PTT, serum electrolytes, CPK, urinalysis, BUN and 
creatinine and a cross-match for blood.  
The wound should be inspected, if fang marks are found, the distance between them needs 
to be measured in order to get an idea of the size of the snake. The distance between fang 
punctures smaller than 8 mm suggests a small snake, between 8 and 12 mm a medium snake 
and a distance greater than 12 mm suggests a large snake. In the case of the patient being 
bitten by a rattlesnake, the fang punctures could be hidden by hemorrhagic blebs and 
edema. If no puncture wounds can be found, we need to consider the fact that scratches and 
abrasions could be envenomed wounds until we demonstrate otherwise. When a snake 
attacks and bites 10 % to 20% of the time it does not inject any venom (dry bite) and if we 
are dealing with a non-venomous snake we could observe a row of tiny teeth without fang 
punctures. As a precaution, the circumference of the limb should be measured every thirty 
minutes for 6 hours and every 4 hours until 24 hours have passed with the aim of 
preventing the development of complications related to important edema. If no systemic 
symptoms are evident, the wound should be cleansed, dressed and slightly elevated.  
In the setting of not only the subject being bitten, but also suffering from envenomation, the 
use of antivenins is required. In the case of pit viper attacks, there are two antivenins, the 
Polyvalent Crotalic Antivenin (PCAV), which is the oldest, derived from horse's serum and 
highly antigenic, which is the reason for it to be discontinued from the United States market. 
In 2000, the FDA approved the Crotalic Polyvalent Fab Immune (FabAV) to manage patients 
with mild to moderate envenomations by American crotalus and since the Polyvalent 
Crotalic Antivenin is no longer marketed, the Fab Immune represents the only treatment 
option available in the United States, regardless of the severity of the envenomation. This 
alternative is derived from sheep’s serum, a property that makes it less antigenic that its 
predecessor. FabAV appears to be effective in the management of severe crotaline snake 
envenomation (Lavonas, Schaeffer, Kokko, Mlynarchek, & Bogdan, 2009). It is available as a 
powder that needs to be reconstituted with normal saline. Regarding the use of PCAV, the 
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5.2 Coral snakes 
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dosing should be greater in children than in adults; for FabAV, since it can be eliminated 
before the venom emerges from tissues, therefore, a fixed dosing schedule is used. When 
using PCAV, a crash cart (including instruments to ensure airway patency, IV adrenaline, 
antihistaminics, steroids, etc) should be readily available because of the antivenin’s elevated 
immunogenicity and risk of anaphylactic reactions. Skin testing should be performed and is 
done by injecting 0.02 ml of 1:10 diluted antivenin. Skin testing is not necessary for use of 
FabAV. Even though the use of antivenin is the only treatment for envenomations, its use is 
not free from adverse reactions, some of which could be life-threatening such as 
anaphylaxis. Some authors recommend the use of 0.25 ml of 1:1000 subcutaneous adrenaline 
to reduce the risk of acute adverse reactions to the serum (Premawardhena, C. E. de Silva, 
Fonseka, Gunatilake, & H. J. de Silva, 1999). If no adverse reactions appear, the full dosage 
should be administered (one vial with 10 ml saline solution) diluted in normal saline 1:4 as a 
slow infusion (1 or 2 ml per hour). Even after negative skin tests, one should be aware of the 
signs or symptoms of anaphylaxis within the first 10-20 minutes. If data suggestive of an 
anaphylactic reaction are not observed, the remaining volume should be passed on within 
two hours. The initial dose should be repeated until the swelling has stopped. There are 
reports in children of up to 75 bottles being used. In case of anaphylactic reaction, the 
infusion must be stopped and diphenhydramine administered (1 or 2 mg / kg IV). The 
infusion can be restarted at a slower rate, but a close watch should be kept and if symptoms 
of anaphylactic reaction reoccur treatment with antivenom should be discontinued. 
 
Fig. 2. Diagram that shows actions that should be taken care of when helping a snakebite 
victim. 
In patients who receive FabAV, the starting dose consists of four to six bottles in a period of 
one hour. Each vial is reconstituted with 10 ml of sterile water mixed in a total dose in 250 
 
Snake Bites in Pediatric Patients, a Current View 133 
ml of saline. The infusion is started slowly to see if there is a reaction to medication, if not, 
the rest of the load is administered in one hour. The initial dose is fixed, regardless of the 
degree of poisoning. Subsequent doses are administered depending on the progression of 
the clinical evolution. 
 
Modified scale that correlates of clinical signs, edema and dose of antivenom in children 
(Christopher-Rodning) Loading dose Subsequent doses 










three hours in 
250 ml mixed 
solution 
Maintenance (value) 
0 Evidence of bite 
without poisoning 
(probably dry bite) 
0 0 0  
1 Mild poisoning, 
pain and edema 
less than 10 cm 
from the lesion. 




Assess clinical status 
2 Moderate 
poisoning: pain, 
edema greater than 
15 cm from the 
lesion site, changes 
in skin, lymph 
regional. 
5 10 6-8 bottles Assess clinical status 
3 Severe poisoning, 









5 20 6-8 bottles 4-5 bottles every 4  
hours 












25 25 10 bottles 4-5 bottles every 4  
hours 
Table 2. Modified scale correlation of clinical signs, edema and dose of antivenom in 
children. 
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When facing bites by Coral Snakes, the FDA extended the expiration date on the only 
product available in the United States to treat these envenomations. Wyeth's Micrurus fulvius 
Antivenin is no longer in production and there has been a need to obtain antivenoms 
produced in other countries (eg, Brazil, Costa Rica) for non-North American coral snakes. 
Mexico shares snake distribution with the United States. This country produces antivenom 
that is likely effective for coral snake bites in the United States. In the absence of such 
antivenom care must be entirely supportive. (R. L Norris, n.d.). Wound care should include 
irrigation, cleansing and dressings. Is convenient to consider tetanus prophylaxis and 
analgesia in case of need. 
8. Complications 
Compartmental syndrome is a limb threatening complication and it is considered a medical 
emergency that should be managed with fasciotomies. Fasciotomies are indicated in patients 
with signs and symptoms related to the syndrome, such as, pain to passive mobilization, 
hipostesia, weakness and elevated compartmental pressure, measured every hour with 
more than 30 mmHg regardless of elevation of the extremity and the administration of the 
antivenin. (Walter, Bilden, & Gibly, 1999) 
9. Prevention 
Snake bites are considered occupational accidents involving farmers, workers in plantations, 
sheepherders and fishermen (Alirol, Sharma, Bawaskar, Kuch, & François Chappuis, 2010). 
The Statistical Yearbook of the Méxican Ministry of Health (SSA) in the chapter on accidents 
and poisoning in the section of hospital morbidity does not appear to report cases of 
snakebites in the years 1995 to 2000. Clearly there is an underreporting of such injuries. This 
assertion is based on the IMSS 1994-1998 reported 2 620 cases with 23 deaths (0.8%). 
(Madrazo-Navarro M, Zarate-Aguilar A, 1998). Although in normal conditions victims are 
adults, we must take into account that children perform these activities in many third world 
countries. In performing these activities, people should wear appropriate clothing (heavy 
pants, rubber boots) and it could be helpful to limit activities that involve staying in areas 
with tall grass to hours with sunlight. Most of the times this is impossible, and in these cases 
is important to educate the population about the appropriate pre-hospital management in 
case of a snake bite. They should know the fastest routes to reach the nearest hospital and 
take into account that children engaged in these activities are at greater risk of bites by 
snakes and that the severity of these lesions is greater, even if they are exposed to the same 
amount of venom as an adult. 
Open rooms with no windows or doors and some habits, such as sleeping on the ground 
exposes people to night snake attack (Alirol et al., 2010) and these practices must be 
eradicated whenever it is possible. Since the snake bites are more common in the legs, feet, 
to be more precise, the mere fact of having children wear shoes dramatically reduces the 
incidence of such bites, as well as keeping children away from sites where snakes may hide, 
especially in the evenings and early hours of the morning in summer and autumn seasons. 
(Hon, Kwok, & Leung, 2004) 
There is very vague knowledge about the procedures to be followed when someone is 
attacked by a snake, below we present some guidelines that contrary to popular belief and 
misinformation should not be performed: 
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• No incisions in places where the bite is located, as excesive bleeding and the risk of 
infection are favored. 
• Do not use tourniquets since they hinder blood flow and therefore cause more tissue 
damage. 
• Do not apply ice, it worsens local lesions caused by poison. 
• Do not administer electric shocks of any kind. 
• Do not use any chemicals or extracts of plants or animals of any kind, so far none have 
been proven scientifically effective as treatment. 
• Do not give alcoholic beverages. 
• Do not suction with the mouth, this favors infections on the bite site and can be 
dangerous if you have a cavity or open lesion in your mouth. In addition there is no 
guarantee of how much venom you can withdraw with this method. 
10. Conclusion 
Snakebites are not an infectious disease, they do not have an epidemic potential and snakes 
themselves are not vectors that carry important diseases throughout the world. Nonetheless, 
the mortality caused by these attacks is greater than the mortality attributed to other 
diseases such as dengue hemorrhagic fever, cholera and Chaga's disease. At least 100 000 
people die as a result of snake bites each year, and around three times as many amputations 
and other permanent disabilities are caused by snakebites annually and agricultural 
workers and children are the most affected (World Health Organization, n.d.). It is 
important to be familiar with first aid procedures as well as proper treatment in a hospital 
environment in order to decrease deaths and prevent complications and sequels derived 
from this very important health issue. 
Science has made tremendous progress with regard to drug treatment for children and 
adults who have been bitten by snakes. Successful treatment will always depend on the 
speed with which you begin handling the victim from the outpatient level, as well as the 
availability of the drugs for proper treatment once the patient enters the hospital. Keep in 
mind that treatment recommendations published in 1999 could represent insufficient 
dosages and it is necessary an accurate clinical assessment to provide an effective therapy. 
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1. Introduction 
Good oral health and dentition is important for efficient mastication, speaking and 
cosmetically for smiling. If left untreated, dental pathologies can lead to pain and infection, 
reduced growth and development, speech disorders, and high treatment costs. Chronic 
infection around one or more teeth can result in damage to localized structures, such as the 
developing permanent teeth. Children who are medically compromised (such as being 
immunocompromised from a disease and/or therapy) are at increased risk of developing 
systemic complications from dental infections which can be fatal. Therefore, the author focuses 
on the role of the general pediatrician in promoting the importance of good oral health for all 
children and in particular those children receiving cancer therapy. Etiology, assessment, and 
prevention of dental caries and oral mucositis are presented, evidence based where available.  
2. Dental caries development 
Dental caries has historically been considered one of the most important global oral health 
burdens. It is still a major health problem in both developing and developed countries. 60-90 % 
of school-aged children are affected by the disease (Petersen, 2003). At present, the distribution 
and severity of dental caries vary in different parts of the world and within the same region or 
country. In permanent dentition, when dental caries experience is expressed as Significant 
Caries Index (SiC), the determined values are relatively high both for America region (SiC = 
4.8) and the European region (SiC = 5.3) whereas the experience is lower in most African 
countries (SiC = 3.4) (World Health Organization [WHO], 2011). In developing countries, the 
prevalence rates of dental caries and its experience are now tending to increase probably due 
to the increasing consumption of sugars and inadequate exposure to fluorides. Conversely, a 
decline in caries has been observed in most developed countries as a result of a number of 
public health measures, including effective use of fluorides, together with changing living 
conditions, lifestyles and improved self-care practices. However, it must be emphasized that 
dental caries as a disease of children has not been eradicated, but only controlled to a certain degree.  
2.1 Etiology of dental caries  
Dental caries is a process that may take place on any tooth surface in the oral cavity where 
dental plaque (biofilm) is allowed to develop over a period of time. Plaque formation is a 
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natural, physiological process. It is an example of a biofilm which means a community of 
microorganisms attached to a surface. The bacteria in the plaque are always metabolically 
active. Some of them are capable of fermenting a suitable dietary carbohydrate substrate 
(such as the sugars sucrose and glucose), to produce acid. The acid produced causes the 
plaque pH to fall to below 5 within 1-3 minutes. Repeated falls in pH may result in 
demineralization of the tooth surface in time. However, the acid is neutralized by saliva, so 
the pH increases and mineral may be regained. This is called remineralization. The 
cumulative results of de- and remineralization processes may be a loss of mineral and a 
carious lesion can be seen. Alternatively, the changes may be so slight that a carious lesion 
never becomes apparent (Kidd, 2005). The formation of the biofilm and its metabolic activity 
cannot be prevented, but dental caries formation can be controlled, its progression in enamel tissue 
can be arrested and even advanced carious lesions (in dentin) may become inactive. 
2.2 Factors known to influence increased dental caries risk  
Socio-economic factors or circumstances may influence increased caries risk. Factors such as 
social deprivation, unemployment, lower socio-economic status, low knowledge, low 
education of parents, and no regular dental check-ups are directly related to dental caries 
resulting in more cariogenic food consumption, less good oral hygiene, saliva problems 
(medications), and reduced fluoride support (WHO, 1994).  
General health may also indicate increased caries risk. Some general diseases such as 
Sjögren’s Syndrome or their treatments (medicines) affect saliva secretion. Also, the 
conditions can result in more cariogenic food and in less good oral hygiene (WHO, 2003). 
Medicines can interfere with dental caries in two ways by leading to voluminous plaque-
formation (containing fermentable carbohydrates) and by leading to a change in saliva 
production and composition. Medicines classified as follows have been proposed to cause 
xerostomia (oral dryness): antispasmodic, antidepressant, antipsychotic, skeletal muscle 
relaxant, parkinsonism therapy, antiarrythmic, antihistamine, appetite depressant, 
anticonvulsant, anxiolytic, antihypertensive, and diuretic. Oral dryness is the third most 
common side-effect from using medicines (Moore, 2008).  
Diet is one of the key factors for dental caries and will be discussed in detail on section 4.1. 
3. Assessment of dental development and referral for dental problems 
Accurate chronologies of primary (deciduous) teeth calcifications as well as permanent 
dentition in particular first permanent molars are of clinical significance to the pediatricians 
(Table 1 and 2). It is often necessary to explain to parents the time sequence of calcification 
in utero and during infancy. The common observation of tetracycline pigmentation, 
developmental enamel defects, and generalized hereditary anomalies can be explained if the 
calcification schedule is known. 
3.1 Chronologic development and eruption of the teeth 
Evidence of development of the human tooth can be observed as early as the sixth week of 
embryonic life. Its life starts with initiation (bud stage) and follows with proliferation (cap 
stage), histodifferentiation and morphodifferentiation (bell stage), apposition, and  
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Upper Primary Teeth Development Chart 
Upper Teeth When tooth emerges When tooth falls out 
Central incisor 8 to 12 months 6 to 7 years 
Lateral incisor 9 to 13 months 7 to 8 years 
Canine (cuspid) 16 to 22 months 10 to 12 years 
First molar 13 to 19 months 9 to 11 years 
Second molar 25 to 33 months 10 to 12 years 
Lower Primary Teeth Development Chart 
Lower Teeth When tooth emerges When tooth falls out 
Second molar 23 to 31 months 10 to 12 years 
First molar 14 to 18 months 9 to 11 years 
Canine (cuspid) 17 to 23 months 9 to 12 years 
Lateral incisor 10 to 16 months 7 to 8 years 
Central incisor 6 to 10 months 6 to 7 years 
Table 1. Eruption and exfoliation timetable of primary human dentition. The first teeth begin 
to break through the gums at about 6 months of age. Usually, the first two teeth to erupt are 
the two bottom central incisors (the two bottom front teeth). Next, the top four front teeth 
emerge. After that, other teeth slowly begin to fill in, usually in pairs -- one each side of the 
upper or lower jaw -- until all 20 teeth (10 in the upper jaw and 10 in the lower jaw) have 
come in by the time the child is 2 ½ to 3 years old.  
 
Upper Permanent Teeth Development Chart 
Upper Teeth When tooth emerges 
Central incisor 7 to 8 years 
Lateral incisor 8 to 9 years 
Canine (cuspid) 11 to 12 years 
First premolar 
(first bicuspid) 10 to 11 years 
Second premolar (second bicuspid) 10 to 12 years 
First molar 6 to 7 years 
Second molar 12 to 13 years 
Third molar (wisdom teeth) 17 to 21 years 
Lower Permanent Teeth Development Chart 
Lower Teeth When tooth emerges 
Third molar (wisdom tooth) 17 to 21 years 
Second molar 11 to 13 years 
First molar 6 to 7 years 
Second premolar (second bicuspid) 11 to 12 years 
First premolar 
(first bicuspid) 10 to 12 years 
Canine (cuspid) 9 to 10 years 
Lateral incisor 7 to 8 years 
Central incisor 6 to 7 years 
Table 2. Eruption and exfoliation timetable of permanent human dentition. Permanent teeth 
begin to come in around the age of 6. In some children, the first permanent molars are the 
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calcification (AlQahtani et al., 2010). Ameloblasts will form enamel whereas odontoblasts 
will form dentin tissue. Following completion of all these stages the tooth will erupt. 
Primary teeth will shed (exfoliate) to their permanent successors. Although many theories 
have been advanced (Marks Jr., 1996; Philbrick et al., 1998; Wise et al., 2002), the factors 
responsible for the eruption of the teeth are not fully understood. The factors that have been 
related to the eruption of teeth include elongation of the root, forces exerted by the vascular 
tissues around and beneath the root, growth of the alveolar bone, growth of dentin, growth 
and pull of the periodontal membrane, hormonal influences (pituitary growth hormone, 
thyroid hormone, and parathyroid hormone-related protein), presence of a viable dental 
follicle, pressure from the muscular action, and resorption of the alveolar crest. A review 
article by Wise et al (Wise et al., 2002) focused on the molecular signals that initiate tooth 
eruption. They stated that tooth eruption is a complex and tightly regulated process 
involving cells of the tooth organ and surrounding alveolus. Mononuclear cells (osteoclast 
precursors) must be engaged into the dental follicle prior to the onset of eruption. These 
cells will turn into osteoclasts which resorb alveolar bone, and create an eruption pathway 
for the tooth to exist its bony container. Interaction of osteoblasts, osteoclasts and dental 
follicle involve a complex interplay of regulatory genes. It should be remembered that the 
time of eruption of both primary and permanent teeth varies greatly and variations of 6 
months on either side of the usual eruption date may be considered normal for a given 
child. Demirjian and Levesque (1980) investigated a large sample of 5437 radiographs from 
a homogenous French-Canadian population, their analysis showed the similarity in timing 
between sexes for the early stages of tooth development (crown formation). However, their 
data indicated the importance of sexual dimorphism during the period of root development 
which girls were more advanced than boys by an average of 0.35 year for four teeth. For the 
stages of root development the mean difference between the sexes for all teeth was 0.54 year. 
The largest difference was for the canine (0.90 year). A study by Proffit and Fraizer-Bowers 
(2009) reviews the mechanism and control of tooth eruption. Finally an extensive review by 
Almonaitiene et al. (2010) analyzed the factors influencing permanent teeth eruption. 
Readers who wish to obtain more information about the details of the tooth eruption 
process are referred to these review articles.  
3.2 Teething and difficult eruption 
In general, the eruption of primary teeth comes before by increased salivation, and the child 
would want to put the hands and fingers into the mouth. Some young children become 
daytime restlessness, an increase in the amount of finger sucking or rubbing of the gum, an 
increase in drooling and some loss of appetite during the time of eruption of the primary 
teeth. These observations may be the only indication that the teeth will soon erupt (Macknin et al., 
2000; Feldens et al., 2010). However, in some children a pronounced change in the mucosa 
often with small hemorrhages could be expected (Tasanen, 1968). Many conditions 
including croup, diarrhea, fever, convulsions, and primary herpetic gingivostomatitis have 
been incorrectly attributed to eruption (Dally, 1996). Leung (1989) reported that serious 
mistakes could be made in the care of infants and toddlers if their symptoms were ascribed 
to teething without completion of a thorough diagnostic evaluation and resulted in the 
overlooking of significant systemic disturbances. Because of the tooth eruption is a normal 
physiologic process, the association with fever and systemic disturbances are not justified. 
Inflammation of the gingival tissues before complete eruption of the tooth crown may cause 
 
What is the Role of Pediatricians on Oral Health? 
 
141 
a temporary painful condition which relieves within a few days. The eruption process may 
be hastened if the child is allowed to chew on a clean teething object. Using finger press 
technique upon where the tooth has been emerging will subside the probably fretful 
condition. The application of a nonirritating topical anesthetic may bring in temporary relief 
in the child has been experiencing extreme difficulty during the teeth eruption (Sood & 
Sood, 2010).  
Primary teeth eruption facts for the pediatricians: 
• A general rule of thumb is that for every 6 months of life, approximately 4 teeth will 
erupt 
• Girls generally precede boys in tooth eruption  
• Lower teeth usually erupt before upper teeth  
• Teeth in both jaws usually erupt in pairs -- one on the right and one on the left  
Primary teeth are smaller in size and whiter in color than the permanent teeth that will 
follow  
• By the time a child is 2 to 3 years of age, all primary teeth should have erupted  
Shortly after age 4, the jaw and facial bones of the child begin to grow, creating spaces 
between the primary teeth. This is a perfectly natural growth process that provides the 
necessary space for the larger permanent teeth to emerge.  
• Between the ages of 6 and 12, a mixture of both primary teeth and permanent teeth 
reside in the mouth 
If baby teeth fall out after a couple of years, why is it important to care for them?  
• They reserve space for their permanent counterparts  
• They give the face its normal appearance  
• They aid in the development of clear speech  
• They help attain good nutrition (missing or carious teeth make it difficult to chew 
causing children to reject foods)  
• They help give a healthy start to the permanent teeth (caries and infection in baby teeth 
can cause dark spots on the permanent teeth developing beneath it).  
3.2.1 Eruption hematoma (eruption cyst) 
A bluish purple, elevated area of tissue called an eruption hematoma rarely develops a few 
weeks before the eruption of a primary or permanent tooth. It is actually a blood-filled cyst. 
It occurs most frequently in the primary second molar or the first permanent molar regions. 
The condition usually develops as a result of trauma to the soft tissue during mastication. 
The condition is self-limited and usually subsides in a few days following the break-through 
of the crown. Therefore, the treatment of the hematoma is rarely necessary. In order to 
expose the crown, surgical incision of the gingival tissue may rarely be needed (Tsiklakis & 
Patsakas, 1989). 
3.2.2 Eruption sequestrum 
The eruption sequestrum is seen occasionally at the time of eruption of the first permanent 
molar. It may develop from either osteogenic (Starkey & Shafer, 1963) or odontogenic tissue 
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a temporary painful condition which relieves within a few days. The eruption process may 
be hastened if the child is allowed to chew on a clean teething object. Using finger press 
technique upon where the tooth has been emerging will subside the probably fretful 
condition. The application of a nonirritating topical anesthetic may bring in temporary relief 
in the child has been experiencing extreme difficulty during the teeth eruption (Sood & 
Sood, 2010).  
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• By the time a child is 2 to 3 years of age, all primary teeth should have erupted  
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can cause dark spots on the permanent teeth developing beneath it).  
3.2.1 Eruption hematoma (eruption cyst) 
A bluish purple, elevated area of tissue called an eruption hematoma rarely develops a few 
weeks before the eruption of a primary or permanent tooth. It is actually a blood-filled cyst. 
It occurs most frequently in the primary second molar or the first permanent molar regions. 
The condition usually develops as a result of trauma to the soft tissue during mastication. 
The condition is self-limited and usually subsides in a few days following the break-through 
of the crown. Therefore, the treatment of the hematoma is rarely necessary. In order to 
expose the crown, surgical incision of the gingival tissue may rarely be needed (Tsiklakis & 
Patsakas, 1989). 
3.2.2 Eruption sequestrum 
The eruption sequestrum is seen occasionally at the time of eruption of the first permanent 
molar. It may develop from either osteogenic (Starkey & Shafer, 1963) or odontogenic tissue 





little or no clinical significance. As the tooth erupts, the fragment will sequestrate. However, 
it can be removed if it causes local irritation.  
3.2.3 Ectopic eruption 
A variety of local factors such as arch length inadequacy may influence a tooth to erupt or 
try to erupt in an abnormal position (Gupta et al, 2011). 
3.3 Natal and neonatal teeth (prematurely erupted primary teeth) 
The normal eruption of the primary teeth typically begins at six months of age. Natal teeth 
(teeth present at birth) and neonatal teeth (teeth that erupt during the first 30 days) are 
usually benign conditions (Cunha et al., 2001). Whatever the conditions they are, both of 
them considered as early eruption of primary teeth. Spouge and Feasby believe that the 
terms natal teeth and neonatal teeth constitute a relatively artificial distinction. Therefore, they 
have suggested that the terms mature and immature are more in keeping with the varying 
prognoses associated with such teeth in clinical point of view (Spouge & Feasby, 1966). The 
incidence of natal teeth ranges from 1:2000 to 1:3500 live births (Seminario & Ivancakova, 
2004). The exact etiology is unknown. Infection, febrile states, trauma, malnutrition, 
superficial position of the tooth germ, hormonal stimulation and maternal exposure to 
environmental toxins has been implicated as causative factors (Cunha et al., 2001). It has 
been previously reported that heavily exposures to polychlorinated biphenyls and 
dibenzofurans caused to born infants with natal teeth in Taiwan (Gladen et al., 1990). 
However, Alaluusa et al. (2002) did not find any association between milk levels of 
polychlorinated biphenyls and dibenzofurans, and the occurrence of natal teeth. Early 
eruption of primary teeth might occur as a hereditary transmission of an autosomal 
dominant gene. A positive familial history has been reported in 8-62 % of natal teeth cases 
(Zhu & King, 1995). Natal teeth are present in 2 % of infants with unilateral cleft lip and 
palate and 10 % of infants with bilateral cleft lip and palate (de Almeida & Gomide, 1996). 
Natal teeth have been reported in association with syndromes such as Ellis-van Creveld, 
Jadassohn-Lewandowsky, Hallerman-Streiff, craniofacial dysostosis, steacystoma multiplex, 
Sotos, Wiedemann-Rautenstrauch, Meckel-Gruber and Pierre Robin (Seminario & 
Ivancakova, 1992; Uzamis et al., 1999; Marakoglu et al., 2004). 
The most commonly affected teeth are the lower primary central incisors (85 %), followed by 
the maxillary incisors (11%), mandibular canines and molars (3 %), and maxillary canines 
and molars (1 %). Natal teeth usually occur in pairs (Zhu & King, 1995). However, an 
unusual case of an infant with fourteen natal teeth was reported by Masatomi et al. (1991). 
Natal teeth might resemble normal primary teeth in size and shape; however, the teeth are 
often smaller, conical and yellowish, and have hypoplastic enamel and dentin with poor or 
absent root development. Most prematurely erupted primary teeth are mobile because of 
limited root development. Some teeth may be supernumerary or mobile to the extent that 
there is danger of displacement of the tooth and possible aspiration. In such cases the 
removal (extraction) of the tooth is indicated. However, Zhu and King (1995) did not find 
any reported cases of aspirated natal or neonatal teeth in the literature. In some cases sharp 
incisal edge of the teeth may cause sublingual ulceration of the infant (Riga-Fede disease) or 
laceration of the mothers’ breasts. If the teeth with rough edges are not hypermobile or not 
supernumerary; smoothing the sharp incisal edges of   teeth or the placement of round 
smooth composite resin over the incisal edges is indicated. However, if the tooth does not 
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interfere with breastfeeding or not hypermobile, no intervention is necessary. Consultation with a 
pediatric dentist is strongly recommended in order to evaluate the preferred treatment and for 
differential diagnosis. Eruption of teeth during the neonatal period causes fewer problems. 
These teeth can usually be maintained even tough root development is limited (Figure 1). 
 
Fig. 1. Intraoral view showing a natal teeth and Riga-Fede disease (quoted from 
Padmanabhan et al. (2010) Neonatal sublingual traumatic ulceration - case report & review 
of the literature. Dent Traumatol  26, 6, Dec, 490-5.) 
3.4 Epstein pearls, bohn nodules, and dental lamina cysts 
Small, white or grayish white lesions on the alveolar mucosa of the newborn are identified 
as inclusion cysts. They are classified as the following three types according to their location 
in oral cavity: Epstein pearls are formed along the midpalatine raphe. Bohn nodules are 
formed along the buccal and lingual aspects of the dental ridges and on the palate away 
from the raphe. Dental lamina cysts are found on the crest of the maxillary and mandibular 
ridges. These lesions are usually multiple but do not increase in size. No treatment is 
indicated since the lesions will spontaneously be shed a few weeks after birth. These lesions 
may be incorrectly diagnosed as the natal teeth (Fromm, 1967; Cetinkaya et al., 2011). 
3.5 Local and systemic factors that influence tooth eruption 
Local factors which influence tooth eruption are ankylosed primary and permanent teeth, 
and ankylosis of primary molars with absence of permanent successors. Local factors 
generally cause delayed teeth eruption (Ertugrul et al., 2002). Referral to a pediatric dentist 
is recommended for appropriate treatment.  
General factors associated with altered tooth eruption are Down syndrome (Trisomy 21 
syndrome), cleidocranial dysplasia, congenital hypothyroidism (Cretinism), juvenile 
hypothyrodism, hypopituitarism, and achondroplastic dwarfism. Sporadic delayed eruption 
of teeth frequently occurs in children with Down syndrome. The first primary teeth may not 
appear until 2 years of age, and the dentition may not be complete until 5 years of age. The 
eruption generally follows an abnormal sequence and some of the primary teeth may be 
retained until 15 years of age (Jara et al., 1993; Ondarza et al., 1997). The prevalence and 
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higher compared to normal healthy and other mentally disabled children. A high prevalence 
of necrotizing ulcerative gingivitis is also reported (Carlstedt et al., 1996; Cichon et al., 1998). 
These higher prevalence relating periodontal diseases cannot only be explained by poor oral 
hygiene alone and may be the result of impaired immune responses and deficient 
phagocytic systems (Morinushi et al., 1997). Dental caries susceptibility is usually low in 
those with Down syndrome (Davidovich et al., 2010). Cleidocranial dysplasia (osteodentin 
dysplasia) has dental significance. The patients exhibit mandibular prognathism. The 
maxilla tends to be short vertically but not in sagittal way. The development of the dentition 
is delayed. One of the distinguishing characteristics is the presence of supernumerary teeth 
(Richardson & Deussen, 1994). The pediatric dentist serves as the coordinator of overall oral 
health care and disease prevention during an extended treatment regimen that usually 
includes two surgical interventions and three stages of orthodontic surgery. 
Hypothyroidism whether it occurs at birth or juvenile stage, causes delayed primary and 
permanent teeth eruption, and delayed primary teeth exfoliation (Mganga & Chindia, 1990). 
Hypopituitarism also causes delayed teeth eruption. Primary teeth may not undergo 
resorption but instead retained throughout the life of the patient. The underlying permanent 
teeth will develop but do not erupt (Conley et al., 1990). Delayed teeth eruption has been 
linked to other disorders, such as fibromatosis gingivae, chondroectodermal dysplasia, 
Gardner syndrome.  
4. Provision of a caries control measurements 
4.1 Cariogenic diet (reduction in the intake of freely fermentable carbohydrates) 
Diet refers to the habitual allowance of food and drink taken by any person from day to day. 
Thus, the diet may exert an effect on caries locally in the mouth by reacting with the enamel 
surface and by serving as a substrate for cariogenic microorganisms. The food per se does not 
cause dental caries. Diet operates via the bacteria and the result may be a low pH at which the 
tooth starts to dissolve. The role of diet for proper tooth formation is a separate issue.  
The consumption of sugar in substantial amounts is a recent trend in many areas of the 
world. Evidence linking caries and sugar has been evaluated from communities with low 
sugar consumption, and the results from severe dietary restrictions in many countries since 
1940s. Another piece of evidence linking diet and caries concerns the rare hereditary disease 
fructose intolerance, which is caused by an inborn error of metabolism. Ingestion of foods 
containing fructose or sucrose causes severe nausea because of lack a certain liver enzyme. 
Consequently children with this disease avoid to eat these foods. The caries experience of 
them is considerably low, indicating that a group of children who are not able to tolerate 
many sugary foods are unlikely to develop much caries. There have been a number of non-
interventional studies and animal experiments to relate dietary habits to the high prevalence 
of dental caries. According to a WHO study group, very little caries occurs in children when 
the national consumption level of sugar is below 10 kg per caput per annum (i.e., about 30 
g/day), but a steep increase may occur from 15 kg upwards (WHO, 2003). Interventional 
human studies also designed in Sweden and Finland. Dentists now base much of dietary 
advice on the results of these two interventional studies, indicating that the frequency of sugar 
intake should be reduced to confine sugar to meal times as much as possible. The goal is not to 
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exclude sugar from the diet but rather to make the patient eat sugar in a sensible way sugar 
discipline (reasonable amounts and mainly at meal times). This also introduces the concept 
that it may be possible to substitute sucrose by substances which will impart sweetness but 
are not cariogenic, which is covered in more detail in section 4.3. However, a comparable 
study on human subjects will probably never be repeated as it would now be regarded as 
unethical to alter diets experimentally in directions likely to increase caries. Sugars 
integrated into the cellular structure of food (e.g. in fruit) are called intrinsic sugars. Sugars 
present in a free form (e.g. table sugar) or added to food (sweets, biscuits, etc.) are called 
extrinsic sugars. These are more readily available for metabolism by the oral bacteria. 
Therefore, they are potentially more cariogenic. Milk contains lactose. It is not generally 
regarded as cariogenic. Cheese and yoghurts, without added sugars, may also considered 
safe for teeth (Ahola et al., 2002). Bread, peanuts (not for children under 5 years), and sugar-
free drinks are some examples of foods and drinks with low potential for dental caries. Thus 
the most damaging sugars for dental health are non-milk extrinsic sugars (NMES) (Moynihan, 
2002). Both frequency and amount of sugars are associated with dental caries. However, at 
the level of the individual patient, it is more practical to advise limiting frequency of intake. 
Since frequency and amount of sugar consumed are closely associated and repeated sugar 
intakes mean several acid attacks on the teeth giving demineralization, efforts to reduce 
frequency should be made. Additionally, selecting food products that only lead a slight 
and/or short pH drop (above critical pH at which the enamel starts to dissolve around pH 
5.5) is another measurement to reduce the unwanted local effects of diet with respect to 
caries. Many common food products containing fermentable carbohydrates can lead to a pH 
of about 4 after their consumption. 
Raw starch (e.g. raw vegetables) is of low cariogenity. Cooked and highly refined (e.g crisps) 
can cause caries, and combinations of cooked starch and sucrose (e.g. cakes, biscuits, 
sugared breakfast cereals) can be highly cariogenic. Fruits contain sugar (fructose, sucrose, 
and glucose) but fresh fruits appear to have low cariogenity. However, the same cannot be 
said for fruit juice. The juicing process releases the sugars from the whole fruit, and these 
drinks are potentially cariogenic. Dried fruits are also cariogenic since they are sticky, 
tending to adhere to teeth, and the drying process releases some of the intrinsic sugars 
(Moynihan, 2002). Some children have particular risk to caries because of dietary factors. 
These children should at least sound warning bells in the pediatrician’s mind as well as 
dentist’s (Fejerskov & Kidd, 2003; Vadiakas, 2008): 
• Infant and toddlers with prolonged breast-feeding on demand 
• Infants and toddlers provided with a feeding bottle at bedtime, or bottle hung up in the 
cot for use during the night with a sugar-containing liquid 
• Children with an increased frequency of eating because of a medical problem, e.g. 
gastrointestinal disease, eating disorders, uncontrolled diabetes 
• Children with an increased carbohydrate intake due to a medical problem, e.g. Chron’s 
disease, chronic renal failure, other chronic illnesses, malnutrition, or failure to welfare 
• Children who are on medications causing reduced salivary flow, irradiation to the 
region of salivary glands 
• Children on long term and/or multiple medications: Are these sugar-based and/or do 
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Measures to reduce caries risk and/or to stop ongoing caries activity in children are: 
• Number of meals and snacks should be kept on a low level. 
• Low sugar consumption is desirable from a cariological point of view 
• Sugars should be eliminated as fast as possible from the oral cavity. Foods needing 
active 
• Chewing lead to an increased salivation, which is desirable. 
It is neither necessary nor practical to stop children eating sweets completely. On the 
contrary, children should be encouraged to eat a balanced meal before any sweets are given. 
Friend and relatives should be encouraged to bring gifts rather than sweets. The 
consumption of bed-time snack or drink (other than water) should be strongly discouraged, 
since salivary flow is virtually absent at night and plaque pH may remain low for many 
hours. 
All dental professionals are encouraged to share current best practice oral health prevention 
strategies with their local community medical providers especially with pediatricians 
(Huston & Wood, 2009). 
4.2 Clinical use of fluorides 
There is substantial evidence that fluoride, through different applications and formulas, works 
to control caries development. The first observations of fluoride's effects on dental caries were 
linked to fluoride naturally present in the drinking water, and then from controlled water 
fluoridation programs. Other systemic methods to deliver fluoride were later suggested, 
including dietary fluoride supplements such as salt and milk. These systemic methods are now 
being questioned due to the fact that many studies have indicated that fluoride's action relies 
mainly on its post-eruptive effect from topical contact with the tooth structure. It is known that even the 
methods of delivering fluoride known as 'systemic' act mainly through a topical effect when they are in 
contact with the teeth. The effectiveness of water fluoridation in many geographic areas is lower 
than in previous eras due to the widespread use of other fluoride modalities. Nevertheless, 
this evidence should not be interpreted as an indication that systemic methods are no longer 
relevant ways to deliver fluoride on an individual basis or for collective health programs. 
Caution must be taken to avoid excess ingestion of fluoride when prescribing dietary fluoride 
supplements for children in order to minimize the risk of dental fluorosis, particularly if there are other 
relevant sources of fluoride intake - such as drinking water, salt or milk and/or dentifrice (Sampaio et 
al., 2011; Jimenez-Farfan et al., 2011). Safe and effective doses of fluoride can be achieved when 
combining topical and systemic methods. Before considering supplementing fluoride, 
recommendations on how to avoid excessive fluoride intake should be followed (Buzalaf & 
Levy, 2011).  
4.2.1 Communal water fluoridation 
Studies evaluating the effect of water fluoridation on dental caries show a reduction in both 
the primary and permanent dentitions of about 50%. Community water fluoridation is safe 
and cost-effective and therefore, should be introduced and maintained wherever socially 
acceptable and feasible. The optimum fluoride concentration will normally be within the 
range 0.5-1.0 mg/l (ppm). At this currently accepted optimal level, water fluoridation will 
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result in some mild enamel fluorosis (McDonagh et al., 2000). The technical operation of 
water-fluoridation systems should be monitored and recorded regularly to prevent toxic 
effects of the element. 
4.2.2 Fluoride-containing toothpaste 
Fluoride toothpaste is the most widely used method of applying fluoride to teeth by so far. 
It is commonly used at home. It also has been using in community and school-based 
preventive programs. A recent systematic review concluded its beneficial use in preventing 
caries in children and adolescents, but only significantly for fluoride concentrations of 1000 
ppm and above (Wong et al., 2011). Brushing teeth with fluoride containing toothpaste twice 
per day is recommended. The patients should brush before bed as the paste provides 
fluoride concentrations in saliva while the child is asleep. The effectiveness of fluoride 
toothpaste is concentration dependent. The relative caries preventive effects of fluoride 
toothpastes of different concentrations increase with higher fluoride concentration. The 
decision of what fluoride levels to use for children under 6 years should be balanced with 
the risk of fluorosis (Walsh et al., 2010). Studies have shown that use of fluoride toothpaste 
from an earl age is associated with higher levels of very mild fluorosis. The very mild grades 
are not aesthetically compromising, the use of fluoride toothpastes should continue to be 
promoted in communities, where or not they are served with fluoridated water or salt 
(WHO, 1994). However, in a recent study, it was indicated that there was weak unreliable 
evidence that starting the use of fluoride toothpaste in children aged <12 months may be 
associated with an increased risk of fluorosis. The evidence if use begins between the age of 
12 and 24 months is equivocal. If the risk of fluorosis is of concern, the fluoride level of 
toothpaste for young children (under 6 years of age) is recommended to be lower than 1000 
parts per million (ppm). More evidence from studies with low risk of bias is needed 
(Rasines, 2010). The author agrees with some other author’s suggestion that children under 
6 should use an adult-concentration paste (1000-1500 ppm fluoride), but a small pea-sized 
portion of it. The child should be encouraged to spit out excess paste and not swallow it. 
Children’s pastes (500 ppm fluoride or less) could be recommended for children at low risk 
of caries living in an area where the water contains fluoride (Kidd, 2005). Some conclusions 
made by the WHO expert committee in 1994 are everyone should be encouraged to brush 
Daily with a fluoride toothpaste, every effort must be made to develop affordable 
fluoridated toothpastes for general use in developing countries, fluoridated toothpaste tubes 
should carry advice that for children under the age of 6 years brushing should be supervised 
and only a very small amount (less than 5 mm) should be placed on the brush or the 
chewing-stick (WHO, 1994). 
4.2.3 Professionally applied fluoride (fluoride varnish in the pediatrician office) 
It has been previously reported that fluoride varnish (a concentrated form of sodium 
fluoride) reduced caries in the primary dentition by 33% and in the permanent dentition by 
46% when compared with placebo (Morinho et al., 2011). Therefore, their wider use is 
encouraged by WHO (1994). Visits to primary care physicians and pediatricians are the 
norm during children’s first few years of life in many countries. Surveys of pediatric 
primary care providers suggest that they are willing to provide preventive dental care for 
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expressed a willingness to apply fluoride varnish (Lewis et al., 2000). In promoting 
preventive dental health, pediatricians benefit all children and particularly the underserved. 
Therefore, pediatricians will require adequate training in oral health in medical school, 
residency, and in continuing education courses. It has been recently reported that multiple 
applications of fluoride at the time of primary tooth emergence seem to be most beneficial to prevent 
dental caries formation. Referrals to dentists for treatment of existing disease detected by 
physicians during regular visits limited the cumulative reductions in caries-related 
treatments, but also contributed to improved oral health (Pahel et al., 2011). Twice yearly 
application of fluoride varnish is indicated for the children over 6 years exposed to a greater 
cariogenic challenge or (in exceptional cases) when it is difficult to control caries in children 
under 6 years. Non-dental health care professionals should seek a professional advice from 
a pediatric dentist for appropriate application of the varnish. 
4.2.4 Dietary fluoride supplements (tablets, drops, vitamins plus fluoride, lozenges) 
The recent data on the value of fluorides administered during pregnancy fails to disclose 
any valid evidence to support such use even in non-fluoridated areas. Fluoride ingestion by 
pregnant women does not benefit the teeth of their offspring, at least not the permanent teeth (Sa 
Roriz Fonteles et al., 2005). In a recent panel by American Dental Association Council on 
Scientific Affairs, the following questions were addressed about the usage of fluoride 
supplements: When and for whom should the supplements be prescribed, and what should 
be the recommended dosage schedule for them?. The panel concluded that dietary fluoride 
supplements should be prescribed only for children who are at high risk of developing caries and 
whose primary source of drinking water is deficient in fluoride (Rozier et al., 2010). Supplements 
if indicated should be prescribed in accordance with the dosages recommended in Table 3 
(AAPD, 2002). The natural (e.g. water) and cumulative (e.g. consumption amount of 
fluoride-rich foods, sources of drinking water) fluoride concentrations, should be 
determined and analyzed before fluoride prescripton. These clinical recommendations 
should be integrated with the practitioner's professional judgment and the patient's needs 
and preferences. Providers should carefully monitor the patient's adherence to the fluoride 
dosing schedule to maximize the potential therapeutic benefit. 
 
Age LESS than 0.3 ppm F* 
0.3-0.6.ppm  
F* 
MORE than 0.6 ppm 
F* 
Birth-6 mos 0 0 0 
6 mos-3 yrs 0.25 mg 0 0 
3 yrs-6yrs 0.50 mg 0.25 mg 0 
6 yrs up to at least 16 yrs 1.00 mg 0.50 mg 0 
Table 3. Dietary fluoride supplementation schedule (*=drinking water fluoride 
concentration). 
4.3 Sugar alcohols, casein phosphopeptides 
Partial sugar substitution with polyols is an important dietary tool in the prevention of 
dental caries that should be used to enhance existing fluoride-based caries prevention 
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programmes. Clinical studies have shown that xylitol, a natural, physiologic sugar alcohol 
of the pentitol type, can be used as a safe and effective caries-limiting sweetener. Habitual 
use of xylitol-containing food and oral hygiene adjuvants has been shown to reduce the 
growth of dental plaque, to interfere with the growth of caries-associated bacteria, to 
decrease the incidence of dental caries, and to be associated with remineralization of caries 
lesions. Other sugar alcohols that have been successfully used as sugar substitutes include 
D-glucitol (sorbitol), which, however, owing to its hexitol nature, normally has no strong 
effect on the mass and adhesiveness of bacterial plaque and on the growth of mutans 
streptococci. A tetritol-type alditol, erythritol, has shown potential as a non-cariogenic sugar 
substitute. Combinations of xylitol and erythritol may reduce the incidence of caries more 
effectively than either alditol alone (Makinen, 2011). Traditional delivering vehicles such as 
chewing-gums, hard candies and mints can only provide contact of the sugar substitutes 
with tooth surface for a few minute or even seconds. Therefore, novel delivery vehicles are 
still needed for the effective delivery of sugar substitutes before they can be considered as 
therapeutically effective.A group of peptides, known as casein phosphor peptide (CPP), 
have been shown to stabilize calcium and phosphate preserving them in an amorphous or 
soluble form known as amorphous calcium phosphate (ACP). Calcium and phosphate are 
essential components of enamel and dentine and form highly insoluble complexes, but in 
the presence of CPP they remain soluble and biologically available. This CPP-ACP complex 
applied to teeth by means of chewing-gum, toothpaste, lozenges, mouth rinses, or sprays is 
able to adhere to the dental biofilm and enamel hydroxyapatite providing bioavailable 
calcium and phosphate ions. When placed on the surface of a tooth with early carious 
lesions, pastes with CPP-ACP complexes can prevent tooth demineralization and improve 
enamel remineralization and enhance fluoride activity. Therefore, use of CPP-ACP based 
compounds offers a potential for use in the prevention of dental caries (Llena et al., 2009). 
Recently, probiotics have been investigating for dental caries prevention and inhibition. In 
caries, there are increases in acidogenic and acid-tolerating species such as mutans 
streptococci and lactobacilli, although other bacteria with similar properties can also be 
found and bifidobacteria, non-mutans streptococci, Actinomyces spp., Propionibacterium 
spp., Veillonella spp. and Atopobium spp. have also been implicated as significant in the 
aetiology of this disease (Aas et al., 2008). Therefore, to be able to develop probiotic or 
prebiotic interventions for applications in dental health care and to understand their 
mechanisms of action and potential risks, it is essential to have a clear understanding of the 
oral microbiota and their functions in dental/oral health and disease. However, some 
products have reached the market, there remains a paucity of clinical evidence to support 
the effectiveness of probiotics to prevent or treat caries (Meurman & Stomatova, 2007). 
4.4 Counseling families on basic oral hygiene  
The considerable potential of mothers should be a major focus of (oral) health professionals 
in developing oral health promotion programs for children and adolescents. Several 
maternal cognitive, behavioral, and psychosocial factors were associated with young 
children's brushing practices. Oral health-specific self-efficacy and knowledge measures are 
potentially modifiable cognitions and intervening on these factors could help foster healthy 
dental habits and increase children's brushing frequency early in life (Finlayson et al., 2007; 
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4.4.1 Feeding baby (Early Childhood Caries-ECC) 
Early childhood caries (ECC) is defined as the presence of 1 or more decayed (noncavitated 
or cavitated lesions), missing (due to caries), or filled tooth surfaces in any primary tooth in 
a 71-month or younger child. In children younger than 3 years of age, any sign of tooth 
smooth surface caries is indicative of severe early childhood caries (S-ECC) (AAPD, 2003a). 
ECC has been found in general population but is more prevalent in low socioeconomic 
groups. It is 5 times more common than asthma, 7 times more common than hay fever, and 
14 times more common than chronic bronchitis (Filstrup et al., 2003). The clinical appearance 
of the teeth in ECC is typical and follows a specific pattern: There is usually early and 
progressive carious lesions of the primary upper incisors in first years of age followed by the 
involvement of the upper and lower first primary molars, and the upper canines and 
sometimes lower canines (according to the sequence of eruption). The lower incisors are 
usually unaffected because of salivary flow from sub-lingual glands, and the contact of the 
tongue and lips at the time of feeding that covers the lower incisors. Therefore, milk and 
carbohydrates spread over all teeth except the lower incisors and prevent pudding or 
gathering of milk around these teeth (Tinanoff et al., 1998). The American Academy of 
Pediatric Dentistry (AAPD) has recognized the unique and virulant nature of ECC and 
accepted it as a serious public health problem. The presence of high levels of ECC, despite a 
reduction in permanent-dentition caries through fluoridation of water and use of 
fluoridated toothpastes, begs for a broader look at social and behavioral factors that 
correlate with this form of the disease. ECC not only affects teeth, but also may lead to more 
widespread health issues such as: chewing difficulty, malnutrition, gastrointestinal 
disorders, delayed or insufficient growth (especially in regard to the height and/or weight 
gain), poor speech articulation, low self-esteem and social ostracism. Additionally, repeated 
prescriptions of antibiotics, severe pain, sepsis and even death may also be observed. ECC is 
an infectious disease. Mutans Streptococci (streptococcus mutans and Streptococcus 
sobrinus species) are the most likely causes ECC and Lactobacilli participates in the 
development of the lesions and play role in lesion progression not its initiation (Parisotto et 
al., 2010). Bifidobacteria are asoosicated with S-ECC. S. mutans and S. sobrinus are also 
associated with lesion recurrence. Diet also plays an important role in the acquisition and 
clinical expression of the disease. Children with S-ECC, had higher scores of cariogenic 
bacteria for between-meal juice, solid retentive foods, and eating frequency than caries-free 
children. S. mutans positive children with ECC consume more cariogenic foods compared to 
caries-free children (Palmer et al., 2010). Acquisition may occur via vertical (from mother to 
child) or horizontal transmission (transmission of microbes between members of a group) 
(Berkowitz, 2006). Further details on vertical transmission of microorganisms will be 
presented in the following section. Risk factors for ECC are cariogenic bacteria, 
inappropriate feeding practices, social variables (education, lack of fluoride, access to 
healthcare, lack of health insurance, Treatment of ECC is generally problematic and costly 
because the cooperation of babies is low. Additionally within the first year after dental 
caries treatments, 40% recurrence rate has been reported around restored teeth and 
occurrence of new decays is common (Graves et al., 2004). Primary pediatric care providers 
are more likely to have earlier contact with children. Therefore, pediatricians as well as 
primary care health professionals will be responsible for the prevention of ECC. The 
diagnosis of impaired dentition and related prevention and outcomes should be included in 
their curricula. Primary prevention of ECC begins in the prenatal and perinatal periods 
 
What is the Role of Pediatricians on Oral Health? 
 
151 
(include pregnancy and first month of birth) and addresses the health of both mother and 
infant. Mother’s or caregiver’s teeth must be examined infants whose mothers have high 
levels of untreated dental caries are at greater risk of acquiring organisms. General approach 
which have been used to prevent ECC include training of mothers or caregivers to follow 
healthy dietary and feeding habits to prevent the development of ECC, early screening for 
signs of caries development (starting from about 7 to 8 month of age) to identify infants who 
are at risk developing ECC and assisting in providing information for parents about 
promoting oral health. Pediatricians can give the following recommendations for prevention 
of ECC to mothers and caregivers (AAPD, 2003b): 
• Elimination of active dental caries lesions, gingival disease, 
• Using fluoride and clorhexidine (Toothpaste, mouthwash, gel, varnish), 
• Twice daily tooth brushing of the dentate infant (around 7th month of age), 
• Oral health evaluation of the infant by a pediatric dentist before the first birthday, 
• Infants should not be put to sleep with a bottle and nocturnal breastfeeding should be 
avoided after the first primary tooth begins to erupt, 
• Mothers should be encouraged to have infants drink from a cup as they approach their 
first birthday, 
• Infants should be weaned from the bottle at 12 to 14 months of age, 
• An attempt should be made to assess and decrease the mother’s/primary caregiver’s 
mutans streptococci level to decrease the transmission of cariogenic bacteria, 
• Stop saliva-sharing activities, such as tasting food before feeding and sharing 
toothbrushes. 
 
Fig. 4. Child’s teeth with ECC. Observe the different phases of development (Quoted from 
Losso EM, Tavares MCR, da Silva JYB, Urban C (2009). Severe early childhood caries: an 
integral approach, J Pediatr 4, 295-300. 
4.4.2 Initial acquisition of Mutans Streptococci (MS) by infants from their mothers  
MS, consisting mainly of the species Streptococcus mutans and Streptococcus sobrinus, are 
commonly cultured from the mouths of infants, with prevalence of infection ranging from 
around 30 % in 3 month old predentate children to over 80 % in 24 month old children with 
primary teeth. MS is usually transmitted to children through their mothers. Domejean et al. 
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(include pregnancy and first month of birth) and addresses the health of both mother and 
infant. Mother’s or caregiver’s teeth must be examined infants whose mothers have high 
levels of untreated dental caries are at greater risk of acquiring organisms. General approach 
which have been used to prevent ECC include training of mothers or caregivers to follow 
healthy dietary and feeding habits to prevent the development of ECC, early screening for 
signs of caries development (starting from about 7 to 8 month of age) to identify infants who 
are at risk developing ECC and assisting in providing information for parents about 
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• Using fluoride and clorhexidine (Toothpaste, mouthwash, gel, varnish), 
• Twice daily tooth brushing of the dentate infant (around 7th month of age), 
• Oral health evaluation of the infant by a pediatric dentist before the first birthday, 
• Infants should not be put to sleep with a bottle and nocturnal breastfeeding should be 
avoided after the first primary tooth begins to erupt, 
• Mothers should be encouraged to have infants drink from a cup as they approach their 
first birthday, 
• Infants should be weaned from the bottle at 12 to 14 months of age, 
• An attempt should be made to assess and decrease the mother’s/primary caregiver’s 
mutans streptococci level to decrease the transmission of cariogenic bacteria, 
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Fig. 4. Child’s teeth with ECC. Observe the different phases of development (Quoted from 
Losso EM, Tavares MCR, da Silva JYB, Urban C (2009). Severe early childhood caries: an 
integral approach, J Pediatr 4, 295-300. 
4.4.2 Initial acquisition of Mutans Streptococci (MS) by infants from their mothers  
MS, consisting mainly of the species Streptococcus mutans and Streptococcus sobrinus, are 
commonly cultured from the mouths of infants, with prevalence of infection ranging from 
around 30 % in 3 month old predentate children to over 80 % in 24 month old children with 
primary teeth. MS is usually transmitted to children through their mothers. Domejean et al. 





The risk of transmission increases with high maternal salivary levels of MS and frequent 
inoculation. Köhler & Andreen (2010) reported that children colonised by MS at an early 
stage developed more caries than those colonised at a later stage and early maternal caries 
prevention is an efficient method to prevent early colonization of MS in their children. 
Factors that affect the colonization of MS may be divided into bacterial virulence, host-
related and environmental factors. Complex interactions among these factors determine the 
success and timing of MS colonization in the child. As clinical studies have shown that 
caries risk is correlated with age at which initial MS colonization occurred, strategies for the 
prevention of dental caries should include timely control of colonization of the cariogenic 
bacteria in the mouths of young children.  
4.4.3 Mechanical and chemical home oral hygiene (reduction of dental plaque and 
microorganisms)  
Dentistry, particularly dentistry for children has come a long way toward reaching a ratio of 
90% prevention to 10% treatment in many developed countries. At the core of this 
preventive approach is home oral hygiene and plaque control. The traditional focus of oral 
hygiene has been and will go on to be the control of the two most prevalent oral diseases, 
caries and periodontal disease. Although plaque control is essential for oral hygiene, it is 
important to realize that no clear relationship exists between plaque control and the 
prevention of caries (unlike with periodontal disease). As discussed previously in the 
section 2.1, the complex etiology of caries centers on the following factors: tooth 
susceptibility, bacterial plaque, refined carbohydrates, and time. Many other variables such 
as oral sugar clearance and salivary flow and pH, add to the complexity of the caries 
process. This complex etiology helps to explain the difficulty in demonstrating a 
relationship between oral hygiene practices and caries prevention. Despite this ambiguity, 
plaque control remains an essential element for oral health. In the absence of oral hygiene 
dental plaque accumulates leading to shifts in bacterial populations away from those 
associated with health. Plaque control efforts should be directed toward two goals: (1) 
limiting the numbers of mutans streptococci in plaque for prevention of caries by 
mechanical elimination of supragingival plaque (toothbrushing) and limitation of dietary 
sucrose, and (2) maintaining the predominantly gram-positive flora associated with gingival 
health by mechanical removal of plaque from the subgingival area (flossing) on a regular 
basis. Brushing twice daily with fluoride toothpaste has been advocated by the profession 
for many years, and this behavior is a routine part of many people’s behavior. This daily 
brushing with fluoride toothpaste is believed to be the primary reason for the decline of 
caries observed in many populations since the 1970s. The behavior should not be taken for 
granted. Children should always be asked whether, and how often, they brush their teeth 
and what toothpaste they use. Most toothpastes contain fluoride, but not all, and it is 
important to check the fluoride concentration in toothpaste to administer proper dosage to 
the child. The use of chemotherapeutic agents, particularly chlorhexidine, can also play a 
role in maintenance of gingival health. The appropriateness and effectiveness of home oral 
hygiene procedures change throughout childhood. It is necessary to involve the parent at 
some level of the oral hygiene procedures. Age categories for specific home oral hygiene 
recommendations are prenatal period, infants (0-1 yrs), toddlers (1-3 yrs), preschoolers (3-6 
yrs), school-aged children (6-12 yrs) and adolescents (12-19 yrs). The American academy of 
pediatric dentistry recommends that children have their first dental visit at approximately 
the time of eruption of the first tooth or, at the latest, by the age of 12 months (AAPD, 
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2003b). Therefore, pediatricians and primary health care providers must refer children to 
pediatric dentists in order to get them their regular dental visits. Objectives to be 
accomplished at the first visit: Instruction of the parents in the use of oral hygiene procedures, 
infant dental examination and fluoride status review, dietary issues related to nursing and bottle 
caries.  
Mouthrinsing for the prevention of dental caries in children and adolescents was established 
as a mass prophylactic method in the 1960s and has shown average efficacy of caries 
reduction between 20-50%. Commonly, weekly or twice monthly rinsing procedures using 
neutral 0.2% NaF solutions have been used in schools or institutions in areas with low 
fluoride concentrations in the drinking water. Today, when dental caries has declined 
substantially in the western countries, and relatively few individuals are suffering from 
caries, the efficiency of large scale mouthrinsing is questioned and more individual 
approaches of caries prevention strategies are needed. Therefore in high risk patients, daily 
mouthrinses using 0.05% NaF can be recommended combined with other selective 
preventive measures such as sugar restriction, improved oral hygiene, antibacterial 
treatments, and so forth. Mouthrinsing solutions have therefore been combined with 
antiplaque agents like chlorhexidine and other agents which can improve the caries 
preventive effect in high caries risk patients. Other agents than sodium fluoride have been 
used, such as stannous and amine fluoride with proven clinical effects. However, although a 
series of new formulas of mouthrinses containing fluoride combined with different 
antiplaque agents have shown promising antibacterial and antiplaque efficacy, their long-
term clinical effects are sparsely documented. Acute and chronic side effects from 
established and recommended mouthrinsing routines are extremely rare but ethanol 
containing products should not be recommended to children for long-term use. (FDI 
Commision, 2002). 
5. Clinical assessment and management of the oral environment in a child 
patient receiving cancer treatment 
5.1 The impact of cancer therapies on the oral cavity  
The likelihood is high that aggressive cancer treatment will have toxic effects on normal 
cells as well as cancer cells. The gastrointestinal tract, including the mouth, is particularly 
prone to damage. This is true whether the treatment is radiation or chemotherapy. Most 
patients being treated for head and neck cancer will experience some oral complications, 
and while most of these are manageable, complications can sometimes become severe 
enough that treatment must be completely stopped. In addition, surgical solutions to tumor 
removal may lead to oral and nutritional problems as well. The most common oral problems 
occurring after radiation and chemotherapy are mucositis (an inflammation of the mucous 
membranes in the mouth), infection, pain, and bleeding. Other possible complications might 
include dehydration and malnutrition, commonly brought on by difficulties in swallowing 
(dysphagia). Radiation therapy to the head and neck may injure the glands that produce 
saliva (xerostomia), or damage the muscles and joints of the jaw and neck (trismus). These 
treatments may also cause hypovascularization (reduction in blood vessels and blood 
supply) of the bones of the maxilla or mandible (the bones of the mouth). In addition, 
treatments may affect other forms of dental disease (caries, or soft tissue complications), or 
even cause bone death (osteonecrosis). By identifying patients at risk for oral complications, 
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reducing the occurrence of problems brought about by different treatment modalities. The 
most important risk factors leading to problems are oral or dental disease that already exists, and poor 
oral care during cancer therapy. Other risk factors include the type of cancer, the chemotherapy 
type and schedule used, the area irradiated and how much radiation is given, how low 
blood counts are decreased and for how long, the patient's age, and the general condition of 
the patient's health pre-treatment. Pre-existing oral conditions may increase the risk of 
infection or other problems. Problems such as caries, calculus and tartar on the teeth, broken 
(fractured) teeth, the condition and quality of existing dental repairs such as crowns or 
fillings, periodontal disease, and appliances such as removable fixtures, or orthodontic 
brackets can make therapy more difficult later on. Bacteria and fungi can live in the mouth, 
and may develop into an infection when the immune system is not working well, or when 
white blood cell counts are low. Both of these factors can be caused by the treatment 
methods used. Where the gums (gingiva) or other soft tissues are irritated, tissues can thin 
and waste away, causing sores in the mouth. These complications can result in a significant 
reduction in the quality of life for the patient.  
5.2 Oral mucositis 
5.2.1 What is oral mucositis? 
Mucositis is a common toxicity associated with both chemotherapy, and head and neck 
radiation used for the treatment of cancer (Scully et al., 2003, 2004). It is characterized by 
ulceration in the oro-oesophageal and gastrointestinal mucosae that results in pain, 
dysphagia, diarrhoea and dysfunction depending on the tissue affected (Sonis & Fey, 2002). 
Oral mucositis results in severe discomfort and impairs patients’ ability to eat, swallow and 
talk. Concomitant therapy-induced myelosuppression places patients at significant risk of 
bacteraemia and sepsis from oral microorganisms resulting in increased days of fever, 
antibiotic use and hospitalization (Donnelly et al., 1995). Historically, mucositis has been 
associated with particular high-risk groups such as patients being irradiated for cancers of 
the head and neck, individuals receiving conditioning regimens for stem cell transplant that 
include total body irradiation or high dose melphalan and patients receiving specific 
induction protocols for acute leukaemia. Mucositis has been consistently reported to occur 
in at least 75% of treated patients in these groups. Radiation-induced mucositis occurs in 
almost all patients who are treated for cancers of the mouth, oropharynx and nasopharynx, 
and in approximately two-thirds of those treated for cancers of the hypopharynx or larynx. 
Mucositis risk and severity are determined by the treatment dose, radiation field size and 
fractionation schedules prescribed for individual patients. Hyperfractionated schedules and 
combination of radiation with chemotherapy increase the prevalence, severity and duration 
of mucositis. In patients receiving cancer chemotherapy, the frequency and severity of 
mucositis is mainly determined by the type(s) and dose of cancer chemotherapeutic agents 
used. five-fluorouracil (5-FU), cisplatin, etoposide and melphalan are particularly 
stomatotoxic (Chi et al., 1995; Pico et al., 1998) and mucositis is common with doxorubicin, 
vinblastine, taxanes and methotrexate, but uncommon with asparaginase and carmustine 
(Symonds, 1998). Finally, mucositis is seen in 75–99% of patients receiving conditioning 
regimens for haemopoietic stem cell transplantation (HSCT) particularly in those that 
combine total body irradiation (TBI) and chemotherapy (Blijlevens et al, 2000). Mucositis is 
the most common symptom and distressing complication of HSCT (Bellm et al., 2000), and 
some 30–50% of patients with HSCT complain that mucositis is their most significant 
toxicity. The only independent risk factor identified for mucositis is the conditioning 
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regimen: high-dose melphalan (HDM) regimens exceed busulphan, busulphan–
cyclophosphamide, cyclophosphamide–TBI, cyclophosphamide–carmustine (BCNU) and 
cyclophosphamide–etoposide–carmustine (Wardley et al., 2000). 
5.2.2 Clinical diagnosis 
Diagnosis of mucositis is clinical and based on the use of known stomatotoxic therapy, and 
the appearance, timing and location of oral lesions. Chemotherapy-induced mucositis occurs 
on the movable mucosae, rarely affecting the dorsum of the tongue, the hard palate or the 
gingiva. Radiation-induced mucositis also affects the movable mucosae and may involve the 
hard palate, albeit rarely. Infections and graft-versus-host disease (GVHD) are the most 
common differential diagnoses. Viral infections differ clinically from mucositis in that they 
are typically croppy, localized and involve keratinized mucosa of the hard palate, gingival 
and dorsal tongue and their onset often coincides with fever. Culture or exfoliative cytology 
at the time of lesion presentation is prudent. Graft-vs-host disease is limited to patients who 
have received allogeneic HSCT and develops following haematologic recovery (beyond 21 
days after transplant) and typically results in dramatic oral lesions that are often lichenoid in 
character, sometimes also with xerostomia (Woo et al., 1997). Neutropenia, induced by 
chemotherapy, may be associated with necrotizing gingivitis. 
The early clinical sign of mucositis is erythema presenting about 4–5 days following 
chemotherapy infusion or at cumulative doses of head and neck radiation of about 10 Gy. 
Patients also often complain of burning and intolerance of spicey foods at this stage. Seven 
to 10 days after chemotherapy or at cumulative radiation doses of 30 Gy, ulcers develop, 
resulting in marked discomfort, often requiring opioid intervention and in many cases 
causing patients to alter their diet. In the case of chemotherapy-induced mucositis, lesions 
are seen mostly on the movable mucosae of the buccal mucosae and lateral and ventral 
surfaces of the tongue. The hard palate and gingiva appear not susceptible to 
chemotherapy-induced mucositis. In contrast, radiation-induced mucositis may involve any 
radiation-exposed area, including the hard palate, albeit rarely. Chemotherapy-induced 
mucositis lasts approximately 1 week and generally heals spontaneously by 21 days after 
infusion. Radiation-induced mucositis stays at a peak for at least 2 weeks following the 
completion of radiotherapy (typically 60–70 Gy). As a result, it is not uncommon for patients 
receiving radiotherapy for cancers of the mouth and contiguous areas, to have severe 
ulcerative oral mucositis persisting for 5–7 weeks. Chronic mucositis following radiation 
therapy does occur, but rarely. A large number of mucositis scoring systems have been 
devised (summarized by Sonis et al, 2004) but most lack standardization or validation. The 
two most commonly used scoring tools to describe toxicity are the WHO and the National 
Cancer Institute (NCI) common terminology criteria for adverse events (Table 4). 
 
Grade Clinical features 
0 - 
1 Soreness/erythema 
2 Erythema, ulcers but able to eat solids 
3 Ulcers but requires liquid diet 
4 Oral alimentation not possible 
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5.2.3 Prevention and treatment options 
There are a number of strategies adopted by oncologists to minimize the adverse effects of 
cancer therapy such as dose reduction, and other preventive treatment options. For 
example, leucovorin has been used for years to minimize the mucositis resulting from use of 
5-FU (Lalla and Peterson, 2005). These are the province of oncologists and are not discussed 
further here. There has been a range of interventions developed for prophylaxis of oral 
mucositis but a more rational approach may be warranted. Indeed, there are very few 
randomized controlled double-blind trials (RCTs) assessing most of the interventions. A 
recent Cochrane review (Worthington, 2011) concluded that cryotherapy (ice chips) and 
Keratinocyte Growth Factor (Palifermin ®) have shown some evidence of benefit in the prevention of 
mucositis. There is weaker less reliable evidence of a benefit associated with aloe vera, amifostine, 
intravenous glutamine supplementation, granulocyte-colony stimulating factor, honey, laser, 
polymixin/tobramycin/amphotericin (PTA) lozenges and sucralfate. There is no evidence that 
chlorhexidine is more effective that placebo and this intervention should not be used in the 
preventionofmucositis. 
The outcomes from studies testing GM-CSF, benzydamine hydrochloride or amifostine are 
mixed. (Mascarin et al, 1999; Tejedor et al, 2000). Benzydamine HCl has been shown in single 
centre studies and in a multicentre double blind randomized placebo controlled trial in radiation 
therapy to reduce the intensity and duration of mucosal damage as well as to delay the need to use 
systemic pain-relievers including opioids (Epstein et al., 1989, 2001). Benzydamine was not 
effective however, in patients receiving accelerated radiotherapy doses of more than 220 
cGy. A preliminary study indicated that the severity of oral mucositis, both objective and 
subjective, in HSCT patients may be reduced by 0.1% topical tretinoin cream which has anti-
inflammatory activity, administered daily from the beginning of the HCST conditioning 
until marrow engraftment (Cohen et al., 1997). Local antimicrobials containing 
amphotericin, polymixin and tobramycin may have some activity (Bondi et al., 1997). Small 
single centre trials show that the incidence, severity and duration of radiochemotherapy-induced 
mucositis can be significantly reduced by oral rinsing with povidone iodine performed in addition to 
the standard prophylaxis scheme (Adamietz et al. 1998). Mixed results have been seen with oral 
glutamine, which is involved in protein and nucleic acid synthesis: one group showed a 
decrease in the severity and duration of oropharyngeal mucositis in autologous HSCT 
patients but not in allogeneic HSCT patients. It is possibly because of interaction with 
methotrexate (Anderson et al., 1998a,b). While similar results were shown in a trial of 
intravenous glutamine in HSCT (MacBurney et al., 1994), and from an uptake-enhanced 
glutamine suspension used orally (Peterson, 2006), others have found no benefit (Schloerb & 
Skikne, 1999). Mucositis invariably requires systemic analgesics, adjunctive medications, 
physical therapy and psychologic therapy in addition to oral care. A recent Cochrane review 
(Worthington, 2004) concluded that there was no evidence that patient controlled analgesia 
(PCA) is better than continuous infusion method for controlling pain, but less opiate was used per 
hour, and duration of pain was shorter, for PCA. Only weak and unreliable evidence that 
allopurinol mouthwash, vitamin E, immunoglobulin or human placental extract improve or 
eradicate mucositis. 
Pain from established mucositis can be reduced by systemic analgesics with non-steroidal 
agents and othernon-opiods used first, combined with opioids such as morphine and 
hydromorphone when pain is severe. In the in-patient setting, PCA provides the most 
effective pain control with lower total doses of opioid. Topical analgesics may combat pain 
and dysphagia when used prior to meals. Capsaicin may also provide analgesia (Berger et 
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al., 1995). Cubukcu & Sevinir (2007) used debridement technique to promote healing of 
established mucositis and to alleviate symptom clusters in a group of children who were on 
induction chemotherapy. They concluded that debridement promoted resolution and 
decreased the severity of oral mucositis significantly. Thus, the subjects had less oral 
discomfort, pain, and nutritional difficulties. In general, mucositis should be treated 
conservatively to avoid further tissue irritation and damaging the remaining cells from which the 
epithelium will regenerate. Plaque control and oral hygiene should be maintained with careful tooth 
brushing (Borowski et al, 1994). The potential benefit of prophylactic rinses with chlorhexidine may 
be to control plaque levels, gingivitis, reduce caries risk and oropharyngeal candidosis, rather than 
any direct effect upon oral mucositis. The patient should be advised to take a soft bland diet, avoiding 
irritants such as tobacco, alcohol or spices. Nutrition should be maintained. 
6. Conclusion 
Tooth caries (decay) remains a substantial problem in young children and is made worse by 
existing barriers that prevent them from obtaining dental care. Because most children are 
exposed to medical care but not dental care at an early age, pediatricians have the 
opportunity to play an important role in helping children and their families gain access to 
dental care. Instructional efforts to increase pediatricians' dental knowledge or opinions of 
the importance of oral diseases are unlikely to be effective in increasing dental referral 
unless they include methods to increase confidence in providers' ability to identify and 
appropriately refer children with disease. Pediatricians can provide oral health promotion 
and disease prevention activities, thereby eliminating or delaying dental disease and the 
need for treatment at a very young age. 
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• To promote the understanding, development and acceptance of invasive procedures 
and hospitalization 
• To help understand the cognitive and affective aspects of disease perception and their 
influences on the quality of life of patients and their families, supporting the diagnosis 
and treatment compliance, thus providing greater progression 
Based on these objectives, the Pediatric Surgery Team of the University Hospital of the 
Faculty of Medicine of Ribeirão Preto of the University of São Paulo (HCFMRPUSP) 
developed a protocol of integrated care for patients and their families. Through this 
protocol, all children and families who will experience a surgical procedure are treated in 
consultation with an interdisciplinary team composed of surgeons and psychologists in 
order to provide guidance and explanation of the possible conflicts related to the surgery for 
both the child and the family. 
This model was developed from concepts described in several papers cited in the 
international literature, especially Canada, USA, France and China, which aimed specifically 
at the orientation of these patients for the procedures they will be undergoing, 
desensitization to invasive procedures, child-parent coping strategies, treatment and 
prognosis, as well as interdisciplinary interaction. 
2. How pediatric illness can interfere with the family dynamic 
Illness represents a modification of the bio-psycho-social scheme in a very particular and 
individual way, known in healthcare literature as one of the main factors that affect anxiety 
levels, quality of life, and individual behavior.  
In the case of children, it is emphasized that they are in the process of building their own 
representations of reality and they do so through the summation of all their experiences.  
Within the many objective and subjective lived experiences in the developing child’s life, the 
importance of the relative and reactive models provided by adults during the child’s early 
social environment stands out. The younger the child, therefore, the greater the influence of 
the behavioral patterns and coping mechanisms displayed by the child’s adult references.  
In the case of illness, which is not represented by any distinctive cognitive or affective form, 
the child is strongly influenced by the actions of those individuals who provide it with 
emotional support because these adults are significant role models who will utilize their 
own prior associations to deal with the new reality of their child’s health.  
The manner in which children therefore deal with this new reality is oftentimes reflective of 
their parents’ coping mechanisms and the way their parents deal with the anxiety that stems 
from fear and uncertainty about their child’s diagnosis/prognoses.  
The new reality creates uncertainty about how, and if, these adults will or will not be 
capable of reasonably and appropriately recoding the experience of surgery and/or 
hospitalization for their children to understand. 
For parents, the expectation surrounding the responsibility they feel to maintain the health 
and wellbeing of their children transforms the surgical procedure into a trigger of extreme 
anxiety.  
 
Interdisciplinary Model of Attention for Children Undergoing Hospitalized Surgical Procedures 167 
The child’s exposure to the risks of a hospitalization or surgery may induce negative 
fantasies and fearful reactions in both the parents and the child, exacerbating a natural 
reaction of anxiety and possibly causing a dysfunctional or pathological reaction of anxiety, 
and consequently a possible behavioral disruption. 
The difficulty in understanding the procedure to be performed on the child, or even the 
hospital context to which the child will be exposed, the possibility of injury, loss or 
separation from the child, the anesthetic risk, and especially the fear of prognosis are some 
of the reasons these parental feelings are evoked. 
For the infant, who is still in full development of its impressions, the principal sentiment is 
fear of the unknown, the pain, and the risk of separation from its attached adults, such as 
the mother.  
Upon admission, everything surrounding the child is new and often scary. The child finds 
itself in a new routine with environmental and social restrictions and is often exposed to 
procedures that cause pain and/or discomfort. 
These potentially anxiety-inducing changes are more intense during hospitalization due to 
the environmental restrictions, the hospital routine, and the prognosis, among other factors.  
However, the process becomes more complex during surgery. There will also be an invasive 
intervention that includes anesthetic procedures, being that various studies show that 
surgery, and anesthesia in particular, are stimuli that trigger stress and anxiety because they 
can be symbolically associated with the fear of loss.  
These factors may lead to behavioral changes in the child during and after hospitalization, 
such changes being more frequent in children who have not constructively addressed and 
coped with the stress they experienced.  
In pediatric surgery, anxiety can be observed both in the child and in the parents, so that 
parental coping techniques, the representation of their anxiety and consequently the manner 
in which they deal with the child, can help or hinder the team’s work and the child’s 
recovery.  
Very anxious parents exacerbate their child’s inappropriate behavior, often hampering 
treatment and even the child’s prognosis. For this group, with greater difficulty in coping 
with fear and anxiety, the child’s behavior often changes during and after hospitalization, 
encouraging behaviors that are disturbing, such as nail biting and enuresis, and emotional, 
such as tantrums and night terrors. The same changes can also occur in the parents.  
Note that empowering both children and adults to face and cope with the illness and 
proposed surgical procedure provides a way to deal with the information and can reduce 
fears and the implicit risks of a hospitalization. It is known that the quantity and quality of 
information received by the family and by the patient influence their trust in the team and 
consequently reduce anxiety and behavioral changes, which improves adherence to 
treatment. 
In this way, we emphasize the idea that when information and psycho-emotional support 
are provided to patients and their families there is often an improvement in the acceptance 
of the proposed procedures and, especially, an increased confidence in the team. 
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This work is done in order to allow patients and their parents to understand the context of 
their clinical situation with detailed quantitative and qualitative information about the 
treatments and proposed procedures. 
Therefore, when the whole family can be prepared and supported by a psychological 
intervention, damage to the child’s behavior and the family’s anxiety can be reduced.  
This procedure is done by encouraging better a better compliance with the treatment as a 
whole, which shows that parental anxiety and pediatric behavioral changes, recognized in 
literature as the main factors that influence a child’s health during the post-operative 
recovery, can be managed.  
The work of this team, carried out by a clinical psychology specialist professional in 
conjunction with surgeon colleagues, all looking for a better pediatric recovery, confirms 
and reinforces the literature about the importance of interdisciplinary work in planning a 
pre-operative preparation for the child and family before a medical intervention.  
Thus, we present the protocol that is necessary for providing comprehensive 
interdisciplinary care to the hospitalized child, especially in the case of a surgery. This work 
is done as much for the children as for their caregivers. 
3. Interdisciplinary care protocol for pediatric surgery at HCFMRPUSP 
This protocol was structured on a 2002 survey that aimed specifically to evaluate parents’ 
understanding of their child’s illness and the surgical procedures to be performed. We 
sought to investigate what were the principal doubts, fears, fantasies, and anxieties 
experienced by parents with regard to the risks and the diagnosis, as well as the 
hospitalization itself.  
This work was carried out in order to understand what were the preconceived notions of the 
general population and also to assess the level of understanding and anxiety in the parents, 
before and after hospitalization of the child. In children, we analyzed changes in behavior 
before and after hospitalization, assembling comparative measurements. 
The results of this study show data that compare to the related literature, where one can 
observe, through research tools, that: 
• Maternal anxiety was significantly reduced, by around 30% on average, one month after 
the surgery when the mother received psycho-affective care and guidance before and 
during the surgical procedure of her child. Mothers without this care and guidance 
display an average reduction of 8% in levels of anxiety. These data point to a conclusion 
that psychological intervention leads to a better adjustment in the way that the 
mother/caretaker represents and copes with the illness, which she consequently passes 
on to the child. 
• The mothers’ levels of informed understanding, measured by correct information about 
the diagnosis, prognosis, and care for the child, before and after the surgery, were much 
more comprehensive in the group receiving psychological treatment, at 80% about 
activity restrictions after surgery and 100% about home care, while these figures 
respectively, were 50% and 40% in the group of mothers who did not receive guidance. 
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Further, the adequacy and retention of the information relayed by the pediatric 
surgeons, of a total of 40 general questions about the treatment, displayed a 67.5% 
satisfactory response rate in the group that was treated with psychological intervention, 
whereas the group that only received the usual guidance displayed a 30% satisfactory 
response rate. The same was true for the unsatisfactory response rate, where the control 
group who received no further guidance answered 22.5% of questions unsatisfactorily, 
demonstrating inadequacy in the care of the children, while the psychologically guided 
group did not offer any inadequate responses. Attention should be paid to the potential 
risks in the post-operative home-care of children whose families were not cared for and 
guided in an interdisciplinary manner. 
• The frequency of unwanted children’s behavior such as bedwetting, nail biting, insomnia, 
night terrors, and overuse or re-attachment of comfort objects (pacifier, bottle) was also 
lower in the group of children who were given therapeutic space to express their concerns 
and be guided in a more appropriate coping mechanism to deal with the fear of 
hospitalization and possible separation from their protective parental figures. 
In this way, it was determined that the reception and guidance of the caregivers and the 
children is beneficial for the family, which produces a more relaxing work environment for 
the professional, which in turn also provides for fewer minor complications, due to the 
parents’ better understanding of appropriate post-operative homecare and of the measures 
to be taken in the hospital itself. 
Therefore, since 2002, this model protocol has been used by the interdisciplinary pediatric 
surgery team at HCFMRPUSP, with constant improvements made with respect to the 
integration of the group for the best possible care for the child and family and seeking to 
promote a less aversive process for those involved in pediatric surgery.  
In this model of care, all children entering the Department of Pediatric Surgery at 
HCFMRPUSP after a medical screening to assess their clinical needs are referred for a 
psychological evaluation so that their psycho-emotional and social needs can be perceived 
in a more global way.  
The first meeting assesses the parents’ and the child’s previous understanding of the health 
issue and the need for clinical or surgical treatment. Also assessed are the psycho-emotional 
resources for coping with clinical questions and hospital situations to which they will be 
submitted.   
When the child’s visit to the hospital requires only clinical, and not surgical, procedures, the 
child and its family are evaluated by a psychologist in their understanding of the diagnosis, 
treatment, and prognosis, as well as their methods of coping with the particular situation.  
During this assessment, the family group receives additional information about ways to 
manage the child’s behavior in order to favor the treatment and are offered, when necessary, 
invitations to join support groups for chronic illnesses or individual counseling when the 
child and/or parents present difficulties in accepting the course of action proposed by the 
professionals.  
Following the chapter is an outline of the protocol for psychological preparation of the pre-
surgery child that is used at HCFMRPUSP. 
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Table 1. Protocol for psychological preparation of the pre-surgery child -  HCFMRPUSP 
Also assessed during this meeting are the issues of the child’s global development, and 
necessary referrals are made to ensure the best possible neuro-psycho-motor development. 
Only after all these issues have been met and forwarded to the appropriate clinical follow-
up services can the child be discharged from the Pediatric Surgery Interdisciplinary Team. 
When the child has an organic impairment that requires surgical treatment, the care of the 
team, in addition to that which is listed above, also includes an interdisciplinary reception 
and guidance where the illness, procedures, processes, treatments and invasive 
interventions are clarified in simple and didactic terms, first by the medical team and later 
by the psychological team.  
In this context, parents/caregivers and children are guided through questions about the 
child’s health, the treatment processes, and the hospitalization. During this first meeting of 
the child to be operated on, a psycho-emotional assessment of the parents and the child 
about the diagnosis, the pre-operative, operative, and post-operative procedures, and the 
hospitalization is performed in order to explain and reduce any doubts or possible negative 
fantasies regarding the experience.  
It is often the case that this work is not concluded after only one session, and returns become 
necessary so that the staff, the child, and the parents are all aware, accepting, and 
comfortable with the procedures and its possible risks and benefits. 
The process of Psychological Intervention is applied to the child and its parents through 
psycho-educational guidelines, or information for caregivers and children.  
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For these sessions, verbal instructions, didactic play materials, such as teaching material 
understandable to laypeople or hospital toys, and real hospital equipment are used as 
technical resources that may promote desensitization to procedures that may occur during 
the doctor visits and on the day of the surgery.  
The handling of these materials is stimulated so that the real medical procedures will have 
been previously simulated in a play environment, seeking to promote desensitization of 
potentially anxiety-inducing situations that parents and children will experience. 
Also provided are clarifications of the doubts and eventually presented inappropriate 
illusions. As part of the psychological intervention process, the most anxious parents and 
children visit the pediatric pre-anesthesia room of the surgery center and also the recovery 
room, where they receive a demonstration and explanation of the procedures that will occur 
there, which are presented by the team’s psychologist. 
If the child experiences any difficulty in interacting with the medical staff, returns are 
scheduled weekly or biweekly, except in the case of an emergency surgery, until the child is 
able to recover from its fear and illusions and interacts appropriately with the team during 
its evaluations and clinical procedures, which are often invasive.  
What occurs, therefore, is an adaptation of the child to the members of the team and to the 
hospital equipment through successive exposure, as well as a systematic desensitization by 
reciprocal inhibition, through relaxation technique training, in the cases where the child 
exhibits resistance to being examined or to remaining calm in the hospital environment. 
When an emergency or urgent surgery is required, the child is hospitalized and this procedure 
of desensitization to the team and the treatment is performed intensively in the infirmary. 
4. The psychological focus on interdisciplinary care in pediatric surgery 
The psychologist works together with the interdisciplinary team, both on an outpatient basis 
and in the infirmary. 
The following take place in the clinic:  
• Pre-operative group therapy that guides and prepares patients and parents for surgery; 
• Therapy for families and patients suffering from syndromes and malformations;  
• Orientation and guidance for children and parents with difficulty accepting or 
understanding processes, procedures, diagnoses and/or prognoses; 
• Clinical therapy for children and adolescents who complain of daytime and nocturnal 
enuresis, encopresis, chronic constipation, and colon management; 
• Guidelines for parents for the management of their children’s behavior. 
The specific objectives of the orientation and psychological counseling are: 
• To guide and inform parents and patients about the disease and the procedures to be 
performed during the surgery and hospitalization; 
• To promote desensitization to the procedures and to the hospital setting; 
• To create awareness of the emotional family aspects that can interfere with adherence to 
pediatric treatment and to improve the quality of life of the patient and the family. 
The following are used as educational materials for working with children and families: 
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• Playful/didactic hospital supplies that replicate those actually used in real procedures; 
• Life-size cloth dolls of that represent a child of approximately one (1) meter in height 
with internal organs that replicate the human body; 
• Real hospital equipment 
The orientation and guidance therapy is performed primarily in groups, optimizing in this 
way the care offered to patients despite the high demand of the clinic. This form of care 
matches the data published in literature that demonstrates that group activities, beyond 
permitting a greater comprehensiveness of care, assists the patient in identifying with other 
people with the same needs, providing a space for clarification of doubts and exchange 
about similar situations between families.  
For these pre-operative guidance and orientation groups, three meetings are generally held, 
following the procedures described below. 
- 1st Meeting – Parents (Informational meeting) 
Informational meeting with the parents about the illness, hospitalization, and surgery of 
their children, as well as the goals of the group meetings with the children. The objective of 
this first meeting is for the parents to have a better understanding of their children’s illness 
and the procedures that will be performed by the team, at the same time becoming aware 
that their children are not the only ones affected by the problem, so that they may thus act 
more appropriately toward the children’s doubts. 
-  2nd Meeting – Children 
This meeting is aimed at assessing the children’s level of anxiety and understanding, as well 
as the children’s own awareness of their health problem, the proposed treatment, and finally 
their reaction to the hospital. The order of activities is: 
• Introductions and meeting of the children and staff; 
• Evaluation of the knowledge and understanding of the children of their own disease; 
• Creating awareness that other children are suffering from the same problem; 
• Fun activities with hospital toys that promote desensitization to hospitalization; 
• Investigation into the expectations of hospitalization and surgery; 
• Explanation in a playful and didactic manner, provided by the doctor with the aid of 
mannequins, about the procedures which the children will go through during 
hospitalization (pre-anesthetic fasting, venous access, surgery, dressings, care and post-
operative changes); 
• Orientation about the sequence of surgery, return visits, and discharge; 
• Final fun activity where the children simulate hospitalization. 
 
- 3rd Meeting – Parents and Children 
The goal of this meeting is to evaluate the degree of comprehension of information received 
and to visit the hospital, in the following order: 
• Investigation into the absorbed information and, when necessary, more illustrative 
repetition of anything not understood; 
• Explanation in a fun and didactic manner, provided by the nurse in charge of pediatric 
surgery, with mannequins and hospital equipment, about the procedures and stay in 
the infirmary; 
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• Familiarization with the hospital accommodations (bedroom, infirmary playroom, 
outdoor playground, pre-anesthetic room and recovery room) where the doctor and 
nurse discuss what happens in each environment; Interactive activities that provide 
information about the affinity between pairs of children, so that staff can properly select 
pairs that should be roomed together; 
• Closing play with the staff. 
In the infirmary, follow-up care and treatment of patients seen in preoperative groups or 
individually in the clinic is continued, and also, when necessary new treatments are 
initiated, using the same criteria from the clinic for patients that begin their treatment 
through a transfer from another center. 
5. Importance of interdisciplinary care in pediatric surgery 
Over 13 years of work (1998-2011) improvements has been observed, with the procedures that 
were adopted, both for pre-operative preparation and for the treatment of chronic patients.  
For out-patient follow-ups and in the infirmary, the improvements were in the affective 
development of emotional conflicts, fears, illusions, prejudices against the disease; 
facilitation of desensitization to procedures and to the hospital setting; lower levels of 
anxiety in both patients and parents, who demonstrated awareness and comfortableness 
regarding the procedures; hospitalizations with fewer complications and faster recoveries.  
This data shows the importance of the performance of an interdisciplinary staff in the 
treatment of a pediatric surgery patient and his/her family.  
The importance of intervention procedures aimed at the pre-operative preparation of 
children and their families is increasingly recognized. We should stress the need for this 
process to be carried out by a specialist in psychology who does not only stop to provide 
information about clinical procedures.  
It is necessary that intervention programs provide conditions in which the parents and 
children can express their fears and anxieties about the situation that they are experiencing 
so that they can understand it more effectively. 
Psychological Intervention, performed by a professional who is qualified to identify the 
emotional characteristics of parents and children in a systematic manner and with 
interdisciplinary support, can reduce the harmful effects to the child-family-professional 
bonds and can also reduce the undesirable aspects of hospitalization and surgery and 
consequently support the healthy development of the child. 
The presence of a psychology professional together with the surgical team is fundamental 
when attempting to provide effective treatment to pediatric patients and their families, 
providing them with an effective understanding of procedures, better interaction with the 
staff, greater adherence to treatment, and consequently fewer risks to the emotional 
development of the child as a result of hospitalization. 
This team believes that the interdisciplinary treatment in pediatric surgery is of utmost 
importance, because surgery is a time of crisis for parents and children, during which they 
are frightened and concerned about the necessity of a surgical intervention.  
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This team believes that the interdisciplinary treatment in pediatric surgery is of utmost 
importance, because surgery is a time of crisis for parents and children, during which they 
are frightened and concerned about the necessity of a surgical intervention.  
 
Complementary Pediatrics 174 
While the child is afraid of the unknown, of pain and of separation from their loved ones, 
the adults, in turn, fear the inherent risks of the invasive procedures, illness, and the 
possible poor prognosis and the treatments to which the child may be submitted.  
Therefore, we believe that a staff trained in the care of both children and caregivers, and able 
to deal with the children’s and adults’ fears and illusions about their reality, is very important 
for the proper development of the measures taken and actions necessary in each case.  
Our experience supports the national and international published literature that is very rich 
in articles about the importance of humanizing clinical care with a child and family during 
illness, especially with those that require hospitalization and who are submitted to invasive 
procedures, aimed specifically at the preparation of these patients for the procedures they 
will be undergoing. Here can be mentioned the studies of desensitization to invasive 
procedures, child-parent coping strategies, treatment and prognosis, as well as 
interdisciplinary interaction. 
From these considerations the importance of guidance and counseling programs for 
children, when subjected to surgery, as well as for parents, can be emphasized, for both the 
literature and the real experience reported here show that these interventions are effective in 
the reduction of anxiety in mothers and children, providing better conditions for 
confronting stressful situations, and lower rates of behavioral changes in children after 
surgical procedures. 
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Adolescence is a product of the modern world. It has developed into a distinct stage of life as a 
result of a shift in many societies requiring a highly trained work force. When this is not 
needed, young people usually acquire skills needed to work as they grow up. As they go 
through puberty, they acquire additional responsibilities, usually with the oversight of parents 
or in apprenticeship to others outside of the family. Young women usually marry close to the 
time of the onset of fertility. However, with increasing education needs, there is an increasing 
gap between physical maturation and the ability to take on adult responsibilities. Young 
people who join the workforce early can be at a disadvantage compared to those who can 
complete more education. Young women have increasing control over their fertility in these 
societies, which also gives them these extra years to become more educated. 
These factors lead to a cohort of young people who have adult bodies without having adult 
responsibilities. They have the luxury of time to contemplate, to take risks, and to define 
themselves in new ways. All of this has led to the phenomenon of adolescence, which 
encompasses and goes beyond the physical changes of puberty. 
This is not to say that adolescent development has not previously existed; it is rather that 
societies’ awareness of this developmental stage of life has only recently emerged or been 
modified because of the societal changes that have occurred and the effects of globalization.  
As a definable period of adolescence is created in a society, it is accompanied by new 
societal issues—children separating emotionally from their parents while still being reliant 
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on them, experimentation with drugs and alcohol, sexual expression outside of traditional 
marriage, body image issues, and others. Healthcare practitioners can provide anticipatory 
guidance to parents and their adolescents, gathering data with sensitive, non-judgmental 
questioning. All of this must be based on an understanding of adolescent development. 
2. Global trends in adolescent demographics 
In many parts of the world, only childhood and adulthood are seen as distinct phases of life. 
Adolescents, as defined by the World Health Organization and United Nations, are those 
individuals aged 10-19 years (United Nations Children’s Fund [UNICEF], 2011). Though 
different healthcare organizations and societies may define adolescents differently because 
of societal, cultural, and economic conditions, the term adolescent in this chapter will refer 
to the above-mentioned age group.  
There are currently 1.2 billion adolescents in the world, making up 18% of the world’s 
population. Eighty-eight percent of adolescents live in the developing world, and more than 
half of the world’s adolescents live in South Asia or East Asia and Pacific region (UNICEF, 
2011) (Figure 1). Previously, much focus was given to preventing communicable diseases of 
childhood. Significant improvement in that regard has come about, and now leaders 
globally are recognizing the need to address and focus on the second decade of life, 
adolescence, in order to sustain and consolidate the achievements made during the first 
decade of children’s lives (UNICEF, 2011).  
 
Source: UNICEF, The State of the World’s Children 2011: Adolescence an age of Opportunity (2011), as cited in 
United Nations, Department of Economic and Social Affairs, Population Division. World Population 
Prospects: The 2008 Revision, www.esa.un.org/undp/wpp2008/index.htm, accessed October 2010. 
Fig. 1. Adolescent population (10-19 years) by region, 2009 
There are some clear demographic differences throughout the world. This may be explained 
by the differences in initiation of decline in fertility and mortality rates. Those countries, 
many of which are in North America and Europe, that had the earliest initiation of decline 
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in fertility and mortality rates, now have low growth rates and an aging population. 
Countries that had a later initiation of decline in fertility and mortality rates, such as those in 
Latin America, the Caribbean, East Asia, and some parts of the Middle East and South Asia, 
continue to have moderate population growth. In most of Sub-Saharan Africa and some 
parts of the Middle East and South Asia, there has not yet been a decline in fertility and 
mortality rates, and so in these parts of the world, young and youthful populations are seen 
(Brown et al., 2002). These differences result in a contrast in the age structure and age-
dependency ratios of individual countries and impact the economic and social structure of a 
country in varying ways (Assaad & Roudi-Fahimi, 2007; Brown et al., 2002).  
When it comes to health care, pediatricians in developed countries have been given the 
responsibility to care for adolescents (American Academy of Pediatrics, 1978). This is largely 
due to the fact that adolescents continue to grow and develop, a hallmark of pediatrics. 
Although the physical development is the first and earliest to be completed, adolescents 
continue to undergo cognitive and emotional development well into their 20’s. The age limit 
of Pediatrics varies across the world. Many developed countries have extended the age limit 
to 18 or even 21 years, while other countries, mostly developing countries, have lower age 
limits.  
Adolescents are generally the healthiest of the population, with their leading causes of death 
being accidents, homicide, and suicide (Brown et al., 2002). HIV/AIDS is the leading cause 
of death in some parts of the world (Brown et al., 2002). All of these causes are preventable, 
and so when it comes to adolescent health, an adolescent’s contact with a healthcare 
provider, for whatever reason, can be seen as an opportunistic time to address these matters. 
Risk-taking behaviors exacerbate the problems that may be faced during adolescence, and in 
some developing countries, work-related disability and mortality is an additional problem 
(Brown et al., 2002). When discussing adolescent health, much attention is frequently given 
to the problems that may be encountered such as risky behaviors. It is important to note, 
however, that it is only a minority of adolescents who are involved with serious problems as 
substance use, teenage pregnancy, and acts of violence (United Nations [UN], n.d.). Most 
adolescents actually go through this stage of life without much turbulence. It is a time when 
many adolescents gain personal growth, development, and independence and attain certain 
skills. Adolescence can and should be viewed as a time of opportunity. 
Some of the problems that face adolescents differ depending on where they live. For 
example, substance use, eating disorders, and lack of exercise are more prevalent in 
developed countries. There are gender gaps when it comes to education, with generally 
more males attending secondary school in comparison to females. In fact, two thirds of 
children who never went to school or dropped out are girls. In South Asia, for example, 52% 
of boys but only 33% of girls are enrolled in secondary school. In contrast, girls in Latin 
America and the Caribbean have higher secondary school enrollment rates than boys, 56% 
and 52% respectively (UN, n.d.). This is important to address because the more education a 
girl receives, the more likely she is to postpone marriage and motherhood (UNICEF, 2011). 
It has also been found that knowledge and skills obtained through formal education is less 
advanced in students coming from developing countries in comparison to those students 
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Reproductive health also varies across regions. Adolescent females are less likely to use 
contraceptives than adult women, and adolescent mothers are more at risk of developing 
complications related to pregnancy than adult mothers (Nugent, 2005). An adolescent 
mother is also more likely to drop out of school and be less educated than an adolescent 
female who has not become pregnant. Marital age has increased in many parts of the world, 
yet in some regions, child marriage (marriage by 18 years) continues to occur and is largely 
driven by ‘poverty, parental concerns about premarital sex and pregnancy, and other 
economic and cultural reasons’ (Nugent, 2005).  
Because of these differences, a pediatrician’s approach to the psychosocial history of an 
adolescent needs to be tailored to meet the needs of different regions/countries. Although 
we recognize each country, and sometimes different parts within the same country, may 
have their own unique issues, it is impossible to address matters of every single country. For 
this reason, in this chapter, we have decided to focus on some regions of the world and give 
an example of one country per region, though keeping in mind that this may not apply to 
every single country within the same region. 
3. Developmental changes that occur during adolescence 
Many changes occur during adolescence, the most obvious being the physical ones. 
Pediatric and other medical references tend to focus on these physical changes, and this 
information is readily available. For this reason, the physical changes that occur during 
puberty and adolescence will not be discussed here. Rather, the focus will be on the other 
developmental changes that occur: the cognitive and emotional changes. These develop 
more insidiously and health care providers may be less familiar with them. In addition, 
healthcare providers may be deceived by the physical appearances of adolescents which are 
not necessarily proportionate to their cognitive and/or emotional development. 
3.1 Cognitive development 
Adolescence is a sensitive and critical period for both normal and maladaptive patterns of 
development. This period was formerly described as the time of transition from concrete 
operational thinking to formal logical (abstract) thinking, including development in 
reasoning and judgment. 
New perspectives emphasize that adolescent thinking is a function of social, emotional, and 
cognitive processes (Steinberg, 2005). There is growing evidence that the brain continues to 
mature throughout adolescence and into early adulthood (Gogtay et al., 2004). During this 
period, brain, behavioral, and cognitive development systems mature at different rates, 
causing adolescence to be a period of increased vulnerability and adjustment.  
Two issues are especially relevant to understanding adolescent psychological development. 
First, brain development in this period is mostly in regions that have an important role in 
regulation of behavior and emotion and to the perception and evaluation of risk and 
reward. Significant changes include myelination and synaptic pruning, which increase the 
efficiency of information processing and enhance transmission of brain messages (Paus, 
2005). Areas associated with more basic functions, including the motor and sensory areas, 
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mature in the early teen years, while the prefrontal cortex, the reasoning area of the brain 
and an important area for controlling impulses, emotions and executive functioning, 
appears to reach adult dimension in the early 20s, with girls developing earlier than boys 
(Geidd et al., 1999; Gogtay et al., 2004; Luna et al., 2010). Executive functions include the 
ability to inhibit impulses, weigh consequences of decisions, prioritize, strategize, long-term 
planning, decision-making, self-evaluation, self-regulation, and the coordination of affect 
and cognition. Second, changes in arousal and motivation brought on by pubertal 
maturation precede the development of regulatory competence (Blakemore et al., 2010). The 
brain's reward center, the ventral striatum, also is more active during adolescence than in 
adulthood.  
This creates a gap between the adolescent's affective experience and the ability to regulate 
arousal and motivation. While the adolescent brain continues to strengthen its connections 
between reasoning and emotion related regions, each adolescent progresses at varying rates 
in developing their ability to think and their own view of the world. 
Adolescent thinking becomes more multidimensional and they are better to contemplate 
hypothetical situations and the relationship between varied actions or decisions and 
outcomes, but decision-making remains susceptible to emotions. 
Adolescent cognitive development can be characterized into 3 stages: early, middle, and late 
(Cromer, 2011; Radzik et al., 2007). 
In early adolescence, the use of formal logical operations is mainly focused on schoolwork 
and in home environments. This includes questioning authority and societal standards. 
There is development of enhanced ability to verbalize thoughts and views, starting with 
those related to their life. These include choices regarding engaging in sports, peer groups, 
dress, and parental rules that adolescents think should be changed. At this stage, they may 
be unable to perceive long-term outcomes of current decision-making.  
In middle adolescence, more complex thinking processes are used. The focus expands to 
include more philosophical and futuristic concerns. Middle adolescents tend to question and 
analyze more extensively in order to form their own code of ethics, identity, and possible 
future goals, which may begin to influence relationships with others. They may perceive 
future implications, but may not apply it in decision-making. 
In late adolescence, complex thinking processes are used to focus on less self-centered 
concepts as well as personal decision-making. Adolescents may think about more global 
concepts such as justice, history, politics, and patriotism. They develop idealistic views on 
specific topics or concerns and may debate and develop intolerance of opposing views. They 
tend to focus on making career decisions and think about their emerging role in society. At 
this stage, they are able to think things through independently and weigh consequences 
before making decisions. Table 1 summarizes the cognitive changes that occur during 
adolescence.  
Understanding cognitive development during this period is helpful in understanding age 
differences in judgment and decision-making, risk-taking, sensation-seeking, and also why 
adolescence can be a time of increased risk for the onset of a wide range of emotional and 





Reproductive health also varies across regions. Adolescent females are less likely to use 
contraceptives than adult women, and adolescent mothers are more at risk of developing 
complications related to pregnancy than adult mothers (Nugent, 2005). An adolescent 
mother is also more likely to drop out of school and be less educated than an adolescent 
female who has not become pregnant. Marital age has increased in many parts of the world, 
yet in some regions, child marriage (marriage by 18 years) continues to occur and is largely 
driven by ‘poverty, parental concerns about premarital sex and pregnancy, and other 
economic and cultural reasons’ (Nugent, 2005).  
Because of these differences, a pediatrician’s approach to the psychosocial history of an 
adolescent needs to be tailored to meet the needs of different regions/countries. Although 
we recognize each country, and sometimes different parts within the same country, may 
have their own unique issues, it is impossible to address matters of every single country. For 
this reason, in this chapter, we have decided to focus on some regions of the world and give 
an example of one country per region, though keeping in mind that this may not apply to 
every single country within the same region. 
3. Developmental changes that occur during adolescence 
Many changes occur during adolescence, the most obvious being the physical ones. 
Pediatric and other medical references tend to focus on these physical changes, and this 
information is readily available. For this reason, the physical changes that occur during 
puberty and adolescence will not be discussed here. Rather, the focus will be on the other 
developmental changes that occur: the cognitive and emotional changes. These develop 
more insidiously and health care providers may be less familiar with them. In addition, 
healthcare providers may be deceived by the physical appearances of adolescents which are 
not necessarily proportionate to their cognitive and/or emotional development. 
3.1 Cognitive development 
Adolescence is a sensitive and critical period for both normal and maladaptive patterns of 
development. This period was formerly described as the time of transition from concrete 
operational thinking to formal logical (abstract) thinking, including development in 
reasoning and judgment. 
New perspectives emphasize that adolescent thinking is a function of social, emotional, and 
cognitive processes (Steinberg, 2005). There is growing evidence that the brain continues to 
mature throughout adolescence and into early adulthood (Gogtay et al., 2004). During this 
period, brain, behavioral, and cognitive development systems mature at different rates, 
causing adolescence to be a period of increased vulnerability and adjustment.  
Two issues are especially relevant to understanding adolescent psychological development. 
First, brain development in this period is mostly in regions that have an important role in 
regulation of behavior and emotion and to the perception and evaluation of risk and 
reward. Significant changes include myelination and synaptic pruning, which increase the 
efficiency of information processing and enhance transmission of brain messages (Paus, 
2005). Areas associated with more basic functions, including the motor and sensory areas, 
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mature in the early teen years, while the prefrontal cortex, the reasoning area of the brain 
and an important area for controlling impulses, emotions and executive functioning, 
appears to reach adult dimension in the early 20s, with girls developing earlier than boys 
(Geidd et al., 1999; Gogtay et al., 2004; Luna et al., 2010). Executive functions include the 
ability to inhibit impulses, weigh consequences of decisions, prioritize, strategize, long-term 
planning, decision-making, self-evaluation, self-regulation, and the coordination of affect 
and cognition. Second, changes in arousal and motivation brought on by pubertal 
maturation precede the development of regulatory competence (Blakemore et al., 2010). The 
brain's reward center, the ventral striatum, also is more active during adolescence than in 
adulthood.  
This creates a gap between the adolescent's affective experience and the ability to regulate 
arousal and motivation. While the adolescent brain continues to strengthen its connections 
between reasoning and emotion related regions, each adolescent progresses at varying rates 
in developing their ability to think and their own view of the world. 
Adolescent thinking becomes more multidimensional and they are better to contemplate 
hypothetical situations and the relationship between varied actions or decisions and 
outcomes, but decision-making remains susceptible to emotions. 
Adolescent cognitive development can be characterized into 3 stages: early, middle, and late 
(Cromer, 2011; Radzik et al., 2007). 
In early adolescence, the use of formal logical operations is mainly focused on schoolwork 
and in home environments. This includes questioning authority and societal standards. 
There is development of enhanced ability to verbalize thoughts and views, starting with 
those related to their life. These include choices regarding engaging in sports, peer groups, 
dress, and parental rules that adolescents think should be changed. At this stage, they may 
be unable to perceive long-term outcomes of current decision-making.  
In middle adolescence, more complex thinking processes are used. The focus expands to 
include more philosophical and futuristic concerns. Middle adolescents tend to question and 
analyze more extensively in order to form their own code of ethics, identity, and possible 
future goals, which may begin to influence relationships with others. They may perceive 
future implications, but may not apply it in decision-making. 
In late adolescence, complex thinking processes are used to focus on less self-centered 
concepts as well as personal decision-making. Adolescents may think about more global 
concepts such as justice, history, politics, and patriotism. They develop idealistic views on 
specific topics or concerns and may debate and develop intolerance of opposing views. They 
tend to focus on making career decisions and think about their emerging role in society. At 
this stage, they are able to think things through independently and weigh consequences 
before making decisions. Table 1 summarizes the cognitive changes that occur during 
adolescence.  
Understanding cognitive development during this period is helpful in understanding age 
differences in judgment and decision-making, risk-taking, sensation-seeking, and also why 
adolescence can be a time of increased risk for the onset of a wide range of emotional and 
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3.2 Emotional development  
Adolescence has been quaintly described as “that awkward period between sexual 
maturation and the attainment of adult roles and responsibilities”(Dahl, 2004). It is a time of 
great change with concurrent but asynchronous physical, cognitive, and emotional 
development. Although most adolescents progress through this phase unscathed with 
gradual, appropriate changes, some may experience significant challenges. Adolescents 
experience many changes in how they interact with their family, peers, society, and 
themselves (Choudhoury et al., 2006). They move from an idealistic opinion of parents 
during childhood, into increased conformity to peer group expectations and values, to the 
development of their own personal values and principles as they progress through early, 
middle, and late adolescence (B. Newman & P. Newman, 1999). This movement mirrors a 
shift in emotional support from family to peers and then to self and intimate partners. This 
is not to say there is or should be separation from the family, as healthy emotional 
development is highly dependent on continued positive interaction with parents throughout 
(Larson & Brown, 2007). However, there is gradual change until parents and the adolescent 
or young adult accept their individual roles and are able to share and challenge each others’ 
personal views and beliefs in a healthy way.  
As previously mentioned, emotional and cognitive development are inextricably linked as 
brain development progresses throughout adolescence into early adulthood. Cognition has 
a significant impact on expression of emotions, and conversely emotion and situational 
contexts have a significant impact on adolescents’ behavioral choices (Steinberg, 2005). 
Emotional development during adolescence involves learning to recognize and master the 
control of emotions experienced so as to facilitate functioning within expected societal 
norms. Emotions serve many important functions including motivating positive behavior, 
achieving goals, providing information about self, and facilitating relationships, including 
intimacy (Larson & Brown, 2007). It involves self-discovery and self-characterization to 
acquire a specific role in society which is facilitated by the enhanced abstract thought 
acquired during adolescence. There is evidence to support an association between cognitive 
maturation and increased regulation of emotional behavior; however it has been proposed 
that these changes are non-linear unlike development during childhood and adulthood 
(Casey et al., 2010). The subcortical limbic system -including the amygdala is important in 
the processing of emotions and emotional responses to social stimuli, whereas the prefrontal 
cortex is responsible for the cognitive control or regulation of emotional behavior. An 
“Imbalance Model” has been put forward that proposes that an imbalance between the 
development of these two systems may be related to the development of psychopathology 
(Casey et al., 2010). Sensitivity to rewards seems to peak in adolescence and may have a 
positive impact, such as academic or athletic achievements or negative influence with thrill 
seeking through use of substances or other high-risk behaviors. This incentive response 
suggests behaviors may be defined from a motivational perspective, and the dorsal and 
ventral striata which receive input from the cerebral cortex have been found to be involved 
in these responses (Somerville & Casey, 2010). There is also a significant association between 
the pubertal stage of maturation and affective measures including sensation-seeking, sex 
and sexual arousal, emotional sensitivity, and sleep, with sensation-seeking peaking in 
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High intensity emotions may also have a significant impact on adolescents’ thought 
processes and by extension to their behavioral choices – these have been referred to as ‘hot’ 
and ‘cold’ cognitions (Dahl, 2004; Somerville & Casey, 2010). ‘Hot cognitions’ refer to 
thinking amidst high intensity emotions and often result in poor decision-making. ‘Cold 
cognitions’ refer to thoughts in a state of calm, more commonly resulting in appropriate 
decision-making. This may explain why the adolescent who is usually even-keeled may, 
under certain ‘hot’ circumstances, make an otherwise unexpected poor decision.  
Healthy emotional development is a key developmental task for adolescents who are 
learning to negotiate increasingly complex and ambiguous social interactions and utilize 
lessons learned from previous experiences to assist in determining future choices. 
Discordance during this time of development may serve as the root of psychopathology. 
Adolescents who fail to learn how to modify their own emotions may become impulsive 
with progression to delinquent behavior or may become alienated both from peers and 
family, leading to parental conflict, relationship challenges, and an increased risk of 
depression, substance abuse, and suicide risk. 
4. Interviewing the adolescent 
Evaluation of an adolescent’s psychosocial status is done through interview and may be an 
uncomfortable task for many healthcare providers. Because adolescents are generally the 
healthiest, contact with healthcare systems may be minimal; therefore, any contact should be 
considered an opportunity to obtain a psychosocial history and provide anticipatory 
guidance. 
The literature available on the psychosocial interview of an adolescent is largely based on 
the North American experience. Even within North America, there are certain issues that 
need to be kept in mind based on the individual background of an adolescent, as will be 
discussed below. The psychosocial interview and history-taking in other parts of the world 
may vary from that conducted in North America depending on local norms, cultures, and 
existing or prevalent conditions. For this reason, three regions of the world, in addition to 
North America, will be presented below with particular focus given to one country per 
region. Unique issues and/or issues that are particularly relevant to that particular 
country/region will be emphasized in each section, in a manner that will be practical for a 
healthcare practitioner to utilize when providing care to an adolescent from the specified 
part of the world.  
4.1 Interviewing the adolescent in North America 
The HEADS acronym was introduced in North America (Goldenring & Rosen, 2004) to assist 
healthcare providers in obtaining a comprehensive adolescent psychosocial history in a 
sensitive manner and is seen by many to be universally applicable across the continent. It is 
important to remember that there is huge diversity in the adolescent population in North 
America, where right-wing fundamentalists, the descendants of African slaves, affluent youth, 
children of illegal migrant workers, rural youth, urban youth, and many others co-exist. Laws 
regarding consent and capacity vary, with many American jurisdictions allowing consent only 
to those over the age of 18 years, while many Canadian provinces have a functional definition 
that allows youth to give consent when they are capable of doing so. 
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Within all this diversity is a need to discuss basic psychosocial issues with children, 
adolescents, and youth. The original HEADS acronym now has many variations. 
• Home: The vast majority of North American adolescents live with at least one parent. 
Careful questioning will elicit the family constellation, which may include 
grandparents, step-parents, siblings and step-siblings, and unrelated friends. Some 
young people may see a pet as being a member of the family. Questions must be asked 
in a way that allows for the teen to disclose that they are homeless, have difficult 
relationships, or have a non-traditional family, such as one with two fathers or two 
mothers. 
• Education: Throughout North America, there is mandatory schooling, usually until age 16. 
Most young people continue through secondary education, which is usually grade 12 or 
age 18. Urban areas, particularly in the United States, have high rates of students who do 
not complete high school. If one asks a young person what their school performance is 
like, they all know that the correct answer is “fine” or “OK”. Specific questions about 
marks, the level of the courses they are taking (with much variation in terms of level of 
schooling offered), how much school they miss, and career goals are all important. 
• Eating: Eating disorders are prevalent in North America, resulting in young people 
being both underweight and overweight. The current focus in schools and health 
systems on obesity focuses on the importance of being thin, which may be a trigger for 
anorexia nervosa or bulimia. More and more, eating disorders are being diagnosed in 
pre-adolescents, often associated with significant anxiety or anxiety disorders. Poverty 
is strongly associated with childhood obesity, with less nutritious foods being available 
and limited opportunities for safe exercise for those living in inner cities. 
• Activities: Some North American adolescents are extremely active as athletes, 
volunteers, or workers. Working more than 16 hours a week often interferes with 
scholastic achievement. Some places require volunteer work for students to graduate 
from high school. Direct questions about screen time are essential, with many young 
people spending 5 or more hours a day in front of a computer or TV screen. Many are 
unaware of the dangers of revealing personal information on the internet to a legion of 
“friends” they have never met. Peer relationships should also be addressed, including 
questions about how the young person spends their lunchtime, if they see their friends 
outside of school, whether their parents allow them to have friends outside their 
religious or cultural group, and if there are discrepancies in the rules about friendship 
for boys and girls within a family. 
• Adherence: Chronic health conditions are not uncommon in North America, with 
adolescents surviving with conditions that were previously fatal. Adolescents have 
many reasons for not taking medications—their family might not be able to afford 
them, they may see them as a sign that they are different from their friends, a chaotic 
household does not lend itself to the organization needed to be adherent, and mental 
health issues can interfere with the ability to regularly take medication. Medications 
that affect physical appearance, such as steroids, can be quite problematic for young 
people. Questions need to be asked in a sensitive manner without making assumptions 
about adherence and the importance placed on medications within a family. 
• Drugs: Most drugs are readily available to North American youth. Alcohol is the most 
common substance used by youth, followed by marijuana and tobacco. Young people 
may respond well to being asked about drugs in their environment first, such as asking, 
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ask about their friendship group and finally to their own personal use. Experimental 
use is common, but questions should be asked about the impact of use on their 
academics, family relationships, and friendships. Young people should also be asked 
about their parents’ use of alcohol, tobacco, and other substances. 
• Safety: Adolescence is a time of risk taking, and this can lead to personal growth and a 
feeling of satisfaction. It can also have severe and even fatal consequences. Safety is an 
issue in recreation, work, driving, and social relationships. Asking about physical safety 
such as drinking and driving or the use of bicycle helmets is important, but so is social 
safety, including questions about bullying and sexual assault. 
• Suicide: An easy way to start a conversation about mental health is to enquire about 
mood, “On a scale of 1 to 10, with 1 being so sad you might kill yourself and 10 being 
the happiest you have ever felt, how would you rate yourself today and in the last 
week?” Questions about sleep, appetite, energy, and concentration are very useful. 
Young people usually don’t want to admit to anything that might sound like a mental 
illness, but are often quick to endorse high levels of stress, so exploring the stress in 
their lives can be a good way to find out about these issues. If a young person admits 
that they have been thinking about suicide, it is important to find out if this is an active 
thought, if they have made a plan, written a suicide note, or done anything else to make 
this a reality. Suicide risk should be taken seriously, and parents need to be brought 
into the discussion to prevent this disaster from happening. In the United States and in 
rural Canada, many families own firearms. These should be removed from the home if 
there is any concern about suicidality. 
• Sex: About 50% of North American youth have had heterosexual sexual intercourse by the 
time they finish high school. In the United States, teen pregnancy rates are high and 
abortions may be difficult to access. Young people need to be asked about their sexual 
activities in a non-judgmental way that does not assume that they have or do not have a 
particular sexual activity and that are non-gendered. A young person who is homosexual 
might not be sexually active, and they are as likely to have heterosexual sex as their 
heterosexual peers. Young people may have sex but not be in a relationship, so questions 
about sex must include both questions linked to a partner and ones that are separate. The 
question, “Have you ever had sex with anyone?” can lead to a fruitful discussion 
The adolescent psychosocial history in three different regions will be discussed below: the 
Caribbean, the Middle East, and South East Asia, with Jamaica, Saudi Arabia, and Thailand 
being an example country from each region respectively. For consistency and practical 
purposes, the HEADS acronym will serve as a guide for the psychosocial interview in each 
region, with differences or variations in the acronym emphasized. The sequence of the 
topics addressed may vary depending on local sensitivities or significance. It is important to 
bear in mind that the reported experiences (unless otherwise referenced) are based on the 
authors’ local experiences. Also keep in mind that some differences may apply to countries 
within the same region, and therefore it is important for one to familiarize himself with 
conditions or behaviors that may be particularly prevalent in a specific country. 
4.2 Interviewing the adolescent in the Caribbean 
Jamaica is the largest English-speaking Caribbean island, situated in the northern Caribbean 
Sea and is classified as a developing country with an upper-middle income economy by the 
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World Bank (The World bank, 2011). Adolescents aged 10-19 years account for almost 20% 
of the total population, with 10-24 year olds representing 27% of the population (Statistical 
Institute of Jamaica, 2011). Similarly, adolescents 10-19 years represent one-fifth of the total 
population in the Caribbean (Crawford et al., 2009). In Jamaica, pediatric services in the 
public health system stop at age 12 years; thereafter care is transferred to adult-centered 
services. In the past decade, the Ministry of Health has increased its focus on adolescent 
health care with the promotion of the adolescent friendly approach in health centers. There 
are currently no national guidelines for adolescent health care in Jamaica, and the practice of 
preventive health care for adolescents is at a less than optimal level (Harrison et al., 2011). A 
minority of physicians recommend regular health maintenance visits for adolescent patients, 
and so screening for potential health concerns should be performed at any visit, whether for 
acute or well care (Harrison et al., 2011).  
Culturally, parents continue to assume primary responsibility for their adolescent’s health 
care and usually accompany them for health visits or send an older family member. Some 
physicians report parents limiting access to teens for confidential discussion (Harrison et al., 
2011), however with appropriate explanation of confidentiality policies to parents and 
adolescents together, confidential discussion with the adolescent is usually possible. It is 
most helpful to introduce the concept to parents as time alone with a health professional 
being an opportunity for adolescents to start accepting responsibility for their own health 
care. The provider’s office should be promoted as a ‘safe-place’ for discussion of any 
concerns affecting an adolescent’s health– physical, emotional, psychological, and not a 
place to “just talk about sex and drugs”. Of course, it is appropriate that parents be kept ‘in 
the loop’ with regard to their adolescent’s care, and once assured of this, most parents and 
adolescents seem to welcome confidential discussion with the health provider. 
Many of the public healthcare facilities in Jamaica are understaffed, and this significantly 
impacts the time available for appropriate discussion with adolescents and parents. The well 
recognized psychosocial history acronym, HEADS, used widely internationally, was created 
to accommodate for this challenge. However in a recent survey, a minority of physicians in 
Jamaica reported being aware of HEADS, and as such, exposure to and training in the use of 
HEADS is being expanded for Jamaican physicians through continued medical education 
efforts.  
As would be expected for any other cultural setting or geographic region, the tool has to be 
modified to be culturally sensitive for the specific population. Some of these modifications 
will be briefly discussed below. 
• Home:  Jamaica and many other Caribbean countries are matriarchal societies and have 
varied family units, including married, common-law, visiting, and single, with the most 
prevalent in Jamaica being the common-law marital relationship (UNICEF, n.d.). A 
positive male influence is therefore frequently absent, and the details as to how this 
affects the adolescent and the family in general, need to be explored. Many children and 
adolescents are also left in the care of extended family, as parents go overseas to seek 
employment, planning to support their family through remittances. Detailed 
information on household members and shared households must be taken including 
the level of supervision, age and gender of other household members or caregivers. The 
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question, “Have you ever had sex with anyone?” can lead to a fruitful discussion 
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World Bank (The World bank, 2011). Adolescents aged 10-19 years account for almost 20% 
of the total population, with 10-24 year olds representing 27% of the population (Statistical 
Institute of Jamaica, 2011). Similarly, adolescents 10-19 years represent one-fifth of the total 
population in the Caribbean (Crawford et al., 2009). In Jamaica, pediatric services in the 
public health system stop at age 12 years; thereafter care is transferred to adult-centered 
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and so screening for potential health concerns should be performed at any visit, whether for 
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will be briefly discussed below. 
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positive male influence is therefore frequently absent, and the details as to how this 
affects the adolescent and the family in general, need to be explored. Many children and 
adolescents are also left in the care of extended family, as parents go overseas to seek 
employment, planning to support their family through remittances. Detailed 
information on household members and shared households must be taken including 
the level of supervision, age and gender of other household members or caregivers. The 





parents (verbal and/or physical), as there may often be concerns surrounding 
separation issues, family conflict, and safety within the home, with the resultant 
externalizing and internalizing behaviors in the adolescent.  
• Education/ Employment:  Similar to other countries, physicians need to enquire about the 
grade currently attained in school, whether the adolescent attends school, what grades 
they are getting, and whether they have been suspended or otherwise disciplined. In 
Jamaica, most adolescents attend public high/secondary schools (grade 7-11) with a 
student:teacher ratio of approximately 35:1. Adolescents with specific challenges or 
needs, such as those with Attention Deficit Hyperactivity Disorder (ADHD) or learning 
disorders, may go unnoticed in schools, and therefore physicians should enquire about 
these issues during health visits with adolescents. Another concern in Jamaican schools 
is bullying, which has recently started to receive more attention both from school 
administrations as well as in the public domain. Culturally, mild bullying has often 
been dispelled with the view that it is  “just toughening you up”, and “those little 
things should not bother you”. More serious bullying is often settled on an individual 
basis with physical retaliation, as the culture is one that promotes the concept of 
“standing up for yourself”. However some adolescents do not cope well with bullying, 
and physicians therefore need to ask questions about bullying, including physical, 
emotional, and relational bullying, in a sensitive manner. For example “Does anybody 
at school say things to you that bother you?”, “Do you feel like you fit in or do people 
ignore you?”, or “Does anybody force you to do things you don’t want to... send you to 
buy lunch without giving you money?”  A balanced approach is important when 
assessing for potential bullying as Jamaicans are a people who oftentimes speak bluntly, 
frequently not utilizing the Westernized social graces of saying things in a ‘politically 
correct way’. Law mandates secondary level education in Jamaica; however, some 
adolescents may simply advance through the education system without actually 
acquiring the expected knowledge and skills. Ultimately, these adolescents leave school 
being unprepared for the adult work force with some becoming street youth with 
exposure to the attendant risks. Vocational/employment challenges are common as 
there are limited job opportunities for adolescents. As a result, some adolescents, 
particularly within ‘inner city’ societies, are wooed to establish an illegal lifestyle, 
joining ‘gangs’ and associating with  ‘area leaders or dons’ in an attempt to make an 
easier living. These concerns have to be carefully asked about as many of these 
adolescents will not admit to being involved with illegal activity, however may respond 
in the positive if asked “Are any of your friends or other young people in your 
community linking up with gangs?”  
• Eating: Anecdotally, there is limited awareness of disordered eating behaviors and 
attitudes in Jamaica both by lay persons as well as healthcare providers. Culturally, 
eating disorders have not been considered a problem in the society as a desire for the 
‘voluptuous’, ‘thick’, ‘full-bodied’ woman has always been thought to be protective 
against body image concerns that focus on achieving low weight. However, national 
surveys have identified that Jamaican adolescents engage in disordered eating 
behaviors (DEB) (Fox & Gordon-Strachan, 2007), and a cross Caribbean survey found 
that although the prevalence of DEBs was less in the Caribbean than in North America, 
the use of extreme weight control measures was greater among Caribbean adolescents 
(McGuire et al., 2002). In clinical practice, the prevalence of DEBs anecdotally appears to 
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be increasing among Jamaican adolescents, perhaps due to increased globalization and 
internalization of the Westernized ‘thin ideal’. Conversely, there is significant concern 
and more awareness about obesity in Jamaican adolescents (Wilks et al., 2007), 
secondary to increasingly inappropriate nutritional intake, fuelled by many popular 
fast-food restaurants. There is also limited emphasis being placed on physical exercise, 
including the removal of scheduled sessions for physical exercise in schools after grade 
9. Additionally, there is limited access to safe outdoor spaces to facilitate exercise in 
some neighborhoods. 
• Activities:  Enquiring about activities engaged in, who time is shared with, and ensuring 
that adolescents have at least one trusted friend, referred to locally as a ‘bredrin’ or a 
‘bonafide’ is important. Jamaican adolescents are technologically savvy, especially 
when Jamaica is still considered to be a developing country, with the vast majority of 
adolescents owning a mobile phone or having easy access to computers and the 
internet, often times with limited supervision. It is therefore important for providers to 
enquire about total media time to ensure this is not interfering significantly with 
schoolwork. It is also important to enquire about internet safety practices, for example 
“Do people you don’t know try to ‘friend’ you… Do you accept people you don’t know 
as friends?” Providers need to take the opportunity to reinforce positive practices and 
give appropriate advice, for example, “Be careful what pictures you send to your 
boy/girlfriend since you don’t know what they’ll do with them if you break up… Once 
the picture is out on the web, you can never get it back”. Due to the small size and 
population of the Caribbean countries, it is particularly important to enquire about and 
advise against disclosing personal information online.  
• Drugs: The local law states that substances such as cigarettes and alcohol are illegal for 
use in persons under 18 years. Monitoring and the consequences for sidestepping these 
are minimal and it is not difficult for ‘under age’ adolescents to access alcohol and 
cigarettes, with it being almost normative for many adolescents. However the level of 
binge-drinking among Jamaican adolescents is significantly less than that noted in 
North America. This more relaxed attitude towards use of these substances is pervasive 
and therefore health providers must ensure to enquire not only about use but also 
frequency and in particular, high risk behavior including driving under the influence. 
Initial questions should be more general, enquiring of friends and then becoming more 
specific: “Do you drink any alcohol, like beer or Smirnoff ice?”, as many young people 
don’t consider these ‘real liquor’. There is generally little difficulty in acquiring 
marijuana although it is illegal in Jamaica. Many Jamaican adolescents do not think of 
marijuana as a “real” or “serious” drug. Additionally, many local musical artists 
identify with the Rastafarian faith which includes the use of marijuana as a part of their 
spiritual experience. A balanced harm-reduction approach with a gradual move 
towards abstinence is therefore most likely to be effective in cases of marijuana use by 
adolescents.  
• Sex and sexuality: Jamaica, is a predominantly Christian country, and in many aspects a 
very religious society. This serves as a stabilizing and positive force in many 
adolescents’ lives, and during the interview, enquiry into their level of involvement in 
church activities and how their religion informs their personal beliefs and practices is 
appropriate. However, religiosity can also have a negative impact, and Jamaican 
adolescents have reported the fear of contradicting church expectations as reasons for 
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be increasing among Jamaican adolescents, perhaps due to increased globalization and 
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schoolwork. It is also important to enquire about internet safety practices, for example 
“Do people you don’t know try to ‘friend’ you… Do you accept people you don’t know 
as friends?” Providers need to take the opportunity to reinforce positive practices and 
give appropriate advice, for example, “Be careful what pictures you send to your 
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(Crawford et al., 2009). The age for consenting to sexual activity in Jamaica and the 
majority of the English-speaking Caribbean is 16 years, however the mean age for 
sexual debut is 13.5 years for males and 16.1 years for females (Jamaica Family Planning 
Board and Division of Reproductive Health, Centers for Disease Control and 
Prevention, 2008). The “Access to Reproductive Health Care Policy” guideline allows 
for the use of non-invasive contraceptives for adolescents who present for care and are 
unwilling to practice abstinence, however many health providers are still 
uncomfortable with this practice (Crawford et al., 2009). Many adolescents experience 
significant pressure to become sexually active from peers and the media, with a vibrant 
dancehall music culture that normalizes casual sex (Crawford et al., 2009). Discussion 
about adolescents and sexual activity is still considered taboo, and so health providers 
may have to first enquire about friends’ sexual activity and then segue into the 
adolescent’s personal activity, facilitating age-appropriate advice and care. Much of the 
local music and media promote men having relationships with multiple women, and 
many adolescent females feel that they cannot expect a monogamous relationship even 
though that is most times their preference. Healthcare providers therefore need to 
enquire of the power shift in relationships and if this is resulting in an unhealthy 
relationship. They may ask “Does your boyfriend refuse to wear a condom even if you 
ask?” or “Does your boyfriend get very jealous and check your phone calls or text 
messages?” It is not uncommon for young women to know that they are not the only 
sexual partner for someone but to still feel unsure of demanding condom use when the 
male partner argues against this. Female adolescents need to be empowered to make 
these demands by improving their concept of self-esteem and self-worth, if even to 
ensure they know how to put on the partner’s condom. Jamaica is a very rigid society 
with regard to its approach towards homosexual orientation. Although often described 
internationally as a ‘homophobic’ society, Jamaicans in general have been found to be 
quite tolerant of homosexuality unless it ‘directly’ affects them. Though there is much 
homophobic rhetoric, many adolescents can identify at least one friend or schoolmate 
whom they think is homosexual and are not at odds unless specifically asked to say 
they are in agreement with homosexual relationships. This is felt to stem from a deep 
religious belief within the society that homosexuality is wrong. Although figures 
among adolescents are limited, and if available, likely to reflect underreporting 
(Crawford et al., 2009), anecdotally the prevalence of adolescent homosexual activity 
seems to be increasing. Healthcare providers must therefore care for their adolescents in 
a non-judgmental manner and enquire of adolescents’ orientation and sexual history.  
• Safety: In Jamaica, the prevalence of violent crimes is very high, and many of these are 
committed against and by adolescents including sexual offences, assault, and even 
homicides (Harriott, 2008). There are many neighborhoods that are unsafe with 
adolescents in these areas being under the added pressure of daily safety concerns. 
These concerns expand to some schools where students may carry concealed weapons 
as well. Questions such as “Do you feel safe in your home…school…community?” can 
be very revealing and the platform for further evaluation. Sexual safety may also be of 
concern as sexual offences are committed most frequently within the home or 
community. Questions such as “Has anyone ever touched you or done anything sexual 
to you that you did not want or like?” may be the only opportunity an adolescent has to 
discuss abuse.  
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• Suicide: Jamaican society is not one that generally embraces mental health treatment or 
mental health challenges as a viable diagnosis in many cases. This underscores the 
importance of screening for these concerns in teens who often have no one to freely 
discuss such things, for example mood disorders. However given the many challenges 
that adolescents face, it should be expected that at least a few are at high risk for 
significant psychopathology or the use of inappropriate coping strategies resulting in 
internalizing and externalizing behaviors. Many parents underestimate the effect of 
stressful changes on their adolescents, including separation from parents whether 
through death, even if by violent means, or migration and often do not seek 
professional help, albeit a somewhat scarce resource.  
Jamaican adolescents face many challenges, a few unique to the local culture, but are also 
resilient, often going from a start with limited resources to becoming world renowned and 
respected figures.  
4.3 Interviewing the adolescent in the Middle East 
Population growth in the Middle East continues to be above the world’s average. The most 
rapid growth of the overall population of young people in the region has been witnessed 
resulting in the “youth bulge” (Assaad & Roudi-Fahimi, 2007). Despite the significant 
numbers of adolescents, there continues to be lack of dedicated adolescent healthcare 
services in the Middle East. Similar to Jamaica and other parts of the Caribbean, in most 
parts of the Middle East, the age limit of Pediatrics is 12 years. Thereafter, individuals in 
their early adolescence are transferred to adult healthcare. This in part has to due with the 
cultural concept that once a young male or female has physical signs of puberty, he or she is 
assumed to be an adult. Years ago, the appearance of such signs signified that one was 
ready to enter a marital relationship and begin childbearing. In recent years, education has 
significantly improved, and secondary school enrollment rates have increased (Assaad & 
Roudi-Fahimi, 2007). This is especially true for females and has resulted in women pursuing 
higher education and delaying the onset of marriage and childbearing (Assaad & Roudi-
Fahimi, 2007). Because of the changes seen in society, many in the Middle East have recently 
become aware of the changing needs of young individuals, and the term ‘adolescent’ or 
‘murahiq’, in the Arabic language, has become more widely used. Murahiq used to 
previously have negative connotation to it, meaning that someone was still immature. In 
recent years, it has become a more socially acceptable term that correctly refers to the 
transitional period between childhood and adulthood.  
Countries are recognizing the changing needs of adolescents and their impact on the 
economy and future of nations. In some Middle Eastern countries, investments in the 
education and health sectors, as well as providing more job opportunities for the young 
have been the focus in the new Millennium. When it comes to healthcare, most have not 
adopted any changes with regards to the age limits of Pediatrics practice, however, some 
institutions in the region have independently taken on the decision to increase the age limits 
to 14 years (Al Buhairan, 2010), and some are even discussing further increase.  
Strong family ties generally exist in the Middle East, young individuals have close 
relationships with their family members, and respect of the elderly is a given. Young 
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higher education and delaying the onset of marriage and childbearing (Assaad & Roudi-
Fahimi, 2007). Because of the changes seen in society, many in the Middle East have recently 
become aware of the changing needs of young individuals, and the term ‘adolescent’ or 
‘murahiq’, in the Arabic language, has become more widely used. Murahiq used to 
previously have negative connotation to it, meaning that someone was still immature. In 
recent years, it has become a more socially acceptable term that correctly refers to the 
transitional period between childhood and adulthood.  
Countries are recognizing the changing needs of adolescents and their impact on the 
economy and future of nations. In some Middle Eastern countries, investments in the 
education and health sectors, as well as providing more job opportunities for the young 
have been the focus in the new Millennium. When it comes to healthcare, most have not 
adopted any changes with regards to the age limits of Pediatrics practice, however, some 
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to 14 years (Al Buhairan, 2010), and some are even discussing further increase.  
Strong family ties generally exist in the Middle East, young individuals have close 
relationships with their family members, and respect of the elderly is a given. Young 





family) until they get married; some even continue to live with their families after marriage 
depending on the family structure and possible financial matters.  
When an adolescent male or female requires a health visit, it is the norm to be accompanied 
by a parent or older sibling. Health conditions are discussed in front of both adolescent 
patient and accompanying family member. This is not to say that adolescents do not keep 
certain information away from their parents or family members, but rather that it is 
culturally expected that parents have the right to know everything about their adolescent 
son or daughter. Interviewing an adolescent independently is foreign. However, when 
done, parents and adolescents have viewed it quite positively. When the healthcare provider 
explains to the family that he or she would like to talk to the adolescent patient 
independently because it is an opportunity for the young individual to begin to take on 
responsibility of his or her health, families are appreciative. Families also tend to appreciate 
the fact that an adult is willing to spend time and talk to the adolescent son or daughter, as 
some parents are sometimes unsure of how to address certain issues and know that the 
adolescent may not be sharing everything with them.  
When it comes to consent taking, policies are institution based. Some policies state that the 
age for consent is 15 years, based on the fact that most males and females have developed 
pubertal signs by then and are therefore considered to be ‘adults’, while other institutions 
state that 18 years is the age for consent. This applies to consent for management or 
treatment of any sort of health condition. Confidentiality issues, therefore, lie within the 
constraints of consent policies.  
As for the specific psychosocial history taking of a Middle Eastern adolescent, different points 
may need to be addressed and/or similar points may need to be addressed differently based 
on the specific country or even part of a country that the adolescent comes from. Though there 
are many cultural similarities between the different Middle Eastern countries, there are also 
some differences that exist. For the sake of the psychosocial interview, the information 
provided below is based on experience with adolescents from Saudi Arabia. The information 
may very well apply to adolescents from neighboring Arabian Gulf States, such as Bahrain, 
Kuwait, Oman, Qatar, and the United Arab Emirates, since culturally they are very similar. 
There may be certain conditions or practices that may be more prevalent in some of the other 
Middle Eastern countries, so it is recommended that each pediatrician familiarize himself with 
those matters based on the adolescent population he serves. 
HEADS can be applied to Middle Eastern adolescents, with certain points to be kept in mind 
or specific modifications to be applied as outlined below: 
• Home: It is necessary to be very specific in asking who lives at home with the 
adolescent, including extended family members and domestic helpers. When asking 
about one’s relationship with family members, one should go beyond asking, “How 
would you describe your relationship with….” and ask “When something is bothering 
you, can you talk about it with your …” or “Who do you speak to when something is 
bothering you or you need to discuss a personal matter?”  Polygamy is seen in some 
families, so asking if the father is married to more than one wife is important, as is 
asking about the presence of half-siblings. If the adolescent comes from a polygamous 
family, further questions regarding the living accommodations and paternal 
relationship with the adolescent and his/her full and half siblings should be pursued.  
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• Education: When asking about school performance, it is important to ask about changes 
in school/academic performance over the past year. Asking about one’s relationship 
with peers at school is also important, including history of bullying (whether one is a 
victim or the offender), as this is often overlooked. Do not assume that all adolescents 
are enrolled in school. Even though some countries have laws for mandatory schooling 
for children and adolescents, these laws are not necessarily enforced. Adolescents with 
special needs are especially at risk of not being enrolled in school. 
• Eating: Eating disorders, such as anorexia nervosa and bulimia nervosa, are not 
prevalent in the Middle East; however, this may be changing with the effects of 
globalization. There is also a lack of awareness of these conditions, so under-diagnosis 
may be another factor affecting the actual prevalence rates. Obesity, on the other hand, 
is a common condition with prevalence rates increasing over the years (El-Hazmi & 
Warsy, 2002). Fast food restaurants have infiltrated societies that were previously 
known to have healthy diets. Furthermore, the heat in many parts of the Middle East 
often precludes outdoor activities and exercise. 
• Activities: Finding out who the adolescent spends time with during recreational or 
extracurricular activities is important; is it friends from school, the neighborhood, or 
extended family members?  Some families may not allow their sons, but maybe more so 
their daughters, to spend time with their school friends outside of school hours; they may 
be expected to spend their time with their cousins or other family members. Technology 
has swept across the Middle East as it has globally. Time and activities spent on the 
Internet, including online chatting and cyber bullying should be asked about. 
• Drugs: In some Middle Eastern countries, tobacco use is common among adults, and 
adolescents may be frequently exposed to family members who smoke. Tobacco use 
includes that found in cigarettes as well as sheesha (narghile or hookah). Sheesha use has 
gained increased popularity in the Arab world over the past two decades and has 
attracted adolescents and young adults to the extent that it has been declared a public 
health problem by the WHO (Martinasek et al., 2011). Other substance use, including 
alcohol, marijuana, and amphetamine use, attracts social stigma, and such a matter is not 
discussed openly. Directly asking about drug use may be considered offensive by some, 
as they may think that you assume that he or she is involved in substance use. This is 
considered to be a very sensitive topic, and so the pediatrician may decide to start off by 
asking about tobacco use among peers. Such a question may be posed: “Some individuals 
your age may be smoking; do you know if any of your peers are smoking?” This can then 
be followed by “Have you ever tried smoking?” and depending on the response you get, 
follow this by more questions related to smoking. Sheesha use should be asked about 
even if the young person denies cigarette smoking. After addressing tobacco, one should 
go on to address alcohol and other substances in a similar fashion. The substances that 
adolescents may be most exposed to in the Arabian Gulf States are cannabis (including 
hashish) and amphetamines. Captagon is a synthetic stimulant that is available and is 
abused and should be asked about. Certain areas have prevalent use of khat (or gat), an 
amphetamine-like stimulant that is usually chewed. Sniffing solvents and other materials 
should also be included in this section of the psychosocial history. 
• Safety: Motor vehicle accidents are a significant cause of death among adolescents in 
this part of the world. Seat belt use has only been recently enforced in some countries, 
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sand dunes, recreational activities, such as sandboarding and others that involve 
motorbikes or four wheel drive vehicles, are often engaged in, and enquiring about 
safety measures pertaining to these should be included. 
• Suicide: As in other parts of the world, adolescents in the Middle East are at risk of 
developing depression. Regularly asking about one’s mood should be done during the 
psychosocial history taking. This can be done in a manner similar to that described 
previously with adolescents in North America. Many healthcare providers are 
uncomfortable asking about suicidal ideations or acts, and suicide is again another 
stigmatizing matter in the Middle East. However, when adolescents have been directly 
asked about this, they tend to respond honestly; for some, it has appeared that they 
were actually relieved that someone had finally opened this subject matter, as it is a 
very difficult matter to discuss. 
• Sex:  Sexuality and sexual activity are topics that are culturally inappropriate to address 
with most Middle Eastern adolescents. Young people have insufficient access to 
information on these matters, and in the few areas where educational curricula contain 
sexual and reproductive health, teachers often skip relevant sections because they are 
uncomfortable or embarrassed to teach them (DeJong et al., 2005). Sexual activity prior 
to the onset of marriage is unacceptable and regarded as shameful. Those adolescents 
that have engaged in some sort of sexual activity tend not to talk about it or discuss it 
freely, as it is considered taboo. The exceptions to bringing up sexuality issues more 
openly during a health care visit include the following: 1) an adolescent who has been 
exposed to any sort of abuse (asking specifically about sexual abuse is considered to be 
appropriate), 2) an adolescent who is involved in risky behaviors, and 3) a married 
adolescent. 
4.4 Interviewing the adolescent in South East Asia 
In Thailand, adolescent medicine is a relatively new field, and the psychosocial history and 
assessment is not consistently done during each adolescent visit. This may be due to lack of 
training and exposure to the field, the overwhelming ratio of physicians per capita, and also 
the healthcare provider’s personal thoughts and attitudes towards conducting the 
psychosocial history itself. A survey conducted in a training institute in Thailand indicated 
that one third of the pediatric residents were not familiar with the HEADS acronym, one 
forth were not confident in conducting a psychosocial assessment, and 7% had never 
conducted the assessment prior to exposure to adolescent medicine (Areemit, In Press).  
Thailand is a newly industrialized country, undergoing many changes. The number one 
cause of death for adolescents (age 13-18 years) is accidents, while child birth (23.7%) is the 
leading causes of hospital admissions (The Royal College of Pediatricians Thailand [RCOP], 
2009). There are both nuclear and extended families; parents and relatives tend to be more 
involved in an adolescent’s life and are commonly present at hospital visits. Depending on 
the institution, pediatricians see children until they are 15-18 years. Asking permission to 
interview the adolescent alone is not yet a part of regular practice. Without adequate 
approach, parents and adolescents may misinterpret this as an indication that the healthcare 
provider thinks there is something “wrong”. Difficult encounters with the parents or the 
adolescent may be anticipated while asking for permission to conduct a psychosocial 
interview in private. However after establishing rapport and showing interest in the 
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parents’ and adolescent’s issues, advocating that this is a part of a regular adolescent visit 
and that the adolescent can learn to discuss his or her own issues with the healthcare 
provider as an appropriate way of development and establishing confidentiality, 
interviewing adolescents independently has been found to be more welcome than 
anticipated. Providing confidential health care for adolescents themselves is more of an 
issue, especially as laws only provide confidential care for adults (18 years or older). In this 
situation, adolescents are given confidentiality with limits regarding issues that may harm 
their heath or somebody else’s health. Healthcare providers then have to use their own 
judgment as to what can be kept confidential. Having said that, most issues that cannot be 
kept confidential will have to be discussed with the adolescent regarding appropriate care 
needed and how this will be addressed with the parents.  
The sequence in conducting a HEADS assessment may differ slightly; when there is no 
urgent presenting issue around sexuality, this topic is preferably kept until the end of the 
interview. This is because sexuality is a very personal and private issue in Thailand, rarely 
discussed with adolescents, and may be considered impolite.  
Discussed below are some pertinent issues for conducting a psychosocial interview for 
adolescents in Thailand.  
• Home: It is not uncommon for parents to migrate from rural neighborhoods to big cities 
in order to earn more income. Twenty percent of children and adolescents live with 
their grandparents or relatives (National Statistical Office (NSO) Thailand, 2008), while 
the family may reunite only twice per year. This can have positive or negative effects, 
depending on the quality of care given. Positive effects include closer care by relatives 
when compared to the hard working parents who may have insufficient time. In an 
extended family, an adolescent may also have a wider range of adults who can be a 
source of support. However, this is not always the case for those who have low 
economic status, come from disrupted families, or are living with elderly or ill 
grandparents who do not have sufficient resources and energy that may be required for 
an adolescent. Co-sleeping or sharing the same bedroom with the care giver (parents or 
grandparents) is common practice. Though adolescents will eventually want privacy, 
many share their room with parents, grandparents, or siblings, especially when there is 
insufficient space within a house.  
• Education and Employment: Usually, the parents and family financially support an 
adolescent/young adult until/if they complete education at the college/university 
level. Unless work is far from home, he or she is expected to live with the family until 
married and for some, even afterwards. If not working, the adolescent can help out in 
the house, thus moving out, getting a job, and living by themselves may not be a 
necessity. The secondary school attendance rate is 77.6%. The main reasons for not 
continuing secondary school are: achieving a certain degree of education already and 
economical issues. Most adolescents who do not continue secondary school will enter 
the workforce (49%), help with the family business (24%), look for a job (10%), or just 
stay at home (8%) (NSO, Thailand, 2008). Though there is a mandatory requirement to 
complete 9 years of school, there is insufficient data regarding the quality of education 
that adolescents receive. It is noted that some adolescents that have difficulties in school 
are allowed to pass through grades without sufficient evaluation and support for 
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adolescents may have lower opportunities for employment (NSO, Thailand, 2008). 
When interviewing about education, in addition to the open ended non-judgmental 
approach, it is very reasonable to ask specifically about attending school, grades/ 
changes in grades, and the school environment.  
• Eating, Body Image and Exercise: Adolescents can be especially prone to hazardous eating 
behavior and unhealthy nutrition choices. Though a regular diet consists of 3 meals per 
day, meals and snacks tend not to be as structured as in Western countries. There is a 
wide variety of eating behaviors depending on lifestyle and the demand of one’s 
everyday life. Skipping breakfast, having breakfast as the only meal of the day, having 4 
meals including a late night meal, or snacking throughout the day may be normal for 
some. In addition, some individuals have religious and spiritual reasons to have only 
one meal per day. Eating disorders have been reported, but are uncommon in Thailand 
possibly due to a low prevalence or under detection (Limsuwan, 1983). On the other 
hand, the prevalence of obesity has increased from 6% in 1995 to 22% in 2008 (RCOP, 
2009), and dieting is common among Thai adolescents (Aekplakorn & Mo-suwan 2010; 
Page & Suwanteerangkul, 2007). The media and peers play a major role in the formation 
of an ideal body image (Thianthai, 2006). Currently, K-pop (Korean pop) and J-pop 
(Japanese pop) are two popular trends (Winn, 2010). These trends portray adolescent 
girls, with small physique, white glowing skin, and big eyes. This has resulted in use of 
cosmetic contact lens to make the cornea look larger and/or change eye color, and 
complications found are associated with poor hygiene and below standard production 
of the contact lenses. Fake orthodontic braces worn to look young and wealthy has been 
associated with heavy metal intoxication. Skin whiteners, popular among adolescent 
girls and women, can pose toxic risks. 
• Activities: Many adolescents in the school system in large cities use their spare time, up 
to 18 hours/week, to attend extracurricular academic school in order to achieve and get 
high scores on the national examination for university entrance. Others may participate 
in motorcycle gangs that race on public streets and highways in the night. These gangs 
may engage in other high risk behaviors such as alcohol use, other substance use, and 
unprotected sexual intercourse. Sixty nine percent of Thai children and adolescents use 
computers and have internet access. Of this group, 21% use it to play games including 
online games (RCOP, 2009). In areas where the internet is easily accessible, some 
internet cafés that are close to schools even provide clothes for students in school 
uniforms to change into.  
• Drugs: Common drugs used are tobacco, alcohol, and amphetamine (NSO, Thailand, 2007; 
RCOP, 2009). Wood alcohol (methanol) can be found especially in areas near the northern, 
northeastern, and eastern borders of the country; teens should have information about 
this in order to avoid complications such as blindness. Other cosmetic medications that 
are used are macro-micro nutrient protein supplements for white glowing skin or for 
muscularity. There is usage of glutathione injection in order to have the glowing clear and 
fair looking skin. Herbal coffee is commonly used for dieting.  
• Suicide and mood: Five to eight percent of Thai adolescents have been found to have 
depressive symptoms, and 1.1% have tried to commit suicide (RCOP, 2009). Due to 
culture, Thai adolescents may not be as verbal and may feel pressured to keep their 
feelings inside. Some may find it hard to verbalize their mood and emotions, especially 
negative ones; on the contrary, when asked in an appropriate manner, suicidal ideation 
can be discussed more openly.  
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• Safety: Though there are laws regarding helmet and seatbelt use, these are more 
strongly implemented in major cities, not in the rural areas. Thirty eight to eighty 
percent of Thai adolescents who drive motorcycles do not wear helmets, 14-45% do not 
wear seat belts, 18-32% were in a vehicle in which the driver had consumed alcohol, 
and 13-21% had consumed alcohol and driven a vehicle themselves (RCOP, 2009). 
There are drivers who drive without a driver’s license. Helmets are mostly worn to 
avoid a penalty rather than for one’s safety.  
• Sex: Sex is a very personal and private issue; it is rarely discussed with adolescents, and 
can even be considered impolite. A study found that there are restrictions imposed by 
traditional culture and that sex education is not regarded as parental duty. The 
generation gap and ‘better not bring it up’ were the limitations in providing sex 
education by parents (Sridawruang et al., 2010). The majority of sexual education is 
taught in secondary school, most of it acknowledging the physical changes of puberty, 
sexually transmitted infections, and HIV. The psychosocial events that may occur 
during puberty are not yet widely addressed. Premarital sex is generally not accepted; 
there are double standard attitudes towards premarital sex, where it is acceptable for 
men but unacceptable for women. More adolescents (18%) are having sexual 
intercourse with only 14% using contraception. With lack of knowledge, 
misconceptions, and difficult access to low cost contraception, the teenage pregnancy 
rate has increased from 10% in 2001 to 15% of all pregnancies in 2004 and has become 
an issue for the country. It is considered very shameful for the unmarried adolescent 
girl and family, leading to late detection and complications. These pregnancies result in 
abortion (20-30%), continuation of the pregnancy and keeping the baby (60%), or 
continuation of the pregnancy but leaving the baby at the hospital for adoption (10%) 
(RCOP, 2009). Of those who continue the pregnancy, a majority will marry the baby’s 
father, some will continue to be a single mother, and for others, the grandparents raise 
the baby as a child of their own. Thailand’s HIV prevalence has been stable at 1.4 per 
1000 since 2005; however 11% of the HIV positive cases are adolescents and youth aged 
below 24 years. This group is thought to be the majority of newly infected people each 
year (Joint United Nations Programme on HIV/AIDS [UNAIDS], 2009). When 
interviewing about this topic, the healthcare provider should ask for permission to ask 
some more personal questions. With a health promotion approach, questions about 
physical changes can be addressed first, followed by psychosocial changes including 
sexual identity. Sexual activity and high-risk behaviors should be addressed by asking 
about the adolescent’s friends’ experiences or common themes in the media first, then 
probing further as needed. 
5. Conclusion 
Adolescence is a dynamic stage of life, with so many changes occurring. Adolescents are a 
significant part of any country’s population and much focus and attention on their needs is 
required, as they impact a country’s health, social, economic, and political status. With the 
rapid global changes and advancement in technology, adolescents are often ‘caught between 
tradition and progress’ (United Nations, n.d.). However, among adolescents globally, there 
are more similarities than there are differences, and as healthcare providers, we can increase 
the number of adolescents that achieve health and success by optimizing their care, 
identifying their challenges, and finding resolutions, in addition to recognizing and 





adolescents may have lower opportunities for employment (NSO, Thailand, 2008). 
When interviewing about education, in addition to the open ended non-judgmental 
approach, it is very reasonable to ask specifically about attending school, grades/ 
changes in grades, and the school environment.  
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possibly due to a low prevalence or under detection (Limsuwan, 1983). On the other 
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girls, with small physique, white glowing skin, and big eyes. This has resulted in use of 
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associated with heavy metal intoxication. Skin whiteners, popular among adolescent 
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in motorcycle gangs that race on public streets and highways in the night. These gangs 
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online games (RCOP, 2009). In areas where the internet is easily accessible, some 
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fair looking skin. Herbal coffee is commonly used for dieting.  
• Suicide and mood: Five to eight percent of Thai adolescents have been found to have 
depressive symptoms, and 1.1% have tried to commit suicide (RCOP, 2009). Due to 
culture, Thai adolescents may not be as verbal and may feel pressured to keep their 
feelings inside. Some may find it hard to verbalize their mood and emotions, especially 
negative ones; on the contrary, when asked in an appropriate manner, suicidal ideation 
can be discussed more openly.  
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• Safety: Though there are laws regarding helmet and seatbelt use, these are more 
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percent of Thai adolescents who drive motorcycles do not wear helmets, 14-45% do not 
wear seat belts, 18-32% were in a vehicle in which the driver had consumed alcohol, 
and 13-21% had consumed alcohol and driven a vehicle themselves (RCOP, 2009). 
There are drivers who drive without a driver’s license. Helmets are mostly worn to 
avoid a penalty rather than for one’s safety.  
• Sex: Sex is a very personal and private issue; it is rarely discussed with adolescents, and 
can even be considered impolite. A study found that there are restrictions imposed by 
traditional culture and that sex education is not regarded as parental duty. The 
generation gap and ‘better not bring it up’ were the limitations in providing sex 
education by parents (Sridawruang et al., 2010). The majority of sexual education is 
taught in secondary school, most of it acknowledging the physical changes of puberty, 
sexually transmitted infections, and HIV. The psychosocial events that may occur 
during puberty are not yet widely addressed. Premarital sex is generally not accepted; 
there are double standard attitudes towards premarital sex, where it is acceptable for 
men but unacceptable for women. More adolescents (18%) are having sexual 
intercourse with only 14% using contraception. With lack of knowledge, 
misconceptions, and difficult access to low cost contraception, the teenage pregnancy 
rate has increased from 10% in 2001 to 15% of all pregnancies in 2004 and has become 
an issue for the country. It is considered very shameful for the unmarried adolescent 
girl and family, leading to late detection and complications. These pregnancies result in 
abortion (20-30%), continuation of the pregnancy and keeping the baby (60%), or 
continuation of the pregnancy but leaving the baby at the hospital for adoption (10%) 
(RCOP, 2009). Of those who continue the pregnancy, a majority will marry the baby’s 
father, some will continue to be a single mother, and for others, the grandparents raise 
the baby as a child of their own. Thailand’s HIV prevalence has been stable at 1.4 per 
1000 since 2005; however 11% of the HIV positive cases are adolescents and youth aged 
below 24 years. This group is thought to be the majority of newly infected people each 
year (Joint United Nations Programme on HIV/AIDS [UNAIDS], 2009). When 
interviewing about this topic, the healthcare provider should ask for permission to ask 
some more personal questions. With a health promotion approach, questions about 
physical changes can be addressed first, followed by psychosocial changes including 
sexual identity. Sexual activity and high-risk behaviors should be addressed by asking 
about the adolescent’s friends’ experiences or common themes in the media first, then 
probing further as needed. 
5. Conclusion 
Adolescence is a dynamic stage of life, with so many changes occurring. Adolescents are a 
significant part of any country’s population and much focus and attention on their needs is 
required, as they impact a country’s health, social, economic, and political status. With the 
rapid global changes and advancement in technology, adolescents are often ‘caught between 
tradition and progress’ (United Nations, n.d.). However, among adolescents globally, there 
are more similarities than there are differences, and as healthcare providers, we can increase 
the number of adolescents that achieve health and success by optimizing their care, 
identifying their challenges, and finding resolutions, in addition to recognizing and 
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1. Introduction  
A dramatic increase in Internet use among young people in the past decade (Lenhart, 2009) 
has contributed to a heightened appreciation for the Internet’s potential positive (Lenhart, 
2009; Rideout, 2001; Ybarra & Suman, 2008) and negative impacts (Guan & Subrahmanyam, 
2009; Juvonen & Gross, 2008; Katzer, Fetchenhauer, & Belschak, 2009; Li, 2006; Mitchell, 
Finkelhor, & Wolak, 2001, 2007; Raskauskas & Stoltz, 2007; Slonje & Smith, 2008; Smith et al., 
2008; Wolak, Mitchell, & Finkelhor, 2006; Ybarra, Diener-West, & Leaf, 2007a; Ybarra, Leaf, 
& Diener-West, 2004) on the health and development of youth. Internet harassment and 
bullying victimization have received particular research attention, and are consistently 
found to be associated with psychosocial problems including depressive symptoms, poor 
caregiver-child relationships, social and behavior problems, and substance use (Guan & 
Subrahmanyam, 2009; Juvonen & Gross, 2008; Katzer et al., 2009; Li, 2006; Raskauskas & 
Stoltz, 2007; Slonje & Smith, 2008; Smith et al., 2008; Wolak et al., 2006; Ybarra et al., 2007a). 
Unwanted online sexual solicitation, defined as being asked to talk about sex, provide 
personal sexual information, or do something sexual when the youth does not want to when 
using the Internet, is another area of adolescent health concern. Online sexual solicitation 
has been associated with psychosocial challenges including depressive symptomatology 
(Mitchell et al., 2001, 2007; Ybarra et al., 2004).  
Certainly, the Internet is but one environment in which youth must navigate. Victimization 
has been noted particularly at school, where youth spend a great deal of their time. Studies 
consistently report that victims of school bullying are significantly more likely to experience 
negative health and social consequences than non-bullied youth, including health problems, 
emotional and school adjustment problems, and poorer peer relationships (Due et al., 2005; 
Hawker & Boulton, 2000; Nansel et al., 2004; Sourander, Helstela, Helenius, & Piha, 2000). 
Unwanted sexual experiences in the schools is similarly associated with psychosocial 
problems, including alcohol use (Fineran & Bolen, 2006).  
Many studies have reported relative rates of bullying online and offline (Juvonen & Gross, 
2008; Katzer et al., 2009; Li, 2006; Raskauskas & Stoltz, 2007; Slonje & Smith, 2008; Smith et 
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1. Introduction  
A dramatic increase in Internet use among young people in the past decade (Lenhart, 2009) 
has contributed to a heightened appreciation for the Internet’s potential positive (Lenhart, 
2009; Rideout, 2001; Ybarra & Suman, 2008) and negative impacts (Guan & Subrahmanyam, 
2009; Juvonen & Gross, 2008; Katzer, Fetchenhauer, & Belschak, 2009; Li, 2006; Mitchell, 
Finkelhor, & Wolak, 2001, 2007; Raskauskas & Stoltz, 2007; Slonje & Smith, 2008; Smith et al., 
2008; Wolak, Mitchell, & Finkelhor, 2006; Ybarra, Diener-West, & Leaf, 2007a; Ybarra, Leaf, 
& Diener-West, 2004) on the health and development of youth. Internet harassment and 
bullying victimization have received particular research attention, and are consistently 
found to be associated with psychosocial problems including depressive symptoms, poor 
caregiver-child relationships, social and behavior problems, and substance use (Guan & 
Subrahmanyam, 2009; Juvonen & Gross, 2008; Katzer et al., 2009; Li, 2006; Raskauskas & 
Stoltz, 2007; Slonje & Smith, 2008; Smith et al., 2008; Wolak et al., 2006; Ybarra et al., 2007a). 
Unwanted online sexual solicitation, defined as being asked to talk about sex, provide 
personal sexual information, or do something sexual when the youth does not want to when 
using the Internet, is another area of adolescent health concern. Online sexual solicitation 
has been associated with psychosocial challenges including depressive symptomatology 
(Mitchell et al., 2001, 2007; Ybarra et al., 2004).  
Certainly, the Internet is but one environment in which youth must navigate. Victimization 
has been noted particularly at school, where youth spend a great deal of their time. Studies 
consistently report that victims of school bullying are significantly more likely to experience 
negative health and social consequences than non-bullied youth, including health problems, 
emotional and school adjustment problems, and poorer peer relationships (Due et al., 2005; 
Hawker & Boulton, 2000; Nansel et al., 2004; Sourander, Helstela, Helenius, & Piha, 2000). 
Unwanted sexual experiences in the schools is similarly associated with psychosocial 
problems, including alcohol use (Fineran & Bolen, 2006).  
Many studies have reported relative rates of bullying online and offline (Juvonen & Gross, 
2008; Katzer et al., 2009; Li, 2006; Raskauskas & Stoltz, 2007; Slonje & Smith, 2008; Smith et 





the schools. These studies use varying definitions for online and offline bullying and/or 
focus on regional or convenience samples. Furthermore, rates in non-school environments 
are not reported. Little has been reported in terms of bullying perpetration across 
environments also. Of note, Wang and colleagues (Wang et al., 2009) report that among 6-
10th graders nationally, 8% bully others online, 27% bully others socially, 37% bully verbally, 
and 13% bully others physically while at school.  Online bullying is treated as a different 
type of bullying however; such that, for example, social bullying that occurs online is 
imperfectly measured. Importantly too, data are lacking about how the bullying experience 
may differ online versus offline. No data have been presented to compare relative rates of 
distress for bullying that occurs online versus offline. It also has been posited that a unique 
aspect of online bullying is the potential for anonymity; this assumes that all victims know 
their offline bullies. No research has examined however, whether this is a valid assumption.  
Even less has been reported about unwanted sexual experiences online and offline. Ybarra 
and colleagues (Ybarra, Espelage, & Mitchell, 2007b) report overlaps in victimization for 
harassment and unwanted sexual experiences online; they do not report however, the 
relative rates of unwanted sexual experiences online and offline. To our knowledge, no 
other studies have reported relative rates of online and offline unwanted sexual solicitation 
in the general population of youth.  
To address these gaps in the literature, we report data from the Growing up with Media 
study, a national survey of over 1,000 youth. Findings have implications for public policy 
initiatives as well as school and other community-based intervention efforts. 
2. Methods  
The Growing up with Media study is a longitudinal survey examining the associations 
between exposure to violent media - particularly new media (e.g., the Internet) - and violent 
behavior. Wave 1 data were collected August-September, 2006 with 1,588 youth-caregiver 
pairs; data were collected again November, 2007 - January 10, 2008 [Wave 2, (n=1,206)] and 
August - November, 2008 [Wave 3, (n=1,159)]. The survey protocol was reviewed and 
approved by the Centers for Disease Control and Prevention Institutional Review Board 
(IRB).  
The sample was obtained from the Harris Poll Online (HPOL) opt-in panel (Harris 
Interactive, 2006), which is comparable to random telephone samples of adult populations 
once appropriate sample weights are applied (Berrens, Bohara, Jenkins-Smith, Silva, & 
Weimer, 2003; Berrens, Bohara, Jenkins-Smith, Silva, & Weimer, 2004; Schonlau et al., 
2004; Taylor, Bremer, Overmeyer, Siegel, & Terhanian, 2001). Recruitment was balanced 
on youth age and sex. Participants were recruited through an email contact with 
randomly identified adult HPOL members who had previously indicated a child lived in 
the household.  Adult respondents (one per household) were required to be equally or 
more knowledgeable than other adults in the home about the youth’s media use, and to 
provide consent for their participation and permission for their child’s participation. 
Youth participants were required to be 10-15 years old, read English, live in the household 
at least 50% of the time, have used the Internet in the last 6 months, and provide assent to 
participate in research.  
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On average, adult surveys lasted 5-minutes and youth surveys 21 minutes. Youth received a 
$20 gift certificate and caregivers a $15 check for their participation at Waves 1 and 2; and 
$25 and $20, respectively at Wave 3. The surveys were administered by Harris Interactive. 
2.1 Sample 
Although parallel questions of bullying online and offline were added at Wave 2, it was not 
until Wave 3 that measures of perpetration and distress were added. To fully answer the 
research questions posed, the current analyses are restricted to Wave 3. The baseline survey 
response rate, 26%, was within the expected range of similar online surveys (Cook, Heath, & 
Thompson, 2000; Kaplowitz, Hadlock, & Levine, 2004).  
To maximize data, respondents were invited to take part in the Wave 2 and Wave 3 surveys 
irrespective of their participation at previous Waves. Response rates were 76% and 73% of 
baseline participants at Wave 2 and Wave 3, respectively. Survey participants in subsequent 
Waves were similar to participants in Wave 1 and also to the national population (See table 
1 below). For example, using weighted data, 49% of the sample was male at Wave 3, and 
49% was male at Wave 1. Seventy-three percent identified as White race at Wave 3 and 71% 
at Wave 1. Twenty-five percent lived in a household with an annual income of $35,000 or 
less at Wave 3 versus 26% at Wave 1.  
 








% (n) % (n) % (n) 
Sex 
Female 51.0 (785) 50.3 (589) 50.8 (568) 
Male 49.0 (792) 49.7 (600) 49.2 (581) 
Age (mean) 12.6 13.7 14.5 
Race 
White 71.3 (1155) 73.9 (900) 72.5 (855) 
Black or African American 13.6 (213) 12.5 (140) 13.6 (145) 
Mixed racial background 8.6 (113) 7.5 (80) 8.2 (84) 
All other 6.5 (96) 6.1 (69) 5.7 (65) 
Hispanic ethnicity 18.1 (206) 16.7 (144) 16.6 (137) 
Annual household income 
<$35,000 25.7 (399) 24.3 (251) 24.8 (241) 
$35,000 - $74,999 39.7 (685) 40.1 (525) 38.6 (490) 
$75,000+ 34.6 (493) 35.6 (413) 36.7 (418) 
Table 1. A comparison of demographic charactaeristics of respondents across waves 
2.2 Measures 
Respondents were asked about bullying victimization as well as perpetration using Olweus’ 
definition of bullying (Olweus, 1994): “We say a young person is being bullied or harassed 
when someone else or a group of people repeatedly hits, kicks, threatens, or says nasty or 
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Table 1. A comparison of demographic charactaeristics of respondents across waves 
2.2 Measures 
Respondents were asked about bullying victimization as well as perpetration using Olweus’ 
definition of bullying (Olweus, 1994): “We say a young person is being bullied or harassed 
when someone else or a group of people repeatedly hits, kicks, threatens, or says nasty or 





can happen at school, online, or other places young people hang out. It is not bullying when 
two young people of about the same strength fight or tease each other. How often has this 
happened to you in the following environments?):   1) at school, 2) on the Internet, 3) on cell 
phones through text messaging, 4) on the way to and from school, and 5) somewhere else. 
For each environment, response options were: every day / almost every day; once or twice a 
week; once or twice a month; less often than once a month; never; and decline to answer.  
Youth who reported bullying victimization in at least one environment were asked two 
follow up questions. First, these youth were asked to indicate how they felt when they were 
bullied in each environment, when thinking about the most serious incident. Responses 
were captured on a 5-point scale: not at all upset; somewhat upset; upset; very upset; 
extremely upset; and decline to answer. Second, youth were asked whether they knew their 
bully: "By "know" we mean you can recognize the person or you know who they are". 
Response options were: yes, no, not sure, and decline to answer. 
Unwanted sexual experiences also were measured using parallel items for experiences when 
online, and experiences when at school. Note that other environments, including on the way 
to and from school, and ‘somewhere else’ were not queried. Text messaging-based 
experiences were queried, but using different measures and therefore are not included in the 
current analyses. Items were based upon those included in and referred to as “unwanted 
sexual solicitation” in the Youth Internet Safety Surveys (Finkelhor, Mitchell, & Wolak, 2000; 
Wolak et al., 2006). We choose to call these experiences “unwanted sexual experiences” to 
avoid connotation that these youth were necessarily solicited for sex. Youth endorsing at 
least one of the following questions were classified as having an unwanted sexual 
experience: 1) Someone tried to get me to talk about sex when I did not want to; 2) Someone 
asked me for sexual information about myself when I did not want to tell the person, e.g., 
really personal questions, like what my body looks like or sexual things I have done; 3) 
Someone asked me to do something sexual that I did not want to do. Response options 
were: everyday/almost every day; once or twice a week; once or twice a month; a few times 
a year; less than a few times a year; never; and decline to answer. Perpetration was asked 
solely for the online environment. Similarly, distress was only queried for youth reporting 
victimization online. Given that the focus of the current paper is comparisons across 
environments, these data are not reported. 
2.3 Data cleaning and statistical analyses 
Data cleaning indicated that 18 youth were likely 9 years of age, and 12 youth were 16 years 
of age at Wave 1. To maximize the amount of data; and because caregivers did not know the 
eligibility criteria (and, therefore, were unlikely to have misreported their child's age 
purposefully), these youth are included in the analyses.  
Data were weighted statistically to reflect the population of adults with children aged 10-15 
years old in the U.S. in 2006 (when the sample was first recruited) according to adult age, sex, 
race/ethnicity, region, education, household income, and child age and sex.(Bureau of Labor 
Statistics & Bureau of the Census, 2006) Adults were the weighting target as they were the 
ones first recruited into the survey. Survey sampling weights also adjust for adult respondents’ 
self-selection into the HPOL (Berrens et al., 2003; Berrens et al., 2004; Schonlau et al., 2004; 
Taylor et al., 2001)  as well as any differential follow-up of youth participants over time. 
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Missing data and “refused” responses were imputed using best-set regression (StataCorp, 
2008). To reduce the likelihood of imputing truly non-responsive answers, participants were 
required to have valid data for at least 85% of the survey questions asked of all youth. 
Eleven respondents did not meet this criterion and were dropped from the Wave 1 sample; 
17 were dropped from the Wave 2 and 10 from the Wave 3 samples.  
Statistical comparisons across environments cannot be made because categories are not 
exclusive; youth can be represented in multiple categories.  
3. Results 
3.1 One-year prevalence rates across environments 





















Every day / almost every 
day 1.3 (15) 0.3 (4) 0.4 (1) 0.9 (3) 0.3 (3) 
Once or twice a week 4.0 (43) 0.3 (5) 0.5 (6) 1.7 (16) 1.5 (13) 
Once or twice a month 3.2 (46) 1.9 (22) 1.7 (13) 1.1 (15) 1.9 (22) 
Less often 22.1 (254) 12.3 (150) 9.5 (73) 7.8 (88) 10.8 (114) 
Never 69.4 (791) 85.3 (968) 88.2 (713) 89.2 (1027) 85.6 (997) 
a Restricted to youth who sent and received text messages at least once in the past year (70%, n=806) 
Table 2. A comparison of 1-year bullying victimization rates across environments 
Overall, 40% of youth reported some bully victimization in the past year. Rates across 
environments are shown in Table 2. An examination of the school-online overlap suggests 
that most of these youth were bullied at school exclusively: 59% were bullied only at school; 
13% were bullied only online; and 28% were bullied both at school and online 




















Every day / almost every 
day 0.3 (5) 0.06 (2) 0.3 (2) 0.03 (1) 0.4 (3) 
Once or twice a week 1.3 (13) 0.6 (7) 0.9 (6) 0.9 (8) 1.2 (11) 
Once or twice a month 1.7 (22) 0.8 (15) 1.0 (11) 0.3 (8) 1.2 (15) 
Less often 10.4 (107) 4.7 (47) 3.4 (25) 3.0 (34) 3.4 (44) 
Never 86.4 (1002) 93.7 (1078) 94.3 (762) 95.8 (1098) 93.8 (1076) 
a Restricted to youth who sent and received text messages at least once in the past year (70%, n=806) 
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Eighteen percent of youth reported being bullies in the past year. Table 3 shows bullying 
rates by environment. The school-online overlap was similar to that noted for victims: 
among youth who bullied in either place, 59% bullied only at school, 10% bullied only 
online, and 31% bullied both online and at school. 
# of different environments youth 
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Fig. 1. Overlap of bullying experiences across environments 
As shown in the Figure, the majority of youth were not victims (60%) or perpetrators (82%) 
of bullying in any environment. For those who were involved in bullying, the most common 
experience was victimization (20%) or perpetration (9%) in one environment. Fewer 
reported being victimized (9%) or perpetrating (4%) across two environments. Very few 
reported being bullied or bullying others in four or all five of the environments queried. 








Every day / almost every day 0.2 (5) 0.4 (7) 
Once or twice a week 1.7 (14) 1.3 (9) 
Once or twice a month 2.1 (17) 2.9 (29) 
Less often 13.7 (169) 13.0 (154) 
Never 82.3 (944) 82.4 (950) 
Table 4. 1-year unwanted sexual experiences victimization rates across environments  
Comparisons of Bully and Unwanted Sexual  
Experiences Online and Offline Among a National Sample of Youth 
 
209 
Almost one in four youth (25%) reported being victims of unwanted sexual experiences in 
the past year. As show in Table 4, 18% of youth reported unwanted sexual experiences at 
school, and 18% online. Among victims, 29% reported being victimized at school only, 29% 
online only, and 42% both at school and online. 
3.2 The bully victimization “experience” across environments 
3.2.1 Distress 
Youth who reported being bullied were asked to indicate how they felt about the most 
serious incident in each environment they were bullied. As shown in Table 5, more youth 
reported being upset by their most serious bullying incident at school (37.5%) than any 
other environment.  
 
Environment Very / extremely 
upset by the most 
serious incident 
Not sure / Do 
not "know" the 
bully 
 % (n) % (n) 
School (n=358) 37.5 (128) 12.0 (44) 
Internet  (n=181) 15.4 (34) 45.8 (84) 
Cell phone text messaging (n=95) 32.9 (28) 29.0 (23) 
On the way to and from school 
(n=122) 
38.8 (46) 22.4 (25) 
Somewhere else (n=152) 36.7 (56) 27.2 (46) 
Table 5. The bully victimization expereince: Victim distress and knowing one’s perpetrator 
(n=1,149) 
3.2.2 Knowing one’s perpetrator 
When asked to indicate if they “knew” the bully (i.e., the respondent could recognize the 
bully or knew who they were), almost half (46%) of youth bullied online said they were not 
sure or did not know who the bully was (see Table 5). About one in four youth said they 
were unsure or did not know their bully via text messaging (29%) and one in three said they 
were unsure or did not know their bully on the way to and from school (22%). Slightly more 
than one in ten youth bullied at school (12%) said they did not know or were unsure about 
the bully’s identity. 
4. Discussion  
Based upon data from 12-17 year-olds surveyed nationally, involvement in bullying and 
unwanted sexual experiences appears common: 40% report being bullied, 18% report 
bullying, and 25% report being victims of unwanted sexual experiences in at least one 
environment that they navigate. Although it is difficult to compare these data with previous 
studies that have focused more specifically on experiences occurring either at school or 
online, it is fair to say that our findings provide further evidence that involvement in youth 
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Fig. 1. Overlap of bullying experiences across environments 
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4.1 School bullying is more common than online bullying 
Bullying is reported more frequently at school than online: 31% of youth report being 
bullied at school compared to 15% online; bully perpetration is reported by 14% of youth at 
school compared to 6% who bully others online. Moreover, an examination of the school-
online overlap suggests that most youth are bullied or bully at school exclusively. Youth 
spend more hours in close immediate proximity with peers at school then they do at home 
or in their neighborhoods in the evening. Interactions in school are inherently social and the 
opportunities for conflict are plentiful (e.g., hallways, lunch, recess). It is not clear that 
online environments provide the same amount of time to bully others. Also too, school 
bullying is often perpetrated by individuals and groups of individuals with an audience 
present (O'Connell, Pepler, & Craig, 1999; Salmivalli, Lagerspetz, Björkqvist, Österman, & 
Kaukiainen, 1996) in order to promote the bully’s popularity or maintain his or her high 
social status. The audience reinforces the behavior, thereby increasing the likelihood that it 
will continue. Although there is an audience online (e.g., Facebook), it is not clear what role 
this audience plays or how strongly their reinforcement is as it is being mediated through a 
computer screen. Perhaps part of the reason rates are higher at school is because the social 
reinforcement is stronger there.  
4.2 School bullying is more distressing than online bullying 
Online bullying may be different or more distressing than offline bullying because of the 
ability to hide one’s identity, and the rapidity and breadth with which the information is 
disseminated. Our data do not support this hypothesis, however. Twice as many youth 
bullied at school (38%) indicate that they feel very or extremely upset by the most serious 
incident compared to youth bullied online (15%). Moreover, while many more youth (46%) 
report not knowing their bully online compared to school, 12% report they do not know 
their bully at school. It seems that the differential power inherent in keeping one’s identity 
secret is more commonly utilized online, but it is possible offline as well (e.g., rumors spread 
around school).  
4.3 Bullying happens other places as well 
Importantly, 11% of youth report being bullied on the way to and from school, and 14% 
“somewhere else”; 4% and 6% report bullying perpetration in these respective 
environments. This serves as a useful reminder that the online/offline discussion does not 
implicitly mean online/school. Young people have to safely navigate a multitude of 
environments each day. Our challenge as researchers is to understand how the experiences 
of youth are similar and different by environment so that our public policy initiatives and 
interventions can be general when appropriate and environment-specific when need be. 
4.4 Few youth have a never-ending bullying experience 
Another concern some have is that technology has created a world in which victims cannot 
hide from bullies. This may be the case for some youth, but it does not appear to be the 
common experience. Most youth are not involved in bullying at all. Among victimized 
youth, the most common victimization experience is being victimized in one versus multiple 
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environments, with school being the one environment most often reported. This suggests 
that for the majority of youth who are involved in bullying, it is not necessarily something 
that follows them from the time they wake to the tiime they go to sleep. Nonetheless, there 
is a very concerning 5% of youth who report being bullied and 2% who report bullying 
others in four or all five of the environments we queried. Certainly, for these youth, bullying 
is an experience that likely seems inescapable. Given that they are bullied in multiple 
environments, this may mean that there are more opportunities to reach them with support 
and other intervention efforts.  It is essential to take steps to identify and target this group of 
kids.   
4.5 Unwanted sexual experiences happen at school and online with equal frequency 
Certainly, unwanted sexual encounters happening online have received the majority of 
academic research attention (Mitchell et al., 2001, 2007; Ybarra et al., 2004). A study 
conducted in 2000 among 2064 8-12th graders attending public school (American Association 
of University Women Educational Foundation, 2001) suggests that eight in ten students 
experience sexual harassment at school sometime in their lives. Rates of unwanted sexual 
experiences in the past year in the current study are the same at school (18%) and online 
(18%). Efforts to recognize and reduce unwanted sexual experiences in the schools need to 
receive just as much attention as those focused online.  
While with good intention, recent public policy efforts to regulate social networking sites 
to reduce the risk of unwanted sexual encounters for adolescents (Berkman Center for 
Internet & Society at Harvard University, 2008) may not reach youth who are most 
vulnerable. Unlike bullying, youth who are victims of unwanted sexual experiences are 
more likely to report being targeted both online and at school (42%) compared to youth 
targeted at school only (29%) or online only (29%). Future research should focus on these 
dually-involved youth to better understand who they are and what researchers and other 
professionals working with adolescents might do to reduce their vulnerability online as 
well as offline.  
4.6 Study limitations and strengths 
This paper is the first to report rates of bullying involvement and unwanted sexual 
experiences online and offline, in school and out of school, using parallel measures among 
youth in a national US sample. It also is the first to report relative rates of distress and the 
frequency of “knowing” the perpetrator among bully victims. It is not however, without 
limitation. The measures for unwanted sexual experiences are less comprehensive than 
those for bullying. It is possible that the general prevalence rate for unwanted sexual 
experiences would be higher if other environments (e.g., cell phone text messaging) were 
queried. It also is possible that caregivers monitored their children while they were 
completing the survey. This may have led to under-reporting, although comparisons across 
environments should still hold as there is little reason to believe youth would be more 
willing to report bullying at school versus online, for example. The sample is based upon 
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4.7 Future research implications 
Environments were queried with the assumption that they were distinct. With the 
convergence of technology, it is possible now for youth to be bullied on their Facebook 
profiles, which they could access on their web-capable cell phones during a break at school. 
In this scenario, youth could potentially click on all three ‘environments’. Future research 
should focus on the conundrum of whether, and if so, how to disentangle these converging 
environments. This would improve our ability to compare prevalence rates of bullying 
across the environments in which young people live in order to better target scarce 
prevention dollars more effectively. It may be however that the “online” “offline” lines have 
so blurred that the question will quickly become ‘have you been bullied’, without respect to 
‘where’. The future challenge for researchers will be to determine when technology is an 
important characteristic to measure and when it is not. 
4.8 ‘Real world’ implications 
With youth more likely to be involved in bullying as a victim or perpetrator at school versus 
online, programs need to continue to prevent and intervene on bullying behavior within 
schools. Certainly, schools are appropriately working to create protocols that address cyber-
aggression and harassment. These prevention efforts should not replace programs that 
address face-to-face bullying, however; instead, they should be viewed as adjuncts to 
existing programming. Bullying experiences online could be incorporated into bully 
prevention programs by simply defining bullying online as bullying which is 
communicated through the online context.  
The relative frequency of sexual harassment both at school and online speaks to the need for 
prevention programs at the school level. In contrast to the vigilance paid to bullying, sexual 
harassment is not a commonly discussed adolescent behavior. As noted above, this needs to 
change.  
5. Conclusion  
Data from 12-17 year olds nationally suggest that youth are more likely to be involved in 
bullying at school compared to online, on the way to and from school, and all other 
environments youth must navigate each day. They are as likely to be a victim of unwanted 
sexual experiences at school as online. Among bullied youth, 38% were very or extremely 
upset by their most serious bullying experience at school compared to 15% online. These 
data do not support a hypothesis that the Internet is introducing a more dangerous 
environment for youth, nor do they support the supposition that online victimization 
experiences are more distressing overall.  
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1. Introduction 
Misuse of alcohol has become a pediatric health care issue during the last decade. In clinical 
practice, patients are first treated in an acute care setting. After sobering up, follow-up 
treatment starts in an outpatient department. To cope with the increasing numbers of 
underage patients with alcohol intoxication, special programs have been developed to 
improve follow-up treatment of these patients. The focus has shifted towards underlying 
neuropsychological and social problems. The main goals of the program are behavioral 
changes and prevention of new events. 
The physiology of alcohol metabolism is clear, however in children and adolescents 
definitions of binge-drinking, problematic alcohol use and alcohol abuse are overlapping. 
Research is being done on epidemiology, risk factors and consequences that should be 
cleared up further. In particular, concerns about brain damage in young adolescents are a 
topic of interest. 
Besides medical attention being paid to this new patient group, policymakers should 
increase awareness of the dangers of alcohol use. National and international policies differ 
substantially in legal drinking age and location of purchase. Media attention and marketing 
also have a huge influence on the drinking behavior of adolescents.  
This chapter deals with the following subjects: 
- Physiology 
- Epidemiology  
- Risk factors 
- Consequences  
- Acute care 
- Hospital admittance 
- Intervention / follow up 
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Ethanol is absorbed in the stomach or small bowel. Approximately 25% is absorbed directly 
from the stomach into the bloodstream; the remainder is absorbed by the small bowel. 
Ethanol cannot be stored; 90% up to 98% of it is broken down in the liver by oxidation. The 
other 2% to10% is removed directly via urine, breathed out through the lungs or excreted in 
sweat. Ethanol reaches its peak-blood-concentration within one hour, particularly when 
ingested on an empty stomach.  
Oxidation of ethanol takes place in two ways. Most of it is done by enzymes known as 
alcohol dehydrogenase (ADH), which produces acetaldehyde, and aldehyde dehydrogenase 
(ALDH), which transforms acetaldehyde into acetate, a non-toxic metabolite. In this process, 
hydrogen is transferred from nicotinamide adenine dinucleotide (NAD+) to become NADH 
(figure 1). Acetate is further metabolized through the citric-acid cycle and leaves the body as 
carbon dioxide and water. A small amount is processed via an alternative pathway, known 
as the ‘microsomal ethanol-oxidizing system’, using cytochrome P-450. In young people, 
this system is hardly used, as it is mainly activated in regular drinkers or when the level of 
alcohol is very high (1). 
 
Fig. 1. Oxidation of Ethanol 
Different subtypes of ALDH exist within the human body. Mitochondrial ALDH-2 has the 
biggest affinity with alcohol. About 50 per cent of East-Asian people have a genetic variation 
which causes their ALDH enzyme not to work very well, resulting in accumulation of toxic 
acetaldehyde. 
The kinetics of alcohol has several metabolic consequences. Due to a changed NAD+/NADH 
ratio, which inhibits gluconeogenesis, the glucose metabolism can be affected. If existing 
glycogen deposits have been used, this might lead to hypoglycaemia. Young persons with low 
glycogen levels are particularly at risk. In other situations alcohol may favor, rather than 
inhibit, gluconeogenesis and may therefore cause hyperglycaemia (2). 
In oxidation, several acid metabolites are being formed, such as lactate and hydroxyacid, 
which causes metabolic acidosis. In metabolic acidosis, renal potassium loss can cause 
hypokalaemia, which could be increased by vomiting. These metabolic alterations also favor 
liver damage. In practice, hypoglycaemia rarely occurs and acidosis is often mild (2) (see 
also Acute Care chapter). 
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Symptoms of alcohol intoxication usually appear at a blood alcohol concentration of 20-50 
mg/dl (0.2-0.5%) (Table 3). However, interpersonal variability can be observed. Children 
have a smaller extracellular volume and could therefore experience symptoms at a lower 
blood concentration. Symptoms of alcohol use will be further discussed below. 
3. Epidemiology 
Of all the substances, alcohol is –by far- the most popular product. Almost all secondary 
school students try out alcoholic beverages at least once before they leave school between 
the age of 16 and 18. The percentage of students who abstain in their secondary school 
period is constant at around 10% (ref). Between 50% and 60% of all students consume 
alcohol every month.  
Over the past years, this percentage has been rather stable. Since 2003, the youngest students 
(12 – 14 years) show an increase in lifetime prevalence of alcohol use and previous month 
alcohol use, especially among girls. Girls also seem to become an increasing cause of 
concern on other scales. Since 2003, young girls (<15 years) engage in binge drinking more 
often and have the same frequency of drunkenness as young boys (3;4). 
Monitoring alcohol related hospital admissions in the Netherlands is part of the Dutch 
Pediatric Surveillance System (NSCK). This unique and effective signaling system collects 
information on several predetermined diseases, disorders or symptoms in Dutch general and 
academic hospitals. Nearly all the Dutch pediatricians participate (92%). Adolescent alcohol 
use was included in 2007, and ever since it has been one of the leading topics of the system.  
When a patient under the age of 18 is admitted because of alcohol related problems, the 
pediatrician in charge reports the case. Questionnaires are distributed to the pediatricians by 
mail or they can download them from the website. The questionnaire consists of four parts, 
exploring (1) previous alcohol use circumstances and hospital treatment, (2) patient 
characteristics, (3) alcohol use patterns, and (4) control variables.  
4. Questionnaire content 
4.1 Intoxication and characteristics of hospital treatment 
Time frame of intoxication (morning [6 a.m.–noon], afternoon [noon–6 p.m.], evening [6 
p.m.–midnight], night [midnight–6 a.m.]), reason for hospitalization (traffic accident, other 
accident, aggression/violence, suicide attempt, reduced consciousness—if yes, period of 
unconsciousness in hours), blood alcohol concentration (BAC, grams of alcohol per liter 
blood), type of alcohol consumed (beer, wine, distilled spirits, premixed drinks, post mixed 
drinks [home-mixed or commercially mixed drinks], other), alcohol-obtaining practice (at 
home, from friends, supermarket, liquor store, hotel and catering industry, other), alcohol-
consuming location (parents’ home, adolescents’ own home, friends’ home, on the street, 
work place, at [a] school [party], public place [sports bar/canteen], commercial place [hotel 
and catering industry/bar/pub/discotheque], holiday, other), alcohol-consuming company 
(nobody, friends, parents, other relatives, strangers, other), and other (illicit) substances 
used (none, cannabis, cocaine, amphetamines / speed, magic mushrooms, Ecstasy, other). If 
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(adolescents’ own acknowledgment, other testimony, judgment of the pediatric doctor, 
laboratory values/urine, other), total time of hospitalization (days), hospital intensive care 
use (days), intravenous fluids (yes/no), and hospitalization aftercare (patient forwarded to 
any medical or aid agency). 
4.2 General and demographic information about the adolescent 
Patient code (control variable consisting of initials of the adolescent, confidential), date of 
birth (dd-mm-yy), gender, living area (first two numbers of postal code), daily occupation 
(educational level, work), school performance (normal, repeating of a class, dropout), family 
situation (traditional, foster parents, living alone), siblings (none, brother[s], sister[s], both), 
position to siblings (oldest, middle, youngest), cultural background (Dutch, Moroccan, 
Turkish, Surinamese, Antillean, other), religious background (none, Roman Catholic, 
Protestant Christian, Jewish, Muslim, Hindu, Buddhist, other), and adolescent registration 
to medical or aid agencies (none, pediatrician, psychologist, other professional, mental 
health care institution, The Netherlands Youth Institute, other). 
4.3 Patterns of alcohol use and other substance use  
Alcohol use in previous months (average number of units per week day [Monday–
Thursday] and average number of units per weekend day [Friday–Sunday]), regular 
drinking places (parents’ home, adolescents’ own home, friends’ home, on the street, work 
place, at [a] school [party], public place [sports bar/canteen], commercial place [hotel and 
catering industry/bar/pub/discotheque], holiday, other), regular (illicit) substance use 
(none, cannabis, cocaine, amphetamines/speed, magic mushrooms, Ecstasy [3,4-
methylenedioxymethamphetamine, or MDMA], other), regular tobacco use (no, yes; if 
possible, estimated number of cigarettes per week), prescribed medication use (no, yes; if 
yes, what type of medication/name], and parental knowledge of alcohol use (parents know 
exactly, parents know approximately, parents believe their adolescent child consumes more 
or less), age of first alcoholic drink.  
4.4 Control variables  
Date of the intoxication, the date of filling in the questionnaire, pediatrician code number, 
and the hospital involved. 
5. 2007 – 2010 Results 
Over the years, the number of adolescents treated with alcohol intoxication increased, as 
also depicted in Table 1. 
 
 2007 2008 2009 2010 
Adolescents treated 297 337 500 684 
Increase previous year  13% 48% 37% 
Usable questionnaires (response) 231 288 440 566 
Table 1. Number of hospitalized adolescents due to alcohol intoxication in Dutch hospitals 
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The actual number of adolescents suffering from alcohol intoxication must be higher due to 
the following considerations: 
- not all hospitals participated in the data collection procedure;  
- not all underage adolescents in hospitals see a pediatrician (instead, they are treated by 
an emergency doctor or other specialist)  
- not all alcohol-related incidents might be diagnosed as alcohol related; and 
- not all the adolescents with an alcohol-related injury or intoxication visit a hospital. 
5.1 Demographic information 
Boys and girls are admitted with alcohol intoxication in about the same percentages (52% 
male vs. 48% female). However, boys generally have a higher level of blood alcohol 
concentration (1.87 vs. 1.69 g/L). Intoxicated girls are younger (15.3 vs. 15.7 years) and are 
hospitalized for shorter periods than boys. Ages range from 11 years up to 17 years, with an 
average of 15.7 years. 
The educational levels of youngsters with alcohol misuse seem to be similar to national 
statistics. Repeating a study year is not seen more frequently in adolescents with alcohol 
intoxication. In the Dutch multicultural society, the family structures and cultural and 
religious backgrounds in this group of patients also correspond with national statistics. The 
youngest child in the family is more frequently admitted with alcohol abuse (44% youngest 
child vs. 32% oldest child), children without siblings are relatively uncommon (7% of 
hospitalized patients have no siblings). These numbers show that adolescent alcohol 
intoxication occurs in all levels of society, making this pediatric health care issue a difficult 
but most important subject to deal with. 
5.2 Intoxication characteristics and alcohol use patterns 
On average, the adolescents admitted to hospital had a blood alcohol concentration of 
around 1.80 g/L. Depending on age, body weight, gender, tolerance and drug use, this 
represents an alcohol consumption of about 15 units.  
 
 2007 2008 2009 2010 
Average BAC* 1.8 1.9 1.8 1.8 
Average reduced consciousness (hours) 2.2 2.9 3.1 3.1 
Maximum reduced consciousness (hours) 16 24 22 48 
* Blood Alcohol Concentration (grams of alcohol / liter blood) 
Table 2. Intoxication characteristics 
On average, reduced consciousness lasted for two to three hours (also known as alcohol 
coma). In 2010, one youngster stayed in a coma for 48 hours.  
Questionnaires on the pattern of alcohol use demonstrate that more alcohol is consumed 
during weekends (0-15 units a day in the weekend, vs. 0-5 units on a week day). For 30% of 
the patients, the alcohol consumption is their first time; the other 70% do have experience in 
consuming alcoholic beverages. Most often they consumed beer (59%), followed by distilled 
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 2007 2008 2009 2010 
Adolescents treated 297 337 500 684 
Increase previous year  13% 48% 37% 
Usable questionnaires (response) 231 288 440 566 
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A New Approach in Adolescent Alcohol Intoxication –  
Clinical Pediatric Experience and Research Combined 
 
221 
The actual number of adolescents suffering from alcohol intoxication must be higher due to 
the following considerations: 
- not all hospitals participated in the data collection procedure;  
- not all underage adolescents in hospitals see a pediatrician (instead, they are treated by 
an emergency doctor or other specialist)  
- not all alcohol-related incidents might be diagnosed as alcohol related; and 
- not all the adolescents with an alcohol-related injury or intoxication visit a hospital. 
5.1 Demographic information 
Boys and girls are admitted with alcohol intoxication in about the same percentages (52% 
male vs. 48% female). However, boys generally have a higher level of blood alcohol 
concentration (1.87 vs. 1.69 g/L). Intoxicated girls are younger (15.3 vs. 15.7 years) and are 
hospitalized for shorter periods than boys. Ages range from 11 years up to 17 years, with an 
average of 15.7 years. 
The educational levels of youngsters with alcohol misuse seem to be similar to national 
statistics. Repeating a study year is not seen more frequently in adolescents with alcohol 
intoxication. In the Dutch multicultural society, the family structures and cultural and 
religious backgrounds in this group of patients also correspond with national statistics. The 
youngest child in the family is more frequently admitted with alcohol abuse (44% youngest 
child vs. 32% oldest child), children without siblings are relatively uncommon (7% of 
hospitalized patients have no siblings). These numbers show that adolescent alcohol 
intoxication occurs in all levels of society, making this pediatric health care issue a difficult 
but most important subject to deal with. 
5.2 Intoxication characteristics and alcohol use patterns 
On average, the adolescents admitted to hospital had a blood alcohol concentration of 
around 1.80 g/L. Depending on age, body weight, gender, tolerance and drug use, this 
represents an alcohol consumption of about 15 units.  
 
 2007 2008 2009 2010 
Average BAC* 1.8 1.9 1.8 1.8 
Average reduced consciousness (hours) 2.2 2.9 3.1 3.1 
Maximum reduced consciousness (hours) 16 24 22 48 
* Blood Alcohol Concentration (grams of alcohol / liter blood) 
Table 2. Intoxication characteristics 
On average, reduced consciousness lasted for two to three hours (also known as alcohol 
coma). In 2010, one youngster stayed in a coma for 48 hours.  
Questionnaires on the pattern of alcohol use demonstrate that more alcohol is consumed 
during weekends (0-15 units a day in the weekend, vs. 0-5 units on a week day). For 30% of 
the patients, the alcohol consumption is their first time; the other 70% do have experience in 
consuming alcoholic beverages. Most often they consumed beer (59%), followed by distilled 





strikingly, 35% of the adolescents treated with alcohol intoxication have been served alcohol in 
the catering industry (as well). Adolescents report that their parents ‘know to some extent ’ or 
even ‘know exactly’ how much alcohol they drink.  
6. Risk factors 
General risk factors for alcohol abuse are plenty. Individual, social, physiological and 
genetic factors influence alcohol use. Not all of these factors have the same level of 
importance, and some risk factors are still to be identified, as adolescents admitted with 
alcohol intoxication are a fairly new patient group. Also, risk seeking behavior overlaps with 
alcohol use. The different definitions of alcohol use, alcohol intoxication, problematic 
alcohol consumption etc., most likely lead to different outcomes in research and they should 
perhaps be looked at as different entities. However, known risk factors should be taken into 
account in individuals presenting with alcohol intoxication and are therefore discussed here. 
A physiological process that could contribute to alcohol intoxication in adolescence is 
decreased sensitivity to most consequences of ethanol, which may lead to relatively high 
levels of alcohol consumption. For example, children do not have an explicitly stumbling 
walk when intoxicated. Possibly, sensitivity of cerebellar receptors is not yet fully 
developed. At the same time, adolescents seem to be more sensitive to other symptoms of 
alcohol use such as the social facilitation which occurs at low doses of alcohol (5;6).  
Among adolescents admitted with alcohol intoxication, boys have a higher ethanol 
concentration than girls (7). Gender distribution is equal in the population, and duration of 
unconsciousness is equal between boys and girls. This shows that boys drink more, but it 
also suggests that girls become intoxicated at lower blood alcohol levels than boys (8). Girls 
probably are more sensitive to the toxic, suppressive effects of alcohol on the central 
nervous system. 
The role of the socio-economic position in alcohol use is not completely clear. Negative 
health behavior is often confined to lower income families. More strikingly, it is one of the 
main factors by which socioeconomic health differences arise (9). Alcohol-related mortality 
is higher in lower socio-economic classes, mainly among middle-aged men (10). The 
educational level of the parent is associated with alcohol consumption. Highly educated 
mothers are correlated with less alcohol consumption (11). At the same time, unskilled 
occupational level of the father is positively correlated with the amount of alcohol 
consumed. Other reports conclude that children from families with higher incomes drink 
more frequently and they more often drink without supervision (12). Material factors such 
as financial worries and material scarcity can also reduce adolescent alcohol consumption 
(9). Lower intelligence scores, familial alcohol problems, peer influence and parental 
attachment can be possible confounders. 
Students at pre-vocational secondary education or pre-university secondary education all 
drink from an early age. It appears that patients with alcohol intoxication on the pre-
vocational level are younger and drink less. Higher educational level it is an independent 
risk factor for higher BAC at admittance.  
Parental knowledge of alcohol use and parental rules influence alcohol use amongst 
adolescents (13). These aspects are striking in clinical practice, with examples of parents 
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offering alcohol to their underage children. Parents who set strict alcohol-specific rules early 
on delay the age of onset and reduce the frequency and quantity of adolescent alcohol 
consumption (14) (Koning). A strict attitude of parents towards alcohol diminishes 
adolescents’ involvement in alcohol use. To positively influence problematic alcohol use in 
their children, parental attitude should be addressed in the treatment of these patients.  
Parental attachment can be another factor of interest in parental involvement. It has been 
described that poor parental attachment is related to an earlier onset of drinking. The 
inverse explanation can be that the younger the adolescent starts using alcohol, the less 
strong the attachment with the parents is (13). The influence of the relation between parent 
and adolescent needs to be clarified further.   
A family history of alcohol use is associated with more alcohol consumption in adolescents; 
and with even higher transmission between parents and adolescents of the same gender 
(15). Alcoholism of the parents is associated with heavy drinking and binge drinking 
patterns during adolescence (16). The explanation of these tendencies can be found in the 
direct exposure to alcohol, as well as in assimilating certain standards and beliefs on alcohol 
use. Adolescents tend to imitate role models. On the other hand, a positive family history 
has been found to lead to a relatively lower sensitivity to alcohol.  
Students living with peers during their college years drink more alcohol (17). Peer influence 
is a risk factor in many risk-seeking attitudes, such as smoking, substance abuse and sexual 
risk behavior. Children are particularly prone to the influence of peers during adolescence. 
Also, underage drinkers can gain access to alcohol through peers by having older friends 
who work in a store.  
Alcohol use is related to substance use. Cannabis in particular is common, but 
amphetamines are used as well, as are ecstasy, happy mushrooms and cocaine. Co-
occurrence is common and therefore patients admitted with alcohol intoxication should 
always be screened for substance abuse (18).  
Cultural influences are connected to local politics, either nationally- or statewide. 
Determining legal drinking age has a strong influence on the availability of alcohol for 
adolescents (19;20). However, this seems to be just one of several factors to be considered. A 
prosperous society and a change in the available types of drinks are likely to have an effect 
on alcohol consumption. An increase in drinking among youngsters has been observed in 
the past decade (21). For Dutch adolescents purchasing alcohol is one of the leading  
expenses (22-24).  
The relationship between alcohol or substance abuse and psychiatric disorders such as 
ADHD is described as a consequence as well as a cause (25;26). Symptoms like physical 
aggression, conduct disorders and violence as well as hyperactivity and oppositional 
behaviors at a young age appear to be risk factors for alcohol use in later life (27). In 
particular, higher quantities of alcohol consumption have been associated with a lack of 
restraint (disinhibition) (28;29). The interpretation of these associations can be causal and 
consequential and are interesting subjects of research still to be carried out. Depression and 
anxiety disorders in relation to alcohol use are mainly studies in adult populations (and not 
in adolescents or children). However, depression occurs more frequently in patients with 





strikingly, 35% of the adolescents treated with alcohol intoxication have been served alcohol in 
the catering industry (as well). Adolescents report that their parents ‘know to some extent ’ or 
even ‘know exactly’ how much alcohol they drink.  
6. Risk factors 
General risk factors for alcohol abuse are plenty. Individual, social, physiological and 
genetic factors influence alcohol use. Not all of these factors have the same level of 
importance, and some risk factors are still to be identified, as adolescents admitted with 
alcohol intoxication are a fairly new patient group. Also, risk seeking behavior overlaps with 
alcohol use. The different definitions of alcohol use, alcohol intoxication, problematic 
alcohol consumption etc., most likely lead to different outcomes in research and they should 
perhaps be looked at as different entities. However, known risk factors should be taken into 
account in individuals presenting with alcohol intoxication and are therefore discussed here. 
A physiological process that could contribute to alcohol intoxication in adolescence is 
decreased sensitivity to most consequences of ethanol, which may lead to relatively high 
levels of alcohol consumption. For example, children do not have an explicitly stumbling 
walk when intoxicated. Possibly, sensitivity of cerebellar receptors is not yet fully 
developed. At the same time, adolescents seem to be more sensitive to other symptoms of 
alcohol use such as the social facilitation which occurs at low doses of alcohol (5;6).  
Among adolescents admitted with alcohol intoxication, boys have a higher ethanol 
concentration than girls (7). Gender distribution is equal in the population, and duration of 
unconsciousness is equal between boys and girls. This shows that boys drink more, but it 
also suggests that girls become intoxicated at lower blood alcohol levels than boys (8). Girls 
probably are more sensitive to the toxic, suppressive effects of alcohol on the central 
nervous system. 
The role of the socio-economic position in alcohol use is not completely clear. Negative 
health behavior is often confined to lower income families. More strikingly, it is one of the 
main factors by which socioeconomic health differences arise (9). Alcohol-related mortality 
is higher in lower socio-economic classes, mainly among middle-aged men (10). The 
educational level of the parent is associated with alcohol consumption. Highly educated 
mothers are correlated with less alcohol consumption (11). At the same time, unskilled 
occupational level of the father is positively correlated with the amount of alcohol 
consumed. Other reports conclude that children from families with higher incomes drink 
more frequently and they more often drink without supervision (12). Material factors such 
as financial worries and material scarcity can also reduce adolescent alcohol consumption 
(9). Lower intelligence scores, familial alcohol problems, peer influence and parental 
attachment can be possible confounders. 
Students at pre-vocational secondary education or pre-university secondary education all 
drink from an early age. It appears that patients with alcohol intoxication on the pre-
vocational level are younger and drink less. Higher educational level it is an independent 
risk factor for higher BAC at admittance.  
Parental knowledge of alcohol use and parental rules influence alcohol use amongst 
adolescents (13). These aspects are striking in clinical practice, with examples of parents 
A New Approach in Adolescent Alcohol Intoxication –  
Clinical Pediatric Experience and Research Combined 
 
223 
offering alcohol to their underage children. Parents who set strict alcohol-specific rules early 
on delay the age of onset and reduce the frequency and quantity of adolescent alcohol 
consumption (14) (Koning). A strict attitude of parents towards alcohol diminishes 
adolescents’ involvement in alcohol use. To positively influence problematic alcohol use in 
their children, parental attitude should be addressed in the treatment of these patients.  
Parental attachment can be another factor of interest in parental involvement. It has been 
described that poor parental attachment is related to an earlier onset of drinking. The 
inverse explanation can be that the younger the adolescent starts using alcohol, the less 
strong the attachment with the parents is (13). The influence of the relation between parent 
and adolescent needs to be clarified further.   
A family history of alcohol use is associated with more alcohol consumption in adolescents; 
and with even higher transmission between parents and adolescents of the same gender 
(15). Alcoholism of the parents is associated with heavy drinking and binge drinking 
patterns during adolescence (16). The explanation of these tendencies can be found in the 
direct exposure to alcohol, as well as in assimilating certain standards and beliefs on alcohol 
use. Adolescents tend to imitate role models. On the other hand, a positive family history 
has been found to lead to a relatively lower sensitivity to alcohol.  
Students living with peers during their college years drink more alcohol (17). Peer influence 
is a risk factor in many risk-seeking attitudes, such as smoking, substance abuse and sexual 
risk behavior. Children are particularly prone to the influence of peers during adolescence. 
Also, underage drinkers can gain access to alcohol through peers by having older friends 
who work in a store.  
Alcohol use is related to substance use. Cannabis in particular is common, but 
amphetamines are used as well, as are ecstasy, happy mushrooms and cocaine. Co-
occurrence is common and therefore patients admitted with alcohol intoxication should 
always be screened for substance abuse (18).  
Cultural influences are connected to local politics, either nationally- or statewide. 
Determining legal drinking age has a strong influence on the availability of alcohol for 
adolescents (19;20). However, this seems to be just one of several factors to be considered. A 
prosperous society and a change in the available types of drinks are likely to have an effect 
on alcohol consumption. An increase in drinking among youngsters has been observed in 
the past decade (21). For Dutch adolescents purchasing alcohol is one of the leading  
expenses (22-24).  
The relationship between alcohol or substance abuse and psychiatric disorders such as 
ADHD is described as a consequence as well as a cause (25;26). Symptoms like physical 
aggression, conduct disorders and violence as well as hyperactivity and oppositional 
behaviors at a young age appear to be risk factors for alcohol use in later life (27). In 
particular, higher quantities of alcohol consumption have been associated with a lack of 
restraint (disinhibition) (28;29). The interpretation of these associations can be causal and 
consequential and are interesting subjects of research still to be carried out. Depression and 
anxiety disorders in relation to alcohol use are mainly studies in adult populations (and not 
in adolescents or children). However, depression occurs more frequently in patients with 





The clustering of social problems and alcohol intoxication was a particular observation of 
interest in a project carried out at the Reinier de Graaf Hospital in Delft, The Netherlands 
(see Protocol chapter). The rate of self-reported social problems was high among the 
adolescents admitted for alcohol intoxication. Among them were family histories of 
addiction (35.3%), divorce or a deceased parent (19.1% and 11,3% respectively); parent-child 
interaction was aberrant in many cases (44.6%), as were school problems (34.3%) and sexual 
abuse (4.4%) or life-events (e.g. severe illness, emotional problems (41.2%). Also common 
were underlying psychiatric disorders (40%) (autism, attention deficit hyperactivity 
disorder, depression or eating disorders). 
These percentages show that the clustering of personal and social issues during puberty 
makes this group vulnerable. 
7. Consequences  
It is important to realize on the long term, that alcohol and substance abuse tend to track on 
into early adulthood and that alcohol use at a young age is a predictor for future alcohol use 
(31). 
Adolescent drinkers are more likely than their non-drinking or experimenting peers to have 
school problems, drugs or engage in criminal activities such as stealing. In a follow up study 
carried out 10 years later, adolescents who had consumed alcohol were still more often 
involved in problem behaviors including unreliable work attendance, substance use 
problems, violent behavior and illegal activities during early adulthood. Early 
experimenters were also at higher risk than non-drinkers to have problems with substance 
use and criminal and violent behavior (32).  
Heavy drinking has been shown to affect neuropsychological performance and could impair 
the growth and integrity of the brain structures. During adolescence, the part of the brain 
that is developing in particular is the frontal lobe. Here, the higher cognitive functions such 
as cognitive processing and executive functions are located (33;34). 
Research with functional magnetic resonance imaging (fMRI) demonstrates that memory, 
attention and visuospatial abilities are negatively affected by alcohol. Alcohol and drug 
abusers perform worse than their peers (35). Increased vulnerability for these neurologic 
effects is seen in women, patients with a family history of alcohol use disorders, heavy 
episodic drinkers and alcohol use combined with drug use. The co-occurrence of psychiatric 
disorders is an important factor to consider in the evaluation of neurocognitive functioning 
in patients with alcohol abuse. As was mentioned before causality is not clear. The role of 
time of abstinence and age of first drink seem to be less related to neurologic damage (36).  
Importantly, as young adulthood is a period when most people make important 
educational, occupational and social decisions, an impaired cognitive function could 
significantly affect their futures.  
Alcohol use increases the risk of high-risk sexual intercourse. Young adolescents report that 
alcohol has caused them to engage in unplanned sex (27). Girls in particular are prone to 
participate in sexual relationships more readily, and even against their will, during 
intoxication. Afterwards, they often regret the incident and it is not uncommon that they are 
traumatized. 
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Alcohol consumption is one of the leading preventable causes of death in the United States 
(37). The WHO recently identified alcohol use amongst young people (10-24 years) as the 
most important factor contributing to disability adjustable life years (DALY’s) (38). In 
particular, consumption of alcohol is associated with injuries and accidents, which are major 
contributors to mortality of adolescents.  
Apart from the psychiatric disorders discussed before, alcohol use is also associated with 
medical conditions such as hepatitis and liver cirrhosis, hypertension, pancreatitis, 
cardiomyopathy, pneumonia and tuberculosis. Also cancers of the mouth, esophagus, 
pharynx, larynx and breast are more common in patients with excessive alcohol 
consumption. Neurologic disease is not uncommon, and alcohol use is associated with 
peripheral neuropathy and myopathy, as well as with central nervous diseases such as 
dementia and stroke. 
8. Acute care 
The acute care of an adolescent presenting with alcohol intoxication is being done conform 
the Advanced Pediatric Life Support protocol (APLS). Most hospitalizations occur during 
the evening or night (93%), (see Epidemiology section). The announcement of an adolescent 
having become unwell at a party or an unconscious youngster smelling of ethanol usually 
gives away the diagnosis. However, as the presentation is often severe, especially the level 
of consciousness, ABCD-assessment should always be done. Reports of reduced 
consciousness vary from a couple of minutes up to 48 hours (!), with an average of 2 hours 
and 11 minutes. According to Dutch research, average time of unconsciousness has risen 
during the past years from 2,2 hours in 2007 to 3,1 hours in 2010  (7). Other presentations 
include traffic accidents, aggression and violence and even suicide attempts (1%). These 
type of symptoms of alcohol intoxication (Table 3) usually appear at a blood alcohol 
concentration of 20-50 mg/dl (0.2-0.5%).  
 
Blood Alcohol Concentration Symptoms Mg/dl ‰ 
20-50 0,2-0,5 Gross motor impairment, difficulty concentrating 
50-100 0,5-0,10 Decreased coordination and reactivity 
100-150 1,0-1,5 Disturbed balance and gait 
150-250 1,5-2,5 Stupor 
300 3,0 Unconsciousness 
400 4,0 Respiratory failure 
Table 3. Symptoms of alcohol intoxication 
At admission of a patient with alcohol intoxication, the following assessments should be 
done: 
- Amount and type of alcoholic consumptions 
- Other substances (e.g. marihuana, cocaine, amphetamines)  
- Other medications (e.g. contraception, benzodiazepines)  
- Blood (blood alcohol concentration, arterial blood gas, glucose, electrolytes, 
electrocardiogram, liver function) 
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The amount of alcohol consumed can be estimated by using the formula, based on the 
Widmark equation, in figure 2 (39). This can be of use in conversations with parents and 
patients about alcohol consumption.  
 
 
Fig. 2. Formula to calculate amount of alcohol consumed 
In general, acute medical complications are serious but mild. The complications seen most 
frequently are reduced consciousness (45%) and hypothermia (43.1%). Electrolyte 
disturbances are most often hypercloremia (31.1%) and low bicarbonate (22%), but 
hypokalemia (11.9%) and hypernatremia (7.7%) are also seen. Hypoglycaemia is not often 
reported, however hyperglycaemia can be seen in some patients (13.6%). Mild acidosis, 
more often metabolic but also respiratory, was observed in 28.8% of patients (2).  
After admittance patients are directly monitored. Treatment mostly consists of 
administering intravenous fluids to rehydrate. Metabolic acidosis, hypoglycaemia and 
hypothermia are corrected. Gastric lavage and activated charcoal are not recommended 
since they are ineffective due to the rapid resorption of ethanol and because they possibly 
enhance the risk of aspiration.  
9. Protocol 
To standardize the care given to an intoxicated adolescent, a program was developed in the 
Reinier de Graaf Hospital, Delft, The Netherlands to follow up on patients with alcohol 
intoxication. The objective of the program is to structurally intervene in the growing 
problem of adolescents with alcohol intoxication. Four main goals were identified:  
- To prevent repetition of intoxication 
- To change the behavior of the adolescent towards alcohol 
- To change the behavior and guidance of the parents 
- To detect psychological co-morbidity 
Consecutively, more insight is obtained into the epidemiology, social environment and 
psychological and cognitive functioning of these patients.  
Based on the short-term and long-term complications mentioned above, the protocol is 
divided into different stages. 
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pediatrician speaks both to the patient and the parents, explaining the reason for admittance 
and emphasizing the seriousness of the event. The patient’s medical and social histories are 
checked and questions are asked about further alcohol use. The dangers of alcohol use are 
explained. This is seen as an important moment for intervention and education. Patient and 
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employee or nurse will help the adolescent to answer questions on alcohol use on a 
government-funded website. Parents are also referred to websites for further information. 
Most of the patients leave the hospital in good clinical health within a day after admittance. 
After discharge, a program starts at the outpatient department of pediatrics and child 
psychology.  
11. Intervention & follow up 
After treatment of the acute problems and sobering up, the multiple alcohol-use related 
problems mentioned above should be attended to in an evaluation. 
Many treatments for alcohol use disorders can be applied to decrease alcohol use. Among 
them are family treatment, (short) motivational enhancement therapy and behavioral therapy, 
which all seem to have a significant positive effect on alcohol and substance use (41).  
After receiving information in the hospital setting, the patients visit a pediatrician and a 
pediatric psychologist at the outpatient clinic. The program consists of several 
appointments. 
At the appointment with the pediatrician, the patient’s general alcohol and drug use, school 
problems and social issues are addressed. By means of a presentation several alcohol related 
problems are addressed, such as epidemiology, metabolism, neurological and physical 
consequences, case reports, peer pressure (for example at sport facilities), media attention 
and marketing strategies of alcohol industries. The role of the parents is emphasized as well; 
alcohol-specific rules are pointed out, such as; rules on vacation are the same as those at 
home, parents are not supposed to drink in front of their children, not to mention invite 
them to try. To optimize the effect of the intervention, these issues can be individualized 
depending on the patient’s interest.  
The child psychologist performs a psychological interview to screen for underlying 
problems. The patient is also evaluated based on behavioral questionnaires (Youth Self 
Report (YSR), Child Behavior Checklist (CBCL) and Teacher Report Form (TRF), to be filled 
in by patient as well as parents and teachers), and earlier and recent educational 
performance. The interaction between parents and adolescent is taken into account, and life 
events and psychosocial history also are important issues for discussion. Once again the 
dangers of alcohol use are explained. 
When indicated, psychological, social, medical or addiction-related treatment is offered. 
Some services can be offered within the setting of the outpatient clinic, for others, the patient 
can be referred elsewhere. Although treatment is not always necessary, follow-up is done at 
all times. After the first appointments the patient will be contacted within 6 months after the 
event to discuss alcohol use and general well-being. However, often the pediatrician or child 
psychologist finds it necessary to see the patient in the mean time because of related issues. 
In conclusion, underlying social and neuropsychological problems can come to light during 
psychological and pediatric screening and can be treated when indicated. The dangers of 
alcohol are being explained extensively to patients as well as parents. Help can consist of 
psychological treatment or referral to detox clinics or other youth care institutions.  
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Preliminary results of the project are promising. At follow-up, 84-88 % of the patients had 
stopped binge drinking and 61% had stopped the consumption of alcohol. Awareness of the 
parents was another factor of interest; at follow up 82,5 % of the parents applied specific 
alcohol rules, including prohibition of alcohol under 16 years of age. Behavioral 
questionnaires were filled in by 89% of the study population. Neuropsychological screening 
was done in 72% of the patients for whom it was indicated. 
12. Tools for screening  
Screening for problematic alcohol use can be useful during follow up of the patients. It can 
be expected that questions about lifestyle are delicate, particularly during adolescence and 
in the direct vicinity of parents or adults. At the same time, detection of problematic alcohol 
use at a young age can reveal alcohol dependency and ensure a more effective intervention. 
So far, no standard screening method has been identified. 
Various self-report questionnaires are available for rapid assessment of drinking behavior, 
such as the Alcohol Use Disorders Identification Test (AUDIT), TWEAK (Tolerance, 
Worried, Eye-opener, Amnesia, Cut Down), the Michigan Alcohol Screening Test, CAGE 
(Cut Down, Annoyed, Guilty, Eye Opener) and the Alcohol Dependence Scale. The AUDIT 
was developed by the World Health Organization (WHO) as a measure for alcohol 
consumption, dependence and alcohol-related problems. The TWEAK focuses more on 
tolerance. It was specifically developed for women and aims to identify possible hazardous 
drinking patterns. The CAGE places emphasis on behaviors consistent with alcohol 
dependence.  
These various screening methods are rapid, non-invasive and inexpensive, but they have 
different outcome parameters and were developed for adults. Applicability for adolescents 
has been investigated and seems to support the AUDIT as the better screening method (42), 
due to its focus on frequency of use, quantity and frequency of binge drinking. This can be 
an advantage in adolescents, because here the early detection of drinking problems is the 
main goal. However, reliability is low because of self-report.  
Biological screening methods can offer more objectivity. Amongst them is the extensively 
used blood alcohol concentration, which is generally determined during the first care. 
However, this test only gives information during a short period after consumption of 
alcohol. It has no role in screening for alcohol use at the outpatient clinic.  
Other traditional and new markers can add to the suspicion of problematic alcohol use. The 
more established markers of alcohol use are mean corpuscular volume (MCV), gamma-
glutamyltransferase (GGT), aspartate aminotransferase (AST) and alanine aminotransferase 
(ALT). Increased values can lead to the differential diagnose of alcohol dependency. Direct 
markers, which are all products of ethanol metabolism, are acetyldehyde, acetic acid, fatty 
acid ethyl ester (FAEE) and ethyl glucuronide (EtG).  
Newer biomarkers include carbohydrate-deficient transferrin (CDT), total serum sialic acid 
(TSA) and 5-hydroxytryptophol (5-HTOL). Transferrin is a plasma protein that carries iron 
through the bloodstream to the bone marrow. Transferrin is a polypeptide with two N-
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significant quantities of alcohol increases the proportion of transferrin with low saturation 
of sialic acid residues. They are referred to as carbohydrate-deficient transferrins (CDT). 
CDT testing is available in a regular hospital lab. 
Sialic acid is a monosaccharide carbohydrate. As a consequence of excessive alcohol 
consumption, saturation of transferrin with sialic acid decreases and total serum sialic acid 
rises. Determination of TSA provides a means of detecting alcohol abuse. 5-
hydroxytryptophol (5-HTOL) is a human metabolite of serotonin (5-hydroxytryptamine, 5-
HT) and is excreted in the urine, where it mainly occurs conjugated with a glucuronic acid 
and, to a lesser extent, in free form or conjugated as a sulphate. After alcohol consumption, 
the 5-HTOL level in various body fluids will rise above normal values.  
The value of these new biomarkers for screening purposes is still under discussion. Several 
factors are of importance; such as detection period after abstinence, patterns of alcohol use 
(episodic drinking, non-heavy chronic patterns, etc.), associated medical disorders, 
demographic differences and cost and availability. Sensitivity and specificity are of 
particular interest and are highly dependent on cut-off points, which have not yet been 
established (43;44)  
The indirect marker CDT and direct marker EtG seem to have the most advantages for all-
around utility. Combinations of different markers, especially CDT and GGT, have been 
studied, and application at multiple time points could significantly increase their usefulness.  
Still, little research has been done among adolescents. Some studies among adults include a 
sub-analysis of patients under 20 years of age, and these show minimal association of 
alcohol consumption and markers (43;44). 
In conclusion, biomarkers of alcohol use are of interest to pediatricians dealing with 
adolescents at the outpatient clinic for obtaining useful information on drinking patterns, 
which would otherwise be obtained by less reliable means like questionnaires. The exact 
role of biomarkers should be clarified further.   
13. Prevention 
Alcohol use in adolescents is influenced by internal and external factors. In the first place, 
health interventions such as government campaigns for mass media as well as smaller 
programs attempt to decrease youth alcohol use. Some studies show effects on knowledge, 
attitude and behavior. However, the effect is uncertain and these health effects can 
disappear over time (45). 
Secondly, the alcohol industry has a major influence via alcohol commercials and brand 
visibility. Advertisements attempt to make the customer feel positive about a specific 
product or brand. Not only adults, but adolescents as well are persuaded to adopt a positive 
attitude towards alcohol and even drink more alcohol (46). Policies concerning alcohol 
advertisement focus on specific high-risk groups. Restricting outdoor alcohol 
advertisements near schools, banning alcohol commercials from television early in the 
evening or on youth-oriented channels and specific advertisement related rules are laid 
down in the law. 
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Another factor that influences alcohol use is media portrayals. The ambience that movies 
and television series create in relation to alcohol increases alcohol consumption, partly 
through the ‘modeling theory’ In particular, the so-called ‘product placements’ which are 
hidden in television shows and movies are often located tactically. Direct relations have 
been described between alcohol use in movies and early-onset teen drinking, drinking 
without parental awareness and acute alcohol consumption (47). 
External risk factors that should be considered when carrying out prevention measures are 
matters of social, economic, physical and legal availability, which are the most important 
predictors of adolescent alcohol consumption, drinking patterns and alcohol-related harm (48).  
Social availability refers to the social context into which drinking is incorporated. As was 
mentioned before, teens and adolescents drink alcohol in the company of their peers. 
Another social factor related to higher alcohol use is parental alcohol consumption. 
Economic availability relates to, prices of alcohol and especially to special promotions which 
increase alcohol consumption. The most frequently used governmental tool to prevent 
alcohol use is increasing taxes on alcoholic beverages. Higher prices lead to lower 
consumption (49). A third factor that can be used in prevention is physical availability, 
which focuses on outlet density and opening hours. Higher outlet density is related to 
higher availability. Especially outlet density and location should be considered, for example 
by decreasing availability near educational institutions. 
A very important factor is legal availability. Alcohol policies for various age groups differ 
around the world, but the increasing number of patients admitted with alcohol intoxication 
demonstrates the infectivity of these laws. All legislation concerning the purchase, sale, 
consumption and possession of alcohol should be critically arranged for underage citizens. 
One of the prime governmental tools to influence alcohol consumption is setting age limits, 
because binge drinking, drinking at school and drinking and driving are related especially 
to the sale of alcohol to underage persons. Research has shown that higher legal age limits 
are related to a decrease of alcohol-related car crashes and other injuries. However, despite 
legal age limits it is still possible for many underage adolescents to obtain alcohol in 
commercial places. Strikingly, compliance with age legislation in commercial establishment 
is not guaranteed; and alcohol can easily be obtained and consumed (50). Falsification of 
identification cards is another way to obtain alcohol.  
Prevention of alcohol use among adolescents should be aimed at patients, parents and 
politics. A conjunct of medical, political and sociological awareness of the dangers of alcohol 
use can decrease alcohol use within modern societies.  
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1. Introduction 
This chapter attempts to characterise the process of chronic disease and infant 
hospitalisation, the relationship between healthcare professionals, children and their 
families, in addition to considering the implications which chronic disease has throughout 
the life of the child and their family. The chapter also considers the changes in the field of 
pediatrics, its gaps and shortcomings and its position in the biomedical field, defining 
technical and scientific principles.  
The chapter intends to contribute to the construction of knowledge within pediatrics in the 
face of contemporary concerns and reflections about chronic disease which can serve as a 
reference point for the promotion of healthcare strategies, principally specialised hospital 
care, for those children in hospital care.  
With the evolution of diagnostic methods and new treatment methods there has been a 
great deal of discussion and research into chronic disease and its implications for the lives of 
child suffers. Chronic disease effects millions of people throughout the world, however, it is 
fundamental that we reflect upon the peculiarities involved when this experience occurs 
during childhood. To be able to speak of chronic illness and of infant hospitalisation, it is 
necessary to locate this stage of the child’s development, which we refer to as childhood, 
whilst also considering the role which children occupy in contemporary society from the 
vantage point of healthcare.  
Until the 18th Century children were the responsibility of the family which ensured the 
transmission of physical life, family possessions and names, but had no specific concern 
with educational. The State and charity were utilised only in cases of abandonment (Aries, 
2009).  
However, from the Renaissance to the Enlightenment the concern with children’s health 
intensified, beginning from a sense of conservation and protection of childhood originating 
with mercantilism, and later, to capitalists with the intention of strengthening and 
expanding armies and a necessity for abundant labour power. Educational performance, 
which began to take centre stage in shaping children, was dominated by vigilance and 
discipline and was concerned with morality and a sense of responsibility. Likewise, the 
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which began to take centre stage in shaping children, was dominated by vigilance and 
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Medicine fitted the function of guiding, controlling and instructing families and society with 
regard to treatments, clothing, toys, education and nutritional timetables, and was founded 
on the new knowledge of comprehensive childcare. A rational and scientific model emerged 
from within pediatric care providing the rules and norms for medical and educational 
practice towards children. (Rago, 1987; Zanoli & Merhy2001) 
Childhood, as the object of study taken by medicine, focused its attention on the confluence 
of three privileged axes: high infant mortality rate, abandoned children and a repositioning 
of the doctor figure as central in the medicalisation of the family (Rago, 1987).  
Raised to a privileged position of knowledge and understanding about the best ways to 
maintain a clean and healthy life, medicine now assumed the political role of recovering the 
trajectories of childhood, hitherto unproblematic, and began to the fulfil the task of 
intervening in private households.  
In addition to education, impoverished and abandoned children were disciplined through 
professional institutions such as orphanages. They provided both discipline and new 
knowledge which was transmitted through the punitive and repressive model, restructuring 
both habits and customs (Rago, 1987).  
The study of hygiene brought to social life new practices and norms of personal hygiene, 
familial hygiene and for the home, focusing principally on maintaining and sustaining 
healthy children and the formation of strong citizens, who would be able to work in the 
future. The relationship between childhood and adulthood was established and the way in 
which an individual had been treated during childhood came to be the main determinant 
for their future possibilities of a healthy adult life. Thus, hygiene became a central concern 
for governments and states in producing subjects and families and was directed towards 
protecting physical and emotional intimacy (Costa, 1983). 
Later, children’s health became harnessed to maternal health, originating in the binomial of 
mother-child. A proposal to protect the mother-child’s health was developed, planned and 
implemented through specific programs and standards of healthcare. However, with this 
move towards preventative and communitarian medicine, a new proposal was presented 
focusing on comprehensive healthcare, both rationalising and hierarchical, establishing 
networks of hospital and outpatient services. There was a refocusing on the concepts of 
multiple causality and risk in the understanding of children’s health. The fight against infant 
mortality was centred on discourses and practices directed towards understanding the 
social determinants of the health-disease process and of the necessity to expand assistance 
until adolescence. A shift occurred from focusing on childcare to focusing on disease, in 
which healthcare became organised and systematised into standards of care (Zanoli & 
Merhy, 2001). 
An important characteristic of early pediatric hospitals is the absence of the mother or any 
other relative during the child’s stay in hospital with the exception of official visiting hours. 
Contact, between healthcare teams and family members, was limited to passing on 
information during discharge, during visits and during more delicate procedures such as 
surgery.  
During these moments of contact with the family, Winnicott (1982) highlights that whilst 
there were positives aspects for the child and their families they also generated mixed 
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feelings amongst parents who assessed their children as being excessively sad. For 
professional healthcare workers it represented extra work re-stabilising and re-establishing 
the child after the conclusion of the visit.  
With the subsequent inclusion of the family and/or the companion in the universe of 
hospitalisation, a change of focus was required from professional health workers, which had 
previously concentrated solely on the child and their pathology, in order to create a more 
comprehensive understanding of the condition of infant hospitalisation. Pediatric care once 
again came to have the family as its goal, which was considered as the primary unit of care, 
whilst not forgetting to take into account valued technological advances included within the 
healthcare perspective (Collet & Rocha, 2004). 
Considering the course which infant care has taken since the 18th century it is possible to see 
that not only were concerns diversified, but that there were also changes in practices of care, 
control, education, training and protection.  
Throughout the 20th Century, with the widening in scope of the role of medicine and 
increasing specialisation and technological development, infancy gained the same number 
of dedicated professionals as adults, composing a long list of healthcare professionals such 
as endocrinologists, neurologists, psychiatrists, infectologists and gastroenterologists 
amongst others.  
Moreover, it is not possible to approach this subject matter without taking into 
consideration Human rights. If before the Enlightenment the child was just another familial 
entity, the 20th Century has repositioned the child at the centre of Human rights legislation 
with the stated objective of protecting them. 
The United Nations (UN) adopted The Geneva Declaration of the Rights of the Child for the 
first time in 1924. However, with the changes to the political landscape during this period, 
the theme achieved a greater impact with the Universal Declaration of Human Rights (UN, 
1948), through which it became universally recognised, for the first time, that the child 
should be subject to special care and attention, as stated in item 2, of article 25 (XXV) 
“motherhood and childhood are entitled to special care and assistance. All children, 
whether born in or out of wedlock, shall enjoy the same social protection”.  
Later, with the Declaration of the Rights of the Child (UN, 1959), ten basic principles were 
established – the right of the child to special protection; to be given the opportunities and 
facilities necessary for healthy and harmonious development; access to the benefits of social 
security, including adequate nutrition, housing, recreation and medical services; to receive 
education and protection against all forms of negligence, cruelty and exploitation – 
becoming a landmark and guide for the performance of both public and private institutions 
and professionals. 
In Brazil, the federal constitution of 1988 establishes in article 227, the Rights of the child and 
the Statute of the Child and Adolescent (SCA, 1990) which regulated the article and was 
drafted based upon the International Instruments of Human Rights of the UN, and in 
particular, the Declaration of the Rights of the Child. Considered a landmark in Brazilian 
constitutional protection of children and adolescents, the SCA stipulates in article 4 that “It 
is the duty of the family, the community, society in general and public authorities to ensure, 
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the Statute of the Child and Adolescent (SCA, 1990) which regulated the article and was 
drafted based upon the International Instruments of Human Rights of the UN, and in 
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education, sport, leisure, professional training, culture, dignity, respect, freedom and family 
and community”. 
Five years later, Brazil promulgated resolution 41 on October 13th 1995 which was directed 
specifically towards the Rights of hospitalised children and adolescents. The resolution is 
composed of 20 rights including protection, care, use of procedures to minimise pain and 
the recognition of pediatric patients as subjects with rights within institutional healthcare.  
However, it is not possible to discern the same concern and legal protections in relation to 
children and adolescents in different countries. The situations of war, famine, poverty and 
malnutrition produce refugees, orphans, and the displaced children of territorial and 
political conflicts on a daily basis.  
The path to the concrete realisation of such rights is long and faced with many obstacles, 
which includes the way in which children are viewed and understood by adults – subjects 
who need to be represented by another voice in order to be heard.  
The developmental approach to the child, of being in a process of formation which is 
incomplete and therefore requiring of norms and standards so that the social and cultural 
debt of becoming adult can be paid off through education and through the adult figure as a 
spokesperson for the child is criticised by Castro (2001), which brings to light a new concept 
of childhood.  
In his theory, Castro (2001) emphasises the importance of legitimising children as being 
capable of exercising their rights through their capacity for action within and understanding 
of the world. Both adults and children become perceived and understood as belonging to 
different age-group categories with different roles and performances in society.  
Qvortrup (2007) demonstrates in his study that the attitudes of society in relation to children 
are ambiguous because whilst at the same time as establishing rules and rights to protect 
children, society departs from these very same rules and rights in relation to adults. Without 
belittling the importance of ensuring these rights and protection to children, since childhood 
and politics are inextricably linked,  present criticism and construction focuses on the 
movements of children only as edification materials for future generations and training as 
political subjects (Qvortrup, 2007). 
However, this critical task becomes a great challenge when the conditions of chronically ill  
hospitalised pediatric patients, who find themselves with reduced levels of autonomy, are 
dependent upon technology, relatives, social support networks and the performance of 
professional health workers, are assumed.  
2. Chronic disease in childhood 
By chronic disease is understood those diseases that present prolonged periods of suffering, 
are incurable, and have profound effects on the everyday life of suffers, affecting social 
relations, the family and health institutions (Canesqui, 2007). Chronic diseases during 
infancy may be considered as events which have a biological, psychological and/or 
cognitive basis, with a prolonged periods of suffering which may produce limitations in 
functions or activities, a loss of social relationships, pharmaceutical dependency, special 
dietary requirements, medical technology, specialised equipment, personal assistance, 
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comprehensive healthcare which not only includes medical attention but also other 
professional healthcare assistance such as psychologists, occupational therapists, nurses and 
physiotherapists amongst others, which need to be accommodated in different ways in the 
various spaces of sociability (Silva, 2001). 
According to the World Health Organisation (WHO, 2003), a chronic condition constitutes a 
health problem which demands permanent health care and management over prolonged 
periods of time, even years or decades. Understanding chronic diseases involves addressing 
a vast array of diseases including both transferable diseases (HIV/AIDS) and non-
transferable diseases (cardio-vascular, cancer and diabetes) and physical disabilities 
(amputations, blindness, and chronic joint diseases) which, although seemingly distinct 
from each other, all require permanent care.  
Chronic diseases have assumed a new place in healthcare in light of the available 
technological support and scientific advances which have led to increased survival rates for 
this group of pathologies. There has been a demographic and epidemiological transition in 
pediatric care which can be characterised by the increase of chronic cases of overweight 
patients, infant obesity, reducing malnutrition and a reduction in infant mortality rates 
between the ages of two months and five years, actions aimed at increasing breast feeding, 
access to pre natal care, treating pneumonia, diarrhoea and the administration of vaccines 
(Moreira & Goldani, 2010). 
This has had a profound impact on hospital care and point towards the construction of a 
new model of healthcare which should be expanded to included the prevention and 
treatment of infant diseases to guarantee the health of individuals so that they can grow 
and develop. The child is now dependent on technology – an increased population has 
grown quantitatively and now demands specialised treatments and services (Moreira & 
Goldani, 2010). 
The wide variety of rare infant diseases which are genetic in origin and their subsequent 
survival is dependent upon both the type of healthcare offered and the available technology. 
The technologically dependent child, besides demanding new services, establishes a 
permanent relationship with the various stages of assistance. There are children who are 
born with chronic diseases, who are assisted by neonatology and in order to survive are 
transferred to pediatric wards. Institutional processes and transfers of responsibilities 
between professionals are developed as well appropriating hospital space for family 
members due to the changes involved in going from being part of life to being hospitalised. 
Against this background of demographic and epidemiological changes, pediatric practices 
were being developed which included diagnostics and the administration of both human 
and financial resources in order to improve the assistance and healthcare given to patients 
(Moreira &  Goldani, 2010). 
However, the experience of chronic disease has at its core the uncertainty of future life and 
affects not only medical conduct, but above all, the course of the life of the patients who, in 
many cases, find themselves unable to plan long term for the future (Adam &  Herzlich, 
2001). Furthermore, chronic disease can alter our everyday routines and habits, which in the 
case of pediatric patients includes going to school, their circle of friends, visiting parks and 
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The diagnosis of chronic disease alters the everyday routine of the patient and their family, 
from initial investigation until confirmation of diagnosis, at which point patients begin to 
adapt to their new circumstances and learn to deal with the suffering, possible limitations 
and fear of dying (Pierre et. al., 1991). 
Often, due to diagnostic examinations, this routine can even begin intrauterine with certain 
types of disability or disease being detected and corrective procedures initiated, for example 
in cases of spina bifida and heart disease. At other times, the baby can present signs or 
symptoms of chronic disease immediately from birth, thus initiating diagnostic procedures 
which can interfere with the construction of the mother-child bond and the establishment of 
the baby’s routine.  
Thus, the experience of living with chronic disease from birth implies a series of changes to 
the lives of the baby and family. Discipline is amongst the numerous challenges faced in 
everyday life, regardless of whether or not treatments require medication. This implies 
amongst other concerns, the frequency with which patients have to undergo examinations, 
consultations, medical procedures and hospitalisation (Vieira &  Lima, 2002). Besides 
dealing with the behaviour and conduct of different healthcare professionals, chronic 
diseases can cause changes in routine which range from those effecting the family, such as 
those responsible becoming unemployed in order to care for the patient, having to move 
home in order to be closer to hospitals and health centres, structural changes to the house, to 
problems at school whether due to architectural barriers, adaptation or rejection of the 
pedagogical model or rejection by peers.  
The constant concern with the care of the child from infancy becomes so great that it can 
interfere with the spontaneity of maternal care. Depending on the severity of the situation, 
accurate knowledge of the disease, the quality of interaction with healthcare staff and 
previous experience, the mother in question may think that she is incapable of providing the 
necessary care for her baby. The mother wrongly assumes that care is only a technical 
competence. Thus, it is fundamental that healthcare professionals are attentive to the need of 
encouraging and stimulating the participation of the mother, not only during the routine of 
medical treatments but also in nurturing the baby (Winnicott, 1988).  
The chronic condition is presented as a delicate reality, becoming a private personal 
experience that the other does not access, dependent upon constant communication between 
the subjects. Because it is a private experience of the subject, it is not easily established 
making the job of deciphering chronic pain necessary amongst healthcare professionals 
(Baszanger, 1991). 
The manner in which the child and the family face chronic disease is associated with the 
organisation and interaction of the family. The support of family and social ties, support 
networks for the family and protection of patients serve as a social fabric which permits a 
greater range for management of encounters and constructing ties which can ensure the 
well-being of patients (Adam &  Herlizch, 2001; Viana et. al. 2007) 
The physical pain, the psychic suffering and the deleterious effects of medical procedures 
are not always taken into consideration in healthcare practices. A narrow view of the 
experience of the chronic condition, which is defined as only discomfort and/or physical 
limitation, ignores or minimises the greater meaning and experience of the pediatric patient 
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(Charmaz, 1983). Considering that a child suffering from a chronic condition can become a 
chronic adult, it becomes essential that the individual stages of life and their respective 
experiences receive special attention in the context of hospitalisation and healthcare. For 
Moreira &  Goldani, (2010: 324) “health conditions in early life are strong determinants of adult 
health and this has not received sufficient attention”. 
For these authors the field needs more profound and systematic studies which are not 
limited to personal experiences, case studies, expert recommendations or small clinical trials 
which have made the child a “therapeutic orphan” (Moreira &  Goldani, 2010: 325). 
3. The hospitalisation process and the phases of infant and juvenile 
development  
It is important to highlight that every child has a chronic disease, regardless of any 
diagnosis, first and foremost, that of being a child. This fundamental and obvious condition 
is unfortunately often forgotten by healthcare professionals, implying that the general level 
of maturity and response expected of these small patients is not consistent with the 
evolutionary period in which they find themselves. Thus, it is fundamental to consider the 
aspects of infant development and the principle characteristics of each phase when 
reflecting upon the attention paid to the health of chronically diseased children.  
During the first two years of a baby’s life the baby literally discovers the world through its 
relationship with the maternal figure and her corporal reactions and sensations. The child 
moves from a state in which everything resolves around them to the discovery of the 
outside world 
The child’s behaviour is based upon the perceptions constructed through the sensory 
exploration of the world and physical activities. Disease and medical procedures which 
cause pain and discomfort can seriously compromise the baby’s relationship with their 
environment and themselves (Muriel et. al. 2011).  
This is a period in which the child avoids the unknown, experiences distress and anguish at 
the mother’s absence, what Bowlby (1984) describes as attachment. Because of this, 
situations of chronic disease and fear can trigger extreme reactions including crying, 
frightened expressions, inertia and greater dependency in their behaviour. Fear can be 
aroused by the presence of unknown persons, unknown places or situations, and the 
response will vary depending on a child’s age, duration of separation and the degree of 
deprivation to which the child has been exposed (Bowlby, 1984). In spite of knowing the 
importance of early experiences in the baby’s life, we still see, in practice, some healthcare 
professionals that believe that because of the fact that their client doesn’t present a 
developed verbal language, chronic disease will somehow not have so many repercussions 
in their lives.  
After this period, the child enters the Pre-operational phase (Piaget, 1976) where its first 
mental concepts are formed and the process of internalising reality commences. The 
imagination finds itself indulged in activity and mental reasoning but forms magical beliefs 
and inadequate concepts characterised by ego-centricism and animism. Accordingly, it is 
fundamental to take care with the information given to children because their thinking is 
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Similarly, the notions of time and reversibility are still under construction. Because of this, 
children often find it difficult to understand why it is necessary for them to have to undergo 
certain treatment which they sometimes associate with discipline and punishment (Santa 
Roza, 1997). 
Often, even simple activities like playing with other children or siblings can become 
compromised. This may occur because of limitations arising from the intense routine of 
treatment, the care taken when in contact with other people (avoidance of trauma or 
bacteria) or the parents fears in relation to any other eventuality that they think threatens 
the health (and consequentially the life) of their children.  
At school age, between the ages of six to twelve, the child will gradually become 
increasingly mature for their physical, intellectual and social condition. It is a phase of 
investment in physical activities and of greater socialisation. However, sufferers of chronic 
conditions may find themselves unable to participate in conventional social interaction and 
banter, which gives rise to the possible loss of friendship ties and changes in familial 
relationships. Further, the comprehension of death which chronic disease brings with it 
becomes more accessible through language and abstract content (Muriel et. al.,  2011).  
Amongst adolescents, who experience a phase characterised by the involvement of formal 
identification, an appreciation of more abstract aspects through a greater intellectual and 
emotional contribution, the experience of chronic disease can place them in conflict with 
their desire to live a more autonomous life and the dependency imposed on them by their 
chronic condition (Muriel et. al., 2011).  
In all of these phases, it is important to point out that school should be considered as a 
primary partner in this process, which implies the availability and time to receive children 
with special requirements, for example, those who have had tracheotomies, gastrostomies or 
colostomies, administered food absences due to prolonged periods of treatment, the possible 
structural and architectural barriers and the relationship with other children.  
However, school may also represent a challenge for children with chronic diseases due to 
the fact that it may expose children to more vulnerable situations, to being stigmatised by 
their colleagues and even bullying. The corporal changes entailed as a result of chronic 
diseases may provoke changes in body-image, the generation of feelings of inferiority, 
depression and embarrassment from the perception that they are different from their peers 
(Castro & Moreno-Jiménez, 2007) 
Because of this, it is important to point out that the monitoring of children with chronic 
diseases involves knowledge from various disciplines. The participation of different 
healthcare professionals aside from doctors, psychologists, social-workers, occupational 
therapists, physiotherapists, and speech-therapists is fundamental. 
Another important aspect of treatment, frequent in the lives of chronically diseased children, 
is hospitalisation, whether due to the deterioration of the patient or as a strategy for 
administering specific medication and procedures. Regarding the hospitalisatision of a child 
or adolescent, in general, what is observed is conformation of this delicate moment for the 
family requiring a reconfiguration of the everyday life and the assimilation of the disease 
which may also induce subjective changes. At the moment of hospitalisation, the experience 
for the pediatric patient is marked by the rupture from the everyday routines of school, 
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friends, family, peers and games. In general, “the activity and freedom characteristic of 
childhood are replaced by passivity, leaving few options for the child to make choices” 
(Mitre, 2006; 286). 
This change produces an estrangement from the experience of being in hospital which will 
differ amongst patients and their relatives. The points of reference in a child’s and 
adolescent’s life are replaced by pale walls, invasive medical procedures, medication and 
machinery, new words and phrases and the sensation of pain and suffering changing the 
everyday routines of these patients (Mitre, 2006). 
The hospitalisation of children may be considered as a potentially traumatic event when the 
full complexity of the human dimension is not fully considered (Santa Roza, 1997). 
Generally, models of care still favour the disease and view the child only as a sick body. We 
have to consider the diverse aspects involved in the process of hospital care when working 
with children, everything from the presentation of physical space to treatment routines, so 
as to avoid iatrogenesis (Santa Roza, 1997). 
Bearing this in mind, we observe an increasing concern with the physical environment of 
hospitals and health centres, especially in pediatric wards. However, it is still common in 
hospitals and health centres to find the presence of unwelcoming and stressful stimuli. 
Unfamiliar and noisy equipment, a plethora of monitors with artificial lights, pipes and 
tubes and needles and tweezers comprise, in general, a threatening and unfamiliar setting.   
With the evolution of technology, and this is not a criticism, merely an observation, some 
hospital wards nowadays resemble spaceships, both architecturally and in terms of the 
complexity of equipment. This is due to advancements in diagnostic and therapeutic 
procedures, modern criterias of optimising resources, and newly discovered diseases, micro-
organisms and consequent treatments. However, this has led to an increased concern with 
creating healthcare spaces separate from society, isolating the infirm and setting the hospital 
in areas outside of cities apart from everyday life (Antunes, 1989). 
In contrast, in economically disadvantaged areas, it is still common to find areas being used 
as pediatric wards which previously had been intended for use by another clientele, or still 
further, had been intended for completely different purposes. This may involve places with 
no windows or natural light, only cold light and few objects which remind you that this is a 
space for children.  
The importance of windows to the outside world is discussed in the work of Antunes (1989), 
where he says, irrespective of what a patient sees, it can be a landscape, cars, people, they 
see what does not exist in the hospital, a life full of movement and they are reminded of the 
temporary suspension of their freedom and autonomy as a result of hospitalisation. In the 
case of infant hospitalisation it is not only the patient who is subject to the architecture of the 
hospital. The accompanying person, usually the mother, is also hospitalised together with 
the child and ends up feeling “trapped” in an environment which sometimes appears far 
removed from everyday life.  
This can contribute to augmenting the feeling of anxiety caused by the concern for the sick 
child and as well as for other related situations, such as concern for another child who 
remained at home, the abandoned job, the lack of support from a partner or family. All of 
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carer, a relationship which, principally during hospitalisation, needs to be capable of 
providing the necessary support for the child experiencing this period (Mitre, 2000).  
Compounding hospitalisation still further, the child is subjected to situations in which they 
do not have any choice. Despite the necessity and effectiveness of hospitalisations the child 
is extremely susceptible to experiences which can cause stress and suffering.  
The feeling of discomfort and pain is one of the characteristics which may accompany the 
hospitalised child. This is both connected to the clinical condition of the patient, which is 
presented through painful symptoms causing discomfort, as well as certain medical 
procedures. The procedure may be a simple puncture, present in almost a hundred per cent 
of hospitalised children because of the need for effective and immediate medication, or 
other equally invasive procedures such as the insertion of different tubes to drain various 
bodily fluids and gasses, the use of catheters or other probes (Mitre, 2000). Depending on 
the child’s age or clinical condition the child is unable to verbalise these feelings. 
The simplest everyday routines are changed due to the fact of hospitalised. The hours of the 
day change, sometimes sleep is interrupted by the routines of the ward, having to constantly 
take temperatures, blood pressure, listening for respiratory and circulatory problems and 
the taking of medication. 
Feeding habits and hygiene routines change as well. Sometimes food is restricted (or even 
temporarily suspended) depending on the clinical condition of the child or the particular 
procedure (examinations, intravenous procedures and punctures and surgery amongst 
others). Hygiene habits may change depending on the time and the place, some patients are 
required to make use of probes or even have to resort to using nappies. In certain cases 
patients have to be bathed in bed which can lead to discomfort and embarrassment 
especially with older children. Moreover, in some places, generally public hospital wards, 
many children and their families and friends have to share the same space without any 
privacy (Mitre, 2000).  
Besides all this, during hospitalisation the child is kept away from their friends, family, toys 
and school; ultimately, their life. This period if often experienced by the child as a gap in 
their life and as if everything appears to be in parenthesis. Everyday life appears so distant 
that some patients lose their notions of time and space. Once, a child asked if the hospital 
had an exit door and elevator to descend to the street. For him, there only appeared to be an 
entrance (Mitre, 2000).  
Santa Roza (1997) describes how in this environment the child experiences situations which, 
even when they don’t constitute a new experience (as in the case of repeated hospital 
admissions), may still sometimes be perceived as frightening. During hospitalisation, the 
child begins to live intensely with the sliding fortunes of their body, experiencing their 
suffering, the suffering of their family and of other children. Sometimes they are present to 
witness death; other times, they fear their own. Fear, anxiety and anguish accompany the 
hospitalisation process. In general, the child is unable to comprehend why they have to pass 
through these unknown experiences which produce fear. This situation may stimulate 
fantasies and thoughts about guilt or punishment as well as the fear of abandonment and 
death.  
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For child sufferers of chronic disease and/or  serious clinical conditions the situation is 
made worse because, in general, hospitalisations occur frequently and for certain children 
the hospital is the everyday routine. Some patients are hospitalised several times a year 
whilst others may stay in hospital for months on end. There are still those patients who 
come and go with such frequency that they begin to spend more time in the hospital than at 
home.  
It is common to know the seriousness of the condition even if it has not already been clearly 
stated. The concern with death exists and manifests itself in different ways. Some children 
joke about this whilst others pass comments about other children who have died.  
Kudo & Pierri (1993) point out that amongst the various factors which directly influence the 
way in which a child will react to the process of hospitalisation are; the type of and degree 
of the affective bond established between mother-child before being hospitalised, the child’s 
personality, the length of stay and the attitude of hospital staff towards them and the child’s 
age. 
Gonzaga & Arruda (1998) highlight, based upon various interviews with hospitalised 
children, that care can be offered by various people during the administration of services 
but that the action of one doesn’t minimise the effects of the others but instead the benefits 
are congregated. The different actors can become sources of care and of feeling cared for. 
However, examples of a lack of care were also mentioned including attitudes of disinterest 
shown by healthcare professionals (doctors and nurses), not executing procedures to 
alleviate pain or the execution of procedures in a cold and mechanical manner without due 
respect and understanding towards the condition and sensitivity of pain. All of these actions 
contribute to the increased anguish and stress that the hospitalised patient experiences.  
It is important to note that the introduction of play and recreational activities presented 
positive results about the experience of infant hospitalisation. Considering that playing is a 
fundamental childhood activity it should also be present during the period of 
hospitalisation. Its absence can lead to the impairment of motor, cognitive, perceptive and 
emotional functions. (Mitre, 2006). 
Play places the hospitalised child in a similar position to other children instead of the 
difference imposed on them by chronic disease (Mitre, 2004). It is an activity which furthers 
and supports the creation of alliances and interactions amongst children, carers and 
healthcare professionals allowing for the construction of a new social network whilst also 
helping to diminish the sensations of isolation and solitude that hospitalisation causes 
(Mitre, 2000). Also, in the child-carer  relationship, play can help reconstruct ties which have 
become fragmented due to the familial breakdown caused by the illness (Mitre & Gomes, 
2004).  
Play and recreational activity also makes possible the expression of feelings, ideas, fears, 
affections and habits. Because play is something which belongs to an individual, social and 
cultural repertoire, it is conducive to the child identifying with familiar elements and 
situations whilst in the hospital environment (Mitre, 2006).  
To value and stimulate play as a possible means of self-expression is to recognise that if you 
work with children it is necessary to respect the uniqueness and specific needs of each child. 
Thus, play in hospital can be considered as a democratic place where individual experiences 
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4. Parental approach to chronic disease and the hospitalisation of the child  
Chronic disease in children and adolescents, besides bringing new variables into the lives of 
the patients, imposes on the parents the need for developing new routines and acquiring 
new knowledge about the conduct and the care of children.  
According to Alves (2009), mothers who live often with the hospitalisation process of 
children learn to provide care and are able to supervise the work of providing assistance, 
judging if they are “right or wrong” in accordance with what they have learnt. 
By exercising their role of providing care to the child, mothers have a function which 
permeates meanings in the universe of nursing, whilst the nurse is, in these cases, in a place 
which does not have clearly demarcated boundaries in the delivery of healthcare. This 
confusing and ambiguous situation can create conflicts and disagreements with regards to 
knowledge and information. However, the disposition of mothers to provide care should 
not be taken as a rule in the same way that it is not specialised care (Alves, 2009). 
The development of care by carers, in general, does not form part of the same option. The 
experience of chronic disease, gradually, inserts them into the hospital routine where they 
learn and act. The permanent presence of companions imprints another dynamic in the 
assistance process, because it provides the opportunity to learn some new technical abilities 
and to amplify other knowledge about the functioning of the hospital and of therapeutic 
techniques (Lima, Rocha e Scochi, 1999). 
The presence of the family within the context of the hospitalisation of children and 
adolescents represented an advance in the relationship between the users and the hospital 
space, but as an isolated initiative it didn’t recognise or take into account the need to 
understand the dynamics involved in the process of chronic disease in children and 
adolescents. The presence of the carer needs to be tracked by a therapeutic project which 
integrates patient care because the carer is attached to assistance and meaning is related to 
the patient’s disease.  
As a vehicle for providing access to the knowledge of patients and carers, dialogue and 
guidelines are indispensable resources. The construction of a therapeutic project, which 
integrates knowledge and establishes performance guidelines within each stage of patient 
care, can be a great resource for structuring and organising more harmonious and co-
responsible relationships.  
At this point the ability and capacity for communication, dialogue and a host of other 
demands and opportunities for the autonomous expressions of the family, comes into play. 
Sharing the provision of care with carers requires the exercise of co-participation. A space 
for dialogue is needed which enables the different actors to express their doubts and 
feelings. This space can not be attached to the duration of time in hospital, but rather 
instituted as a means for the management of daily services.  
The investment in the relationships between healthcare professionals, patients, and their 
carers, founded and guided by such factors as the initial contact and dialogue between 
patients and doctors, may empower the role and autonomy of children and their carers.  
The appreciation of knowledge of paediatric patients about the process of chronic disease 
and the relationships which they experience within the context of hospitalisation are as 
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important as the experiences of carers. The right of children to express themselves can 
provide valuable information for healthcare practices which may be reconsidered in favour 
of a more comprehensive and friendly service.  
Beginning with this understanding, it is possible to construct relationships within healthcare 
which will not be guided by the subjection and control of the patient, but where you can 
affirm the capacity of the paediatric patient to express, create and reinvent standards which 
make possible for autonomously administering the margin of risk to life, amplifying 
capacities for coping with the disease together with the most important relationships. 
The recognition, on the part of healthcare teams, of the conditions in which the body is 
encountered, the subjectivity of the patient, is the first step towards incorporating a new 
understanding of the patient, taking into consideration the factors involved in the patient’s 
life.  
Taken as a proposal to consider care as a value (Pinheiro, 2007), understanding it as an 
integral action which has meanings related to the understanding of healthcare such as the 
right to medical and other specialised treatments, allows the patient to actively participate in 
the decisions taken in regard to the conduct of their own case.  
Healthcare begins when a dialogical relationship between the patient and healthcare 
professionals is initiated, which transcends the simple game of the active questions of 
healthcare professionals and the passive responses of patients towards the construction of a 
space of exchanges, where the medical knowledge of the doctor incorporates itself into the 
lived experiences of the individual. With this, it is possible to establish relationships which 
are guided by partnership between people which have the objective of finding the shortest 
route to the restoration of health.  
Caprara e Franco (1999) emphasise the need to overcome both the informative model that 
relays information and the paternalistic model which protects the patient from their own 
disease, towards a model of communication which includes other important actors in the 
life of the patient. It is an overcoming which requires a change in attitude and 
understanding about the healthcare process and the place of the other within this 
relationship.  
For Deslandes (2004a), the possibilities of communication are related to the social position 
which individuals occupy. In the relationship between doctors and patients there exists, 
historically, a differentiation between the place and value of their speech. 
However, the construction of an active communication begins by recognising the place of 
the patient as that of a subject in the relationship. According to Deslandes (2004b), the 
necessary movement in order to change this logic of attention within healthcare not only 
incorporates a new understanding of patients and their lived experiences, but also a change 
which observes the organisational culture in which are concentrated the relationships of 
knowledge-power, gender and social status. These are these factors present in the 
organisational culture which are able to feed certain types of relationships between the 
actors in institutions.  
Healthcare taken as a value, (Pinheiro, 2007) proposes that we recognise the ethos of the 
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dimensions of individual life with its habits and customs and communitarian life, both 
being originating dimensions in the character and identity of the subjects. It is to be able to 
incorporate the ethos of the other in a process which extends itself making that therapeutic 
moment a unique moment of contact and dialogue.  
5. Final considerations 
It is important to highlight that working closer with chronically diseased children implies 
certain challenges can’t be ignored by healthcare professionals. Firstly, every child, 
independent of their diagnosis, should be perceived as and treated as a child and not only as 
a clinical case or disease. It is not enough to have knowledge and mastery over techniques 
and procedures, it is also necessary to have knowledge of infant development and the 
perception that care is not limited to treating only symptoms. Part of the professional role 
should include helping children to deal with the barriers which originate with disease and 
expanding their limitations in favour of greater quality of life. 
The various forms of healthcare need to be introduced to the child, not merely as the 
recipient of diagnostic and therapeutic techniques, but rather as a subject that possesses 
various ways to elaborate their experiences of living with chronic illness. The ways which 
children elaborate about the experience are different from adults, but this doesn’t render 
them incapable of valuing the experience and extracting from it new meanings which 
healthcare staff can help to produce.  
Hospitalisation contexts carry the potential to produce something new, transmuting into 
new pathways which allow for new perspectives as well as generating closure, diminishing 
the creative wagers of the subjects. The potential to change situations which cause fatigue, 
polarisations of care and dichotomies of knowledge is contained in the capacity to unite 
healthcare staff collectively towards an objective, the construction of which is shared 
between the patient, family and healthcare professionals (Alves, 2009). 
In this sense, the meetings with each patient can promote changes in the perception of the 
subject because there are moments which are full of creative possibilities orientated towards 
solutions for coping with chronic infant disease, producing positive changes for the patients, 
families and healthcare professionals.  
The participation of relatives in the hospitalised context and care of chronically diseased 
children also needs to be rethought so that the dichotomies and disputes of space and 
knowledge can be broken down. Learning about care inevitably occurs in families which 
accompany the daily care provided to the child making this experience a way to integrate 
different cultural knowledge and values. 
Within the world of attention and assistance, acceptance and dialogue are wires, not only 
permeated by concepts and theoretical frameworks, but through the capacity to meet and 
produce subjectivity, revising values, perspectives and expectations. 
To this end, necessary changes to the dynamics and processes of healthcare staff are needed, 
beginning with a management model which is shared and constructed in a collective fashion 
between healthcare professionals and the users of such services in order that it may become 
possible to break and minimise distance and to value the capacity for collective union.  
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Finally, to highlight the contribution of Ayres (2005), in relation to the concept which he 
calls Projects for human happiness. For the author, this concept refers to the idea of lived 
experiences, positively valued, which are not dependent on a state of complete well-being in 
the life of the subjects. In cases of disease, these projects can be constructed from the various 
values and guidelines which orientate healthcare. He makes the salient point that happiness 
materialises in the lives of individuals through the construction of everyday life projects, a 
concept which can’t be defined universally or as an external entity. Projects for human 
happiness are associated with the capacity to overcome obstacles and move in the direction 
of values held by both the individual and collective.  
The way to construct, in healthcare, Projects for human happiness involves the evaluation of 
values which orientate the processes of chronic disease and healthcare, as much as in 
regards to the integration of care by the different actors who participate, as well as the closer 
cultural, economic and social ties between healthcare professionals, patients and relatives. 
Above all, the view of the child should be complete, going beyond the supposed organic 
limitations and inability to express feelings and experiences.  
There exist many different ways for the child to access the contents of pain and happiness. 
Nevertheless, a leading Projects for human happiness agent for carriers of chronic disease 
requires going beyond the implementation of technical methods and procedures or 
structural knowledge of disciplines, in order that new meanings and new ways of listening 
and new points of view can be expressed in spaces of care and attention. 
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1. Introduction 
Our experience is related to the treatment of a lifethreating disease (leukaemia) and from it 
should be applicable the same concepts or strategies to any other severe chronic disease. 
Since the early 1970s, a cure for childhood cancer has become a reality: over 80% of cases are 
now cured. Yet, despite the relatively high cure rate, the diagnosis of leukemia continues to 
place a heavy burden on family functioning. The parents must walk the narrow line 
between focusing too much on the child’s disease and treatment and maintaining a normal 
family life. Because cure is such a real possibility, the children must be prepared for a full 
and active participation in adult life, just like their peers. Proper discipline must be 
maintained within as normal a family life as possible. The child’s continued attendance at 
school and participation in normal childhood activities is imperative in the child’s 
preparation for adulthood. 
For all these reasons, psychosocial intervention has become a necessity in the treatment of 
the child, even for those children who eventually will die from the disease. 
Although there is little disagreement that the ultimate goal of treatment for childhood 
cancer is the total cure of the child-medical, educational, psychological, and social-the 
issue is how best to achieve this end. The literature is filled with research-based 
conclusions on which type of psychosocial intervention is best, including when and how 
one should communicate with the child about the diagnosis, how to help the parents 
maintain some sense of normality in their family life, how to help the child return to 
school, how to keep the siblings informed, how to start parent groups, how to involve 
parents in medical decision-making, how to prepare for the terminal phase when it occurs 
for some children, and how to continue to monitor long-term survivors. Problems occur 
whenever the approach must be modified to meet the needs and cultural preparation and 
expectations of the children and their families. This is especially true when one tries to 
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for some children, and how to continue to monitor long-term survivors. Problems occur 
whenever the approach must be modified to meet the needs and cultural preparation and 
expectations of the children and their families. This is especially true when one tries to 






What works in one cultural setting may not work as well in others. How might a center 
apply programs from one country or setting to another? Not all hospitals can afford a 
psychosocial team.  
Not all cultures appreciate intervention by a psychologist or psychiatrist. What can pediatric 
hematologists do to modify their approach to the children and their families with maximal 
success, in a manner most appropriate to and respectful of the needs of the families within 
their own cultural setting? And above all, how can a center best monitor its intervention 
programs, to ensure that the needs of the children and their families are being met 
appropriately, in their best interests, and with greatest effectiveness and use of resources? 
How do we help a family whose child has been diagnosed with a life-threatening illness? 
How do we help the children and their families cope with the illness and its treatment? As 
the medical treatment of childhood cancer has moved from an inevitable death sentence to 
an approximately 80% cure rate, the importance of including the psychosocial in the 
treatment of the children has now been so integrated that the majority of the pediatric 
cancer centers throughout the world now view treatment as a biopsychosocial process. 
From the very beginning, with the shock of the diagnosis itself, the children and their 
families undergo a critical change in their lives. The illness has a high social and economic 
cost, even if the treatment itself is done free of charge to the families. Whether the child is 
treated in countries with limited resources or in the wealthier countries, personal, family, 
and cultural circumstances can block access to a full cure, a cure that treats the child at all 
levels:  medical, psychological and social. As the families face the task of adjustment to this 
new reality, with the support of the hospital health care team the families can find a source 
of renewed energy and the inner strength to cope with the disease and the treatment 
process.  
Each phase of treatment has its own characteristic that contribute to the reaction of parents 
and children. The phases are the following: acute phase, during treatment, after treatment, 
long-term follow-up, end-of-life. 
2. A Multidisciplinary effort: Type of strategy in all the phases of the disease 
From the earliest years, the effort to care for the child with cancer has been 
multidisciplinary, multi-institutional, and international, involving a highly cooperative and 
collaborative effort of physicians, nurses, psychologists, social workers, and allied health 
care professionals all working together across national borders. When, thirty years ago, 
physicians treating the children found themselves struggling with the psychological and 
social repercussions of the cancer on their young dying patients and their families issues 
that ranged far beyond their medical expertise and training, psychosocial practitioners 
helped in dealing with these broader human concerns. The pediatric oncologists and 
hematologists from countries throughout the world began working cooperatively with 
psychiatrists, social workers, nursing care specialists, and psychologists. To the credit of all 
involved, this cooperative multidisciplinary, multi-institutional and international effort has 
been from the very earliest years and continues to be the hallmark of the treatment of 
childhood cancer. It is important that all members of the health care team engage in 
psychosocial support, and not just the psychosocial personnel. 
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3. Research: Psychosocial research is essential to build up different clinical 
approaches 
The primary psychosocial concern in child cancer care is to help the children and their 
families cope with the diagnosis of cancer and its aftermath. The children and their families, 
the great majority of whom are struggling with the new diagnosis but who do not show 
signs of falling apart, need our support. How can we most effectively help mentally healthy 
children whose lives have been suddenly turned upside down with the diagnosis of a life-
threatening illness? We can’t expect the families to wait for intervention until we can fully 
determine which intervention works most effectively and validly. We must try to help the 
child and family who have an immediate here-and-now need for support, while pursuing 
scientifically valid controlled research designed to sort out effective from ineffective 
interventions. The optimal clinical service is the application of the best available evidence-
based findings applied locally in cultural context. Well done research is costly and difficult 
to accomplish in centers with limited resources. However, the health care team even a center 
with limited resources can listen carefully to the children and their families to find out how 
they are functioning and how they are responding to the service that is offered. It is 
recommended that parents be asked formally how well they view the center’s functioning 
and this satisfaction within a simple nonrandomized like study. Modifying one’s approach 
based on a reflection on the families’ level of satisfaction with the service can help make the 
service better. Even in countries with limited resources, it is possible and critically essential 
to give full attention to the psychosocial needs of the children and their families.  
4. Alliance between parents and physicians: The basis in all the phases of 
the disease 
It is clear that a hospital health care team can not do it all. Parents should be invited 
increasingly to participate actively in their child’s medical, psychological and social care, 
brought in as part of the decision-making process and support system. There should be a 
healthy, cooperative, and open alliance between the parents and the members of the health 
care team, including the establishment of parent groups for self-help and for raising 
supplementary and critical funding.  
Wasteful expenditure of negative energy by anyone involved might be more profitably 
used, and in turn mobilize new and even more powerful positive energies, by cooperating 
toward fighting the disease in a therapeutic alliance. This alliance may take one or both of 
two forms: (a) an alliance between individual family members parents and children and 
individual medical staff members; and (b) an alliance between families as a group and 
health care team members as a group. These therapeutic alliances are formed when both 
parties work together with a common purpose pooling resources toward a common goal: 
curing the cancer and minimizing its medical and psychosocial side-effects, and mobilizing 
the energies of all members of society to this end. 
The role of physicians and health care team members working together in cooperation with 
parents as equal partners is to: 
1. Dedicate time, energy and creativity to collaborate with parent associations by 
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2. Encourage all parents, especially shy or cautious parents, to join a parent association 
and help activate parents to organize such associations where they do not already exist. 
3. Have parent association members, together with members of the health care team, 
cooperate in deciding upon a global medical, psychosocial and social-cultural 
intervention program, toward which they all can converge their united energies. 
4. Do all in their power to ensure that cured children and young adults are successfully 
reintegrated into society, without being penalized in school, work, social relations or 
insurability for having had cancer as a child.  
5. Open communication: At diagnosis, during treatment, at the end of life 
Communicating the diagnosis and how best to do is the first step in a communicative 
process and relationship that involves the medical team and the family, and that allows for 
growth and change over time. As the evidence mounts that the children, siblings, and 
parents would be best served by being encouraged to bring into the open their anxieties 
about the illness and its possible consequences, studies have been paying more attention to 
how parents and medical personnel communicate with the child. The initial diagnosis is a 
model for all future interchanges of information between the medical professionals and 
families and between the family members themselves, especially between parent and child. 
As the families of the children diagnosed with cancer struggle to face the new emotional 
crisis which is challenging the relationships among the family members and the very 
balance of family life, we need to help the families strengthen their coping skills, alleviate 
their anxiety and offer the type of support the children and families are seeking, in specific 
ways that are most important to the children and families at a given moment. Basic to 
effective family coping is the belief that communication of both happy and painful thoughts 
and feelings, by the parents and by the children, is a healthier state of mental well being 
than retaining those thoughts in silence. This belief is a prerequisite to mutual support 
among family members. The families which allow open discussion of the illness and its 
prognosis are able to cope more effectively with the illness within their own family, and are 
also able to give and receive the support of other parents in the clinic.  
Management of this communicative process has an important influence on how all involved 
child, parents, other family members, and medical staff work and care for the child together. 
At diagnosis the child and family’s level of anxiety is very high, and their level of prior 
information and understanding varies greatly. Most parents want to know as much as 
possible about the disease, treatment procedures, prognosis, practical coping details, and 
emotional impacts. The staff’s communication of the diagnosis and treatment plan should be 
done in a way that is responsive to these needs, and that develops confidence and trust 
among the pediatric cancer staff, patient and family. 
Our general view is that full and open communication between the medical care team and 
the family (including the child), and within the entire family, is the ideal situation. However, 
this is not always possible or preferable. It also must be done in a way that is sensitive to 
different cultural styles and preferences. 
The communicative session should be conducted in a private space, with comfortable 
seating and an environment conducive to discussion of painful issues, as a conversation 
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between equals. Both parents and the chairman or a senior medical staff member should be 
present, as well as the head nurse or another staff member. The attendance of the family’s 
local physician should be encouraged unless parents do not agree. If requested the child 
with cancer (according to age), other family members (e.g. grandparents: they are significant 
sufferers that often receive little attention!) or close friends also may attend this session. 
When communicating with the child, the physician should explain the disease at the level of 
development of the child, using pictures and analogies such as the flower garden to help the 
child’s understanding. The physician should make sure that the dialogue is truly a two-way 
interaction, with the child invited to ask questions and having the answers explained as 
clearly as possible. Depending on age and level of development, the physician should talk to 
the siblings as well, explaining to them the basic elements of the disease and its treatment, 
and having them as well communicate back to the parents what they understand about the 
illness. In this way, an open system of communication is set up within the family.  
6. The siblings: At diagnosis, during treatment, over the time 
From the earliest intervention periods, the health care team members have all they can do, 
first to focus on the needs of the children with cancer, and then on the needs of the parents. 
The parents are overwhelmed by their concerns for the sick child, giving their immediate 
and full attention to the medical treatment of their sick child. Without any ill intention on 
the part of already overburdened parents, siblings are often inadvertently ignored. We 
should try to give attention to the needs of the siblings as well, and not let them be 
forgotten. During this time of crisis, when the parents are already giving their almost 
undivided attention to the sick child, how does one bring the needs of the siblings to 
parents’ attention? How does one encourage and help the family to return to as normal a 
family life as possible as soon as possible? There are general principles for helping take care 
of the needs of siblings that apply throughout the treatment process, and there are 
principles specific to each phase of treatment: what to expect both for themselves and for 
their brother or sister now versus after physical changes occur, or changes in their 
relationships with their brother, sister, and parents, and what they can do to help during 
these transitions; and what adverse effects the siblings might have on the patient (for 
example, “spreading germs,” e.g., a cold, or picking fights). Members of the health care team 
can speak with parents about the need to support the siblings, despite all of the other 
burdens that go into caring for the ill child. They can encourage the parents to share and 
generate suggestions regarding how to involve the siblings from the very beginning. Parents 
need to communicate with and listen to siblings. As an instinctively human reaction, in the 
absence of factual information, siblings tend to fear the worst, even for their own health. 
When parents and members of the health care team attempt in good faith to shield the 
siblings from knowledge about the illness, such well-intentioned hiding of the truth often 
drives the siblings to fear even worse possibilities, and can lead to feelings of isolation, guilt, 
and resentment. 
At the time of diagnosis, health care team members and other parents when feasible should 
share with the parents of a newly diagnosed child the need to keep siblings informed from 
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encouraged to bring the siblings to the hospital if the siblings wish to go, let them visit with 
their brother or sister, and let them see how the hospital looks; parents should be 
encouraged to explore the benefits of immediately telling the siblings, and should help 
choose which person will be the one to inform the siblings, using simple and age-
appropriate language and phrasing when delivering the news of the diagnosis; and siblings 
should have explained to them that they were in no way responsible for causing the cancer.  
7. Living a normal life/back to school: During treatment 
Improvements in the ability of medical care made it possible for children diagnosed with 
cancer to live longer and, in increasing frequency, to be cured. The children are able, 
while in remission, to live a relatively normal life, somewhat free of their concerns about 
their illness. We need to help the children to engage in the educational and social 
activities that accompany normal growth and development . It is not enough for young 
people simply to survive what was once a life-threatening illness. Survival means that the 
children have to continue to be educated toward one day becoming fully functioning 
adult members of society. Thus, parents and professionals have the increasing 
responsibility of promoting sound academic and social development as the children go 
through the treatment process.  
Going back to school has a very normalizing influence on the child. Integration into school is 
a critical and essential part of the normal psychological and social development of any child. 
Children with cancer are not only entitled to attend school, but they must be stimulated to 
do so. Even while in the hospital, children should continue their schooling, as an indication 
to them of hope for cure, that their life will continue as normal, despite the illness. Programs 
should be developed to help the children continue their schooling while in the hospital, and 
to help them return to their normal life as school children as soon as possible, and their 
teachers trained to treat the children as normally as possible. We should pay special early 
attention to patterns and difficulties of socially adaptive behavior in the children and most 
importantly be aware of the strong link between the use of cranial radiation and subsequent 
learning deficits. As a group, children with cancer function at less socially adapted levels in 
school than peers, have a tendency not to reach out to others, not to initiate activities, not to 
try new things, and not to express feelings freely. The children retain a self-protective 
attitude. And so, in addition to already being devastated by the emotional stresses 
associated with a child having cancer and undergoing what to them were extraordinary 
medical treatments, we know that the cognitive side effects of the therapy place a group of 
the children at a higher risk not only for learning difficulties, but also for subsequent 
adaptive behavioral problems. 
We cannot freeze children for years during treatment while their peers continue to grow and 
develop, leaving the children with cancer developmentally far behind and in a catch-up 
mode. We must prepare children for their future. Not only should we give priority to the 
children continuing to live a normal life during the course of treatment, we have in fact 
come to view childhood cancer as a golden opportunity for the children to learn skills in 
coping that can give them a running start on their preparation for engaging in a fully 
functioning adulthood.  
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8. Long-Term survivors or better “cured” subjects: After treatment, long-term 
follow-up 
How well are the children responding to the increasingly successful treatments? Programs 
oriented to the needs of the long-term survivor should begin when the child goes off 
therapy, with centers focusing on the sequelae specific to each form of illness, treatment, 
toxicity, and future problems specific to each child’s needs. Centers should offer counseling 
programs for the more serious medical and psychosocial problems, adapted to the need of 
each individual and local culture. Centers should develop specialty clinics, managed by the 
pediatric oncologist who treated the children, and having available a full range of adult and 
young adult specialists as consulting physicians. Each long-term survivor should be 
monitored for special conditions related to their unique history as well as their age-specific 
developmental concerns. Programs should include psychological counseling for the 
survivors experiencing adjustment difficulties and significant side effects.  
As medicine continues to achieve an increasingly higher success rate in long-term survival, 
we should follow survivors to determine further potential long-term sequelae. The long-
term role of each pediatric hematology/oncology center is to follow the survivors until there 
is assurance that the child will have no further long-term sequelae. It is important and 
critically necessary to follow the child until the disease is considered “cured” (at about five 
years). After that time, one should not over-medicalize the survivor, but help the child to 
make the transition to normal health-care status. When specific sequelae (such as heart 
problems) are known for a particular child, that child should be followed for the issue of 
concern specific to that child.  
The clinic should keep a careful computerized record of essential data particular to each 
survivor so that in the future, when the now-adult survivor is seen by an adult physician, 
the data on the survivor’s previous cancer experience will be available upon request.  
Psychological research studies that have followed the survivors of childhood cancer for many 
years after successful treatment have found, not only that the now-adult-survivors are doing 
well, but that in many way having learned from the challenges of their childhood cancer 
experience they are better prepared for the more pressing challenges of adulthood than are 
their peers. The so-defined resilience is not an utopia but a always more visible reality.  
9. Impending death: At the end of life 
Despite the remarkable growth in the percentage of cures and the increasing sense of hope 
being given to newly diagnosed children and their families, many of the children are not 
able to be cured. Death for some remains a reality. There are three periods of time 
surrounding this final phase of life that have become the subjects of research. The first is the 
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curative, for physical or mental distress. There can be a long delay between the moment 
when the physician determines that the child will not be cured and the moment when 
everyone involved agrees that the child has entered the last or final phase of life. 
In managing this transition from the curative to the palliative phase of the child’s treatment, 
it is critical to protect the child. The expectations of the family must be considered to help 
them avoid feelings of guilt for not having done everything possible. However, a real 
dilemma is created for everyone if aggressive therapy is continued when the possibilities of 
cure are virtually not existent. 
The decision to move from the intent to cure to palliative care should be made with the 
parents and the full health-care team, certainly including the nurses. Depending on age and 
level of development, the child should also be involved in the decision, with older children 
especially participating more actively. The child should know as much as possible and 
developmentally appropriate about the seriousness of his/her situation. However, if the 
child wishes to remain less informed, this wish should be respected, and whatever 
information is given should allow the child to retain a margin of hope. 
The continuation of curative treatment beyond the point when cure is no longer possible 
should be avoided (the so-called ‘‘ruthless obstinacy’’ treatment). 
After a child dies, that individual child’s medical history should be evaluated. This 
evaluation should be made by the health-care team as a group. It is very important to reflect 
on all events, even minor ones, that occurred during the course of the child’s treatment. It is 
critical to reflect on the choices that were made and why, in order to help the staff come to 
terms with their own grieving and to learn from the experience in order to help future 
families. 
The center’s health-care team should be prepared to modify its overall philosophical goals 
and reset directions and guidelines when appropriate, based on such review of individual 
cases and parental comments. 
After the child dies, hospitals should offer bereavement counseling on the part of physicians 
and nurses to help clarify past care and guide future grieving. Parents and siblings, when 
appropriate, can be invited to discuss with the physician both the level of care and the 
surviving family members’ current needs. A first-step aid to bereavement is for the 
physician, about three to four months after the child dies, to call back the parents (and 
siblings, when age-appropriate) and to discuss with them the details of the terminal phase, 
to help them work through their understanding of what happened. If at this point, some 
families need further help in grieving, they can be referred to parent-self-help grieving 
groups or to one-on-one therapy. For the majority of the families, the one follow-up 
interview appears to be a sufficient step in helping them to move forward through the 
grieving process. 
10. Final recommendations for application: Since diagnosis on 
Psychosocial interventions have become so fully incorporated into the care of children with 
cancer that they are now considered, not just an appendage, but a critical component in the 
care of the child with cancer. Where do we go from here?  
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1. As we health care professionals become more experienced in dealing with the children 
with cancer and their families, we cannot forget that for each newly diagnosed family, it 
is truly all brand new. Each case is individual. We should continue to bring to the 
newly diagnosed children and their family a fresh sensitivity that acknowledges the 
newness of their experience.  
2. Children, even the youngest, sense the seriousness of their illness. They pick up the 
fears and anxieties of the adults around them. They do their best to communicate with 
us, at all ages. Even the youngest try to talk to us, often without words, often just by 
their body language. How well do we listen? Do we truly listen? We need to develop 
more effective ways of attending to what the children are experiencing and their mode 
of communicating that awareness. 
3. Many of our interventions have proceeded far ahead of our success in measuring their 
effectiveness. While many new instruments have been developed and older 
instruments have been creatively applied specific to the study of the children and their 
families, we need to continue this creative effort and plunge more deeply into the study 
of the effectiveness of our interventions. 
4. Parent groups are critical to the continued success of each clinic’s efforts, not only by 
forming support services for one another on mutual psychosocial needs, but as 
importantly in teaming with physicians in raising funds to keep the clinic up-to-date 
and growing both in research and in intervention. Health care professionals and parents 
should strengthen their alliance, making it a priority to continue sharing decision-
making, not only in individual cases, but in parental support of the clinic’s growth. 
5. Among the newly diagnosed families, there will be a small percentage 15% or so who 
bring with them pre-diagnosis problems that can seriously interfere with the child’s 
treatment. We should continue to develop ways to help identify these families at the 
very beginning, so that we can refer them for the extra psychosocial help that they will 
need in order to cope with the treatment. With our remaining resources, we will then be 
better able to help the families who bring with them a stronger history of coping 
abilities and who are less encumbered by long-standing behavioral, social, financial, or 
legal problems. 
6. Burnout is a very serious possibility for those working with children with cancer and 
their families. Acknowledging this very real fact and talking about it openly within the 
health care team can help prevent serious burnout and alleviate the milder and more 
subtle forms of burnout.  
7. While there is an ongoing need for professionals to publish their findings in refereed 
journals, it is equally important to translate these findings into readable, clear, and 
simple booklets or pamphlets for the children, for their parents, and for their teachers. 
We owe it to the children and their families to continue developing clear and simply 
written booklets that can help explain some of the complexities of the treatment in ways 
that they can understand. 
8. Much of our psychosocial long-term follow-up study during these past years has 
focused on potential negative sequelae of the illness and how best to prevent and/or 
ameliorate them. The next step in helping the children as they grow into adulthood 
should be to focus on the potential for growth associated with their illness. The 
children-becoming-young-adults, by overcoming their illness,  have a golden 
opportunity to develop their skills in coping and learning to deal with future life’s 
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9. Medicine advances most effectively by narrowing its scope. Psychology advances by 
broadening its scope and generalizing to theory. Both together are necessary in the 
treatment of the child with cancer. As we continue to develop the research and 
intervention efforts with the children with oncological and hematological illnesses, we 
have seen our biopsychosocial efforts become a model for the increasing integration of 
the psychosocial in the treatment of children with a variety of chronic illnesses (Roberts, 
2003). We should continue to disseminate our research and intervention findings 
among pediatric practitioners who are dealing with similar issues in different settings 
and with different chronic childhood illnesses.  
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1. Introduction 
The professional liability crisis remains a common problem for obstetricians. Approximately 
90% of American College of Obstetricians and Gynecologists fellows have been sued at least 
once and 25% have been sued four or more times. Approximately 15% of obstetricians have 
ceased obstetric practice because of exorbitant premiums and the prevalence of 
nonmeritorious claims in this field of practice. The average age at which an 
obstetrician/gynecologist stops providing obstetrical care is currently 48 years of age; the 
age at which most physicians approach the peak of judgment and experience.  
This current liability crisis is very relevant to all practitioners who care for newborns. 
Neonatologists, pediatricians, hospitalists, and nurse practitioners all provide critical care to 
sick newborns in different venues. These newborns are younger, more fragile, often 
extremely small and the risk of life long chronic disease, pain and disability are significant 
for these patients. Parents often experience emotional and economic distress when their 
newborn is in the NICU. These factors have contributed to an increased number of 
allegations against practitioners of neonatal/perinatal medicine. 
Juries tend to have a natural sympathy for disabled children even when allegations are 
nonmeritorious. In addition, many states exempt minors from the statute of limitations for 
medical liability which can lead to a physician defending claims 10-20 years after the alleged 
incident. Capping noneconomic damages in children is difficult. The increase in litigation 
cases is mirrored by an increase in the awards received by the plaintiff. Today the average 
jury award for poor obstetric and neonatal outcome exceeds $3,000,000. Obstetricians pay 
some of the highest insurance premiums, up to $300,000 per year in some states. Efforts at 
tort reform, award caps and the policing of junk science have not been uniformly successful. 
The purpose of this Chapter is to identify the etiology, pathology and prevention of 
common allegations of professional liability for the obstetrician and practitioner of neonatal-
perinatal medicine. The author has reviewed 100 closed cases of alleged professional 
liability against obstetricians for causation of poor neonatal outcome and 100 closed cases of 
alleged professional liability involving practitioners of neonatal perinatal medicine as an 
expert. These cases were reviewed over a 25 year period (1985-2010). Approximately 75% of 
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the cases were reviewed for the defense and 25% for the plaintiff. Of these, 75% of the cases 
were settled, 19% were dismissed and 6% went to trial with a favorable jury verdict for the 
defense in 75% of the trial cases. Based on our experience, we developed an evidence-based 
work-up that can confirm or refute allegations of acute intrapartum asphyxia sufficient to 
cause cerebral palsy. 
2. Common allegations of obstetrical professional liability 
Table 1 lists the eight major categories that resulted in allegations of obstetric professional 
liability. The most common obstetrical allegation was failure to perform a timely C-section. 
The inability to recognize and react to nonreassuring fetal heart tones was the dominant 
allegation. Poor communication between the nurse, obstetrician and anesthesiologist in 
making the decision and provisions to perform an emergency C-section was common. The 
ability to perform an emergency C-section as a rescue procedure for the patient and/or fetus 
is a necessary part of the practice of moderate obstetrics. Although only accounting for 3% 
of all cesarean sections, the timeliness of cesarean sections is a frequent source of litigation. 
Even today it is unclear if this 30 minute rule from decision to incision is valid and more 
studies need to be performed. In fact, a recent study showed that approximately one-third of 
primary C-section deliveries were performed for emergency indications and were 
commenced more than 30 minutes after the decision to operate, mainly for nonreassuring 
fetal heart rate tracings. In this study, adverse neonatal outcomes were not increased. 
Unfortunately despite limited data, the 30 minute response time has become a medical/legal 
benchmark for adequacy of obstetrical care when a cesarean section is indicated. 
Failure to triage a mother appropriately was the next most common allegation of 
professional liability against practitioners of obstetrical care. It is essential that all emergency 
rooms have specific protocols in the evaluation and management of the pregnant patient 
even when the primary complaint may not be obstetrically related. Misdiagnosis of 
preeclampsia/HELLP syndrome can be fatal to the mother and newborn. More common in 
group practices, the problems that result from a failure to follow-up on specific tests ordered 
in the prenatal period. The failure to follow-up on fetal ultrasounds that demonstrated twin 
to twin transfusion is a specific example. “If you do not document it, you did not do it” is a 
common cause of speculation 
Complicated deliveries can result in catastrophic neonatal outcomes. Many high-risk 
situations, such as delivering a poorly controlled diabetic, VBAC, forceps, and vacuum 
require that the obstetrician initiate pediatric/neonatal presence in the delivery room. 
Infants born under these situations can appear stable and decompensate 12-48 hours after 
the initial event. The pediatrician needs to be alert for signs and symptoms of anemia, 
seizures and any altered neurologic status. A twin pregnancy is high risk and should 
command the presence of appropriate personnel for the delivery. 
Regionalization continues to have a role and is in the best interest of the mother and 
newborn. The state and perinatal centers oversee the rules and regulations that dictate the 
level of care of the high risk mother and newborn provided at specific hospitals. Triplets and 
higher order pregnancies, newborns with known congenital anomalies and extremely low 
birthweight newborns are best delivered and cared for in a tertiary center. The best 
ambulance is the uterus. Ego can cloud good judgment and compromise the care and 
outcomes of the mother and fetus. 
 






Case Examples N = 100 
1. Failure to 
perform a timely  
C-section 
Non-reassuring fetal heart tones 
Poor communication between OB’s 
and Anesthesiologists 
Obstetrical nurse failure to interpret 
ominous fetal strip 
Nurse spent too long trying to 
obtain FHT when none were present
Inadequate fetal monitoring for 
prolonged periods of time 
Postponing aggressive 
treatment for the next shift 
Inadequate physician sign out 
at change of shifts 
Failure of midwife to recognize 
ominous fetal heart tracings 
Failure of midwife to have 
appropriate resuscitation 
equipment and personnel for 
home delivery 
40% 
2. Failure to 
triage mother 
appropriately 
Failure to follow-up test results 
Failure to give antenatal steroids 
Emergency room triage errors 
(misdiagnosis of Mirror Syndrome) 
Misdiagnose pre-eclampsia as 
gallbladder disease in ER 
Mother sent home at 39 weeks in 
active labor 
Failure to detect rupture of 
membranes 
Failure to rule out abruption 
Failure to diagnose HELLP 
syndrome 
Diagnostic difficulties due to 
maternal obesity 
Failure of triage nurse and/or 
house staff to present an 






Uterine rupture with VBAC 
Double footling breech delivered 
vaginally 
Neonate born with fractured 
ribs, skull fracture, fractured 
clavicle 
Twin pregnancy in which in 
utero demise of viable twin was 
due to nonviable twin death 
17% 
4. Failure to 
transport mother 




Expected difficult delivery with 
complicated neonate was not 
preemptively transferred to a 
tertiary care center 
Delivery of triplet or higher order 
pregnancy in a level 2 center 
Congenital anomalies 
Complicated twin pregnancies, 
triplets, quadruplets (twin to 






Dosing errors with Pitocin 
Using Pitocin instead of Magnesium
Failure to follow Pitocin protocol 
Failure to discontinue Pitocin 
with non-reassuring fetal heart 
tones and/or hyperstimulation 
5% 




Failure to diagnose chorioamnionitis
Failure to obtain and document GBS 
status 
Failure to recognize fetal 








Late preterm newborns 2% 
8. Failure to 
educate patient 
Patient not instructed exactly when 
she should go to the hospital for 
labor 
  1% 
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Another common allegation of professional liability with poor neonatal outcome involves 
the use of Pitocin. In our experience, many obstetricians and obstetrical nursing personnel 
were not familiar with their hospital specific protocol for the use of Pitocin. Failure to 
discontinue Pitocin with nonreassuring fetal heart tones and the inability to recognize 
hyperstimulation generates arguments for poor neonatal outcome. Since 1994 the use of 
antenatal steroids to enhance fetal pulmonary and brain maturation has become the 
standard of care. Failure to give antenatal steroids between 24 and 34 weeks gestation with 
evidence of imminent delivery can result in poor newborn outcomes. 
Neonatal sepsis can have significant morbidity and mortality. Failure to obtain and 
document Group B Streptococcus (GBS) status was common. Failure to recognize fetal 
tachycardia as a fetal response to chorioamnionitis was noted. Chorioamnionitis is one of 
the most common causes for newborn depression often requiring significant resuscitation in 
the delivery room. The presence of maternal chorioamnionitis which can include a fever, 
elevated white count, left shift, fetal tachycardia and foul-smelling amniotic fluid should 
mandate the presence of pediatrics/neonatology for the delivery. 
In the last decade a significant awareness on the dangers of induction for convenience 
and/or maternal request has evolved. Numerous studies have shown that the late preterm 
newborn has significant morbidity and mortality compared to their term counterparts. One 
should never assume that a late preterm newborn at 34-36 weeks will have an uneventful 
nursery course. In our experience and supported by numerous studies, the male infant is at 
least one week behind in maturation compared to their female counterparts. Some of the 
most severe cases of hypoxic respiratory failure can occur in these late preterm newborns. 
A common pathway leading to litigation from the previous eight categories of the 
obstetrical allegations discussed is whether with a reasonable degree of medical certainty a 
deviation in the standard of care caused morbidity and/or mortality in the newborn. The 
proportion of cerebral palsy associated with intrapartum hypoxia-ischemia is 8-14.5%. 
Despite this fact, the use of junk science, unethical expert witness testimony, and speculation 
in childbirth litigation persist. 
3. Proposed work-up to confirm or refute allegations of acute intrapartum 
asphyxia 
The next section summarizes our work in developing a workup for the newborn to confirm 
or refute the 4 essential and 5 suggestive criteria proposed in defining an acute intrapartum 
event sufficient to cause cerebral palsy as defined in the 2003 ACOG and AAP Task Force 
publication on Neonatal Encephalopathy and Cerebral Palsy. (Table 2) 
Each case of alleged intrapartum asphyxia is unique and no single test can time an alleged 
event. The College criteria have been criticized for being too restrictive and potentially not 
being able to identify many cases of intrapartum asphyxia. Many consider a sentinel event 
to be a critical and essential first step in linking intrapartum asphyxia to neonatal 
encephalopathy. Aside from a sentinel event during labor, the College criteria are 
postdelivery assessments. Despite this controversy, we feel this proposed workup will 
provide significantly more objective evidence-based data in the medical record to support or 
refute allegations of intrapartum asphyxia. Table 3 outlines an evidence-based work-up to 
be considered in term and near term newborns with unexplained depression at birth with 
evidence of encephalopathy including seizures. 
 




ESSENTIAL CRITERIA (Must meet all four) Clinical work-up 
Evidence of a metabolic acidosis in fetal umbilical 
cord arterial blood obtained at delivery (pH < 7.0 and 
base deficit ≥ 12 mmol/L) 
Arterial Cord Gas 
Early onset of severe or moderate neonatal 
encephalopathy in infants born at 34 or more weeks 
of gestation 
EEG 
Cerebral palsy of the spastic quadriplegic or 
dyskinetic type MRI Head 
Exclusion of other identifiable etiologies such as 
trauma, coagulation disorders, infectious conditions, 
or genetic disorders 
Newborn Weight, Length and Head 
Circumference 
Placental Pathology 
CBC with Differential, blood cultures 
U/S Head 
MRI Head 
Criteria that suggest an intrapartum timing Clinical Work-Up 
A sentinel (signal) hypoxic event occurring 
immediately before or during labor 
Electronic Fetal Heart Rate Interpretation 
CBC with Differential, Platelets, 
NRBCs 
A sudden and sustained fetal bradycardia or the 
absence of fetal heart rate variability in the presence 
of persistent, late, or variable decelerations, usually 
after a hypoxic sentinel event when the pattern was 
previously normal 
Electronic Fetal Heart Rate Interpretation 
CBC with Differential, Platelets, 
NRBCs 
Apgar scores of 0-3 beyond 5 minutes Apgar Score 10 and 15 min 
Onset of multisystem involvement within 72 hours of 
birth 
PT, PTT, Fibrinogen, LFTs, Creatinine, 
Electrolytes, Glucose, Calcium, ECHO 
Early imaging study showing evidence of acute 
nonfocal cerebral abnormality 
Ultrasonography of the head 
MRI of the head 
EEG: electroencephalogram; MRI: magnetic resonance imaging; NRBC: nucleated red blood cell; PT: 
prothrombin time; PTT: partial thromboplastin time; LFT: liver function tests; ECHO: echocardiogram 
Table 2. Criteria to define an acute intrapartum event sufficient to cause cerebral palsy 
Umbilical cord blood gas assessments are the most objective determinants of the fetal 
metabolic condition at the moment of birth. Umbilical arterial blood reflects fetal status 
more directly and umbilical venous blood more closely reflects whether the oxygen 
exchange of the uteroplacental unit is optimal. Westgate et al recommend obtaining cord 
blood from the artery and vein. However, in clinical practice this is not practical and an 
umbilical cord arterial gas is most often obtained. Fetal scalp blood sampling has been 
virtually eliminated in clinical practice without an increase in adverse newborn outcomes. 
An ongoing dilemma with the College criteria is the requirement of metabolic acidemia to 
determine whether an insult occurred intrapartum. Many term newborns who are delivered 
in the presence of fetal acidemia are not recognized by intrapartum events and are triaged to 
the regular nursery with an uneventful hospital course. Studies have demonstrated when 
the umbilical artery pH was less than 7.0 at birth, 67% had a metabolic component in their 
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umbilical arterial pH less than 7.0 at birth, neurologic damage was found in 23%, with the 
remaining 77% being neurologically normal at the time of neonatal discharge. The pH is a 
direct measurement, whereas the base deficit is a calculated value obtained by the Siggard-
Andersen alignment nomogram. This nomogram can confirm the biochemical authenticity 
of arterial cord blood gases. Umbilical arterial pH decreases and the base deficit increases 
during the course of normal labor, because a buffer base is depleted before the pH declines. 
The pH decreases approximately 0.07 units for every 10-mm Hg increment increase in 
PCO2. The respiratory component of acidosis cannot damage the newborn, and when 
present, the onset of hypoxia can be established because this component cannot last more 
than 20 to 30 minutes. In our experience, the absence of a cord arterial blood gas leads to 
more speculation between the plaintiff and defense experts than any other laboratory value 
and should be drawn in all deliveries and sent for analysis when clinically indicated. 
 
Clinical Work-Up Days of Life 1 2 3 7 
1 Arterial Cord Gas X    
2 Apgar Scores at  10’ and 15’ (if 5 minutes  ≤  6) X    
3 Physical Exam:  Newborn weight, length and head circumference X    
4 Placental Pathology X    
5 CBC with differential, Platelets, blood cultures X    
6 U/S Head X X   
7 NRBCs X X X  
8 PT, PTT, Fibrinogen, LFTs, Creatinine, Electrolytes, Glucose, Calcium, ECHO  X   
9 EEG  X   
10 MRI Head    X 
Table 3. Proposed Clinical Work-Up of Newborns > 34 weeks GA with Alleged Perinatal 
Asphyxia in the First Week of Life 
Neonatal encephalopathy is a clinically defined syndrome of disturbed neurological function 
in the earliest days of life, manifested by depression of tone and reflexes, subnormal levels of 
consciousness, and often times, seizures. After intrapartum asphyxia, hypotonia is the norm 
and, in general, early hypertonia or absence of hypotonia (normal tone) point to other 
neurological abnormalities. The grading of neonatal encephalopathy as mild, moderate, or 
severe was originally described by Sarnat and Sarnat. The presence of seizures is required to 
meet the Sarnat criteria for moderate to severe encephalopathy. Neonatal seizures can be 
subtle, often presenting with oxygen desaturations and focal motor abnormalities such as eye 
deviation, smacking of lips, and staring. Also, the presence of atypical apnea with 
desaturations frequently was not identified as seizures and delayed appropriate therapy. An 
electroencephalogram can be used to confirm the presence of seizures. Seizures soon after 
birth (1–6 hours or more than 24 hours of life are not consistent with acute intrapartum 
asphyxia). When seizures occurred within 24 hours, 48% of newborns were significantly 
negatively affected compared with when the seizures occurred after 24 hours. 
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Cerebral palsy (CP) is most often not diagnosed until well after the first year of life. White 
matter lesions such as cystic periventricular leukomalacia is a common lesion of prematurity 
(less than 34 weeks of gestation), often results in spastic diplegia, and is usually not 
associated with intrapartum asphyxia in the term infant. However, focal noncystic white 
matter injury is increasingly recognized in term newborns with neonatal encephalopathy. In 
term newborns, the gray matter is the most metabolically active and therefore most 
vulnerable to an acute intrapartum event. Although spastic quadriplegia with a dyskinetic, 
chorioathetoid component is the most common subtype of CP associated with an acute 
profound hypoxic intrapartum event, it is not specific to intrapartum hypoxia. 
The majority of cases involving neonatal encephalopathy and CP are associated with 
maternal and antenatal factors such as intrauterine infection, maternal/fetal coagulation 
problems, antenatal hemorrhage, abnormal presentation, preterm birth, and 
developmental/chromosomal abnormalities. Plotting out weight, length, and head 
circumference is a vital component of the initial newborn assessment. The presence of 
microcephaly at birth can be consistent with an earlier pregnancy insult and usually results 
in a poor neurological outcome. The presence of intrauterine growth restriction and status of 
small for gestational age at birth can be associated with poor neurodevelopmental 
outcomes. 
The placenta can be an excellent source of information to confirm alternate etiologies such as 
metabolic disorders, adverse growth events, and infections. Intraamniotic infection is the 
most common antecedent to birth depression, low Apgar scores, and neonatal 
encephalopathy in term newborns. The presence of chorioamnionitis and funisitis are 
significant risk factors for CP in term/near-term newborns. Fetal inflammatory response 
syndrome caused by cytokine expression in the fetus after exposure to maternal infection 
can also result in neonatal encephalopathy, often with negative cultures, cord arterial pH 
more than 7.0, and Apgar scores more than 3 to 5 at 5 minutes. Infection, inflammation, 
thrombosis, and coagulopathy are recognized as being associated with white matter-
mediated damage caused by the elevated fetal cytokines and are ultimately associated with 
periventricular leukomalacia and encephalopathy. A newborn with neutropenia (absolute 
neutrophil count less than 2,000) and a band-to-segmented neutrophils ratio of more than 
0.2 on a complete blood count more probably than not has clinical sepsis despite negative 
cultures. Newborn blood cultures should be obtained any time sepsis is suspected. A genetic 
work-up may be helpful to direct postnatal testing. Newborn thrombophilias also can be a 
congenital cause of abnormal neonatal outcome and may present as a hemorrhagic or 
thrombotic lesion. Many known thrombophilias, such as antithrombin III deficiency, protein 
C or S deficiency, prothrombin genetic deficiencies, hyperhomocystinemia, and factor V 
Leiden mutation, can all lead to strokes in the newborn, which can cause neonatal 
encephalopathy with CP and mental retardation and/or fetal/neonatal death. Meconium 
stained amniotic fluid is often erroneously associated with intrapartum fetal distress. In 
reality, 15% of the 4,000,000 annual births in the United States have meconium-stained 
amniotic fluid.  
Vaginal bleeding during labor can signal trauma, such as a ruptured uterus, abruptio 
placenta/placenta previa, or fetal bleeding from a vasoprevia. When bleeding leads to fetal 
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neutrophil count less than 2,000) and a band-to-segmented neutrophils ratio of more than 
0.2 on a complete blood count more probably than not has clinical sepsis despite negative 
cultures. Newborn blood cultures should be obtained any time sepsis is suspected. A genetic 
work-up may be helpful to direct postnatal testing. Newborn thrombophilias also can be a 
congenital cause of abnormal neonatal outcome and may present as a hemorrhagic or 
thrombotic lesion. Many known thrombophilias, such as antithrombin III deficiency, protein 
C or S deficiency, prothrombin genetic deficiencies, hyperhomocystinemia, and factor V 
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Vaginal bleeding during labor can signal trauma, such as a ruptured uterus, abruptio 
placenta/placenta previa, or fetal bleeding from a vasoprevia. When bleeding leads to fetal 





tracing such as bradycardia (usually less than100 beats per minute for more than 10 
minutes) and/or repetitive late decelerations with absent fetal heart rate variability. 
Bleeding can also be concealed and such fetal heart rate tracings may be the only suggestion 
of fetal compromise. 
The presence of anemia in the newborn at birth also can point to nonpreventable etiologies 
such as maternal–fetal transfusion as well as chronic abruption. Unexplained anemia in the 
newborn should prompt the pediatrician/neonatologist to request a maternal Kleihauer-
Betke test. In the newborn, a complete blood count with differential and a platelet count at 
birth as well as nucleated red blood cell often can be helpful in differentiating the patient 
with intrapartum asphyxia from other causes of encephalopathy. 
The presence of thrombocytopenia (less than 150,000) as well as an elevated hemoglobin 
(greater than 18 g/dL) and hematocrit (greater than 55%) in the newborn can be consistent 
with chronic hypoxia in utero. Serial nucleated red blood cell counts in the first 3 days of life 
can provide helpful information because an elevated nucleated red blood cell count at birth 
with delayed clearance (greater than 72 hours) does not support a diagnosis of acute 
intrapartum asphyxia. The proportion of CP associated with intrapartum hypoxia-ischemia 
is 8% to 14.5%.Certain preexisting conditions such as perinatal ischemic stroke, 
neuromuscular disorders, and certain in-born errors of metabolism can present at birth with 
a clinical picture not unlike intrapartum asphyxia. Likewise, elevated lymphocyte counts in 
the fetus may be predictive of earlier hypoxia that antedates labor. Finally, a detailed note 
by the obstetrician after delivery that summarizes the intrapartum course may be helpful in 
ruling out asphyxia in labor as the cause of newborn depression. 
Nonspecific criteria collectively suggestive of intrapartum timing include sentinel hypoxic 
intrapartum event. Cord prolapse, ruptured uterus, maternal shock amniotic fluid embolus, 
and acute bleeding can result in catastrophic intrapartum asphyxia. 
The National Institute of Child Health in Human Development’s Research Planning 
Workshop on electronic fetal heart rate monitoring offers standardized definitions for such 
tracings. The participants agreed that tracings with a normal fetal heart rate pattern 
including baseline heart rate within the normal range and normal fetal heart rate variability 
with the presence of accelerations and absent of decelerations (type I) confers an extremely 
high likelihood of a normally oxygenated fetus. At the other end of the spectrum, when 
there is bradycardia or repetitive (greater than 50% of contractions) late or significant 
variable decelerations, each with absent fetal heart rate variability (type III), there is a 
substantial risk of impending damaging asphyxia. However, the false positive rates of these 
patterns (type III) are very high, and the majority of nonreassuring fetal tracings during 
labor are associated with normal outcomes. Thus, none of these patterns can be used to 
predict CP and mental retardation as an outcome ascribed to intrapartum asphyxia. 
However, if accelerations occur above a normal baseline and variability of any degree is 
present, then it frequently rules out intrapartum acidosis or asphyxia as a cause of neonatal 
encephalopathy and CP. An in-depth review of the fetal heart rate tracing is helpful in 
confirming or refuting asphyxia as the cause of newborn depression. 
Apgar scores can be subjective. Numerous factors can affect the Apgar scores, including 
intrapartum maternal sedation or anesthesia, congenital malformations, the individual 
assigning the score, resuscitative efforts, and the presence of an infection. This can result in 
 
Risk Management in Obstetrics and Neonatal-Perinatal Medicine 
 
277 
speculation on the quality and response to resuscitation. Although low Apgars are poor 
predictors of long-term neurologic outcome, there is a good correlation with extremely low 
Apgars (0, 1, and 2) at 15 to 20 minutes and subsequent neurologic dysfunction. For 
example, Apgar score of less than 3 at 15 minutes was associated with a 53% neonatal 
mortality rate and a 36% CP incidence. Conversely, it is also true that 75% of children with 
CP have normal Apgar scores. The fine details of resuscitation require documentation or 
they could be used erroneously to support intrapartum asphyxia. Inability to achieve an 
adequate airway in a depressed newborn or failure of a previously damaged fetus to 
transition to extrauterine life are common etiologies of low Apgar scores and can 
erroneously lead to the assumption that this depression is attributable to the obstetric care. 
This is also important because the 30-minute decision–incision guideline may impact Apgar 
scores, as well as umbilical and neonatal blood gas sampling. It is paradoxical to note, 
however, that in 50% to 65% of cases, the decision–incision interval exceeds 30 minutes, but 
the lower Apgar scores and blood gases are usually found in those who have an interval of 
less than 30 minutes and often less than 15 minutes. 
Multisystem organ dysfunction is physiologically related to the diving reflex. In the majority 
of cases, intrapartum asphyxia deprives all other organs of oxygenated blood before the 
flow of oxygen to the brain is diminished. Studies have demonstrated that a cord pH 6.92 or 
less is the threshold linked with neonatal organ dysfunction at 72 hours of birth. Many 
expert witnesses erroneously consider a transient decrease in urine output (less than 2 
mL/kg-1/h-1) or a slight elevation in liver enzymes to be signs of 
multiorgan failure. The presence of pulmonary hypertension, tricuspid insufficiency, 
hypocalcemia, hypoglycemia, abnormal cardiac enzymes, and coagulopathy may be more 
supportive of multiorgan failure after a significant intrapartum event if other causes cannot 
be ruled out. 
Several patterns of brain injury may result from hypoxic-ischemic episodes in the fetus and 
depend on the severity of cerebral hypotension, the maturity of the brain at the time of 
injury, and the duration or recurrence of the event. Cerebral edema usually appears 
approximately 24 hours after a significant asphyxial episode and resolves in 3 to 5 days. The 
presence of cerebral edema on an ultrasonogram on the first day of life would not be 
consistent with an acute intrapartum asphyxial event. The evolution of cystic periventricular 
leukomalacia in preterm newborns takes 2 to 3 weeks after an insult to be visualized using 
conventional imaging studies such as computed tomography and ultrasonography scans. 
Magnetic resonance imaging has emerged as a valuable tool for determining the timing and 
etiology of neonatal brain injury. Hypoxia-ischemia in term newborns typically results in 
one of two characteristic patterns of brain injury: 1) a basal ganglia distribution pattern 
involving deep gray nuclei, hippocampus, and perirolandic cortex with additional cortical 
involvement when severe, and 2) a watershed distribution pattern involving intervascular 
boundary-zone white matter plus cortical gray matter when severe. Acute total asphyxia 
mainly involves the brain stem nuclei, thalami, and basal ganglia and is associated with 
dystonic CP and brain stem deficits. Prolonged partial asphyxia involves mainly the cerebral 
cortex, especially parasagittal regions, and is associated with spastic quadriplegia and 
microcephaly. In term newborns, basal ganglia and thalamic lesions evolve through a 
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after birth may appear normal even when there has been severe injury to the brain. It is 
important to consider not only which imaging studies to obtain but also when to schedule 
them to optimize the results in attempting to determine the timing of the alleged insult. 
Neuroimaging can be helpful in approximating a window of time when the injury might 
have occurred. 
4. Allegations of professional liability in neonatal-perinatal medicine 
We next identified the most common events in the care of sick newborns leading to 
litigation against practitioners. Multiple allegations were common due to the prolonged care 
of the newborn. Table 4 lists the top ten allegations of professional liability against 
practitioners of neonatal perinatal medicine. The ten most frequent allegations brought 
against practitioners who care for newborns included: inadequate airway/intubation (21%), 
failure to recognize air leak (18%), delayed transfer to Level III facility (14%), inadequate 
treatment of seizures (11%), delayed attendance at delivery (10%), cardiac tamponade 
(malpositioned central line) (6%), failure to perform eye exam (6%), medication error (6%), 
midgut volvulus (5%), and hyperbilirubinemia (kernicterus) (3%). Meritorious allegations 
against practitioners in newborn care are frequently preventable events. Substandard 
neonatal resuscitation in the delivery room can also propagate non-meritorious allegations 
against obstetricians.  
 
Allegation N = 100 
Inadequate airway/intubation 21% 
Failure to recognize air leak (pneumothorax) 18% 
Delayed transfer to Level III facility 14% 
Inadequate treatment of seizures 11% 
Delayed attendance in the NICU/delivery room 10% 
Cardiac tamponade (central line) 6% 
Failure to do eye exam (blindness) 6% 
Medication error (overdose) 6% 
Midgut volvulus 5% 
Hyperbilirubinemia (kernicterus) 3% 
Table 4. Top ten allegations against practitioners of newborn medicine 
We found that the most common allegations were a result of difficulties in the management of 
airways and air leaks in newborns. The procedural skills, including proficiency in intubation 
and thoracentesis, require a significant amount of clinical experience. Evolving technology 
over the last two decades with steroids, surfactants and ventilation have reduced the acuity of 
neonatal lung disease with concomitant reduction in intubations and chest tube placement. 
The recent restrictions on the time that pediatric residents are allowed to spend in intensive 
care units, set by the Accreditation Council for Graduate Medical Education, has contributed 
even more to their reduced experience with these procedures. More than half of all intubation 
attempts by pediatric residents are unsuccessful leading to multiple attempts by caregivers to 
properly place the endotracheal tube. Also, general pediatricians are often the primary 
caregiver when resuscitation of newborns in the delivery room is required. Their residency 
programs must ensure they become proficient in the resuscitation and care of the newborn. 
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Procedural skills teaching based on observing the skill, performing the skill, then teaching 
the skill is not adequate for proper training. Improving opportunities for clinical experience 
with intubation and thoracentesis may reduce legal actions against practitioners. 
Simulation-based training can have a role to provide a realistic medical situation in which 
learners can gain exposure to clinical tasks and anatomical regions. Approximately 10% of 
newborns require some form of resuscitation at birth, and a skilled resuscitator is necessary 
for all deliveries even when they are considered low risk. In our clinical experience, the most 
common etiology of decompensation in a newborn is airway related, with chest 
compressions rarely indicated when an adequate airway is effectively established. When an 
adequate airway is achieved, but newborns do not respond to resuscitation, one needs to 
expediently consider a pneumothorax in the differential diagnosis. Failure to recognize an 
air leak was the second most common allegation found in this study. An unrecognized air 
leak is the most common etiology for sudden unexplained death in unsuccessful newborn 
resuscitation. A tension pneumothorax is an acute life threatening event that may not allow 
the time for x-ray confirmation. Prompt recognition and needle aspiration of the pleural 
space should result in rapid clinical improvement for these newborns. It has been our 
experience that poor newborn outcomes as a result of improper delivery room resuscitation 
often are erroneously attributed to the delivering obstetrician. A depressed newborn 
requiring vigorous resuscitation with poor Apgars more often than not creates the mindset 
that it must be the obstetrician’s fault. 
Due to the critical state of newborns in the NICU, numerous protocols have been instituted 
to reduce iatrogenic events. When set protocols were not followed rigorously, we found that 
cardiac tamponade and blindness resulted in allegations of malpractice. Central lines are 
frequently used in the treatment of newborns for both medication and nutrition infusion, 
but their use carries significant risks. The possible malposition and migration of a central 
catheter can result in perforation of the myocardium or pericardial effusion which can be 
fatal. It is recommended that the central line be optimally placed outside of the right atrium 
to reduce these risks. Newborns with central lines must be carefully monitored with serial 
radiographs to confirm the position of the central line throughout the course of their 
treatment. Another protocol set forth in the care of newborns is an eye exam for all preterm 
newborns less than 33 weeks gestational age at 4 to 6 weeks chronological age. A newborn is 
almost never too sick for an eye exam, although nurses may feel that their patient is too 
unstable to be dilated and examined. 
The potential for rapid decline in an unstable newborn requires that their caregivers not 
delay in proper treatment measures. A prolonged response time for physicians during an 
emergency situation, as well as delayed transfer of newborns to a proper level NICU were 
common allegations found in this study. All hospitals have contracts that require trained 
personnel to be at a high-risk scenario within a certain time frame. A delayed response to a 
page, and the lack of an alternative plan to notify a skilled resuscitator can result in 
catastrophic consequences for a compromised newborn. In addition, critical care of a 
newborn often requires advanced services that are not available in all NICUs. Level I, II, II+, 
and community Level III centers have set policies and regulations overseen by their regional 
perinatal center. The lack of experience of nursing and respiratory personnel in a low 
volume NICU can contribute to deviations in the standard of care. Regionalization 
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Common allegations in this study also resulted from a failure to recognize life-threatening 
conditions including seizures and intestinal mid-gut volvulus. Newborn seizures can be 
difficult to clinically diagnose due to subtle abnormal ocular and focal movements. Subtle 
motor abnormalities with concomitant desaturation and/or apnea often represent seizure 
activity. The first line of medication in the treatment of seizures in newborns is 
phenobarbital at a loading dose of 20 mg/kg to achieve therapeutic levels of 20-40 g/mL. 
An adequate airway is essential if one desires to increase phenobarbital dosing. Persistent 
seizures may require the addition of phenytoin or ativan. Inadequately treated seizures can 
result in permanent neuronal cell damage due to enhanced metabolic activity. Malrotation 
of the intestine is usually observed in the neonatal period and presents with signs of acute 
intestinal obstruction and often bilious emesis. Mid-gut volvulus is a true surgical 
emergency, where delay can result in ischemic necrosis of the entire gut which is most often 
lethal. The upper GI series is the method of choice for diagnosing malrotation. Importantly, 
an acutely ill newborn with a history of bilious emesis needs immediate surgical 
consultation. Early diagnosis and treatment of these two conditions is essential in facilitating 
good outcomes. 
Medication errors are preventable events that frequently occur in the NICU and are a 
common source of allegations. It has been previously reported that out of every five adverse 
drug events in pediatric patients, three of those events occurred in an NICU. Errors are 
particularly dangerous in the NICU due to the fragile state of newborns. The rapidly 
changing body weight, different rates of organ development affecting drug 
pharmacokinetics, and need for dilutions of medications contribute to the common 
occurrence of medication errors in the NICU. In this study, medication errors occurred as a 
result of incorrect dosing, documentation, or processing. Morphine, sodium 
supplementation, and aminoglycosides were the most frequent pharmacological agents 
administered inappropriately. With the advent of computerized order entry, a reduction in 
ordering errors is expected due to standardized templates for physicians and nurses. The 
computerized system also provides an additional way to intercept errors before they affect 
the newborn. Documentation, communication, and attention to detail can help to reduce 
preventable medication errors. 
In the 21st century, kernicterus still occurs throughout the United States. The most common 
allegations in our experience were delayed contact and response of the blood bank as well as 
the inability to perform a timely exchange transfusion. An umbilical venous line is relatively 
easy to place, even in a newborn up to a week old. However, withdrawing blood is often 
problematic when using a 3.5 or 5.0 umbilical venous catheter due to the thin walled 
umbilical vein that collapses with minimal negative pressure. An exchange catheter in the 
exchange transfusion tray should be utilized whenever possible to expedite the procedure. 
Too often, subspecialty services are called to gain vascular access, which can greatly delay 
initiation of the exchange transfusion. A thorough physical exam documenting any signs or 
symptoms of kernicterus should be charted prior to, during, and after the exchange 
transfusion. 
Although tort reform in some states has reduced non-meritorious legal suits, professional 
liability involving caregivers of mothers and newborns is significant. We have identified 
common areas in obstetrics and newborn medicine that resulted in malpractice claims. All 
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practitioners in our field need to examine these areas within their practice and address any 
deficiencies, implement new protocols, and improve communication and documentation in 
the medical record. Addressing the issues described can potentially have a favorable impact 
on the medical malpractice crisis, and more importantly avoid potentially preventable 
devastating outcomes. We cannot overemphasize the importance of honesty, humility, 
compassion and competency in all our interactions with our patients. 
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1. Introduction 
Though the main aim of modern medicine is the prevention of healthy people, the most of 
the medical service for treatment today is applied as medical treatment of patients. One of 
the very important reasons of the service of medical treatment is choice of wrong drugs, and 
the other is not be able to use the planned treatment truly. The patients may not take the 
drugs that clinicians suggested themselves. This situation is known to be closely related to 
the presence of social health organization of patients. The patients may misuse a true 
treatment. Also the clinicians may cause the problem of drug misuse, especially the 
antibiotics. Whatever the reason is, the drug misuse causes the public health to deteriorate 
and economical loses and, this is inevitable. Moreover, some of the drug misuses, like of 
antibiotics, may imbalance the ecology and cause the problem to convey to next generations 
(Gokalp & Mollaoglu, 2003). 
World Health Organization has defined the use of rational medication as “providing 
medication to individuals easily, at the lowest prices, and for the most suitable dosages and 
periods according to clinical findings and personal characteristics of individuals” 
(Baytemur, 2005; Cetinkaya et al, 2010; Ozdemir, 2010). Antibiotics are among the most 
important discoveries of the past century (Çetinkaya et al, 2010; Karabay, 2009). 
Antibiotic use among the infants at newborn intensive care units is gradually increasing. In 
a study conducted over 29 newborns in USA, it was determined that 43% of the patients 
used antimicrobial during their stay. Undergoing microbial application poses a risk in terms 
of resistance. To avoid the use of antibiotics, in this sense, there have been training programs 
developed by the American Society of Infection (Patel & Saiman, 2010). 
Antibiotics sits atop in the list of most frequently used medication in all countries. Similarly 
in Turkey, antibiotics are placed on the top in terms of the average per capita medication 
with a ratio of 17-19% (Çetinkaya et al, 2010; Özdemir, 2010; Ozgunes, 2005). The frequency 
of antibiotics usage in Turkey for in-patients is over 30%. This ratio increases over 50% for 
intensive care units (Çetinkaya et al, 2010; Sardan, 2005). While the consumption costs of 
antibiotics in USA exceed 7 million dollars per year, such medications establish the 30% of 
the total medication budgets of all hospitals. Nearly half of the antibiotics usage is still not 
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appropriate despite strict control programs and such effort (Akan, 2006; Çetinkaya et al, 
2010). In Turkey, antibiotic treatment is prescribed too frequently (Bal, 2005; Celen et al, 
2005; Çetinkaya et al, 2010; Özgüneş, 2005;). In a study it is stated that antibiotics are being 
prescribed to significant portion of the patients who apply to clinics (15-48%) and only 2-
2.5% of those prescribed medication was based on culture results (Çetinkaya et al, 2010; 
Özgüneş, 2005). 
Since the prevalence of drug errors are high, it is that imperative that nurses understand the 
factors leading to errors, and avoid them to the best of their ability (Dinc, 2011).  
Without considering by whom it was prescribed, nurses are responsible for the every each 
medication that is administered personally on legal grounds, moral grounds, and ethical 
grounds (Dinç, 2011). 
All professional nurses should take these issues seriously. Safe and correct medication is one 
of the principal responsibilities of a nurse during patient care. For a nurse to make free 
decisions over right medication, correct administration, and providing appropriate means 
for measurement and monitoring is important for the assessment of the side effects of 
medication and the patient reactions against it. Reliable medication requires knowledge 
synthesis, experience, critical approach and intellectual norms (Dinç, 2011).  
Comparing to that on an adult, medication administration greatly differs on children, while 
bringing along responsibilities. It is of the physician's responsibility to write down the doses 
into drug master file. Nurse, on the other hand, is responsible for administering the medication 
at the correct amount and on the correct time. Nurse has to know when this medication would 
start to be effective, for how long it would be effective, what side-effects it might cause, any 
toxic indications, and counter-measures in respect thereof (Kavakli et al, 1998).  
In a study carried out to analyze the knowledge and behavior of pediatricians regarding to 
the rational use of antibiotics, as well as the socio-demographic factors that might be 
affecting, 89.8% of the participants reported that, when prescribing antibiotics, they need to 
see the patient first, whereas, 78.1% indicated that they were prescribing antibiotics 
according to the patient’s clinical condition, 71.1% reported that they had paid attention to 
the appropriateness of the symptoms, and 67.2% told that they were going to take 
microbiological culture samples for examination. As for the question ‘who should give 
education about antibiotics’ 32.1% replied as the physician who had prescribed the medication, 
23.4% said the junior doctors, 21.9% said pharmacists, 17.2% said the pediatric nurse, 9.4% 
said nurses (Çetinkaya et al, 2010). 
The pediatrics nurses auditing the medication use, evaluation by them if the importance of 
regular use of the medication is understood or not, to obtain the suitable feedback from the 
patent and the patient’s family by the prescribing physician, adverse effects and what they 
should do under such circumstances etc., providing training and consultancy on all these 
are among their duties (Çetinkaya et al, 2010; Çetinkaya &Tengir, 2006). 
2. Pharmacological concepts 
If taken by a living organism, drug is an agent that brings changes in body functions. 
Administration of drugs is of the principal practices in nursing. Safety of the patient is the 
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basis in preparation of medication, and during their administration. Along with the nurse's 
skill in administering drugs, he / she has to possess adequate information about the drug 
(Gorgulu & Ulusoy, 1996).  
2.1 Sources of drugs 
These are the basic sources of drugs:  
• Natural sources: Minerals (like Iron), animals (such as insulin), and plants (such as 
opium) 
• The synthetics (chemical agents manufactured in laboratories): Synthetic drugs have the 
same chemical composition with the natural ones, and they are obtained much cheaper; 
just not every drug could be acquired in this way, though (Görgülü & Ulusoy, 1996). 
2.2 Drug nomenclature 
Drugs have multiple names: 
• “Chemical Name” shows its chemical composition. 
• “Generic Name” (family, registry name) describes the common name of the drug, given 
by its first manufacturer. This name is given after its chemical name. 
• “Official Name” is the name for the official publications that would certificate the drug  
• “Trade Name” or sometimes “Brand Name” is given by the drug's authenticated 
manufacturer. There can be more than one trade names. 
Nurses can recognize the drugs they used frequently by their generic names and trade 
names (Çavuşoğlu, 2000; Dinç, 2011; Görgülü & Ulusoy, 1996). Because nurses happen to be 
facing the drugs under good deal of different names, they need to be careful about the name 
before its administration (Dinç, 2011). 
2.3 Classification of drugs 
Drugs are classified in various ways. As some could be classified by the body systems, such 
as “affecting respiratory system”, “affecting cardiovascular system”, some could be grouped 
by the syndromes they eliminate (Dinç, 2011; Görgülü & Ulusoy, 1996). Any drug may 
belong to more than one categories, as in the aspirin, which is an analgesic, antipyretic and 
anti-inflammatory drug (Dinç, 2011).  
2.4 Pharmaceutical type of drugs 
A pharmaceutical drug or medicine refers to the final state of medical substances, intended 
or ready for use in medical applications. The active element of the drug is processed to 
become useable with other solids or liquids. Drugs are available in different forms so they 
could be easily taken according to varying needs and conditions: 
1. Solid Pharmaceutical Types: powder, cachet, package, capsules, tablet, pastille, pilular, 
sugar-coated pill, extracts. 
2. Semi-liquid semi-solid Pharmaceutical Types: Suppository, ovular, ointments. 
3. Liquid Pharmaceutical Types: Solutions, solution for injections, syrup, potion, elixirs, 
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basis in preparation of medication, and during their administration. Along with the nurse's 
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2.5 Drug effects 
Nurse should be aware of the curing, thus, desired effect of a drug before administering it. 
Since drugs are chemical compounds they may result in more than one effect, therefore, 
they may not react the same way for every patient (Dinç, 2011). 
2.5.1 Curing effects 
These are the desired physiological effects of a drug. Every drug has an intended curing 
purpose. Aspirin can be used to wear off a pain, reduce fever, help inflammations over 
edema. It is important for a nurse to know about the curing effects of prescribed medicines. 
By this way, nurse can properly brief the patient and assess the desired effects of medicine. 
(Dinç, 2011). 
2.5.2 Side effects / adverse effects 
Drugs can result in undesired, and sometimes, unexplained reactions in the body. No drug is 
completely safe. The side-effects can be predictable; these effects can show up even if drug is 
taken at the appropriate doses. Should the severity of side-effects start exceeding the desired 
effects, this medication should be abandoned by whom it was prescribed (Dinç, 2011). 
Adverse drug reactions are undesired, and, most often, unpredictable effects. They may 
result in anomalies which would incapacitate the patient. Some of them may show up at 
short notice, some may take even months (Dinç, 2011).Side effects are those which surface as 
an unsettling effect to the patient although the dose was appropriate. These may result from 
the preservatives and other ingredients, or even the drug itself (Çetinkaya &Tengir, 2006). 
Nurses should be alarmed for any side effects especially when dealing with new drugs. A 
nurse should be aware of the fact that even mildly occurring adverse effects may result in 
severe allergic reactions with high toxicity. Early detection of adverse effects may prevent 
the patient from getting harmed (Dinç, 2011). 
2.5.2.1 Toxic effects 
Toxicity determines the level of toxication a substance can cause. The toxicity occurs with 
the accumulation of drug in the blood due to either high dosage, or oral administration and 
digestion of an non-oral medication, or failure in metabolism and excretion mechanism. 
Depending on the drug activity, toxic effects can be deadly (Dinç, 2011). 
2.5.2.2 Idiosyncratic reactions  
These are unusual reactions in which the patient shows either excessive or too little reaction 
against a medication. These are unpredictable and it is not possible to determine which 
patient might develop an idiosyncratic reaction (Dinç, 2011). 
2.5.2.3 Allergic reactions 
Drug reaction, according to the UN World Health Organization, is defined as “unexpected 
and harmful reactions that a medicine provided with appropriate doses for the intent of 
diagnosis, treatment, or preservation is causing” (Çetinkaya et al, 2008; Sin, 2005). Allergic 
reactions constitute only one part of undesired drug reactions (Çetinkaya et al, 2008; Sin, 
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2005). Due to lack of feedback, the frequency of reactions on the patients obtaining their 
medication at outpatient services cannot be determined (Çetinkaya et al, 2008; 2005; Sin, 
2005; Tomaç & Üstündağ). As for the hospitalized incidents, the observation rate for drug 
reactions is 15 – 30% (Çetinkaya et al, 2008; Sin, 2005). 
Allergic reactions can be mild as well as they could be serious. Allergic symptoms vary 
according to patient and medication. With respect to different drug types, antibiotics have 
the highest incidence rate for allergic reactions (Dinç, 2011). 
Allergic medicine reactions, to get her with the most common form of skin reactions 
constitute 5-10% of the medicine side effects. It is presumed that the hospital expenses due 
to medicine reactions are 7000 per unit bed year and morbidity and mortality costs are 
presumed to be more than 136 million dollars only in USA (Çetinkaya & Tengir, 2008).  
Antibiotics like Vancomycin, Cephalosporins, and Penicillins, besides, anticonvulsant drugs, 
narcotic analgesics, and anti-emetics are of the examples to the drugs that cause undesired 
effects on children. Because most of these effects proceed mildly, the situation can be 
brought under control easily. However, every three out of ten reactions last longer and 
require hospitalization. An example to such most serious reactions is “respiratory arrest” 
which is caused by anaphylaxis, or application of benzodiazepine – narcotic analgesic 
combination, following a Cephalosporin antibiotic treatment (Pala & Baktir, 2011). 
Penicillin was found by Fleming in 1928. Penicillin group of drugs are the most frequently 
prescribed antibiotic, and they usually are the most common reasons of medicine allergy 
(Çetinkaya & Tengir, 2008). 
Indeed, penicillin allergy is one of the most encountered problems (Çetinkaya et al, 2008; 
Tomaç & Üstündağ, 2005). It was determined in a study that three out of five antibiotics 
prescribed in the world in 1999 were derivatives of penicillin. For this reason, penicillin, 
among all drugs, constitutes the most researched antibiotic group for their allergic reactions 
(Çetinkaya et al, 2008; Mungan, 2005).  
It is estimated that the chance for an allergic reaction to occur following penicillin is 2% for 
every treatment cure (Çetinkaya et al, 2008; Mungan, 2005). Among children, rate for penicillin 
allergy is not determined (Cetinkaya & Cag, 2004; Çetinkaya et al, 2008). For the children 
having medical history of their parents with penicillin allergy, the rate of allergy development 
by the age of 16 is 26%. The 39% of children who were hospitalized due to drug reactions later 
showed life-threatening incidents (Çetinkaya et al, 2008; Park & James, 2005). 
A research to analyze the knowledge and application of nurses in Penicillin Allergy Test and 
the factors underlying has been conducted; a total of 161 nurses and midwifes working in 
twenty-two healthcare centers located in Konya, Turkey has participated. The 83.5% of the 
participants told that penicillin should be administered at the healthcare centers, 92.1% 
opted for a nearby medical facility in case of an emergency, and 91.3% of them told that a 
doctor, at least, should be present at the site of administration for the same reasons. In the 
end, it was suggested that nurses and midwifes should acquire knowledge about the 
penicillin test before any penicillin treatment was placed in order, so as precautionary 
actions could be taken during the application (Çetinkaya et al, 2008). 
Patients should definitely be given adequate written material. They should be asked to carry 
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cards, name of the active agent, drug's trade name, severity of the reactions that was 
observed, assessment tests (history, skin test, IgE test, IPT), suggested alternative drug and 
its doses should be indicated (Çetinkaya et al, 2008; Dursun & Bavbek, 2005).Administration 
method, the treatment and its length may affect allergic reactions' development. This is what 
all healthcare personnel should adequately know about. Physicians should monitor these 
reactions very carefully, because it will be decisive in respect to patient's future drug regime; 
and if ignored, the treatment will become more and more complicated, effectively requiring 
much higher costs (Çetinkaya & Tengir, 2008). 
2.5.2.4 Drug tolerance and addiction 
Any decrease in physiological response following the repeated use of medication or 
chemical compounds is called “drug tolerance”. This tolerance is discovered when the 
patient starts requiring new doses after steady use of lower doses for a long period. For 
acute cases, this is not often the case, and tolerance does not develop. The time period 
required to observe such development can be one month, or even more. Moreover, “cross 
tolerance” may develop should any drug tolerance occurred initially, and caused other 
drugs of the similar pharmaceutical properties fail over the same receptor area (Dinç, 
2011). 
Drug tolerance is not drug addiction. There are two types of drug addictions: psychological 
and physical. In psychological addiction patient requires the medication not for its desired 
effects, but for other benefits (Dinç, 2011).  
Opioid resistance develops among the long-time opioid users. Despite the increasing doses it 
gets never enough, and patient gradually starts showing abstinence syndrome (Anand, 2007). 
2.5.2.5 Drug interactions 
If a drug alters the effect of another drug, the matter at hand is a drug interaction. The 
occurrence of such is frequent among the people taking multiple medicines at once. Any 
drug can increase or decrease the effectiveness of another drug, can affect the metabolism 
and alter the rate of absorption and / or excretion (Dinç, 2011). 
If the combined effects of two drugs equal to the sum of the effect of each drugs 
individually, drug accumulation takes place (Dinç, 2011). 
Synergistic effect is told when two drugs are taken simultaneously. By this effect, the 
physiological effectiveness is increased comparing to that if taken one by one (Dinç, 2011).    
2.6 Dose responses of drugs 
The differences in people's drug responses are called polymorphism. Factors contributing to 
this can be environmental, genetic or cultural ones (Dinç, 2011). 
The reason for treatment with medicine is to prevent diseases, decrease the effect of a 
disease or keep that under control. To this end, sufficient amount of medicine should be 
delivered to the targeted tissues without causing intoxication. Pharmacokinetics studies the 
period of time a medicine is absorbed, distributed inside, metabolized, and egested from the 
body. This period involves a steady and dynamic interaction between the human bodies and 
drugs (Çetinkaya &Tengir, 2006). 
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The term “bio-availability” is used for the part of the dose that reaches to the circulatory 
system. The dose interval between the beneficial part of a drug and that causing side effects 
is called “therapeutic index”. The time it takes for drug concentration in blood serum to be 
halved is called “half-life”. Half-life is affected by other drugs, tissue perfusion and organ 
functions. Determination of the blood level is easier than that of a tissue, in most of the 
cases. Volume of distribution is a parameter, used to determine the relation between the 
applied dose and blood concentration of a drug. Volume of distribution is affected by the 
chemical properties of the drug and patient's physiological condition. “Stable drug level” 
indicates the egested amount of drug matching the amount of drug which was taken. 
Usually in clinical practices, stable drug level is attained following 4-5 half-lives.  
“Clearance” is the term showing the excretion rate of a drug. Clearance of any drug 
depends on the volume of distribution, half-life, and patient’s physiology, blood 
circulation of organs, the organ functions, and drug's chemical properties. In clinical 
terms, clearance is studied in two types: linear (first degree) and nonlinear (zero degree). 
A drug showing linear pharmacokinetics results in proportional increase to blood and 
tissue concentrations as the dose increases. Most of the drugs used in newborns (amino 
glycosides, Vancomycin, Phenobarbital, caffeine, catecholamine) are egested this way. As 
for the drugs showing nonlinear pharmacokinetic properties, there will be a sharp 
increase in blood concentration even if there is a mild change in the dose level. Such an 
unpredictable change is related to enzyme saturation levels in the liver. Therefore, almost 
all of the drugs egested from liver have nonlinear pharmacokinetics. These drugs, on the 
other hand, tend to show linear excretion properties if given in therapeutic doses. 
Approaching to the toxicity levels, this relation becomes nonlinear. Phenytoin is a good 
example to such drugs (Ovali, 2008).   
In order to measure the effects of some drugs, checking blood levels may be required. In the 
use of amino glycosides, the measurement of both the lowest and the highest concentrations 
in the blood might be useful. Should the lowest concentration be observed above expected, 
an excretion problem can be considered, thus, dose intervals are extended (or narrowed 
when the concentration was lower). Deviations in the maximum values, on the other hand, 
require changes in the dose amount, not in the interval. Because those inspections require 
considerable amount of blood taking, for the infants, it is a better idea to make with clinical 
overview instead of following the routine, unless the drug levels are required in case of 
necessity (Oval, 2008).   
Factors related to the growth and development of a child may affect the drug effect and its 
excretion. Maturation lag or natal disorders do affect the drug absorption, its effect and 
excretion (Kavakl et al, 1998). 
Comparing to adults, newborns exhibit great differences physiologically, anatomically, and 
pharmacologically. Renal functions in the newborn are reduced since the glomerular and 
tubular functions are infrequent, and blood circulation at the kidneys is low. Glomerular 
filtration and tubular functions reach to their mature levels after 20 weeks from delivery, 
whereas, this is 2 years for renal functions. Newborn's ability for water-retention and 
excretion of solutes are insufficient. All of these reasons cause extended half-lives. On a full-
term infant the liver is immature. Enzymes playing role in drug mechanisms are not 
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pharmacologically. Renal functions in the newborn are reduced since the glomerular and 
tubular functions are infrequent, and blood circulation at the kidneys is low. Glomerular 
filtration and tubular functions reach to their mature levels after 20 weeks from delivery, 
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enzyme maturation is completed. Glycogen stores are minimal at the liver of premature 
infants; they cannot stockpile large protein molecules. The albumin and other proteins 
which are involved in drug metabolism are kept in minimum amounts; subsequently, the 
free fractionation of drugs increases (Ozcengiz, 2011). 
Drug response in infants varies according to the body's muscle – fat – water distribution, 
protein binding, body temperature, the cardiac outflow, physiological maturation of heart, 
maturation of blood – brain barrier, efficiency of the liver and kidneys, and whether a 
congenital malformation exists or not. Total body water is higher in premature newborns 
comparing to a newborn, and in newborns in comparing to a 2 years old. The rate of fat and 
muscle increases with the age, a significant characteristic for the clinical applications of 
newborn. Water-soluble drugs have higher volume-distribution. Thus, starting doses are 
greater to attain desired blood-levels. Because the fat-rate is lower in newborns, drugs 
redistributed to the fatty tissues, as well as those redistributed to muscle-tissues have longer 
effects. There are also other factors affecting a newborn’s drug-response. Since the volume-
distribution is wider, the excretion is delayed. Liver and kidney functions are insufficient; 
the rate of protein binding is low. Moreover, the presence of prematurity, sepsis, congestive 
cardiac failure, increased intra-abdominal pressure, controlled ventilation, and insufficient 
nutrition do affect the drug response adversely. Ultimately, reviewing the drug 
pharmacokinetics and pharmacodynamics are required for each and every newborn 
(Özcengiz, 2011). 
For a drug to be used in the body, first, it should be absorbed (should pass to the blood from 
its entry point), be distributed (its delivery through circulation to the impact area) and be 
transformed to its active state. Later on, it is broken up with the metabolism, and egested 
from body as a drug metabolite. This mechanism prevents the toxicity of regular medication 
due to accumulation in body. For infants and children, absorption, distribution, metabolism, 
and excretion mechanisms differ from those in adults due to the immaturity of their body 
systems (Çetinkaya &Tengir, 2006). 
3. Drug pharmacokinetics 
The term pharmacokinetics refers to the way a drug is handled by the body. Pharmacokinetic 
measures, such as area under the curve (AUC) and concentration at the maximum (Cmax) 
and parameters calculated from those measures, such as clearance, half-life, and volume of 
distribution, reflect the absorption (A), distribution (D), and elimination (E) of a drug from 
the body. A drug can be eliminated by both metabolism (M) to one or more active and 
inactive metabolites and excretion of the unchanged drug. The overall set of processes is 
often referred to as ADME, which ultimately controls systemic exposure to a drug and its 
metabolites after drug administration (Buxton & Benet, 2011). 
This systemic exposure, reflected in plasma drug and/or metabolite concentrations, is 
generally used to relate dose to both beneficial and adverse effects. All drugs show inter- 
and intra-individual variance in pharmacokinetic measures and/or parameters (Buxton & 
Benet, 2011). Variances can sometimes be substantial. In the pediatric population, growth 
and developmental changes in factors influencing ADME also lead to changes in 
pharmacokinetic measures and/or parameters. To achieve AUC and Cmax values in 
children similar to values associated with effectiveness and safety in adults, it may be 
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important to evaluate the pharmacokinetics of a drug over the entire pediatric age range in 
which the drug will be used. Where growth and development are rapid, adjustment in dose 
within a single patient over time may be important to maintain a stable systemic exposure.  
Developmental changes in the pediatric population that can affect absorption include effects 
on gastric acidity, rates of gastric and intestinal emptying, surface area of the absorption site, 
and gastrointestinal enzyme systems for drugs that are actively transported across the 
gastrointestinal mucosa, gastrointestinal permeability, and biliary function. 
3.1 Absorption 
Absorption is the period of a drug to pass into body-liquids and to be brought to its receptor 
zone (Çetinkaya &Tengir, 2006). 
Similarly, developmental changes in skin, muscle, and fat, including changes in water 
content and degree of vascularization, can affect absorption patterns of drugs delivered via 
intramuscular, subcutaneous, or percutaneous absorption (Buxton & Benet, 2011). 
Drugs are delivered through intravascular (intravenous) or extravascular (intramuscular, oral, 
sublingual, subcutaneous, or rectal) routes. A drug administered via extravascular route 
should be absorbed in order to reach its receptor zone (Çetinkaya &Tengir, 2006). 
The absorption of most drugs at the gastrointestinal system is through passive diffusion. 
Absorption is affected by the delivery route, drug density, medium’s acidity, and the local 
circulation. For newborns and infants, the drugs given orally usually have a belated 
absorption (Çetinkaya &Tengir, 2006). 
A drug to pass from cell-membrane shouldn’t be ionized. Acidic drugs ionize at alkaline 
medium. Since these drugs do not ionize at the acidic medium they are absorbed well. The 
stomach pH of a newborn is acidic (1-3); by the 4th month the acidity approaches to that of 
an adult’s 50%, and around the age of 3 it gets near-adult-values (0.9-1.5) (Çetinkaya 
&Tengir, 2006). 
Decreasing stomach activity for newborns and infants affect the drug absorption, too. For 
newborns, stomach is empties in 6-8 hours; this number reaches to adult values of 2 hours at 
the age of 6-8 months. Irregular peristaltic movements until the 8th month cause this 
procrastination, also delaying drug’s blood-levels. Furthermore, newborns do not exhibit 
efficient absorption since their intestinal enzyme developments were delayed (Çetinkaya 
&Tengir, 2006). 
Absorption of intramuscular or subcutaneous drugs depends on the tissue perfusion at the 
primer application zone. Since the circulation at muscles and various tissues are less than 
sufficient, the absorption of intramuscular or subcutaneous drugs is decreased (Çetinkaya 
&Tengir, 2006). 
Slow blood circulation can also affect the drug absorption in newborns. Drug distribution 
can be limited for the infants carrying cardiovascular disease (Çetinkaya &Tengir, 2006). 
Oral use: Although oral use is the most frequent drug administration type, this is not 
preferred for newborns. Stomach acids secretion in newborns and infants is low; their 
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important to evaluate the pharmacokinetics of a drug over the entire pediatric age range in 
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the age of 6-8 months. Irregular peristaltic movements until the 8th month cause this 
procrastination, also delaying drug’s blood-levels. Furthermore, newborns do not exhibit 
efficient absorption since their intestinal enzyme developments were delayed (Çetinkaya 
&Tengir, 2006). 
Absorption of intramuscular or subcutaneous drugs depends on the tissue perfusion at the 
primer application zone. Since the circulation at muscles and various tissues are less than 
sufficient, the absorption of intramuscular or subcutaneous drugs is decreased (Çetinkaya 
&Tengir, 2006). 
Slow blood circulation can also affect the drug absorption in newborns. Drug distribution 
can be limited for the infants carrying cardiovascular disease (Çetinkaya &Tengir, 2006). 
Oral use: Although oral use is the most frequent drug administration type, this is not 
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that of acidic ones (Ampicillin) is increased. Moreover, gastro-intestinal motilities are 
irregular; these are slower in newborn and infants, while they are faster than adults in 
children (Pala & Baktr, 2011). 
Rectal use: It is an alternative route when oral use is not applied due to nausea, vomiting, or 
other reasons. Some analgesic – antipyretic drugs, valproic acid, Diazepam, Phenobarbital, 
and some corticosteroids can be administered this way. Absorption of the drugs that are 
applied as a suppository in the rectum is neither regular, nor exact (Pala & Baktr, 2011). 
Intramuscular use (IM): it is weak and irregular for newborns and infants. This is caused by 
the irregularities in blood circulation and vasomotor functions (Pala & Baktr, 2011). 
Percutaneous use: With the stratum corneum layer too thin, skin hydration is excessive in 
newborns. Therefore, locally applied drugs are absorbed more than that in the adults, 
making undesired toxicity quite possible. Especially, topical preparations containing 
corticosteroid require significant attention (Pala & Baktr, 2011). 
3.2 Distribution 
Distribution of a drug may be affected by changes in body composition, such as changes in 
total body water and adipose tissue, which are not necessarily proportional to changes in 
total body weight. Plasma protein binding and tissue binding changes arising from changes 
in body composition with growth and development may also influence distribution (Buxton 
& Benet, 2011). 
Prior to the absorption, drug is carried to organs and tissues through blood-circulation. 
Composition of body liquids and the drug’s level of protein-binding affect the distribution 
level. Plasma albumin is a primer binding-place for drugs. This binding phenomenon 
delimits the amount of free drug in circulation, hence, preventing drug to attain at toxic 
levels (Çetinkaya &Tengir, 2006). 
The amount of binding to plasma protein differs from one drug to another. Therefore, 
density and the amount of the drug that reached to the receptor zone are not proportional to 
dose. Neonatal albumin has lower binding capacity to some drugs (Phenytoin).  
Should the active free drugs remain at high levels in blood, the chances for toxic effects to 
surface become more likely. The water amount in body is a significant parameter used to 
determine the highest attained drug density. The total water amount of premature infants 
constitutes the 80-85% of their total weight, whereas this ratio is 75% for interm infants, and 
it is at adult-like levels (50-60%) by the end of age two. Given the amount of total weight to 
adjust proportional dose levels, administering drugs that are water-soluble results in 
insufficient drug density in blood-plasma; thus, more appropriate doses are used for infants 
(Çetinkaya &Tengir, 2006). 
The ability to metabolize drugs in newborns (especially premature infants) is quite limited 
due to physiological immaturity (Çetinkaya &Tengir, 2006). 
Once metabolized, drugs transform into water-soluble compositions for excretion at 
kidneys. Most of this bio-transfer takes places in the liver. Two-to-three weeks from 
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delivery, liver enzymes begins to maturate; at about the 4th week liver functions are fully 
developed and the excess drugs can be metabolized. If this period is not taken into account, 
the non-metabolized drugs begin to accumulate at toxic levels (Çetinkaya &Tengir, 2006).  
Because the metabolism rate of an infant (and small child) is faster than an adult, certain 
drugs can be metabolized also faster. Another factor is the change in liver size. Fetal liver is 
the 4% of total weight in infants, while this is 2% for adults. This alone explains why many 
drugs are disposed more quickly, and, accordingly, why the children require medication in 
higher-doses (Çetinkaya &Tengir, 2006). 
The volume of body liquids vary comparing to adults. Comparing to total weight, body 
liquids in children are more than they are in adults (Pala & Baktr, 2011). 
The relative mass of fatty tissues and skeleton muscle tissues are less than those at adults. 
Especially fat-soluble drugs have greater distribution volume; they should be used in lower 
doses (Pala & Baktr, 2011). 
The rate of drugs’ protein binding is lower since the total protein concentration is lower than 
that in adults. Since the free drug concentration in the blood is higher, so is for the toxicity 
risk (Pala & Baktr, 2011). 
The blood-brain barrier isn’t fully developed. There is a risk for hypersensitivity against the 
drugs affecting the central (Pala & Baktr, 2011). 
3.3 MetabolIsm 
Drug metabolism usually occurs in the liver, but may also occur in the blood, 
gastrointestinal wall, kidney, lung, and skin. Developmental changes in metabolizing 
capacity can affect both absorption and elimination, depending on the degree to which 
intestinal and hepatic metabolic processes are involved. Although developmental changes 
are recognized, information on drug metabolism of specific drugs in newborns, infants, and 
children is limited. In general, it can be assumed that children will form the same 
metabolites as adults via pathways such as oxidation, reduction, hydrolysis, and 
conjugation, but rates of metabolite formation can be different (Buxton & Benet, 2011). 
There are qualitative and quantitative differences in biotransformation between a newborn 
and other age groups. (Pala & Baktr, 2011). 
The metabolism capacity of most drugs is rudimental in newborns; on the contrary, various 
metabolism pathways show significant development during the first one year (Pala & 
Baktr, 2011). 
In some cases, the dominant metabolic route differs at the infants and children. Caffeine 
synthesis due to the methylation of teophylline is developed well at infants (Pala & Baktr, 
2011). 
Glucuronidation at infants is insufficient (Pala & Baktr, 2011). 
Sulfide conjugation is developed at infants. Paracetamol absorption is similar to adults (Pala 
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3.4 Protein binding 
Protein binding may change with age and concomitant illness. In certain circumstances, an 
understanding of protein binding may be needed to interpret the data from a blood level 
measurement and to determine appropriate dose adjustments. In vitro plasma protein binding 
studies can determine the extent of binding of the parent and the major active metabolite(s) 
and identify specific binding proteins, such as albumin and alpha-1 acid glycoprotein. Optimal 
estimates of the degree to which protein binding is linear may be obtained by testing 
maximumand minimum observed concentrations (Buxton & Benet, 2011). 
The main reason that age affects drug action is that drug elimination is less efficent in 
newborn babies and in old people, so that drugs commonly produce greater and more 
prolonged effects at the extremes of life. Other age-related factors, such as variation in 
pharmacodynamic sensitivity, are also important with some drugs.  
3.5 Excretion 
Drug excretion by the kidney is controlled by glomerular filtration, tubular secretion, and 
tubular re-absorption (Buxton & Benet, 2011). Because these processes mature at different 
rates in the pediatric population, age can affect systemic exposure for drugs where renal 
excretion is a dominant pathway of elimination. Consideration should also be given to the 
maturation of other excretory pathways, including biliary and pulmonary routes of 
excretion. Glomerular filtration rate (GFR) in the newborn, normalized to body surface area, 
is only about 20% of the adult value, and tubular function is also reduced. Accordingly, 
plasma elimination half-lives of renal eliminated drugs are longer in neonates than in adults. 
In babies born at term, renal function increases to values similar to those in young adults in 
less than a week, and indeed continues to increase to a maximum of approximately twice 
the adult value at 6 months of age. The increase in renal function occurs more slowly in 
premature infants. Renal immaturity in premature infants can have a very large effect on 
drug elimination. For example, in premature newborn babies the antibiotic Gentamicin has 
a plasma half-life of 18 hours or greater, compared with 1-4 hours for adults, and 
approximately 10 hours for babies born at term. It is, therefore, necessary to reduce and/or 
space out doses to avoid toxicity in premature babies.    
Drugs and their metabolites are excreted through sweat, urine, stools, or enzymes. By the 
time kidney functions develop, disposing drugs via urinary system is limited. The 
glomerular filtration speed and the circulation in kidneys are 30-40% of adults; this ratio is 
even smaller for infants delivered before 34 weeks. Following the first two weeks, the 
glomerular filtration speed is doubled, eventually reaches to adult-levels in 2.5 – 5 months 
(Çetinkaya &Tengir, 2006). Glomerular filtration speed meets adult levels in 6 – 12 months 
(Pala & Baktr, 2011). The half-lives of drugs also change (Pala & Baktr, 2011). 
4. Pharmacodynamic changes in children 
Results obtained from clinical trials and experimentation with the animals show that 
receptor development leads to changes in drug response. Serotonin is a neurotransmitter 
paying important role in the behavioral and psychiatric disorders. Serotonin at the brain 
steadily decreases with the increasing age. The pharmacodynamic response of Dopamine, 
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also an important neurotransmitter, varies largely in the newborn and adult test animals. 
Many neurological, psychiatric and behavioral disorders are related to the dopamine at SSS. 
Among the pharmacodynamic responses of the drugs which are being used against this 
type of disorders may show significant differences during infancy and childhood. 
Major factors affecting the newborn’s response to a treatment: Gestation age, chronological 
age, weight, development phase, liquid-electrolyte balance, disorder level at the organ systems 
and functions, presence of co-existing diseases, accompanying other medication (Oval, 2008).  
5. Principles of pharmacotherapy for the pediatric patients 
• Assessment of clinical / laboratory findings regarding to the drugs used, 
• Confirmation of patient’s age, body weight, and dose regime; making out the 
discrepancies in drug absorption, distribution, metabolism and excretion between the 
infants and children, 
• Choosing the most suitable dose type and regime, 
• Preparation of a stabile and suitable dose form if no commercial package is available, 
• Using the most affective, safest, and fine tasted economic drugs by use of comparative 
tests, 
• Monitoring adverse effects and drug reactions, recognizing the undesired outcomes on 
children, 
• Applying changes in the drugs, dose, or dose intervals when necessary, 
• Regular communication with the patient and patient relatives during the treatment 
(Pala & Baktr, 2011). 
5.1 Major problems of pediatric patients related to drug use 
• They have inadequate prospectus knowledge 
• Dose forms are insufficient for the pediatric population 
• Pharmacokinetics, effectiveness, and reliability data through clinical tests are either 
insufficient or completely absent 
• The parameters regarding primary activity for each age groups should be determined 
• Duration of disease, age groups, and maturation period should be considered 
• Oral suspensions should be developed 
• Tablets and capsule sizes should be at appropriate sizes for pediatric patients 
• Appropriate dose types should be improved for individual use (Pala & Baktr, 2011). 
The drug manufacturers design drugs according to adult population. With the increasing 
doses on pediatric patients, the drugs used in adults generally cause trouble (Schultheis et 
al, 2006). Although most drugs in the market are steadily used on pediatric patients today, 
only one fourth of these drugs have actually been approved by the FDA (Food and Drug 
Administration) for their use on infants (Pala & Baktr, 2011).  FDA has a website in order to 
give assistance for who might be willing to carry out clinical tests on pediatric patients 
(Schultheis et al, 2006). 
5.1.1 Dose forms 
Regarding new products in the market, drug manufacturers generally take little interest in 
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also an important neurotransmitter, varies largely in the newborn and adult test animals. 
Many neurological, psychiatric and behavioral disorders are related to the dopamine at SSS. 
Among the pharmacodynamic responses of the drugs which are being used against this 
type of disorders may show significant differences during infancy and childhood. 
Major factors affecting the newborn’s response to a treatment: Gestation age, chronological 
age, weight, development phase, liquid-electrolyte balance, disorder level at the organ systems 
and functions, presence of co-existing diseases, accompanying other medication (Oval, 2008).  
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infants and children, 
• Choosing the most suitable dose type and regime, 
• Preparation of a stabile and suitable dose form if no commercial package is available, 
• Using the most affective, safest, and fine tasted economic drugs by use of comparative 
tests, 
• Monitoring adverse effects and drug reactions, recognizing the undesired outcomes on 
children, 
• Applying changes in the drugs, dose, or dose intervals when necessary, 
• Regular communication with the patient and patient relatives during the treatment 
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• Pharmacokinetics, effectiveness, and reliability data through clinical tests are either 
insufficient or completely absent 
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• Duration of disease, age groups, and maturation period should be considered 
• Oral suspensions should be developed 
• Tablets and capsule sizes should be at appropriate sizes for pediatric patients 
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Regarding new products in the market, drug manufacturers generally take little interest in 





reasons, likely obligations, limited sources, and the little market share of pediatric drugs can 
be told. Not having been approved, most of the products are kept being used on the infants 
and children. Formulation of these medications may not be appropriate for pediatric 
patients just because they are fit for adults. Liquid forms are preferred for oral use on 
infants. Infants have difficulty in swallowing capsules and tablets. Besides they are too sized 
for them, their active ingredients are equally too much. Measuring the appropriate dose 
becomes, therefore, difficult.  Most drugs do not dissolve in the water entirely. To make use 
of some drugs on the infants orally, suspensions should be formed. Carboxymethylcellulose 
and methylcellulose are used to achieve this. Most of the intravenous drugs used in adults 
are very concentrated. Therefore, their use on infants and children are quite difficult. Due to 
difficulties in dosing, toxic reactions are reported related to digoxin and morphine use on 
infants. The parenteral drugs to be used on infants, but are used in adults, are diluted in 
injection water or in 0.9% NaCl. The stability of these drugs should be tested for their active 
components and sterilities.  The excipient components used in drug production are often 
inert matters, some of which might result in undesired effects. The benzyl alcohol used as 
preservative show serious toxic properties on infants; sorbitol used in high volumes as 
excipient may result in diarrhea. In addition, the propylene glycol used in preparations such 
as Phenytoin, Phenobarbital, digoxin, diazepam, vitamin D, and hydralzine, leads to 
hyperosmolarity on infants (Pala & Baktr, 2011). 
5.1.2 Dosing in children 
Calculation according to body weight is a preferred way of measuring the infant dose, 
especially using the Clark formula (Pala & Baktr, 2011). 
Clark Formula: 
Infant dose = Infant weight (kg)/ 72 x adult dose 
Many clinic experiments show that the dose calculations according to the surface area (m2) 
are more suitable than those using body weights for their least erroneous, thus, preferred 
aspect. Respiration metabolism, blood volume, extracellular liquid amount, glomerular 
filtration speed, and renal blood circulation are among the physiological parameters 
showing strong correlation with the body surface. Most of these functions have a direct 
affect on drug elimination (Pala & Baktr, 2011). 
Since the metabolism is faster in children, infant doses (per kg. weight) can be greater than 
that of adults (Pala & Baktr, 2011). 
Among the drugs given to infants in greater amount (per kg.) are as follow: Phenytoin, 
Diazepam, Imipramine, Phenobarbital, Teophylin, Chlomypramin, Carbamazepine, 
Enprophylin, Haloperidol, Ethosuximide, Digoxin, Chlorpromazine, Clonazepam, some 
anti-cancerogenic drugs (Pala & Baktr, 2011).  
With the lower renal and hepatic functions, infants require longer drug intervals comparing 
to children and adults. For children to get appropriate doses, thorough clinical tests and 
drug’s blood level studies are required. Due to certain ethical reasons, carrying out clinical 
studies over the children is difficult. In addition to the outstanding ethical reasons, too little 
size of the samples resulting in inefficiency in determination, insufficient experimental 
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equipment specific to children, other varying parameters on a long-term study, contribute to 
such difficulties (Pala & Baktr, 2011). 
6. Drugs 
6.1 Antibacterial drugs 
Antibacterial (chemical agents which cease the reproduction of microorganisms or kill them) 
agents are the most frequently used group of pediatric drugs. These drugs are to be 
influential as bactericide or bacteriostatic corrupting the structure or the functions of the 
microbial cell (Eroğlu, 2002; Oval, 2002). 
6.1.1 Penicillin 
Penicillin influences the gram-positive coccus, some gram-negative microorganisms and 
spirochetes. They are used in order to provide prophylaxis in streptococcus, pneumococcus, 
staphylococcus, salmonella, shigella infections, venereal diseases and also in rheumatic 
fever (Kavakl et al, 1998). 
6.1.1.1 Oral preparations 
Penicillin G has a variable absorption level as it is acid-labile. Penicillin V is acid-resistant and 
absorbed better (Eroğlu, 2002). 
400.000 U=250 mg penicillin, 25.000-50.000 U/kg/day rheumatic fever prophylaxis; 400.000 
U/day (every 12 hours) (Eroğlu, 2002). 
6.1.1.2 Parenteral preparations 
6.1.1.2.1 Benzyl penicillin (crystallized penicillin G) 
The antibacterial spectrum is limited. It cannot be administered by oral route as it is 
decomposed in gastric acid and is not well-absorbed by digestive tract (Rang et al, 1998; 
Dökmeci 2000). 
Newborn: IV 15-30 min. 6 dose/day every 4 hours established optimal treatment. 
Newborn: <2000g: 50.000 U/kg/day (every 12 hours) 
In Meningitis: 100.000 U/kg/day (every 12 hours) 
Newborn: >2000g: 75.000 U/kg/day (every 12 hours) 
In Meningitis: 150.000 U/kg/day (every 12 hours) 
Infant (I), child (C): 100.000-250.000 U/kg/day (every 4-6 hours) 
In Serious Infections: 200-400.000 U/kg/day (every 4-6 hours) 
Higher doses are required in B group streptococcal meningitis (Apak, 1996). 
Side effects are as follows: allergy, shock, anaphylaxis, serum disease, rash, gastrointestinal 
system (GIS) (Eroğlu, 2002). 
6.1.1.2.2 Procaine penicillin G 
After IM injection it is a slowly absorbed, water-insoluble crystal salt of penicillin G. It is 
used in pneumococcus, streptococcus and meningococcal infections. Newborn: 50.000 






reasons, likely obligations, limited sources, and the little market share of pediatric drugs can 
be told. Not having been approved, most of the products are kept being used on the infants 
and children. Formulation of these medications may not be appropriate for pediatric 
patients just because they are fit for adults. Liquid forms are preferred for oral use on 
infants. Infants have difficulty in swallowing capsules and tablets. Besides they are too sized 
for them, their active ingredients are equally too much. Measuring the appropriate dose 
becomes, therefore, difficult.  Most drugs do not dissolve in the water entirely. To make use 
of some drugs on the infants orally, suspensions should be formed. Carboxymethylcellulose 
and methylcellulose are used to achieve this. Most of the intravenous drugs used in adults 
are very concentrated. Therefore, their use on infants and children are quite difficult. Due to 
difficulties in dosing, toxic reactions are reported related to digoxin and morphine use on 
infants. The parenteral drugs to be used on infants, but are used in adults, are diluted in 
injection water or in 0.9% NaCl. The stability of these drugs should be tested for their active 
components and sterilities.  The excipient components used in drug production are often 
inert matters, some of which might result in undesired effects. The benzyl alcohol used as 
preservative show serious toxic properties on infants; sorbitol used in high volumes as 
excipient may result in diarrhea. In addition, the propylene glycol used in preparations such 
as Phenytoin, Phenobarbital, digoxin, diazepam, vitamin D, and hydralzine, leads to 
hyperosmolarity on infants (Pala & Baktr, 2011). 
5.1.2 Dosing in children 
Calculation according to body weight is a preferred way of measuring the infant dose, 
especially using the Clark formula (Pala & Baktr, 2011). 
Clark Formula: 
Infant dose = Infant weight (kg)/ 72 x adult dose 
Many clinic experiments show that the dose calculations according to the surface area (m2) 
are more suitable than those using body weights for their least erroneous, thus, preferred 
aspect. Respiration metabolism, blood volume, extracellular liquid amount, glomerular 
filtration speed, and renal blood circulation are among the physiological parameters 
showing strong correlation with the body surface. Most of these functions have a direct 
affect on drug elimination (Pala & Baktr, 2011). 
Since the metabolism is faster in children, infant doses (per kg. weight) can be greater than 
that of adults (Pala & Baktr, 2011). 
Among the drugs given to infants in greater amount (per kg.) are as follow: Phenytoin, 
Diazepam, Imipramine, Phenobarbital, Teophylin, Chlomypramin, Carbamazepine, 
Enprophylin, Haloperidol, Ethosuximide, Digoxin, Chlorpromazine, Clonazepam, some 
anti-cancerogenic drugs (Pala & Baktr, 2011).  
With the lower renal and hepatic functions, infants require longer drug intervals comparing 
to children and adults. For children to get appropriate doses, thorough clinical tests and 
drug’s blood level studies are required. Due to certain ethical reasons, carrying out clinical 
studies over the children is difficult. In addition to the outstanding ethical reasons, too little 
size of the samples resulting in inefficiency in determination, insufficient experimental 
 
The Administration and Dose of Most Frequently Used Drugs in Pediatrics 
 
303 
equipment specific to children, other varying parameters on a long-term study, contribute to 
such difficulties (Pala & Baktr, 2011). 
6. Drugs 
6.1 Antibacterial drugs 
Antibacterial (chemical agents which cease the reproduction of microorganisms or kill them) 
agents are the most frequently used group of pediatric drugs. These drugs are to be 
influential as bactericide or bacteriostatic corrupting the structure or the functions of the 
microbial cell (Eroğlu, 2002; Oval, 2002). 
6.1.1 Penicillin 
Penicillin influences the gram-positive coccus, some gram-negative microorganisms and 
spirochetes. They are used in order to provide prophylaxis in streptococcus, pneumococcus, 
staphylococcus, salmonella, shigella infections, venereal diseases and also in rheumatic 
fever (Kavakl et al, 1998). 
6.1.1.1 Oral preparations 
Penicillin G has a variable absorption level as it is acid-labile. Penicillin V is acid-resistant and 
absorbed better (Eroğlu, 2002). 
400.000 U=250 mg penicillin, 25.000-50.000 U/kg/day rheumatic fever prophylaxis; 400.000 
U/day (every 12 hours) (Eroğlu, 2002). 
6.1.1.2 Parenteral preparations 
6.1.1.2.1 Benzyl penicillin (crystallized penicillin G) 
The antibacterial spectrum is limited. It cannot be administered by oral route as it is 
decomposed in gastric acid and is not well-absorbed by digestive tract (Rang et al, 1998; 
Dökmeci 2000). 
Newborn: IV 15-30 min. 6 dose/day every 4 hours established optimal treatment. 
Newborn: <2000g: 50.000 U/kg/day (every 12 hours) 
In Meningitis: 100.000 U/kg/day (every 12 hours) 
Newborn: >2000g: 75.000 U/kg/day (every 12 hours) 
In Meningitis: 150.000 U/kg/day (every 12 hours) 
Infant (I), child (C): 100.000-250.000 U/kg/day (every 4-6 hours) 
In Serious Infections: 200-400.000 U/kg/day (every 4-6 hours) 
Higher doses are required in B group streptococcal meningitis (Apak, 1996). 
Side effects are as follows: allergy, shock, anaphylaxis, serum disease, rash, gastrointestinal 
system (GIS) (Eroğlu, 2002). 
6.1.1.2.2 Procaine penicillin G 
After IM injection it is a slowly absorbed, water-insoluble crystal salt of penicillin G. It is 
used in pneumococcus, streptococcus and meningococcal infections. Newborn: 50.000 






Side effects: Allergy, shock (Apak, 1996). 
6.1.1.2.3 Benzathine penicillin G 
It is a salt of penicillin G which establishes quite low serum levels, which is water-insoluble 
and whose effect however remains for 3-4 weeks. In rheumatic fever prophylaxis, 600.000-
1.200.000 U/dose IM (each month) is applied. Penadur LA, Deposilin are its derivatives. It 
does not cause shock (Apak, 1996; Dökmeci, 2000; Eroğlu, 2002). 
Monitoring: Shall high doses be applied in patients with renal failure the serum sodium and 
potassium levels should be monitored. They should be monitored in terms of extravasation 
(Kanmaz, 2010). 
Caution: The crystallized penicillin G should only be used IV. Procaine and benzathine 
penicillin G should only be used IM (Kanmaz, 2010). 
Incompatible Drugs: Amphotericin B, aminophylline, aminoglycosides, metoclopramide 
(Kanmaz, 2010). 
The things to be considered by nurse applying the drug: Nurse should know whether child is 
allergic to the drug or not (Kavakl et al, 1998). 
After the vial is diluted with sterile water the drug should be well dissolved before the 
desired dose is taken from the vial. 
In case that high dose of Penicillin G is rapidly administered by IV route it can cause such 
electrolyte imbalances as potassium and sodium. So the drug should be administered very 
slowly. When administered by IM route, the injection area should be carefully selected; the 
drug should be administered deep and the area should be frequently changed (Kavakl et al, 
1998). 
After the drug is administered by parenteral route the children should at least be monitored 
for an hour especially in terms of allergy and anaphylaxis. The presence of erythema and 
pallor in the injection area of IV and IM can be a sign of sensitivity. And also in case that the 
child is observed with anxiety, nausea, vomiting, dyspnea, tremor, instant febrility, and rash 
it should be considered that it might be an allergic reaction. Allergic reactions should 
immediately be notified to doctor. Drug, tools and equipment should all be available for an 
emergency (Kavakl et al, 1998). 
In case of an extravasation hyaluronidase can be used (Kanmaz, 2010). 
Toxicity symptoms should be closely monitored in newborns, infants and people with renal 
failure. Bleeding time should be monitored (Kavakl et al, 1998). 
In oral route the best is to administer the drug with water pre-meals. Administering the drug 1 
hour before, or 2 hours later than the meals decreases the effect of gastric acid or the possibility 
that foods delay the absorption of drugs. Child should be prevented from drinking acid 
beverages 1 hour before and after the administration of drug (Kavakl et al, 1998). 
Tablet drugs should be protected against light. Oral suspensions and syrups should be 
preserved in refrigerator. The infusion solutions of penicillin G can stay for 24 hours under 
room temperature (Kavakl et al, 1998). 
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6.1.2 Penicillines resistant to penicillinase enzyme 
This group of penicillin cannot hydrolyze with staphylococcal penicillinase. This antibiotic 




IM, IV (15-30min.), <2000g <14 days: 50 mg/kg/day (every 12 hours), 
<2000g >14 days: 75 mg/kg/day (every 8 hours), 
>2000g <14 days: 75 mg/kg/day (every 8 hours), 
>2000g >14 days: 100 mg/kg/day (every 6 hours), 
For others: IV (15-30 min.), IM 100-200 mg/kg/day (every 4-6 hours), PO: 50-100 
mg/kg/day (every 6 hours) (Eroğlu, 2002; Küçüködük 1994). 
Side effects: It can cause interstitial nephritis. The dose should be adjusted in renal failure. 
Along with other penicillin it can produce cross allergic reaction (Apak, 1996). 
6.1.2.2 Aminopenicillin 
6.1.2.2.1 Amoxicillin 
Even if administered with meals through GIS amoxicillin is absorbed faster and almost 
completely and has fewer side effects compared to ampicillin. It is an acid resistant 
ampicillin derivative and administered at a dose of PO; 25-50 mg/kg/day (every 8 hours) 
(Longo et al, 2002). 
In a study where Feder and his friends (1999) compared the effects of Amoxicillin and 
Penicillin V it has been found out that amoxicillin does better than penicillin V in the 
treatment of angina caused by group a beta-hemolytic streptococcus (Feder et al, 1999). 
6.1.2.2.2 Ampicillin 
It covers the gram negative spectrum of penicillin. Newborn: IM, IV (15-30 min.), <7 days 
<2000 g: 50 mg/kg/day (every 12 hours), >2000 g: every 8 hours, >7 days <2000 g: 100 
mg/kg/day, >2000 g: every 6 hours. 
Infant, child: 50-100 mg/kg/day, PO (every 4-6 hours), Sepsis: 100-200 mg/kg/day IV 
(every 4 hours), Meningitis: 200-400 mg/kg/day IV (every 4 hours), in other infections: 100-
200 mg/kg/day IV (every 4-6 hours) (Eroglu, 2002; Dokmeci, 2000; Kucukoduk, 1994).  
Mode of Administration: IV slow 
Preparation: Vials are prepared with 5-10 ml sterile water. 
Miscible Serums: 5% Dex, SF 
Drugs to be confronted at the end point: Fat emulsions, Acyclovir, Aminophylline, Calcium 
gluconate, Cefepime, Furosemide, Heparin, Insulin, Magnesium sulfate, Metronidazole, 
Potassium chloride, Vancomycin. 
Incompatible Drugs: Dex/Amino acid, Amicasin, Dopamine, Epinephrine, Fluconazole, 
Gentamicin, Midazolam, Sodium bicarbonate. 





Side effects: Allergy, shock (Apak, 1996). 
6.1.1.2.3 Benzathine penicillin G 
It is a salt of penicillin G which establishes quite low serum levels, which is water-insoluble 
and whose effect however remains for 3-4 weeks. In rheumatic fever prophylaxis, 600.000-
1.200.000 U/dose IM (each month) is applied. Penadur LA, Deposilin are its derivatives. It 
does not cause shock (Apak, 1996; Dökmeci, 2000; Eroğlu, 2002). 
Monitoring: Shall high doses be applied in patients with renal failure the serum sodium and 
potassium levels should be monitored. They should be monitored in terms of extravasation 
(Kanmaz, 2010). 
Caution: The crystallized penicillin G should only be used IV. Procaine and benzathine 
penicillin G should only be used IM (Kanmaz, 2010). 
Incompatible Drugs: Amphotericin B, aminophylline, aminoglycosides, metoclopramide 
(Kanmaz, 2010). 
The things to be considered by nurse applying the drug: Nurse should know whether child is 
allergic to the drug or not (Kavakl et al, 1998). 
After the vial is diluted with sterile water the drug should be well dissolved before the 
desired dose is taken from the vial. 
In case that high dose of Penicillin G is rapidly administered by IV route it can cause such 
electrolyte imbalances as potassium and sodium. So the drug should be administered very 
slowly. When administered by IM route, the injection area should be carefully selected; the 
drug should be administered deep and the area should be frequently changed (Kavakl et al, 
1998). 
After the drug is administered by parenteral route the children should at least be monitored 
for an hour especially in terms of allergy and anaphylaxis. The presence of erythema and 
pallor in the injection area of IV and IM can be a sign of sensitivity. And also in case that the 
child is observed with anxiety, nausea, vomiting, dyspnea, tremor, instant febrility, and rash 
it should be considered that it might be an allergic reaction. Allergic reactions should 
immediately be notified to doctor. Drug, tools and equipment should all be available for an 
emergency (Kavakl et al, 1998). 
In case of an extravasation hyaluronidase can be used (Kanmaz, 2010). 
Toxicity symptoms should be closely monitored in newborns, infants and people with renal 
failure. Bleeding time should be monitored (Kavakl et al, 1998). 
In oral route the best is to administer the drug with water pre-meals. Administering the drug 1 
hour before, or 2 hours later than the meals decreases the effect of gastric acid or the possibility 
that foods delay the absorption of drugs. Child should be prevented from drinking acid 
beverages 1 hour before and after the administration of drug (Kavakl et al, 1998). 
Tablet drugs should be protected against light. Oral suspensions and syrups should be 
preserved in refrigerator. The infusion solutions of penicillin G can stay for 24 hours under 
room temperature (Kavakl et al, 1998). 
 
The Administration and Dose of Most Frequently Used Drugs in Pediatrics 
 
305 
6.1.2 Penicillines resistant to penicillinase enzyme 
This group of penicillin cannot hydrolyze with staphylococcal penicillinase. This antibiotic 




IM, IV (15-30min.), <2000g <14 days: 50 mg/kg/day (every 12 hours), 
<2000g >14 days: 75 mg/kg/day (every 8 hours), 
>2000g <14 days: 75 mg/kg/day (every 8 hours), 
>2000g >14 days: 100 mg/kg/day (every 6 hours), 
For others: IV (15-30 min.), IM 100-200 mg/kg/day (every 4-6 hours), PO: 50-100 
mg/kg/day (every 6 hours) (Eroğlu, 2002; Küçüködük 1994). 
Side effects: It can cause interstitial nephritis. The dose should be adjusted in renal failure. 
Along with other penicillin it can produce cross allergic reaction (Apak, 1996). 
6.1.2.2 Aminopenicillin 
6.1.2.2.1 Amoxicillin 
Even if administered with meals through GIS amoxicillin is absorbed faster and almost 
completely and has fewer side effects compared to ampicillin. It is an acid resistant 
ampicillin derivative and administered at a dose of PO; 25-50 mg/kg/day (every 8 hours) 
(Longo et al, 2002). 
In a study where Feder and his friends (1999) compared the effects of Amoxicillin and 
Penicillin V it has been found out that amoxicillin does better than penicillin V in the 
treatment of angina caused by group a beta-hemolytic streptococcus (Feder et al, 1999). 
6.1.2.2.2 Ampicillin 
It covers the gram negative spectrum of penicillin. Newborn: IM, IV (15-30 min.), <7 days 
<2000 g: 50 mg/kg/day (every 12 hours), >2000 g: every 8 hours, >7 days <2000 g: 100 
mg/kg/day, >2000 g: every 6 hours. 
Infant, child: 50-100 mg/kg/day, PO (every 4-6 hours), Sepsis: 100-200 mg/kg/day IV 
(every 4 hours), Meningitis: 200-400 mg/kg/day IV (every 4 hours), in other infections: 100-
200 mg/kg/day IV (every 4-6 hours) (Eroglu, 2002; Dokmeci, 2000; Kucukoduk, 1994).  
Mode of Administration: IV slow 
Preparation: Vials are prepared with 5-10 ml sterile water. 
Miscible Serums: 5% Dex, SF 
Drugs to be confronted at the end point: Fat emulsions, Acyclovir, Aminophylline, Calcium 
gluconate, Cefepime, Furosemide, Heparin, Insulin, Magnesium sulfate, Metronidazole, 
Potassium chloride, Vancomycin. 
Incompatible Drugs: Dex/Amino acid, Amicasin, Dopamine, Epinephrine, Fluconazole, 
Gentamicin, Midazolam, Sodium bicarbonate. 





6.1.2.2.3 Ampicillin sodium sulbactam 
Dose: Dose is determined by your doctor. Typically, adults and children weighing over 30 kg 
- 375-750 mg 2 times daily for 5-14 days. Children under 30 kg body weight, have completed 
one year of age - 25 - 50 mg /kg body weight per day in two divided doses every 12 hours.  
Uses: Broad-spectrum antibiotic useful against group B. streptococcus, Listeria monocytogenes, 
and suscetible E coli species  
Adverse Effectes: Very large doses may results in CNS excitation or seizure activity. Moderate 
prolongation of bleeding times (by approximately 60 second) may occure after repeated 
doses. Hypersensitivity reaction (maculopapular rash, ulticarial rash, off fever) are rare in 
neonates (Young & Mangum, 2010). 
6.1.3 Side effects of penicillin 
6.1.3.1 Allergic reactions 
Penicillin allergy can be diagnosed by taking a skin test. Acute allergic reactions can be such 
delayed reactions as anaphylaxis, angioneurotic edema and urticarial; and also be fever, 
eosinophilia, hemolytic anemia, serum disease, urticarial and maculopapular rash. The 
presence of rash is not indication to cease drug use (Eroğlu, 2002). 
6.1.3.2 Dose-related effects 
High doses can cause CNS toxicity, hypopotassemia and coagulation impairments (Apak, 
1996; Eroğlu, 2002). 
6.1.4 Cephalosporins 
Their mechanisms of action resemble to penicillin. They are grouped in four generations. As 
the generation increases the activity against gram (-) also increases.  The ones aside from 
cefuroxime and third-generation are not able to penetrate CNS. They cannot be used in 
bacterial meningitis treatment. Cephalosporins are commonly used because of their clinical 
utilities in the treatment of common infections (Rang et al, 1998; Zeph, 2002). 
While maculopapular rash, drug-related fever and positive Coomb’s test are the major side 
effects such reactions and anaphylaxis as urticarial and serum diseases are rarely seen (Rang 
et al, 1998; Zeph, 2002). 
Cephalosporins cause allergic reactions in patients allergic to Penicillin. With the use of 
cephalosporin side effects are observed in 10% of the patients allergic to Penicillin (Puchner 
& Zacharisen, 2002). 
6.1.4.1 First-generation cephalosporins 
They are active against gram (+) cocci including staphylococcus aureus, and such gram (-) 
organisms as E. coli and Klebsiella. They are inactive against enterococci and H. influenzae. 
First-class cephalosporins cannot cross the blood-brain barrier and so are not effective in the 
treatment of central nervous system infections (Apak, 1996; Behrman & Kliegman, 2001; 
Dökmeci, 2000; Eroğlu, 2002). 
 




Administered at the dose of 30 mg/kg/day (every 12 hours) PO, It has such side effects as 
hypersensitivity reactions, rarely renal toxicity, neuropathy, and eosinophilia (Apak, 1996; 
Behrman & Kliegman, 2001; Eroğlu, 2002). 
6.1.4.1.2 Cephalothin 
Newborn; IV (15-30 min.), IM <7 days; 40 mg/kg/day administered every 12 hours; >7 
days; 60 mg/kg/day administered every 8 hours. The side effects are the same as in 
cephadroxil (Apak, 1996; Eroğlu, 2002). 
6.1.4.1.3 Cefazolin sodium 
Newborn; 40 mg/kg/day IM-IV administered every 6 hours. Cefazol, Cefamezin, 
Maksiporin, Cefozin are its derivatives. It rarely has such side effect as rash, positive 
Coomb’s test, coagulopathy in uremic patients (Apak, 1996; Eroğlu, 2002). 
6.1.4.2 Second-generation cephalosporins 
They are used in gram (+) cocci, penicillinase producing and not producing H. influenzae, in 
Klebsiella pneumonia related bronchopulmonary infections, in E. Coli or proteus related 
nosocomial infections, in urinary infections caused by enterobacters and in the treatment of 
sinusitis and otitis media for the ones allergic to amoxicillin (Dökmeci, 2001). 
Unlike others Cefuroxime is the only second-generation cephalosporin to cross blood-brain 
barrier. In case of an infection it is able to penetrate CNS. It is especially used in H. 
influenzae meningitis and sepsis treatment (Eroğlu, 2002). 
6.1.4.2.1 Cefaclor 
It is used in the treatment of upper and lower respiratory tract, urinary tract, skin and soft 
tissue infections as well as in otitis media and susceptible organisms. And it is administered 
every 8 hours at a dose of 20-40 mg/kg/day (Behrman & Kliegman, 2001; Eroğlu, 2002). 
6.1.4.2.2 Cefoxitin 
In children older than 3 months it is administered every 6-8 hours at a dose of 60-80 
mg/kg/day either as IV or IM. It can cause thrombophlebitis, diarrhea and 
pseudomembranous colitis (Apak, 1996; Eroğlu, 2002). 
6.1.4.3 Third-generation cephalosporins 
Compared to first-generation cephalosporins they are less active against gram (+) cocci; 
however more active against most of the strains of gram (-) cocci. While they are moderately 
active against Pseudomonas aeruginosa they are more active against H. influenza and N. 
gonorrhoeae. They can easily penetrate into CNS from inflamed meninges. They are usually 
discharged from kidneys (Dökmeci, 2000). 
6.1.4.3.1 Cefotaxime sodium 
Treatment of neonatal meningitis and sepsis caused by susceptible gram-negative organisms 
(e.g. E coli, H influenzae, and Klebsiella), Treatment of disseminated gonococcal infections. 





6.1.2.2.3 Ampicillin sodium sulbactam 
Dose: Dose is determined by your doctor. Typically, adults and children weighing over 30 kg 
- 375-750 mg 2 times daily for 5-14 days. Children under 30 kg body weight, have completed 
one year of age - 25 - 50 mg /kg body weight per day in two divided doses every 12 hours.  
Uses: Broad-spectrum antibiotic useful against group B. streptococcus, Listeria monocytogenes, 
and suscetible E coli species  
Adverse Effectes: Very large doses may results in CNS excitation or seizure activity. Moderate 
prolongation of bleeding times (by approximately 60 second) may occure after repeated 
doses. Hypersensitivity reaction (maculopapular rash, ulticarial rash, off fever) are rare in 
neonates (Young & Mangum, 2010). 
6.1.3 Side effects of penicillin 
6.1.3.1 Allergic reactions 
Penicillin allergy can be diagnosed by taking a skin test. Acute allergic reactions can be such 
delayed reactions as anaphylaxis, angioneurotic edema and urticarial; and also be fever, 
eosinophilia, hemolytic anemia, serum disease, urticarial and maculopapular rash. The 
presence of rash is not indication to cease drug use (Eroğlu, 2002). 
6.1.3.2 Dose-related effects 
High doses can cause CNS toxicity, hypopotassemia and coagulation impairments (Apak, 
1996; Eroğlu, 2002). 
6.1.4 Cephalosporins 
Their mechanisms of action resemble to penicillin. They are grouped in four generations. As 
the generation increases the activity against gram (-) also increases.  The ones aside from 
cefuroxime and third-generation are not able to penetrate CNS. They cannot be used in 
bacterial meningitis treatment. Cephalosporins are commonly used because of their clinical 
utilities in the treatment of common infections (Rang et al, 1998; Zeph, 2002). 
While maculopapular rash, drug-related fever and positive Coomb’s test are the major side 
effects such reactions and anaphylaxis as urticarial and serum diseases are rarely seen (Rang 
et al, 1998; Zeph, 2002). 
Cephalosporins cause allergic reactions in patients allergic to Penicillin. With the use of 
cephalosporin side effects are observed in 10% of the patients allergic to Penicillin (Puchner 
& Zacharisen, 2002). 
6.1.4.1 First-generation cephalosporins 
They are active against gram (+) cocci including staphylococcus aureus, and such gram (-) 
organisms as E. coli and Klebsiella. They are inactive against enterococci and H. influenzae. 
First-class cephalosporins cannot cross the blood-brain barrier and so are not effective in the 
treatment of central nervous system infections (Apak, 1996; Behrman & Kliegman, 2001; 
Dökmeci, 2000; Eroğlu, 2002). 
 




Administered at the dose of 30 mg/kg/day (every 12 hours) PO, It has such side effects as 
hypersensitivity reactions, rarely renal toxicity, neuropathy, and eosinophilia (Apak, 1996; 
Behrman & Kliegman, 2001; Eroğlu, 2002). 
6.1.4.1.2 Cephalothin 
Newborn; IV (15-30 min.), IM <7 days; 40 mg/kg/day administered every 12 hours; >7 
days; 60 mg/kg/day administered every 8 hours. The side effects are the same as in 
cephadroxil (Apak, 1996; Eroğlu, 2002). 
6.1.4.1.3 Cefazolin sodium 
Newborn; 40 mg/kg/day IM-IV administered every 6 hours. Cefazol, Cefamezin, 
Maksiporin, Cefozin are its derivatives. It rarely has such side effect as rash, positive 
Coomb’s test, coagulopathy in uremic patients (Apak, 1996; Eroğlu, 2002). 
6.1.4.2 Second-generation cephalosporins 
They are used in gram (+) cocci, penicillinase producing and not producing H. influenzae, in 
Klebsiella pneumonia related bronchopulmonary infections, in E. Coli or proteus related 
nosocomial infections, in urinary infections caused by enterobacters and in the treatment of 
sinusitis and otitis media for the ones allergic to amoxicillin (Dökmeci, 2001). 
Unlike others Cefuroxime is the only second-generation cephalosporin to cross blood-brain 
barrier. In case of an infection it is able to penetrate CNS. It is especially used in H. 
influenzae meningitis and sepsis treatment (Eroğlu, 2002). 
6.1.4.2.1 Cefaclor 
It is used in the treatment of upper and lower respiratory tract, urinary tract, skin and soft 
tissue infections as well as in otitis media and susceptible organisms. And it is administered 
every 8 hours at a dose of 20-40 mg/kg/day (Behrman & Kliegman, 2001; Eroğlu, 2002). 
6.1.4.2.2 Cefoxitin 
In children older than 3 months it is administered every 6-8 hours at a dose of 60-80 
mg/kg/day either as IV or IM. It can cause thrombophlebitis, diarrhea and 
pseudomembranous colitis (Apak, 1996; Eroğlu, 2002). 
6.1.4.3 Third-generation cephalosporins 
Compared to first-generation cephalosporins they are less active against gram (+) cocci; 
however more active against most of the strains of gram (-) cocci. While they are moderately 
active against Pseudomonas aeruginosa they are more active against H. influenza and N. 
gonorrhoeae. They can easily penetrate into CNS from inflamed meninges. They are usually 
discharged from kidneys (Dökmeci, 2000). 
6.1.4.3.1 Cefotaxime sodium 
Treatment of neonatal meningitis and sepsis caused by susceptible gram-negative organisms 
(e.g. E coli, H influenzae, and Klebsiella), Treatment of disseminated gonococcal infections. 





Newborn; < 7 days: (100 mg/kg/day) 12 hours interval, > 7 days; (150 mg/kg/days) IV-IM 
8 hours interval, others; 100-200 mg/kg/days IV-IM 6-8 hours interval, for Meningitis; 200 
mg/kg/days IV 6 hours interval (Apak, 1996; Eroğlu, 2002; Küçüködük, 1994). 
Adverse Effects: neurotoxicity risk increases if used with Aminoglykosides. It may result in 
hypersensitivity for penicillin sensitive people (Apak, 1996; Eroğlu, 2002). Side effects are 
rare but include rash, phlebitis, diarrhea, leukopenia, granulocytopenia, and eosinophilia 
(Young & Mangum, 2010). 
6.1.4.3.2 Ceftazidime 
Treatment of neonatal meningitis and sepsis caused by susceptible gram-negative organisms 
(e.g. E. coli, H. influenze, Neisseria, Klebsiella, and Proteus species), especially Pseudomonas 
aeruginosa. Resistance among strains of Serratia and Enterobacteriaceae is increasing (Kanmaz, 
2010; Young & Mangum, 2010). 
Dose: 30 mg/kg per dose IV infusion by syringe pump over 30 minutes, or IM. To reduce 
pain at IM injectione site, ceftazimide may be mixed with 1% lidocaine without epinephrine 
(Kanmaz, 2010; Young & Mangum, 2010).Newborn; IM-IV <7 days and <2000 g; 100 
mg/kg/days every 12 hours, >2000 g; 100 mg/kg/days every 8 hours, >7 days; 100-150 
mg/kg/days every 8 hours, for others; 100-150 mg/kg/days (max 6 g) IV-IM every 8 hours 
(Apak, 1996; Eroğlu, 2002). 
Adverse Effects: Reported adverse effects are uncommon but include rash, diarrhea, elevated 
hepatic transminases, eosynophilia, and positive Coombs’ test (Kanmaz, 2010; Young & 
Mangum, 2010). 
Administration and Storage Conditions: When the drug in powder gets diluted it can be stored 
for 24 hours under room temperature; and 7 days in refrigerator. It has not been approved 
to use preparations containing L-Arginine on children. As the forms administered to 
children contain sodium carbonate it releases carbon dioxide bubbles when diluted 
(Kanmaz, 2010). 
Incompatible Drugs: Fluconazole, Midazolam, Vancomycin (Kanmaz, 2010). 
6.1.4.4 Fourth-generation cephalosporins 
6.1.4.4.1 Maxipime 
Administered at a dose of 50-100 mg vial every 8 hours (Eroğlu, 2002). 
6.1.5 Aminoglycosides 
They inhibit the protein synthesis ribosomes. They have bactericidal effects on gram (-) 
enteric bacilli and S. aureus. And they are discharged from kidneys. Dose adjustment is 
important even in minor renal failures (Eroğlu, 2002). 
6.1.5.1 Amicacin 
Uses: Amicacin belongs to the aminoglycoside family of antibiotics. It has a very broad 
spectrum of activity. Bactericidal effect on bacteria of the strains of Gram-positive and 
Gram-negative and are resistant to certain enzymes produced by bacteria - betalactamase. 
Amicacin bacteria disrupts protein synthesis (Young & Mangum, 2010). 
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Newborn ; Gestation age   ≤ 27 → 18 mg/kg/dose  every 48 hours 
 28-30 → 18 mg/kg/dose every 36 hours 
   31-33 → 16 mg/kg/dose every 36 hours 
  ≥ 34→ 15 mg/kg/dose every 24 hours (Kanmaz, 2010).  
Side Effects: Nephrotoxicity, ototoxicity, arthralgia, rash, eosinophil, neuromuscular block 
may develop (Apak, 1996). 
> 1/100- Dizziness, sense of hearing and balance.  
1/1000- Fever. Rash and itching. Disturbances in liver function. Changes in the blood 
picture. 
<1/1000- Headache. Lowering blood pressure. Reducing the number of white blood cells, 
platelet count. Anemia. Tingling. Convulsions. Arthralgia (Young & Mangum, 2010). 
Incompatibility: Lipid solution, Ampicillin, amphotericin B, phenytoin (Kanmaz, 2010). 
6.1.5.2 Gentamicin 
It is one of the most commonly used aminoglycosides (Krdak & Kilicturgay, 1996; Rang et 
al, 1998). 
Uses: Treatment of infections caused by aerobic gram-negative bacilli (e.g. Pseudomonas, 
Klebsiella, E. coli). Usually used on combination with a B-lactam antibiotic (Young & 
Mangum, 2010). High serum levels are required for bactericidal effect. Side effects are less 
seen with longer dose intervals. The volume of distribution increases in patients with PDA 
and clearance decreases. In premature and asphyxiated infants serum half-life prolongs 
(Kanmaz, 2010). 
 
Gestation age  ≤29 weeks→ 0-14 mg/kg/dose every 72 hours 
 30-36 weeks →0-14 mg/kg/dose every 48 hours 
         >14 mg/kg/dose every 24 hours 
 37-44 weeks→ 0-7 mg/kg/dose every 48 hours 
         >7 mg/kg/dose every 24 hours 
 ≥45 weeks every 24 hours for all (Kanmaz, 2010).  
Adverse Effects: The most frequently reported adverse reactions are occular burning and 
irritation upon drug instillation, non-specific conjunctivitis, conjunctival epithelial defects, 
and conjunctival hyperemia. 
Other adverse reactions which have occurred rarely are allergic reactions, thrombocytopenic 
purpura, and hallucinations (Young & Mangum, 2010). 
Garamycin, Genta, Gensif, Gentamicin, Gentrex are its derivatives. It has ototoxic and 
nephrotoxic side effects (Krdak & Klçturgay, 1996; Rang et al, 1998). Temporary tubular 
dysfunction: loss of calcium, magnesium and sodium via the urinary system. Vestibular 
and auditory toxicity. When used with patients using pancuronium neuromuscular 
blockage may increase. In the event that extravasation develops hyaluronidase can be 






Newborn; < 7 days: (100 mg/kg/day) 12 hours interval, > 7 days; (150 mg/kg/days) IV-IM 
8 hours interval, others; 100-200 mg/kg/days IV-IM 6-8 hours interval, for Meningitis; 200 
mg/kg/days IV 6 hours interval (Apak, 1996; Eroğlu, 2002; Küçüködük, 1994). 
Adverse Effects: neurotoxicity risk increases if used with Aminoglykosides. It may result in 
hypersensitivity for penicillin sensitive people (Apak, 1996; Eroğlu, 2002). Side effects are 
rare but include rash, phlebitis, diarrhea, leukopenia, granulocytopenia, and eosinophilia 
(Young & Mangum, 2010). 
6.1.4.3.2 Ceftazidime 
Treatment of neonatal meningitis and sepsis caused by susceptible gram-negative organisms 
(e.g. E. coli, H. influenze, Neisseria, Klebsiella, and Proteus species), especially Pseudomonas 
aeruginosa. Resistance among strains of Serratia and Enterobacteriaceae is increasing (Kanmaz, 
2010; Young & Mangum, 2010). 
Dose: 30 mg/kg per dose IV infusion by syringe pump over 30 minutes, or IM. To reduce 
pain at IM injectione site, ceftazimide may be mixed with 1% lidocaine without epinephrine 
(Kanmaz, 2010; Young & Mangum, 2010).Newborn; IM-IV <7 days and <2000 g; 100 
mg/kg/days every 12 hours, >2000 g; 100 mg/kg/days every 8 hours, >7 days; 100-150 
mg/kg/days every 8 hours, for others; 100-150 mg/kg/days (max 6 g) IV-IM every 8 hours 
(Apak, 1996; Eroğlu, 2002). 
Adverse Effects: Reported adverse effects are uncommon but include rash, diarrhea, elevated 
hepatic transminases, eosynophilia, and positive Coombs’ test (Kanmaz, 2010; Young & 
Mangum, 2010). 
Administration and Storage Conditions: When the drug in powder gets diluted it can be stored 
for 24 hours under room temperature; and 7 days in refrigerator. It has not been approved 
to use preparations containing L-Arginine on children. As the forms administered to 
children contain sodium carbonate it releases carbon dioxide bubbles when diluted 
(Kanmaz, 2010). 
Incompatible Drugs: Fluconazole, Midazolam, Vancomycin (Kanmaz, 2010). 
6.1.4.4 Fourth-generation cephalosporins 
6.1.4.4.1 Maxipime 
Administered at a dose of 50-100 mg vial every 8 hours (Eroğlu, 2002). 
6.1.5 Aminoglycosides 
They inhibit the protein synthesis ribosomes. They have bactericidal effects on gram (-) 
enteric bacilli and S. aureus. And they are discharged from kidneys. Dose adjustment is 
important even in minor renal failures (Eroğlu, 2002). 
6.1.5.1 Amicacin 
Uses: Amicacin belongs to the aminoglycoside family of antibiotics. It has a very broad 
spectrum of activity. Bactericidal effect on bacteria of the strains of Gram-positive and 
Gram-negative and are resistant to certain enzymes produced by bacteria - betalactamase. 
Amicacin bacteria disrupts protein synthesis (Young & Mangum, 2010). 
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   31-33 → 16 mg/kg/dose every 36 hours 
  ≥ 34→ 15 mg/kg/dose every 24 hours (Kanmaz, 2010).  
Side Effects: Nephrotoxicity, ototoxicity, arthralgia, rash, eosinophil, neuromuscular block 
may develop (Apak, 1996). 
> 1/100- Dizziness, sense of hearing and balance.  
1/1000- Fever. Rash and itching. Disturbances in liver function. Changes in the blood 
picture. 
<1/1000- Headache. Lowering blood pressure. Reducing the number of white blood cells, 
platelet count. Anemia. Tingling. Convulsions. Arthralgia (Young & Mangum, 2010). 
Incompatibility: Lipid solution, Ampicillin, amphotericin B, phenytoin (Kanmaz, 2010). 
6.1.5.2 Gentamicin 
It is one of the most commonly used aminoglycosides (Krdak & Kilicturgay, 1996; Rang et 
al, 1998). 
Uses: Treatment of infections caused by aerobic gram-negative bacilli (e.g. Pseudomonas, 
Klebsiella, E. coli). Usually used on combination with a B-lactam antibiotic (Young & 
Mangum, 2010). High serum levels are required for bactericidal effect. Side effects are less 
seen with longer dose intervals. The volume of distribution increases in patients with PDA 
and clearance decreases. In premature and asphyxiated infants serum half-life prolongs 
(Kanmaz, 2010). 
 
Gestation age  ≤29 weeks→ 0-14 mg/kg/dose every 72 hours 
 30-36 weeks →0-14 mg/kg/dose every 48 hours 
         >14 mg/kg/dose every 24 hours 
 37-44 weeks→ 0-7 mg/kg/dose every 48 hours 
         >7 mg/kg/dose every 24 hours 
 ≥45 weeks every 24 hours for all (Kanmaz, 2010).  
Adverse Effects: The most frequently reported adverse reactions are occular burning and 
irritation upon drug instillation, non-specific conjunctivitis, conjunctival epithelial defects, 
and conjunctival hyperemia. 
Other adverse reactions which have occurred rarely are allergic reactions, thrombocytopenic 
purpura, and hallucinations (Young & Mangum, 2010). 
Garamycin, Genta, Gensif, Gentamicin, Gentrex are its derivatives. It has ototoxic and 
nephrotoxic side effects (Krdak & Klçturgay, 1996; Rang et al, 1998). Temporary tubular 
dysfunction: loss of calcium, magnesium and sodium via the urinary system. Vestibular 
and auditory toxicity. When used with patients using pancuronium neuromuscular 
blockage may increase. In the event that extravasation develops hyaluronidase can be 






Incompatible Drugs: Amphotericin B, Ampicillin, Furosemide, Heparin (>1 U/ml), 
Imipenem/Cilastatin, Indomethacin, Methicillin, Mezlocillin, Nafcillin, Oxacillin, Penicillin 
G, Propofol, Cefepime, Ticarcillin/Clavulanate (Kanmaz, 2010). 
6.1.5.3 Streptomycin sulfate 
It is an antibiotic and anti-tuberculostatic drug. It affects some gram negative and positive 
microorganisms (Kavakl et al, 1998). It is used with Isoniazid and other tuberculosis drugs 
in tuberculosis meningitis and progressive tuberculosis. In tuberculosis meningitis it is 
administered by IM route every 12 hours 20-40 mg/kg/day. The maximum dose is 1 g/day. 
The length of treatment period is usually 2-3 months. Higher doses and/or more prolonged 
therapy may result to destruction in 8th cranial nerve (Eroğlu, 2002). 
Side effects: Myocarditis, Ataxia, nuisance, vomiting, ototoxicity, nephrotoxicity and 
hypersensitivity can be seen (Kavakl et al, 1998). 
6.1.5.4 tobramycin 
It is more active against P. Aeruginosa than gentamycin. Newborn; IV (30-60 min.) , IM; <7 
days <34 weeks <1500g; 3 mg/kg every 24 hours, >1500g; 2.5 mg/kg every 18 hours, >34 
weeks >1500g; 2.5 mg/kg every 12 hours, >after 7 days; 5 mg/kg every 12 hours, for older 
people; 5-7.5 mg/kg/day IM, IV every 6-8 hours (Eroğlu, 2002; Küçüködük, 1994). 
6.1.5.5 Netilmicin 
Treatment of infections caused by aerobic gram-negative bacilli (Young & Mangum, 2010). It 
is antimicrobial effective and indicated for the treatment of sepsis caused by susceptible E. 
coli, Klebsiella, Enterobacter, Pseudomonas, H. influenza, Salmonella, Shigella, Staphylococci and of 
respiratory tract and surgical infections. And it is used in the treatment of complicated 
urinary system infections, sepsis, skin and skin joint infections, lower respiratory infections 
and intra-abdominal infections (Köksal & Mangum, 2010). 
Uses: Serious life-threatening infections with bacteria sensitive to Netromycin (sepsis, 
endocarditis) (Young & Mangum, 2010). 
Dose: The dose to be used in the first week ≤29 gestational weeks 5 mg/kg/dose every 48  
 
 
The dose to be used in the first week  ≤29 gestational weeks 5 mg/kg/dose every 48 hours 
 30-33 weeks 4.5 mg/kg/dose every 48 hours 
 34-37 weeks 4 mg/kg/dose every 36 hours 
 ≥38 weeks 4 mg/kg/dose every 24 hours 
After the first week 4 mg/kg is administered as first dose. After 12-24 hours following the 
end of infusion the dose interval is calculated on the basis of serum concentration (Kanmaz, 
2010). 
 
The Administration and Dose of Most Frequently Used Drugs in Pediatrics 
 
311 
Side Effects: 1/100- Rash, pruritus. Protein in the urine, an increase of uric acid in urine. 
Dizziness and balance disorders. The deterioration of hearing. 1/1000- Changes in blood 
picture. Urticaria. Changes in the liver. <1/1000- Headache. Anemia. Lowering blood 
pressure. Kidney damage (Young & Mangum, 2010). 
Administration and Storage Conditions: Ampoules should be diluted before use. The drug 
diluted with SF can be stored for 3 days in refrigerator (Kanmaz, 2010). 
Incompatible Drugs: Amphotericin B, Ampicillin, Furosemide, Heparin, Methicillin, 




It inhibits the protein synthesis by binding to ribosome. It can be used with sulphonamide 
for otitis media treatment (Eroğlu, 2002; Gallardo & Thomas, 1999). 
Uses: Erythromycin is used alternatively instead of penicillin to treat bacterial infections, 
especially in patients allergic to penicillin. The drug is effective in the treatment of 
diphtheria treatment of whooping cough, pneumonia caused by Mycoplasma pneumonia 
(including infants), Legionnaires' disease, the treatment of Chlamydia, Gonorrhea, Syphilis, 
endocarditis, urinary tract inflammation, conjunctivitis (Young & Mangum, 2010). 
Dose: 10 mg/kg PO (Young & Mangum, 2010). While erythromycin estolate should be 
administered every 3 hours; ethylsuccinate one should be administered every 6 hours with 
food. In chlamydia treatments: Estolate form 12.5 mg/kg/dose every 6 hours for 14 days. In 
serious infections 5-10 mg/kg/dose every 6 hours with a slow infusion for 60 min. or 10 
mg/kg/dose PO. In ophthalmia neonatorum treatment: 0.5% cream for each conjunctiva 
(Kanmaz, 2010). 
Side effects: It is accepted as one of the most dependable antibiotics. The side effects are 
rarely seen and usually light and limited to skin. However in several occasions angioedema 
and urticarial have been observed to develop (Gallardo & Thomas, 1999). 
Drug Interaction: The plasma clearance of midazolam decreases by 50%. Theophylline and 
carbamazepine serum concentration may increase. When used together with sisapride, it 
causes serious dysrhythmias (Kanmaz, 2010). 
Monitor: Heart rate and blood level should be monitored during IV use. Liver function tests 
should be carried out. Hemogram can be used for eosinophilia (Kanmaz, 2010). 
6.1.6.2 tetracyclines 
It inhibits bacteria protein synthesis. It has wide-spectrums active against gram (+) and 
gram (-) bacteria (Behrman & Kliegman, 2001; Eroğlu, 2002). Its use is limited in infants and 
children because of the side effects. Tetracycline prevents growth accumulating in bones 
and teeth. It should be used on ones older than 8 years old. It may increase intracranial 





Incompatible Drugs: Amphotericin B, Ampicillin, Furosemide, Heparin (>1 U/ml), 
Imipenem/Cilastatin, Indomethacin, Methicillin, Mezlocillin, Nafcillin, Oxacillin, Penicillin 
G, Propofol, Cefepime, Ticarcillin/Clavulanate (Kanmaz, 2010). 
6.1.5.3 Streptomycin sulfate 
It is an antibiotic and anti-tuberculostatic drug. It affects some gram negative and positive 
microorganisms (Kavakl et al, 1998). It is used with Isoniazid and other tuberculosis drugs 
in tuberculosis meningitis and progressive tuberculosis. In tuberculosis meningitis it is 
administered by IM route every 12 hours 20-40 mg/kg/day. The maximum dose is 1 g/day. 
The length of treatment period is usually 2-3 months. Higher doses and/or more prolonged 
therapy may result to destruction in 8th cranial nerve (Eroğlu, 2002). 
Side effects: Myocarditis, Ataxia, nuisance, vomiting, ototoxicity, nephrotoxicity and 
hypersensitivity can be seen (Kavakl et al, 1998). 
6.1.5.4 tobramycin 
It is more active against P. Aeruginosa than gentamycin. Newborn; IV (30-60 min.) , IM; <7 
days <34 weeks <1500g; 3 mg/kg every 24 hours, >1500g; 2.5 mg/kg every 18 hours, >34 
weeks >1500g; 2.5 mg/kg every 12 hours, >after 7 days; 5 mg/kg every 12 hours, for older 
people; 5-7.5 mg/kg/day IM, IV every 6-8 hours (Eroğlu, 2002; Küçüködük, 1994). 
6.1.5.5 Netilmicin 
Treatment of infections caused by aerobic gram-negative bacilli (Young & Mangum, 2010). It 
is antimicrobial effective and indicated for the treatment of sepsis caused by susceptible E. 
coli, Klebsiella, Enterobacter, Pseudomonas, H. influenza, Salmonella, Shigella, Staphylococci and of 
respiratory tract and surgical infections. And it is used in the treatment of complicated 
urinary system infections, sepsis, skin and skin joint infections, lower respiratory infections 
and intra-abdominal infections (Köksal & Mangum, 2010). 
Uses: Serious life-threatening infections with bacteria sensitive to Netromycin (sepsis, 
endocarditis) (Young & Mangum, 2010). 
Dose: The dose to be used in the first week ≤29 gestational weeks 5 mg/kg/dose every 48  
 
 
The dose to be used in the first week  ≤29 gestational weeks 5 mg/kg/dose every 48 hours 
 30-33 weeks 4.5 mg/kg/dose every 48 hours 
 34-37 weeks 4 mg/kg/dose every 36 hours 
 ≥38 weeks 4 mg/kg/dose every 24 hours 
After the first week 4 mg/kg is administered as first dose. After 12-24 hours following the 
end of infusion the dose interval is calculated on the basis of serum concentration (Kanmaz, 
2010). 
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diluted with SF can be stored for 3 days in refrigerator (Kanmaz, 2010). 
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It inhibits the protein synthesis by binding to ribosome. It can be used with sulphonamide 
for otitis media treatment (Eroğlu, 2002; Gallardo & Thomas, 1999). 
Uses: Erythromycin is used alternatively instead of penicillin to treat bacterial infections, 
especially in patients allergic to penicillin. The drug is effective in the treatment of 
diphtheria treatment of whooping cough, pneumonia caused by Mycoplasma pneumonia 
(including infants), Legionnaires' disease, the treatment of Chlamydia, Gonorrhea, Syphilis, 
endocarditis, urinary tract inflammation, conjunctivitis (Young & Mangum, 2010). 
Dose: 10 mg/kg PO (Young & Mangum, 2010). While erythromycin estolate should be 
administered every 3 hours; ethylsuccinate one should be administered every 6 hours with 
food. In chlamydia treatments: Estolate form 12.5 mg/kg/dose every 6 hours for 14 days. In 
serious infections 5-10 mg/kg/dose every 6 hours with a slow infusion for 60 min. or 10 
mg/kg/dose PO. In ophthalmia neonatorum treatment: 0.5% cream for each conjunctiva 
(Kanmaz, 2010). 
Side effects: It is accepted as one of the most dependable antibiotics. The side effects are 
rarely seen and usually light and limited to skin. However in several occasions angioedema 
and urticarial have been observed to develop (Gallardo & Thomas, 1999). 
Drug Interaction: The plasma clearance of midazolam decreases by 50%. Theophylline and 
carbamazepine serum concentration may increase. When used together with sisapride, it 
causes serious dysrhythmias (Kanmaz, 2010). 
Monitor: Heart rate and blood level should be monitored during IV use. Liver function tests 
should be carried out. Hemogram can be used for eosinophilia (Kanmaz, 2010). 
6.1.6.2 tetracyclines 
It inhibits bacteria protein synthesis. It has wide-spectrums active against gram (+) and 
gram (-) bacteria (Behrman & Kliegman, 2001; Eroğlu, 2002). Its use is limited in infants and 
children because of the side effects. Tetracycline prevents growth accumulating in bones 
and teeth. It should be used on ones older than 8 years old. It may increase intracranial 





6.1.6.2.1 Chlortetracycline hydrochloride 
PO: administered every 6 hours at a dose of 25-50 mg/kg/day (Köksal & Reisli, 2002). 
6.1.6.2.2 Oxytetracycline 
Child; PO: 25-50 mg/kg/day every 8 hours, IM: 15-20 mg/kg/day every 8-12 hours, IV: 10-
20 mg/kg/day every 12 hours (Eroğlu, 2002). 
6.1.7 Other antimicrobial drugs 
6.1.7.1 Clindamycin 
It is a derivative of lincomycin. It inhibits protein synthesis. It is active against gram (+) cocci 
and anaerobes (Köksal & Reisli, 2002). Its metabolism in premature is highly variable 
(Kanmaz, 2010). 
Dose: 5-7.5 mg/kg/dose IV slow infusion for 30 min. or PO (Kanmaz, 2010). 
Newborn; (IM/IV), <7 days <2000g: 10 mg/kg/day every 12 hours >2000g: 15 mg/kg/day 
every 8 hours, >7 days <2000g: 15 mg/kg/day every 8 hours, >2000g: 20 mg/kg/day every 
4 hours, infant and children; 10-25 mg/kg/day (PO) every 6-8 hours or 25-40 mg/kg/day 
IV, IM every 6-8 hours (Eroğlu, 2002). 
Side effects: Such gastrointestinal symptoms as nausea, vomiting, nuisance, and diarrhea are 
frequent (Apak, 1996; Eroğlu, 2002). Pseudomembranous enterocolitis may develop. Given 
fast by infusion it may cause syncope and respiratory arrest. Cleocin, Clindan, Klinoksin are 
its derivatives (Eroğlu, 2002). 
6.1.7.2 Chloramphenicol 
It inhibits protein synthesis. It has wide spectrum. It is bacteriostatic for many organisms in 
low concentrations. Newborn; <14 days 25 mg/kg/day PO, IV, every 12 hours >14 days 
<2000g: 25 mg/kg/day PO, IV, every 4 hours, >2000g: 50 mg/kg/day PO, IV every 4 hours, 
infant and children; 50-100 mg/kg/day PO, every 6 hours IV 100 mg/kg/day every 4 hours 
(Eroğlu, 2002; Dökmeci, 2001). 
Side effects: Non dose-related aplastic anemia is a rarely seen; but a serious complication. 
Dose-related bone marrow suppression is frequently seen and reversible (Eroğlu, 2002). 
6.1.7.3 Rifampicin 
It is an antimicrobial and antibacterial agent. It is used with at least one more 
antituberculosis agent in tuberculosis treatment. And administered as single dose 10-20 
mg/kg/day PO (Dökmeci, 2001). 
6.1.7.4 Vancomycin 
It inhibits cell wall synthesis in gram (+) bacteria (Dökmeci, 2001). 
Uses: Drug of choice for serious infections caused by Methicillin-Resistant Staphylococcus (e.g. 
S. Aureus and S. Epidermidis) and Penicillin-Resistant Pneumococci (Dökmeci, 2001; Young & 
Mangum, 2010). Dose restriction is required in case of a renal failure. It cannot be administered 
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by oral route as it cannot be absorbed well enough. IM administration causes tissue necrosis. It 
is administered only by IV route in systemic infection treatments (Dökmeci, 2001). 
Dose: IV infusion by syringe pump over 60 minute. Meningitis: 15 mg/kg per dose. 
Bacteremia: 10 mg/kg per dose (Young & Mangum, 2010). Newborn; IV, <7 days <1200g; 15 
mg/kg/day every 24 hours, >1200g; 30-45 mg/kg/day every 12 hours, >7 days <1200g; 15 
mg/kg/day every 24 hours, >7 days >1200g; 30-45 mg/kg/day every 8-12 hours. For others; 
45-60 mg/kg/day every 6-8 hours (Dökmeci, 2001; Ekenel et al, 2001; Eroğlu, 2002). 
Adverse Effects: Nephrotoxity and ototoxity: Enhanced by aminoglycoside therapy. Rash and 
hypotension (red man syndrome): Appears rapidly and resolves within minutes to hours. 
Lengthening infusion time usually eliminates risk for subsequently doses. Neutropenia: 
Reported after prolonged administration (more than 3 weeks). Phlebitis: May be minimized 
by slow infusion and dilution of the drug. (Eroğlu, 2002; (Young & Mangum, 2010). 
Preparation: The maximum concentration should be 5 mg/ml. 
Miscible Serums: 5% Dex, 10% Dex, SF 
Drugs to be confronted at the end point: Dex/Amino acid mixture, Lipid solution, Acyclovir, 
Aminophylline, Ampicillin, Amicasin, Fluconazole, Heparin (concentration ≤1 U/ml), 
Calcium gluconate, Meropenem, Midazolom, Potassium chloride, Ranitidine, Sodium 
bicarbonate. 
Incompatibility: Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Ceftriaxone, Dekort, Heparin 
(concentration >1 U/ml) 
Storage Conditions: The solution diluted with sterile water as 50 mg/ml can be stored for 14 
days in refrigerator. 
6.1.7.5 Sulphonamide 
The main indications are non-complicated urinary infections. Erythromycin-sulphonamide 
combination is effective in the treatment of otitis media. It is used in acute rheumatic fever 
prophylaxis. However it is not effective in group A streptococcus infection. Such drug-
related reactions as fever and rash may develop (Dökmeci, 2001). 
6.2 Antiviral drugs 
6.2.1 Acyclovir 
Acyclovir is one of the most commonly used antiviral drugs (Kavakl et al, 1998). Treatment 
of neonatal herpes simplex infections varicella zoster infections with CNS and pulmonary 
involvement, and herpes simplex encephalitis (Kavakl et al, 1998; Young & Mangum, 2010). 
It can be used for the treatment of herpes simplex virus infections of newborn, varicella 
infections of children taking immunosuppressive and of immunodeficient children (Kavakl 
et al, 1998). 
Dose: 20 mg/kg per dose Q8 hours IV by syringe pump over 1 hour. Prolong the dosing 
interval in prematures infant <34 weeks PMA, or in patients with significant renal 
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by oral route as it cannot be absorbed well enough. IM administration causes tissue necrosis. It 
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Lengthening infusion time usually eliminates risk for subsequently doses. Neutropenia: 
Reported after prolonged administration (more than 3 weeks). Phlebitis: May be minimized 
by slow infusion and dilution of the drug. (Eroğlu, 2002; (Young & Mangum, 2010). 
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Calcium gluconate, Meropenem, Midazolom, Potassium chloride, Ranitidine, Sodium 
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Incompatibility: Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Ceftriaxone, Dekort, Heparin 
(concentration >1 U/ml) 
Storage Conditions: The solution diluted with sterile water as 50 mg/ml can be stored for 14 
days in refrigerator. 
6.1.7.5 Sulphonamide 
The main indications are non-complicated urinary infections. Erythromycin-sulphonamide 
combination is effective in the treatment of otitis media. It is used in acute rheumatic fever 
prophylaxis. However it is not effective in group A streptococcus infection. Such drug-
related reactions as fever and rash may develop (Dökmeci, 2001). 
6.2 Antiviral drugs 
6.2.1 Acyclovir 
Acyclovir is one of the most commonly used antiviral drugs (Kavakl et al, 1998). Treatment 
of neonatal herpes simplex infections varicella zoster infections with CNS and pulmonary 
involvement, and herpes simplex encephalitis (Kavakl et al, 1998; Young & Mangum, 2010). 
It can be used for the treatment of herpes simplex virus infections of newborn, varicella 
infections of children taking immunosuppressive and of immunodeficient children (Kavakl 
et al, 1998). 
Dose: 20 mg/kg per dose Q8 hours IV by syringe pump over 1 hour. Prolong the dosing 
interval in prematures infant <34 weeks PMA, or in patients with significant renal 





disseminated or CNS infections for 21 days (Young & Mangum, 2010).As this drug’s 
intestinal absorption is not that good it should be taken by oral route at high doses. The 
drug reaches its peak after 1.5-2 hours following being administered by oral route. Almost 
30-90% of it is discharged by urinary system (Kavakl et al, 1998). 
Adverse Effects: The most common side effects are nausea, vomiting, diarrhea and headache. 
Other reported side effects include agitation, confusion, rash, anemia, and muscle pain. 
Hypersensitivity reactions, seizures, agitation, confusion, anemia, hepatitis, and muscle pain 
have also been reported (Apak, 1996; Kavakl et al, 1998; Young & Mangum, 2010). 
The things to be considered by nurse applying the drug: In application by IV route a vial of 500 
mg is diluted with 10 ml sterile water. The vial is shaken until the drug is fully dissolved. 
The desired dose is taken into syringe. In order to decrease concentration a single dose 
should be administered every 1 hour with infusion solution and if possible with infusion 
pump. Fast application may result in phlebitis and kidney destruction. The infusion area 
should be changed in order to avoid thrombophlebitis. The prepared solution should be 
used within 12 hours. 
As the drug gets discharged from urinary system the child should be provided with 
adequate hydration pre-application and during application. The nephrotoxicity risk 
decreases after 2 hours following infusion application. 
Nurse should attentively observe the observable side effects of the drug and should notify 
doctor if any is observed. If necessary, drug use should be ceased at once (Kavakl et al, 1998). 
6.2.2 Gansklovir 
It is an antiviral drug used for the prevention of hearing loss in infants with symptomatic 
congenital CMV infection (Dökmeci, 2001; Kanmaz, 2010). 
Children; first line treatment, 10 mg/kg/day IV (1 hour, slow) every 8-12 hours, 14-21 days; 
Maintenance, 5-6 mg/kg/day IV every 12-24 hours for 5 days in a week (Dökmeci, 2001). 
The dose should be halved in case of a serious neutropenia (<500/mm3) (Kanmaz, 2010). 
Side Effects: Granulocytopenia, anemia, thrombocytopenia (Kanmaz, 2010). 
Incompatible Drugs: Enalaprilat, Fluconazole, Linezolid, Propofol, Remifentanil, Aztreonam, 
Cefepime, Piperacillin-Tazobactam (Kanmaz, 2010). 
6.2.3 Interferons 
These composites produced by body cells against viral infections can be synthesized via 
recombinant DNA technology in our day. The activities of these substances in the treatment 
of virus infections are a matter of research (Biçer, 2008). 
6.3 Antifungal drugs 
6.3.1 Amphotericin B liposome 
It destroys the cell membrane permeability. It is used in progressive and fatal infections as a 
result of toxicity (Apak, 1996; Dökmeci, 2001; Eroğlu, 2002). 
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Uses: Treatment of systemic fungal infections resistant to conventional amphotericin B 
therapy or in patients with renal or hepatic dysfunction (Young & Mangum, 2010).Dose: 5 to 
7 mg/kg dose Q24 hours IV infusion by syringe pump over 2 hours (Young & Mangum, 
2010). 
It is administered by IV route every 2-6 hours in a 5% dextrose solution. It is started with 
0.25 mg/kg/day and increased by 0.25 mg/kg/day in 1-2 days and can be advanced up to 
1-1.5 mg/kg/day (Apak, 1996; Dökmeci, 2001; Eroğlu, 2002). 
Side Effects: Anemia, thrombocytopenia, hypokalemia, nausea/vomiting, and fever/chills 
(Young & Mangum, 2010). 
6.3.2 Fluconazole 
It is active against oropharynx, esophagus, urinary and systemic candidiasis. It is orally 
well- absorbed. It interacts with Warfarin, Phenytoin, Cyclosporine and Rifampin (Eroğlu, 
2002). 
6.3.3 Nystatin 
It is used in skin and mucosal candidiasis infections (Apak, 1996; Kanmaz, 2010). It 
resembles to Amphotericin B as structure. It cannot be absorbed via gastrointestinal 
channels, skin and mucosae. It may have fungicidal or fungistatic effect (Kanmaz, 2010). 
Dose: Topical: cream or ointment can be used on the affected area every 6 hours. Therapy 
should be maintained even after symptoms disappear (Kanmaz, 2010). 
PO: from 100.000 U/ml solution 2 ml for term infants, 1 ml for preterm ones every 6 hours 
for each side of mouth. Therapy should be maintained even after symptoms disappear 
(Kanmaz, 2010). 
Side effects: Cream or ointment related rash (Kanmaz, 2010). 
Administration Properties: Oral suspension must be shaken well before use. This suspension 
includes <1% alcohol, saccharin, 50% sucrose (Kanmaz, 2010). 
6.4 Other drugs 
6.4.1 Acetaminophen 
It is a drug whose analgesic and antipyretic effect is almost equal to aspirin. However it 
does not resemble to aspirin in terms of gastric mucosa destruction and bleeding. It has no 
antirheumatic effect being only active against mild and moderate fever. It is used in cases of 
nuisance, muscle and joint pain, neuralgia and fever. It is also advised in situations where 
aspirin is contraindicated or not tolerated (Kavakl et al, 1998). 
The dose, route of administration, duration and discharge of drug: 
Oral: loading dose 24 mg/kg, maintenance dose 12 mg/kg/dose 
Rectal: loading dose 30 mg/kg, maintenance dose 20 mg/kg 
Maintenance dose intervals 
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 >32 weeks: 8 hours 
Term 6 hours (Kanmaz, 2010). 
age-appropriate daily dose: 
0-1 month→ 40 mg 
4-11 months →80 mg 
1-2 age →120 mg 
2-3 age →160 mg 
4-5 age →240 mg 
6-8 age →320 mg 
9-10 age→400 mg 
11 years old and older→480 mg (Kavakl et al, 1998). 
The drug is administered every 4-6 hours. It should not exceed more than 5 doses within 24 
hours. The drug can be in tablet, capsule, drop, suspension, syrup and suppository forms. 
The drug gets absorbed by gastrointestinal system, reaches the highest level in blood within 
half an hour-one hour and sustains its effect for almost 5 hours. 
It is metabolized in liver and discharged from body via urinary system. It reaches fetus 
through placenta (Kavakl et al, 1998). 
Side effects of the drug: As a result of higher dose intake and more prolonged therapy 
vomiting, nausea, confusion, fever, coma, hepatic and renal tubular necrosis can be 
observed (Kavakl et al, 1998). Liver toxicity occurs with excessive doses or after prolonged 
administration (>48 hours) of therapeutic doses. Rash, fever, thrombocytopenia, leupenia, 
and neutropenia have been reported in children (Young & Mangum, 2010). 
The things to be considered by nurse applying the drug: Nurse should be warned not to exceed 
recommended dose. For children who have received higher doses and more prolonged 
therapy liver, kidney and hematopoietic functions should be analyzed. 
In case of children with nutritional deficiency it may result in toxicity in liver even if higher 
doses are not administered. 
If the drug is used to reduce fever it should not be forgotten that it can mask the serious 
disease condition. 
The drug should be stored in tight-closed, light-proof bottles and kept away from the reach 
of children (Kavakl et al, 1998). 
6.4.2 Adenosine 
Acute treatment of sustained paroxysmal supraventricular tachycardia. It may also be useful 
in establishing the cause of the SVT. 
Dose: 50 mcg/kg rapid IV push (1 to 2 seconds). Increase dose in 50 mcg/kg increments Q2 
minutes until return of sinus rhythm. 
Adverse Effects: > 1 / 100 Pain in the chest. Shortness of breath. Dizziness and headache. The 
in flow of hot face. Speeding up heart rate. Tingling in the extremities. Nausea. 1/100- 
1/1000 Sweating. Lowering blood pressure. Anxiety. Seeing the fog. >1/1000 The attack of 
an asthma attack. 
 




As a bronchodilator in asthma attack it is administered 2 times at 20 minutes intervals by SC 
route at a dose of 0.01 mg/kg/dose. Higher dose Administration may result in arrhythmia 
and/or hypotension (Kartal, 2002). 
Uses: The resuscitation - the cessation of the heart - together with other measures. Injections 
performed only by health services, which provides further information about the drug.  
Dose: 0.0.1 to 0.03 mg/kg. IV push or SC (Young & Mangum, 2010). 
6.4.4 Activated charcoal 
It is used as absorbent in oral drug overdose treatment. The dose of 0.25-1 gr/kg can be 
administered by PO route every 4 hours if necessary (Eroğlu, 2002). 
6.4.5 Albuterol 
Albuterol is used as a bronchodilator in the treatment of bronchospasm developed in 
children with reversible respiratory tract disease. It affects the smooth muscles (Kavakl et 
al, 1998). 
The dose, route of administration, duration and discharge of drug: 
The age-appropriate daily dose of albuterol: 
2-6 age → 0.1-0.2 mg/kg/dose 3 times a day, 4 mg 3 times a day (the highest applicable 
dose) 
6-12 age → 2 mg/dose 3 times a day, 24 mg/day (the highest applicable dose) 
12 ages and older → 2-4 mg/dose 3-4 times a day, 8 mg 4 times a day (the highest applicable 
dose). 
The drug is administered every 4-6 hours as 0.5% solution 0.01-0.05 ml/kg by inhalation via 
nebulizer. It can be administered more frequently on children with need. 
Aerosol inhalation is administered on children above 12 at 90 µ/sprey and the drug reaches 
the highest level in blood after ½- 2 hours. It is metabolized in liver and discharged from 
body via urinary system (Kavakl et al, 1998). 
Side effects of the drug: Tachycardia, peripheral vasodilatation, tremor, nervousness, 
hyperactivity, hypokalemia, irritation in oropharynx are potential side effects (Kavakl et al, 
1998). 
The things to be considered by nurse applying the drug: The drug should be well shaken before 
inhaler application. Mouth should be washed with water after each application in order to 
avoid mouth and throat dryness. 
It should be administered with precaution in children with hyperthyroidism, diabetes, 
mellitus and heart disease. Addictiveness may develop in prolonged therapy and the usual 
dose may not be enough. 





 >32 weeks: 8 hours 
Term 6 hours (Kanmaz, 2010). 
age-appropriate daily dose: 
0-1 month→ 40 mg 
4-11 months →80 mg 
1-2 age →120 mg 
2-3 age →160 mg 
4-5 age →240 mg 
6-8 age →320 mg 
9-10 age→400 mg 
11 years old and older→480 mg (Kavakl et al, 1998). 
The drug is administered every 4-6 hours. It should not exceed more than 5 doses within 24 
hours. The drug can be in tablet, capsule, drop, suspension, syrup and suppository forms. 
The drug gets absorbed by gastrointestinal system, reaches the highest level in blood within 
half an hour-one hour and sustains its effect for almost 5 hours. 
It is metabolized in liver and discharged from body via urinary system. It reaches fetus 
through placenta (Kavakl et al, 1998). 
Side effects of the drug: As a result of higher dose intake and more prolonged therapy 
vomiting, nausea, confusion, fever, coma, hepatic and renal tubular necrosis can be 
observed (Kavakl et al, 1998). Liver toxicity occurs with excessive doses or after prolonged 
administration (>48 hours) of therapeutic doses. Rash, fever, thrombocytopenia, leupenia, 
and neutropenia have been reported in children (Young & Mangum, 2010). 
The things to be considered by nurse applying the drug: Nurse should be warned not to exceed 
recommended dose. For children who have received higher doses and more prolonged 
therapy liver, kidney and hematopoietic functions should be analyzed. 
In case of children with nutritional deficiency it may result in toxicity in liver even if higher 
doses are not administered. 
If the drug is used to reduce fever it should not be forgotten that it can mask the serious 
disease condition. 
The drug should be stored in tight-closed, light-proof bottles and kept away from the reach 
of children (Kavakl et al, 1998). 
6.4.2 Adenosine 
Acute treatment of sustained paroxysmal supraventricular tachycardia. It may also be useful 
in establishing the cause of the SVT. 
Dose: 50 mcg/kg rapid IV push (1 to 2 seconds). Increase dose in 50 mcg/kg increments Q2 
minutes until return of sinus rhythm. 
Adverse Effects: > 1 / 100 Pain in the chest. Shortness of breath. Dizziness and headache. The 
in flow of hot face. Speeding up heart rate. Tingling in the extremities. Nausea. 1/100- 
1/1000 Sweating. Lowering blood pressure. Anxiety. Seeing the fog. >1/1000 The attack of 
an asthma attack. 
 




As a bronchodilator in asthma attack it is administered 2 times at 20 minutes intervals by SC 
route at a dose of 0.01 mg/kg/dose. Higher dose Administration may result in arrhythmia 
and/or hypotension (Kartal, 2002). 
Uses: The resuscitation - the cessation of the heart - together with other measures. Injections 
performed only by health services, which provides further information about the drug.  
Dose: 0.0.1 to 0.03 mg/kg. IV push or SC (Young & Mangum, 2010). 
6.4.4 Activated charcoal 
It is used as absorbent in oral drug overdose treatment. The dose of 0.25-1 gr/kg can be 
administered by PO route every 4 hours if necessary (Eroğlu, 2002). 
6.4.5 Albuterol 
Albuterol is used as a bronchodilator in the treatment of bronchospasm developed in 
children with reversible respiratory tract disease. It affects the smooth muscles (Kavakl et 
al, 1998). 
The dose, route of administration, duration and discharge of drug: 
The age-appropriate daily dose of albuterol: 
2-6 age → 0.1-0.2 mg/kg/dose 3 times a day, 4 mg 3 times a day (the highest applicable 
dose) 
6-12 age → 2 mg/dose 3 times a day, 24 mg/day (the highest applicable dose) 
12 ages and older → 2-4 mg/dose 3-4 times a day, 8 mg 4 times a day (the highest applicable 
dose). 
The drug is administered every 4-6 hours as 0.5% solution 0.01-0.05 ml/kg by inhalation via 
nebulizer. It can be administered more frequently on children with need. 
Aerosol inhalation is administered on children above 12 at 90 µ/sprey and the drug reaches 
the highest level in blood after ½- 2 hours. It is metabolized in liver and discharged from 
body via urinary system (Kavakl et al, 1998). 
Side effects of the drug: Tachycardia, peripheral vasodilatation, tremor, nervousness, 
hyperactivity, hypokalemia, irritation in oropharynx are potential side effects (Kavakl et al, 
1998). 
The things to be considered by nurse applying the drug: The drug should be well shaken before 
inhaler application. Mouth should be washed with water after each application in order to 
avoid mouth and throat dryness. 
It should be administered with precaution in children with hyperthyroidism, diabetes, 
mellitus and heart disease. Addictiveness may develop in prolonged therapy and the usual 
dose may not be enough. 





The serum potassium level, heart rate, respiration rate, blood gases of children should be 
closely monitored when the drug is administered (Kavakl et al, 1998). 
6.4.6 Aminophylline 
Treatment of neonatal apnea, including post-extubation, post-anesthesia, and prostaglandin 
E1-inducted. Bronchodilator. May improve respiratory function (Kavakl et al, 1998; Young 
& Mangum, 2010). 
Dose: Loading dose: 8 mg/kg IV infusion over 30 minutes, or PO. Maintenance: 1.5 to 3 
mg/kg per dose PO, or IV slow push Q8 to 12 hours. In preterms infants, changing from IV 
aminophylline to PO theophylline requires no dose adjustment (Young & Mangum, 2010). 
The dose of 20 mg/kg/day should not be exceeded in rectal application. IM administration 
of drug is not advised as it causes long-term pains in the injection area (Kavakl et al, 1998). 
When the drug is administered by IV route it reaches the highest level in blood within 30 
minutes; by oral route it reaches within 1-2 hours. 
The drug is metabolized in liver and discharged from body via urinary system. It reaches 
fetus through placenta in pregnancy period and is transmitted to child through natural 
nutrition in lactation period (Kavakl et al, 1998). 
Side Effects: An allergic reaction (difficulty breathing; closing of your throat; swelling of your 
lips, tongue, or face; or hives); seizures; increased or irregular heartbeats; or severe nausea 
or vomiting (Kavakl et al, 1998; Young & Mangum, 2010). 
The things to be considered by nurse applying the drug: The solution should be given in 20-30 
minutes in IV administration. In infants younger than 6 months it should be slowly 
administered by infusion prepared in 5% dextrose. And it should not be mixed with other 
drugs. 
In oral administration the drug should be administered with water half an hour or one hour 
before or 2 hours after meals as drug absorption is faster when child is hungry. Child should 
not break or chew the tablet; but swallow it as a whole. Tablet is not advised for children 
under the age of 12. Rectal route of administration is used for children who cannot take by 
oral route. If possible, drug use should be adjusted according to the excretion times of 
children as drug absorption is faster when rectum is empty. After the administration of drug 
child should be laid in supine position for 15-20 minutes. As the absorption via rectal route 
in children is way faster than adults the probability of toxicity is also higher. So nurse 
should be warned not to exceed recommended dose. 
Vital signs and inputs/outputs are observed and recorded at frequent intervals. Instant and 
clear tachycardia is one of the symptoms of toxicity. 
When side effect-related symptoms appear the drug should not be administered and doctor 
should be notified. In the event that the symptoms are light it can be administered with 
higher doses. 
Such commonly consumed beverages as coffee, tea, coke can increase the reactions. While a 
diet rich in protein increases the output of drug; a diet rich in carbohydrate decreases the 
output of it. These conditions result in changes in the drug level in blood. So it may be 
required to readjust the dose. 
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The drug should be stored in refrigerator. Suppository forms should be stored either outside 
or in refrigerator according to the recommendation of the manufacturer (Kavakl et al, 1998). 
6.4.7 Acetylsalicylic acid 
As an antipyretic and analgesic it is administered 4-6 times a day at a dose of 30-65 
mg/kg/day via PO route in infants and children (Dökmeci, 2000). 
6.4.8 Atropine 
Reversal of severe sinus Bradycardia, particularly when parasympathetic influences on the 
heart predominate. Also used to reduce the muscarinic effects if neostigmine when 
reversing neuromuscular blockade. 
Dose: IV: 0.01 to 0.03 mg/kg per dose IV over 1 minute, or IM. Dose can be repeated Q10 to 
15 minutes to achieve desired effect, with a maximum total dose of 0.04 mg/kg (Young & 
Mangum, 2010). 
Endotracheal: The same dose can be administered from ET tube. Right after ET tube, 1 ml SF 
should be given and PPV should be applied for homogenous distribution. 
Oral: 0.02 mg-0.09 mg/kg/dose every 4-6 hours (Kanmaz, 2010). 
Adverse Effects: Cardiac arrhythmias can occurs, particularly during the first 2 minutes 
following IV administration; usually a simple A-V dissociation more often caused by 
smaller rather than larger doses. Fever, especially in brain-damaged infants. Abdominal 
distention with decreased bowel activity. Esophageal reflux. Mydriasis and cyclopedia 
(Young & Mangum, 2010). 
6.4.9 Calcium gluconate 10% 
Uses: Treatment and prevention of hypocalcaemia, usually defined as a serum ionized 
calcium concentration less than approximately 4 mg/dL. Treatment of asymptotic infants is 
controversial. 
Dose: Symptomatic hypocalcaemia – acute treatment: 100 to 200 mg/kg per dose. 
Maintenance treatment: 200 to 800 mg/kg per day (Young & Mangum, 2010). 
The things to be considered by nurse applying the drug: The drug should be administered by IV 
route in a way not to exceed 0.5 ml per minute. Besides, 1000 ml serum, prepared in 
physiologic, can be administered every 12-24 hours. The temperature of solution should be 
close to the body temperature. The fast delivery of calcium to heart at higher concentrations 
may result in fatal cardiac arrest. So the drug should be administered very slowly when 
parenteral route is used. The heart rate should be checked and monitored. When the drug is 
administered by non-diluted IV route paresthesias, peripheral vasodilatation and 
hypotension can be observed. If the child is observed with any symptom drug 
administration should be ceased and the child should be ensured to rest for half an hour or 
one hour. It can cause extravasation (the process of exuding or passing out of a vessel into 






The serum potassium level, heart rate, respiration rate, blood gases of children should be 
closely monitored when the drug is administered (Kavakl et al, 1998). 
6.4.6 Aminophylline 
Treatment of neonatal apnea, including post-extubation, post-anesthesia, and prostaglandin 
E1-inducted. Bronchodilator. May improve respiratory function (Kavakl et al, 1998; Young 
& Mangum, 2010). 
Dose: Loading dose: 8 mg/kg IV infusion over 30 minutes, or PO. Maintenance: 1.5 to 3 
mg/kg per dose PO, or IV slow push Q8 to 12 hours. In preterms infants, changing from IV 
aminophylline to PO theophylline requires no dose adjustment (Young & Mangum, 2010). 
The dose of 20 mg/kg/day should not be exceeded in rectal application. IM administration 
of drug is not advised as it causes long-term pains in the injection area (Kavakl et al, 1998). 
When the drug is administered by IV route it reaches the highest level in blood within 30 
minutes; by oral route it reaches within 1-2 hours. 
The drug is metabolized in liver and discharged from body via urinary system. It reaches 
fetus through placenta in pregnancy period and is transmitted to child through natural 
nutrition in lactation period (Kavakl et al, 1998). 
Side Effects: An allergic reaction (difficulty breathing; closing of your throat; swelling of your 
lips, tongue, or face; or hives); seizures; increased or irregular heartbeats; or severe nausea 
or vomiting (Kavakl et al, 1998; Young & Mangum, 2010). 
The things to be considered by nurse applying the drug: The solution should be given in 20-30 
minutes in IV administration. In infants younger than 6 months it should be slowly 
administered by infusion prepared in 5% dextrose. And it should not be mixed with other 
drugs. 
In oral administration the drug should be administered with water half an hour or one hour 
before or 2 hours after meals as drug absorption is faster when child is hungry. Child should 
not break or chew the tablet; but swallow it as a whole. Tablet is not advised for children 
under the age of 12. Rectal route of administration is used for children who cannot take by 
oral route. If possible, drug use should be adjusted according to the excretion times of 
children as drug absorption is faster when rectum is empty. After the administration of drug 
child should be laid in supine position for 15-20 minutes. As the absorption via rectal route 
in children is way faster than adults the probability of toxicity is also higher. So nurse 
should be warned not to exceed recommended dose. 
Vital signs and inputs/outputs are observed and recorded at frequent intervals. Instant and 
clear tachycardia is one of the symptoms of toxicity. 
When side effect-related symptoms appear the drug should not be administered and doctor 
should be notified. In the event that the symptoms are light it can be administered with 
higher doses. 
Such commonly consumed beverages as coffee, tea, coke can increase the reactions. While a 
diet rich in protein increases the output of drug; a diet rich in carbohydrate decreases the 
output of it. These conditions result in changes in the drug level in blood. So it may be 
required to readjust the dose. 
 
The Administration and Dose of Most Frequently Used Drugs in Pediatrics 
 
319 
The drug should be stored in refrigerator. Suppository forms should be stored either outside 
or in refrigerator according to the recommendation of the manufacturer (Kavakl et al, 1998). 
6.4.7 Acetylsalicylic acid 
As an antipyretic and analgesic it is administered 4-6 times a day at a dose of 30-65 
mg/kg/day via PO route in infants and children (Dökmeci, 2000). 
6.4.8 Atropine 
Reversal of severe sinus Bradycardia, particularly when parasympathetic influences on the 
heart predominate. Also used to reduce the muscarinic effects if neostigmine when 
reversing neuromuscular blockade. 
Dose: IV: 0.01 to 0.03 mg/kg per dose IV over 1 minute, or IM. Dose can be repeated Q10 to 
15 minutes to achieve desired effect, with a maximum total dose of 0.04 mg/kg (Young & 
Mangum, 2010). 
Endotracheal: The same dose can be administered from ET tube. Right after ET tube, 1 ml SF 
should be given and PPV should be applied for homogenous distribution. 
Oral: 0.02 mg-0.09 mg/kg/dose every 4-6 hours (Kanmaz, 2010). 
Adverse Effects: Cardiac arrhythmias can occurs, particularly during the first 2 minutes 
following IV administration; usually a simple A-V dissociation more often caused by 
smaller rather than larger doses. Fever, especially in brain-damaged infants. Abdominal 
distention with decreased bowel activity. Esophageal reflux. Mydriasis and cyclopedia 
(Young & Mangum, 2010). 
6.4.9 Calcium gluconate 10% 
Uses: Treatment and prevention of hypocalcaemia, usually defined as a serum ionized 
calcium concentration less than approximately 4 mg/dL. Treatment of asymptotic infants is 
controversial. 
Dose: Symptomatic hypocalcaemia – acute treatment: 100 to 200 mg/kg per dose. 
Maintenance treatment: 200 to 800 mg/kg per day (Young & Mangum, 2010). 
The things to be considered by nurse applying the drug: The drug should be administered by IV 
route in a way not to exceed 0.5 ml per minute. Besides, 1000 ml serum, prepared in 
physiologic, can be administered every 12-24 hours. The temperature of solution should be 
close to the body temperature. The fast delivery of calcium to heart at higher concentrations 
may result in fatal cardiac arrest. So the drug should be administered very slowly when 
parenteral route is used. The heart rate should be checked and monitored. When the drug is 
administered by non-diluted IV route paresthesias, peripheral vasodilatation and 
hypotension can be observed. If the child is observed with any symptom drug 
administration should be ceased and the child should be ensured to rest for half an hour or 
one hour. It can cause extravasation (the process of exuding or passing out of a vessel into 






In order to ensure well absorption by oral route the drug should be administered 1-1.5 hours 
after meals. In order to promote intestinal absorption the use of milk and milk products 
should be decreased. As calcium gluconate increases the digital toxicity it should be 
attentively administered in patients receiving digital. 
The effect of drug on tetany treatment is evaluated by neuromuscular recovery (Kavakl et 
al, 1998). 
Administration: It can be either slowly administered by IV route in 10-30 minutes or used as 
continuous infusion. 
Miscible Serums: 5% Dex, 10% Dex, SF 
Drugs to be confronted at the end point: Dex/Amino acid, Lipid solution, Aminophylline, 
Ampicillin, Amicasin, Dobutamine, Furosemide, Heparin, Midazolom, Meropenem, 
Potassium chloride, Vancomycin 
Incompatibility: Amphotericin B, Fluconazole, Sodium bicarbonate 
Side effects: Bradycardia, cardiac arrest, tissue necrosis, intestinal bleeding, diarrhea, gastric 
irritation. It should be used carefully in patients who receive digital treatment and has 
bradypnea. 
6.4.10 Captopril 
Uses: Treatment of moderate to severe hypertension. Afterload reduction in patients with 
congestive heart failure. 
Dose: 0.01 to 0.05 mg/kg per dose PO Q8 to 12 hours. Adjust dose and interval based on 
response. Administer 1 hour before feeding. 
Adverse Effects: Captopril produces the following side effects: Angioedema with involvement 
of the face, mouth, larynx, tongue, and glossitis, neutropenia, anemia and 
thrombocytopenia, proteinuria, acidosis, tachycardia, cardiac arrest, arrhythmias, rash and 
erythema multiform, exfoliate dermatitis, photosensitivity, elevated liver enzymes in serum, 
liver cell injury, cholestasis jaundice, gastric irritation, hepatitis, drowsiness, nervousness, 
depression, paresthesias of hands, confusion, ataxia, bronchitis, bronchospasm, pneumonia 
eosinophil, rhinitis (Young & Mangum, 2010). 
6.4.11 Ceftriaxone 
Uses: Treatment of neonatal sepsis and meningitis caused by susceptible gram-negative 
organisms (e.g. E coli, Pseudomonas, Klebsiella, H influenzae). Treatment of gonococcal 
infections. 
Dose: Septis and disseminated gonococcal infection: 50mg/kg Q24 hours. Meningitis: 100 
mg/kg loading dose, then 80 mg/kg Q24 hours. Uncomplicated gonococcal ophthalmia: 50 
mg/kg (maximum 125 mg) single dose. (note: topical antibiotic therapy alone is inadequate 
and is unnecessary if systemic treatment is administered). IV administration: infusion by 
syringe pump over 30 minutes. Avoid administration of calcium-containing solution or 
products within 48 hours of the last administration. IM administration: to reduce pain at the 
injection site, reconstitute with 1% lidocaine without epinephrine. 
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Adverse Effects: Not recommended for use in neonatal with hyperbilirubinemia! Displaces 
bilirubin from albumin binding sites, resulting in higher free bilirubin serum concentration. 
Concurrent administration of ceftriaxone and calcium-containing solutions or products in 
neonates is contraindicated. Eosinophilia, Thrombocytosis, leukopenia. Increase in AST and 
ALT. Skin rash. Transient gallbladder precipitations occasionally associated with colicky 
abdominal pain, nausea, and vomiting (Young & Mangum, 2010). 
6.4.12 Chloral hydrate 
Uses: Sedative/hypnotic for short-term use only. Chloral hydrate has no analgesic after a 
feeding to reduce gastric irritation. 
Dose: 25 to 75 mg/kg per dose PO. Oral preparation should be diluted or administered after 
feeding to reduce gastric irritation. 
Adverse Effects: Chloral hydrate may lead to unpleasant side effects, including: drowsiness, 
nausea, vomiting, and diarrhea. Toxic doses (overdoses) can cause a marked drop in blood 
pressure and severely compromised respiration (breathing). Signs of an overdose of chloral 
hydrate can include: confusion, seizures, difficulty breathing, slurred speech, slow or 
irregular heartbeat, vomiting, weakness, and a lowered body temperature. Chronic use of 
chloral hydrate is also associated with a severe withdrawal syndrome and may induce liver 
damage (Young & Mangum, 2010). 
6.4.13 Iron 
Indication: The prevention and treatment of iron-deficiency induced anemia. 
Pharmacology: Ferrous salts are preferred as they are absorbed 2-3 times better than ferric 
salts when administered by oral route. Ferrous sulfate, ferrous fumarate, ferrous gluconate 
can also be used. Absorption is better on an empty stomach. Half or one-third of it is 
absorbed when taken with food. 
Dose: Premature infants: Elemental iron 2 mg/kg/dose PO, started after 4 weeks in doses 
divided into 2-3. For babies lighter than 1000 gr 4 mg/kg/day may be administered. For 
patients receiving EPO treatment: 6 mg/kg/day 
Iron dextran: For ones who cannot take by oral route 0.4-1 mg/kg/day is administered as 
continuous infusion in D/AA. 
Side effects: Iron treatment should not be launched as long as premature infants do not get 
adequate vitamin E. Hemolysis may increase in that case. Diarrhea and constipation, 
lethargy, hypotension, black-colored stool and erosion in gastric mucosa can be observed. It 
may be required to seek for occult blood in stool in suspicious cases (Kanmaz, 2010). 
6.4.14 Dexamethasone 
Uses: Dexamethasone is used primarily in the intensive and short-term treatment of severe 






In order to ensure well absorption by oral route the drug should be administered 1-1.5 hours 
after meals. In order to promote intestinal absorption the use of milk and milk products 
should be decreased. As calcium gluconate increases the digital toxicity it should be 
attentively administered in patients receiving digital. 
The effect of drug on tetany treatment is evaluated by neuromuscular recovery (Kavakl et 
al, 1998). 
Administration: It can be either slowly administered by IV route in 10-30 minutes or used as 
continuous infusion. 
Miscible Serums: 5% Dex, 10% Dex, SF 
Drugs to be confronted at the end point: Dex/Amino acid, Lipid solution, Aminophylline, 
Ampicillin, Amicasin, Dobutamine, Furosemide, Heparin, Midazolom, Meropenem, 
Potassium chloride, Vancomycin 
Incompatibility: Amphotericin B, Fluconazole, Sodium bicarbonate 
Side effects: Bradycardia, cardiac arrest, tissue necrosis, intestinal bleeding, diarrhea, gastric 
irritation. It should be used carefully in patients who receive digital treatment and has 
bradypnea. 
6.4.10 Captopril 
Uses: Treatment of moderate to severe hypertension. Afterload reduction in patients with 
congestive heart failure. 
Dose: 0.01 to 0.05 mg/kg per dose PO Q8 to 12 hours. Adjust dose and interval based on 
response. Administer 1 hour before feeding. 
Adverse Effects: Captopril produces the following side effects: Angioedema with involvement 
of the face, mouth, larynx, tongue, and glossitis, neutropenia, anemia and 
thrombocytopenia, proteinuria, acidosis, tachycardia, cardiac arrest, arrhythmias, rash and 
erythema multiform, exfoliate dermatitis, photosensitivity, elevated liver enzymes in serum, 
liver cell injury, cholestasis jaundice, gastric irritation, hepatitis, drowsiness, nervousness, 
depression, paresthesias of hands, confusion, ataxia, bronchitis, bronchospasm, pneumonia 
eosinophil, rhinitis (Young & Mangum, 2010). 
6.4.11 Ceftriaxone 
Uses: Treatment of neonatal sepsis and meningitis caused by susceptible gram-negative 
organisms (e.g. E coli, Pseudomonas, Klebsiella, H influenzae). Treatment of gonococcal 
infections. 
Dose: Septis and disseminated gonococcal infection: 50mg/kg Q24 hours. Meningitis: 100 
mg/kg loading dose, then 80 mg/kg Q24 hours. Uncomplicated gonococcal ophthalmia: 50 
mg/kg (maximum 125 mg) single dose. (note: topical antibiotic therapy alone is inadequate 
and is unnecessary if systemic treatment is administered). IV administration: infusion by 
syringe pump over 30 minutes. Avoid administration of calcium-containing solution or 
products within 48 hours of the last administration. IM administration: to reduce pain at the 
injection site, reconstitute with 1% lidocaine without epinephrine. 
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Adverse Effects: Not recommended for use in neonatal with hyperbilirubinemia! Displaces 
bilirubin from albumin binding sites, resulting in higher free bilirubin serum concentration. 
Concurrent administration of ceftriaxone and calcium-containing solutions or products in 
neonates is contraindicated. Eosinophilia, Thrombocytosis, leukopenia. Increase in AST and 
ALT. Skin rash. Transient gallbladder precipitations occasionally associated with colicky 
abdominal pain, nausea, and vomiting (Young & Mangum, 2010). 
6.4.12 Chloral hydrate 
Uses: Sedative/hypnotic for short-term use only. Chloral hydrate has no analgesic after a 
feeding to reduce gastric irritation. 
Dose: 25 to 75 mg/kg per dose PO. Oral preparation should be diluted or administered after 
feeding to reduce gastric irritation. 
Adverse Effects: Chloral hydrate may lead to unpleasant side effects, including: drowsiness, 
nausea, vomiting, and diarrhea. Toxic doses (overdoses) can cause a marked drop in blood 
pressure and severely compromised respiration (breathing). Signs of an overdose of chloral 
hydrate can include: confusion, seizures, difficulty breathing, slurred speech, slow or 
irregular heartbeat, vomiting, weakness, and a lowered body temperature. Chronic use of 
chloral hydrate is also associated with a severe withdrawal syndrome and may induce liver 
damage (Young & Mangum, 2010). 
6.4.13 Iron 
Indication: The prevention and treatment of iron-deficiency induced anemia. 
Pharmacology: Ferrous salts are preferred as they are absorbed 2-3 times better than ferric 
salts when administered by oral route. Ferrous sulfate, ferrous fumarate, ferrous gluconate 
can also be used. Absorption is better on an empty stomach. Half or one-third of it is 
absorbed when taken with food. 
Dose: Premature infants: Elemental iron 2 mg/kg/dose PO, started after 4 weeks in doses 
divided into 2-3. For babies lighter than 1000 gr 4 mg/kg/day may be administered. For 
patients receiving EPO treatment: 6 mg/kg/day 
Iron dextran: For ones who cannot take by oral route 0.4-1 mg/kg/day is administered as 
continuous infusion in D/AA. 
Side effects: Iron treatment should not be launched as long as premature infants do not get 
adequate vitamin E. Hemolysis may increase in that case. Diarrhea and constipation, 
lethargy, hypotension, black-colored stool and erosion in gastric mucosa can be observed. It 
may be required to seek for occult blood in stool in suspicious cases (Kanmaz, 2010). 
6.4.14 Dexamethasone 
Uses: Dexamethasone is used primarily in the intensive and short-term treatment of severe 






Dose: 0.075 mg/kg per dose Q12 hours for 3 days, 0.05 mg/kg per dose Q12 hours for 3 days, 
0.025 mg/kg per dose Q12 hours per 2 days, and 0.1 mg/kg per dose Q12 for 2 days IV or PO. 
Adverse Effects: 1/100 Accumulation of fat around the body and face, growth retardation in 
children, susceptibility to infectious diseases, the activation of diabetes, muscle weakness, 
abnormal menstruation, body hair in women, akne. Most of these symptoms occurs as a 
result of long-term glucocorticoid therapy. 1/1000 Disturbances in water management, 
reducing the level of potassium in the body, accumulation of water in the body, raised blood 
pressure, heart failure, allergic reactions, accelerated blood clotting, gastrointestinal 
disorders, increased appetite, weight gain, damage the lining of the digestive tract, sagging 
skin, mental disorders manifested by extreme changes in mood, insomnia, headache, 
increased intraocular pressure in the eye lens opacity. If there are troublesome symptoms 
should seek medical attention. 
6.4.15 Diazepam 
It is effective as anxiolytic and muscle- relaxing agent. In treatment of status epilepticus 0.1-
0.5 mg /kg/dose is administered 2 times at 5-15 minutes intervals by IV route in newborns-
infants-children. Its effect by IM route is limited. To decrease anxiety: 4 times 0.2-0.3 
mg/kg/day PO (Eroğlu, 2002). 
6.4.16 Digoxin 
Digoxin is an antiarrhythmic and cardiac glycoside drug (Kavakl et al, 1998). It is a highly 
active cardiac glycoside with a half-life of 48 hours (Dökmeci, 2000; Küçüködük, 1994). 
Uses: Treatment of heart failure caused by diminished myocardial contractility. Treatment of 
SVT, atrial flutter, and atrial fibrillation (Young & Mangum, 2010). 
 
Dose: Old Dose Maintenance Interval 
 29 < 0.015 mg/kg 0.004 mcg/kg 24 
 30-36 0.02 mg/kg 0.005 mg/kg 24 
 >37 0.035 mg/kg 0.006 mg/kg 12 (Young & Mangum, 2010). 
Total digoxin dose; premature baby: 0.02 mg/kg PO, after birth of newborn; 0.01-0.03 
mg/kg IM, IV / 0.04 mg/kg PO, infant; 0.03-0.04 mg/kg IM, IV / 0.05 mg/kg PO, children; 
0.010-0.015 mg/kg IM, IV, PO. Higher doses result in fatal arrhythmias (Dökmeci, 2000; 
Küçüködük, 1994). 
Adverse Effects: Toxic Cardiac Effects: PR interval prolongation, sinus bradycardia or SA 
block, trail or nodal ectopic beats, ventricular arrhythmias. Nontoxic Cardiac Effects: QTc 
interval shortening, ST segment sagging, T-wave amplitude dampening, heart rate slowing 
(Young & Mangum, 2010). 
The things to be considered by nurse applying the drug: Before nurse administers Digoxin to a 
child he or she should very carefully obtain prior Digoxin use history. Serum digoxin, 
potassium, magnesium and calcium levels should be determined by laboratory 
investigations before digoxin administration. Nurse should measure radial heart rate for a 
minute before administrating the drug to child and if any abnormality presents he or she 
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should check apical pulse and its rate, rhythm and properties and notify doctor. The drug 
can be administered by IV route either directly or via a solution including 5% dextrose or 9% 
sodium chloride. Absorption may delay if the drug is administered by oral route after 
meals. And absorption may also delay when administered with antacids. IM administration 
of drug is not advised especially for children with diabetics or mild tissue perfusion as it 
causes pain. When IM route is used the drug should be administered deep into a large 
muscle mass and then the area should be massaged after injection. No more than 5 mL 
should be administered in one area. In case that digoxin is administered with such drugs as 
diuretics which decrease potassium level and some antibiotics toxicity may develop. 
Besides, calcium should not be administered to digitalized children. It may have fatal 
consequences. If the drug is used for atrial fibrillation treatment purposes nurse should 
check heart rate and if it is below 60 or above 100 beats per minute then he or she should 
notify doctor. The drug should be administered with precaution and at fewer doses in 
children with hyperkalemia having kidney and hepatic impairment. The inputs/outputs of 
child should be followed, edema should be monitored and daily weight check should be 
ensured. Cardiac arrhythmia and anorexia in children are early symptoms of toxicity. Nurse 
should pay attention to those symptoms. If it is suspected of toxicity blood digoxin level 
should be measured and EGK should be performed. Nurse should store the drug in tight-
closed and light-proof bottles. If any color change is observed the drug should not be used 
(Kavakl et al, 1998). 
6.4.17 Dobutamine 
It is used in temporary treatment of heart failures related to the depression caused by 
cardiac rigidity. 0.0025-0.010 mg/kg/min is administered by IV infusion according to the 
patient’s response (Eroğlu, 2002). 
Dose: 2 to 20 mg/kg per minute continuous IV infusion. Begin at a low dose and titrate by 
monitoring effects. Use a large vein for IV (Kanmaz, 2010). 
Side Effects: Volume replacement should be performed before drug use as it may cause 
hypotension in hypovolemic patients. Tachycardia may develop at higher doses. 
Arrhythmia, hypertension and vasodilatation in skin may also develop. If it exudes or 
passes out of a vessel it causes tissue ischemia (Kanmaz, 2010). 
Administration and Storage Conditions: Diluted drug can be stored for 6 hours under room 
temperature and 48 hours in refrigerator. Slight color change does not mean that the drug is 
spoiled (Kanmaz, 2010). 
6.4.18 Dopamine 
It is indicated for all kinds of hypotension, heart failure and circulatory impairments. To 
increase cardiac output and to improve organ perfusion it is started to be administered by 
IV infusion at a dose of 0.002-0.005 mg/kg/min (100 mg dopamine in 250 ml 5% dextrose) 
as 0.400 mg/ml solution. It can be advanced up to 0.020 mg/kg/min (Apak, 1996). 
Uses: Treatment or hypotension 
Dose: 2 to 20 mcg/kg per minute continuous IV infusion. Begin at a low dose and titrate by 





Dose: 0.075 mg/kg per dose Q12 hours for 3 days, 0.05 mg/kg per dose Q12 hours for 3 days, 
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The things to be considered by nurse applying the drug: Before nurse administers Digoxin to a 
child he or she should very carefully obtain prior Digoxin use history. Serum digoxin, 
potassium, magnesium and calcium levels should be determined by laboratory 
investigations before digoxin administration. Nurse should measure radial heart rate for a 
minute before administrating the drug to child and if any abnormality presents he or she 
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should check apical pulse and its rate, rhythm and properties and notify doctor. The drug 
can be administered by IV route either directly or via a solution including 5% dextrose or 9% 
sodium chloride. Absorption may delay if the drug is administered by oral route after 
meals. And absorption may also delay when administered with antacids. IM administration 
of drug is not advised especially for children with diabetics or mild tissue perfusion as it 
causes pain. When IM route is used the drug should be administered deep into a large 
muscle mass and then the area should be massaged after injection. No more than 5 mL 
should be administered in one area. In case that digoxin is administered with such drugs as 
diuretics which decrease potassium level and some antibiotics toxicity may develop. 
Besides, calcium should not be administered to digitalized children. It may have fatal 
consequences. If the drug is used for atrial fibrillation treatment purposes nurse should 
check heart rate and if it is below 60 or above 100 beats per minute then he or she should 
notify doctor. The drug should be administered with precaution and at fewer doses in 
children with hyperkalemia having kidney and hepatic impairment. The inputs/outputs of 
child should be followed, edema should be monitored and daily weight check should be 
ensured. Cardiac arrhythmia and anorexia in children are early symptoms of toxicity. Nurse 
should pay attention to those symptoms. If it is suspected of toxicity blood digoxin level 
should be measured and EGK should be performed. Nurse should store the drug in tight-
closed and light-proof bottles. If any color change is observed the drug should not be used 
(Kavakl et al, 1998). 
6.4.17 Dobutamine 
It is used in temporary treatment of heart failures related to the depression caused by 
cardiac rigidity. 0.0025-0.010 mg/kg/min is administered by IV infusion according to the 
patient’s response (Eroğlu, 2002). 
Dose: 2 to 20 mg/kg per minute continuous IV infusion. Begin at a low dose and titrate by 
monitoring effects. Use a large vein for IV (Kanmaz, 2010). 
Side Effects: Volume replacement should be performed before drug use as it may cause 
hypotension in hypovolemic patients. Tachycardia may develop at higher doses. 
Arrhythmia, hypertension and vasodilatation in skin may also develop. If it exudes or 
passes out of a vessel it causes tissue ischemia (Kanmaz, 2010). 
Administration and Storage Conditions: Diluted drug can be stored for 6 hours under room 
temperature and 48 hours in refrigerator. Slight color change does not mean that the drug is 
spoiled (Kanmaz, 2010). 
6.4.18 Dopamine 
It is indicated for all kinds of hypotension, heart failure and circulatory impairments. To 
increase cardiac output and to improve organ perfusion it is started to be administered by 
IV infusion at a dose of 0.002-0.005 mg/kg/min (100 mg dopamine in 250 ml 5% dextrose) 
as 0.400 mg/ml solution. It can be advanced up to 0.020 mg/kg/min (Apak, 1996). 
Uses: Treatment or hypotension 
Dose: 2 to 20 mcg/kg per minute continuous IV infusion. Begin at a low dose and titrate by 





Adverse Effects: > 1/100 Headache. Additional heartbeat, increased heart rate. Pain in the chest. 
Nausea and vomiting. Shortness of breath. 1/1000 Heart arhythmia. Changes in the ECG. 
Lowering blood pressure. Allergic reactions. Pulmonary edema (Young & Mangum, 2010). 
Monitor: Heart rate and intra-arterial blood pressure should continuously be monitored. 
Urinary output and peripheral perfusion should be observed. A large vein is recommended 
to use. Extra care should be shown in terms of extravasation. Pallor may be observed 
through the subject vein. If it exudes or passes out of a vessel it causes necrosis, in which 
case 1 mg/ml phentolamine should be injected around lesion (Kanmaz, 2010). 
Administration and Storage Conditions: The opened ampoule should be stored in refrigerator and 
consumed within 24 hours. Ampoules with color change should not be used (Kanmaz, 2010). 
Miscible Serums: 5% DX, 5% DSF, SF, D/AA, fat emulsions (Kanmaz, 2010). 
Incompatible Drugs: Amphotericin B, Acyclovir, Furosemide, Indomethacin, Insulin, Sodium 
bicarbonate (Kanmaz, 2010). 
6.4.19 Fentanyl 
Uses: Anelgesia, sedation, anesthesia.  
Dose:  Sedation and analgesia: 0.5 to 4 mcg/kg per dose IV slow push. Repeat as require 
(usually Q2 to 4 hours). 
Infusion rate: 1 to 5 mcg/kg per hours. Tolerance may develop rapidly following constant 
infusion. 
Anesthesia: 5 to 50 mcg/kg per dose (Young & Mangum, 2010). 
Neonatal dose:  IV  slow             0.3-2 mcg/kg/dose 
          IV infusion dose:   0.3-5 mcg/kg/hour (Anand, 2007).  
Adverse Effects: Respiratory depression, Sometimes nausea, Vomiting, Bradycardia, 
Hypotension, Extremely bronchospasm. At high doses observed in a small chest muscle 
stiffness, which may hamper rescue breathing (Young & Mangum, 2010). 
Preparation: 1 ml fentanyl from 50 mcg/ml ampoules gets diluted with 4 ml SF. 
Miscible Serums: 5% DX, 10% DX, SF 
Drugs to be confronted at the end point: Dex/Amino acid mixture, Dekort, Dobutamine, 
Dopamine, Furosemide, Heparin, Midazolam, Potassium Chloride. 
Incompatible Drugs: Phenytoin, Azithromycin. 
Storage Conditions: It should be protected against light. Diluted ampoules can be stored for 
24 hours in refrigerator. 
6.4.20 Furosemidum 
Uses: Diuretic that may also improve pulmonary function. It is used in pulmonary edema, in 
heart failures and for increasing urinary discharge 
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Dose: 1 mg/kg IV slow push, IM or PO. May increase to a maximum of 2 mg/kg per dose IV 
or 6 mg/kg per dose PO. 
Adverse Effects: > 1 /100 Decreased blood potassium levels, which implies a weakening of 
the muscles. Decreased levels of magnesium, calcium and sodium. Increasing levels of uric 
acid in the blood. Reduce the volume of blood in case of longer treatment. 1/1000 Digestive 
disorders. <1/1000 Phlebitis. Changes in the blood picture. Allergic reactions. If you get a 
rash you should immediately contact your doctor and stop taking the drug. Dizziness and 
tinnitus. Increased blood sugar levels (Young & Mangum, 2010). 
It develops hypotension, hyponatremia, hypokalemia, alkalosis and hypercalciuria. It is 
highly ototoxic especially when administered fast. 
Administration and Storage Conditions: The ampoules should be protected against light. 
Compatible: SF and sterile water. 
Incompatible: Dopamine, Dobutamine, Erythromycin, Fluconazole, Midazolam. 
6.4.21 Glucagon 
Uses: It is used in patients with diabetes in decline due to excessively low blood sugar. This 
condition usually occurs as a result of too much insulin. 
Dose: 200 mcg/kg per dose IV, IM, SC 
Adverse Effects: 1 /100 Nausea and vomiting. 1/1000- <1/1000 Allergic reactions (Young & 
Mangum, 2010) 
6.4.22 Heparin 
Uses: Preventing blood clots, the risk of their formation is increased, e.g. after surgical 
procedures in acute myocardial infarction. Heparin is also used to treat blood clots in the 
legs and lungs in congestion of the arteries. The use of heparin also gives good results in the 
treatment of frostbite and burns (Young & Mangum, 2010). Prevention of peripheral and 
central catheters from congestion. Its use in renal vein thrombosis is still a matter of 
discussion (Kanmaz, 2010). 
Dose: IV for each ml of liquid 0.5-1 Unit 
For thrombosis treatment 70 Unit/kg bolus in 10 minutes, 28 Unit/kg/hour continuous 
infusion (Young & Mangum, 2010). 75 units/kg bolus over 19 minutes.  
Adverse Effects: Side effects in the form of bleeding occurs in approximately 10% of patients.  
>1/100 Bleeding. A decline in platelet count. Changes in the functions of the liver.  
<1/1000 Allergic reactions, allergic shock. Disturbances in the function of the adrenal cortex. 
Hair loss (Young & Mangum, 2010). 
Preparation: Added onto the solution as half of the total. 
Miscible Serums: SF, 5% DX, 10% DX 
Drugs to be confronted at the end point: Dex/Amino acid mixture, Acyclovir, Amphotericin B, 
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through the subject vein. If it exudes or passes out of a vessel it causes necrosis, in which 
case 1 mg/ml phentolamine should be injected around lesion (Kanmaz, 2010). 
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Neonatal dose:  IV  slow             0.3-2 mcg/kg/dose 
          IV infusion dose:   0.3-5 mcg/kg/hour (Anand, 2007).  
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Hypotension, Extremely bronchospasm. At high doses observed in a small chest muscle 
stiffness, which may hamper rescue breathing (Young & Mangum, 2010). 
Preparation: 1 ml fentanyl from 50 mcg/ml ampoules gets diluted with 4 ml SF. 
Miscible Serums: 5% DX, 10% DX, SF 
Drugs to be confronted at the end point: Dex/Amino acid mixture, Dekort, Dobutamine, 
Dopamine, Furosemide, Heparin, Midazolam, Potassium Chloride. 
Incompatible Drugs: Phenytoin, Azithromycin. 
Storage Conditions: It should be protected against light. Diluted ampoules can be stored for 
24 hours in refrigerator. 
6.4.20 Furosemidum 
Uses: Diuretic that may also improve pulmonary function. It is used in pulmonary edema, in 
heart failures and for increasing urinary discharge 
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or 6 mg/kg per dose PO. 
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acid in the blood. Reduce the volume of blood in case of longer treatment. 1/1000 Digestive 
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tinnitus. Increased blood sugar levels (Young & Mangum, 2010). 
It develops hypotension, hyponatremia, hypokalemia, alkalosis and hypercalciuria. It is 
highly ototoxic especially when administered fast. 
Administration and Storage Conditions: The ampoules should be protected against light. 
Compatible: SF and sterile water. 
Incompatible: Dopamine, Dobutamine, Erythromycin, Fluconazole, Midazolam. 
6.4.21 Glucagon 
Uses: It is used in patients with diabetes in decline due to excessively low blood sugar. This 
condition usually occurs as a result of too much insulin. 
Dose: 200 mcg/kg per dose IV, IM, SC 
Adverse Effects: 1 /100 Nausea and vomiting. 1/1000- <1/1000 Allergic reactions (Young & 
Mangum, 2010) 
6.4.22 Heparin 
Uses: Preventing blood clots, the risk of their formation is increased, e.g. after surgical 
procedures in acute myocardial infarction. Heparin is also used to treat blood clots in the 
legs and lungs in congestion of the arteries. The use of heparin also gives good results in the 
treatment of frostbite and burns (Young & Mangum, 2010). Prevention of peripheral and 
central catheters from congestion. Its use in renal vein thrombosis is still a matter of 
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Dose: IV for each ml of liquid 0.5-1 Unit 
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Preparation: Added onto the solution as half of the total. 
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Dekort, Dobutamine, Dopamine, Fentanyl, Fluconazole, Furosemide, Insulin, Meropenem, 
Midazolom, Penicillin G, Potassium chloride, Sodium bicarbonate, Bactrim (Young & 
Mangum, 2010). 
Incompatible Drugs: Amicasin (if concentration is intense), Diazem, Gentamicin (if 
concentration is intense), Phenytoin, Vancomycin (Kanmaz, 2010). 
Storage Conditions: It should be stored at room temperature under 25°C in its package 
(Young & Mangum, 2010). 
6.4.23 Hydroxyzine hydrochloride 
Uses: Sedative/hypnotic. Anesthesia induction. Treatment of refractory seizures. 
Dose: IV: 0.05 to 0.15 mg/kg over at least 5 minutes. Repeat as required, usually Q2 to 4 
hours. May also be given IM. Dosage requirements are decreased by incurrent use of 
narcotics. 
Adverse Effects: Pediatric patients: desaturation 4.6%, apnea 2.8%, hypotension 2.7%, 
paradoxical reactions 2.0%, hiccough 1.2%, seizure like activity 1.1% and nystagmus 1.1%. 
The majority of airway-related events occurred in patients receiving other CNS depressing 
medications and in patients where midazolam was not used as a single sedating agent 
(Young & Mangum, 2010). 
6.4.24 Ibuprofen 
It is a non-steroidal anti-inflammatory agent with analgesic and antipyretic effect. As an 
analgesic and antipyretic it is administered at a dose of 10-15 mg/kg/dose every 4-6 hours 
by PO route and 40-60 mg/kg/day at maximum (Dökmeci, 2000). 
Uses: Rheumatic Diseases. Menstrual pain. Pain of different origins. 
Dose:  
3-6 months > 5 kg  50 mg 3-4 times a day 
6-12 months 50 mg 3 times a day 
1-4 ages 100 mg 3-4 times a day 
The maximum dose for children and newborns is: 
3 months– 4 age 30 mkg 3-4 times a day (Pursell, 2010).  
Adverse Effects: >1/100 Abdominal pain, burning sensation in the throat, nausea, diarrhea. 
Fatigue.  
Headache. Rash. 1/1000 Allergic reactions. Symptoms of allergy may be asthma, rhinitis, 
and rash. Bleeding from the gastrointestinal tract. Gastric ulcer. Blurred vision. The 
deterioration of hearing. Anxiety. Insomnia (Young & Mangum, 2010). 
6.4.25 Indomethacin 
Uses: Closure of ducts arteriosus. Prevention of intraventricular hemorrhage. 
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Dose:(mg/kg)    
Age at 1st dose  1st  2nd  3rd 
<48 0.2 0.1 0.1  
2 to 7 d 0.2 0.2 0.2  
>7 d 0.2 0.25 0.25  
Adverse Effects: The most common side effects are nausea, vomiting, diarrhea, stomach 
discomfort, heartburn, rash, headache, dizziness and drowsiness (Young & Mangum, 2010). 
6.4.26 Imipenem 
Uses: Restricted to treatment of no-CNS infections caused by bacteria, primarily 
Enterobacteriaceae and anaerobes, resistant to other antibiotics (Kanmaz, 2010; Young & 
Mangum, 2010). 
Dose: 20 to 25 mg/kg per dose Q12 hours IV infusion over 30 minutes 
Adverse Effects: Seizures occur frequently in patients with meningitis, preexisting CNS 
pathology, and severe renal dysfunction. Local reaction at the infection and increased platelet 
counts are the most frequent adverse effects. Other including eosinophilia, elevated hepatic 
transaminases, and diarrhea also occur in more than 5% of patients (Young & Mangum, 2010). 
Incompatible Drugs: Amicasin, Fluconazole, Gentamycin, Clonazepam, Sodium bicarbonate, 
Tobramycin (Kanmaz, 2010). 
6.4.27 Insulin 
Indication: For adjuvant treatment in hypoglycemia and hyperpotassemia. 
Pharmacology: It ensures intracellular glucose transmission. It converts glucose into 
glycogen, ensures amino acid intake and transmission of K into muscle tissue and cell. It 
increases fat synthesis. It inhibits lipolysis and the conversion of protein to glucose. It is 
decomposed in liver and kidneys. Serum half-life is 9 minutes for adults. 
Dose: Intermittent dose: 0.1-0.2 U/kg, every 6-12 hours SC 
Continuous infusion: 0.01-0.1 U/kg/hour 
Only regular insulin can be given IV. The dose is adjusted according to blood sugar. 
Side effects: Hypoglycemia and increase in insulin resistance. It can cause normoglycemic 
hyperinsulinemia and metabolic acidosis. 
Monitor: Blood sugar should be monitored at 15-30 min. intervals after infusion and dose 
adjustment. 
Administration and Storage Conditions: A solution of 1 U/ml concentration should be 
prepared by diluting with sterile water or SF. Should wait for 20 minutes to give time for 
connection of plastic to IV catheters before continuous infusion. It should be stored in 
refrigerator. 
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and rash. Bleeding from the gastrointestinal tract. Gastric ulcer. Blurred vision. The 
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Uses: Closure of ducts arteriosus. Prevention of intraventricular hemorrhage. 
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Uses: Parental nutrition source of calories and essential fat acids. 
Adverse Effects: 1/100- 1 / 1000 Fever. Chills. Nausea. Redness of the skin. <1/1000 Allergic 
shock. Changes in the blood picture, which occur most frequently in infants. Increase or 
decrease in blood pressure. Rash. Changes in liver function. Shortness of breath. Long-term 
painful erection (Young & Mangum, 2010). 
6.4.29 Caffein 
It is MSS stimulator and vasoconstrictor of cerebral vessels. It is used for vascular headache 
and as analeptic. Neonatal apnea loading dose: 10 mg/kg, maintenance 5-10 mg/kg/day 
(Biçer, 2008). 
6.4.30 Ketamine 
General anesthetic, sedative, hypnotic, analgesic and amnestic. IV, IM. It protects 
cardiovascular functions. It improves lung compliance, has bronchodilator effect. As 
ketamine favorably alters the heart and respiratory functions it can be used as a sedative 
agent in patients who receive mechanical ventilation and have myocardial depression 
induced by benzodiazepines and opiates. It can be used in cases where spontaneous 
ventilation is requested while sedation is provided (Biçer, 2008). 
Neonatal Dose: 
 
IV slow 0.5-2 mg/kg/dose 
IV Inf. Dose 0.5-1 mg/kg/h 
IM, SC 2 mg/kg/dose 
Oral 5-8 mg/kg/dose (Anand, 2007). 
Sedation: 0.5-2 mg/kg/dose IV, can be repeatedly administered at doses of 0.5 mg/kg/dose 
at 2-5 min. intervals or with 1-2 mg/kg/hour infusion until adequate sedation is achieved 
(Max. 5 mg/kg). 4-5 mg/kg/dose IM (if adequate sedation is not achieved within 10 
minutes), one more dose of 2 mg/kg/dose can be administered. Rapid sequential 
intubation: 0.5-2 mg/kg/dose IV or 3-7 mg/kg/dose IM (1 dose). Caution: It acts fast; but 
slow. Aspiration and laryngospasm can be observed in patients who ventilate 
spontaneously in the unprotected airway. Atropine and glycopyrronium bromide are 
advised to use before ketamine as it increases saliva and bronchial secretions. It should not 
be administered in cases of increase in intracranial pressure, suspected head trauma and in 
convulsions whose etiology is unknown and where intracranial pressure may have 
increased. It can cause such reactions as hallucination and delirium and these phenomena 
increase by age and dose. The administration of benzodiazepines 5 minutes before ketamine 
is active against these phenomena (Biçer, 2008). 
Side Effects: Laryngospasm, out-of-anesthesia reaction, tachycardia, hypertension, increase 
in intracranial pressure (Biçer, 2008). 
 




Uses: Treatment of hypothyroidism  
Dose: PO: 10 to 14 mcg/kg. IV 5 to 8 mcg/kg 
Adverse Effects: Prolonged over treatment can produce premature craniosynostosis and 
acceleration of bone age (Young & Mangum, 2010). 
6.4.32 Magnesium sulfate 
Uses: Postpartum eclampsia. Tetanus. 
Warning: Injection should not be administered in renal failure. Injections should be done 
slowly by controlling the breath of the patient (Young & Mangum, 2010). 
6.4.33 Meropenem 
Uses: Limited to treatment of pneumococcal meningitis and other serious infections caused 
by susceptible gram-negative organisms resistant to other antibiotics, especially extended-
spectrum beta-lactamase producing Klebsiella pneumonia (Young & Mangum, 2010).  
Dose: 20 mg/kg per dose IV 
Less than 32 weeks GA, less than or equal to 14 days PNA: administered Q12 hours; after 14 
days PNA: administered Q8 hours. 32 weeks and older GA, less than or equal to 7 days 
PNA: administered Q12 hours; after 7 days PNA: administered Q8 hours. Meningitis and 
infections caused by Pseudomonas species, all ages: 40mg/kg per dose Q8 hours. Give as an 
IV infusion over 30 minutes. Longer infusion times (up to 4 hours) may be associated with 
improved therapeutic efficacy (Young & Mangum, 2010). 
Adverse Effects: Diarrhea (4%), nausea/vomiting (1%) and rash (2%). May cause 
inflammation at the injection site. The use of carbapenem antibiotics can result in the 
development of cephalosporin resistance in Enterobacter, Pseudomonas, Serration, Proteus, 
Citrobacter, and Acinetobacter species. The risk of pseudomembranous colitis and fungal 
infections are also increased (Young & Mangum, 2010). 
Administration:  IV 30 min. infusion 
Preparation: 500 mg meropenem is diluted with 10 ml proper solution. 50 mg/ml 
concentration is obtained. 
Miscible Serums: 5% Dex, 10% Dex, SF 
Drugs to be confronted at the end point: Dex/Amino acid, Lipid solution, Acyclovir, 
Aminophylline, Dopamine, Dobutamine, Fluconazole, Gentamicin, Heparin, Sodium 
bicarbonate, Vancomycin. 
Incompatibility: Amphotericin B, Metronidazole, Acyclovir, Calcium gluconate, Diazepam, 
Zidovudine. 
Storage Conditions: Diluted with sterile distilled water it can be stored for 2 hours under 






Uses: Parental nutrition source of calories and essential fat acids. 
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and as analeptic. Neonatal apnea loading dose: 10 mg/kg, maintenance 5-10 mg/kg/day 
(Biçer, 2008). 
6.4.30 Ketamine 
General anesthetic, sedative, hypnotic, analgesic and amnestic. IV, IM. It protects 
cardiovascular functions. It improves lung compliance, has bronchodilator effect. As 
ketamine favorably alters the heart and respiratory functions it can be used as a sedative 
agent in patients who receive mechanical ventilation and have myocardial depression 
induced by benzodiazepines and opiates. It can be used in cases where spontaneous 
ventilation is requested while sedation is provided (Biçer, 2008). 
Neonatal Dose: 
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IM, SC 2 mg/kg/dose 
Oral 5-8 mg/kg/dose (Anand, 2007). 
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at 2-5 min. intervals or with 1-2 mg/kg/hour infusion until adequate sedation is achieved 
(Max. 5 mg/kg). 4-5 mg/kg/dose IM (if adequate sedation is not achieved within 10 
minutes), one more dose of 2 mg/kg/dose can be administered. Rapid sequential 
intubation: 0.5-2 mg/kg/dose IV or 3-7 mg/kg/dose IM (1 dose). Caution: It acts fast; but 
slow. Aspiration and laryngospasm can be observed in patients who ventilate 
spontaneously in the unprotected airway. Atropine and glycopyrronium bromide are 
advised to use before ketamine as it increases saliva and bronchial secretions. It should not 
be administered in cases of increase in intracranial pressure, suspected head trauma and in 
convulsions whose etiology is unknown and where intracranial pressure may have 
increased. It can cause such reactions as hallucination and delirium and these phenomena 
increase by age and dose. The administration of benzodiazepines 5 minutes before ketamine 
is active against these phenomena (Biçer, 2008). 
Side Effects: Laryngospasm, out-of-anesthesia reaction, tachycardia, hypertension, increase 
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Uses: Treatment of hypothyroidism  
Dose: PO: 10 to 14 mcg/kg. IV 5 to 8 mcg/kg 
Adverse Effects: Prolonged over treatment can produce premature craniosynostosis and 
acceleration of bone age (Young & Mangum, 2010). 
6.4.32 Magnesium sulfate 
Uses: Postpartum eclampsia. Tetanus. 
Warning: Injection should not be administered in renal failure. Injections should be done 
slowly by controlling the breath of the patient (Young & Mangum, 2010). 
6.4.33 Meropenem 
Uses: Limited to treatment of pneumococcal meningitis and other serious infections caused 
by susceptible gram-negative organisms resistant to other antibiotics, especially extended-
spectrum beta-lactamase producing Klebsiella pneumonia (Young & Mangum, 2010).  
Dose: 20 mg/kg per dose IV 
Less than 32 weeks GA, less than or equal to 14 days PNA: administered Q12 hours; after 14 
days PNA: administered Q8 hours. 32 weeks and older GA, less than or equal to 7 days 
PNA: administered Q12 hours; after 7 days PNA: administered Q8 hours. Meningitis and 
infections caused by Pseudomonas species, all ages: 40mg/kg per dose Q8 hours. Give as an 
IV infusion over 30 minutes. Longer infusion times (up to 4 hours) may be associated with 
improved therapeutic efficacy (Young & Mangum, 2010). 
Adverse Effects: Diarrhea (4%), nausea/vomiting (1%) and rash (2%). May cause 
inflammation at the injection site. The use of carbapenem antibiotics can result in the 
development of cephalosporin resistance in Enterobacter, Pseudomonas, Serration, Proteus, 
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Administration:  IV 30 min. infusion 
Preparation: 500 mg meropenem is diluted with 10 ml proper solution. 50 mg/ml 
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Zidovudine. 
Storage Conditions: Diluted with sterile distilled water it can be stored for 2 hours under 





temperature, 18 hours in refrigerator; diluted with 5% Dex for 1 hour under room 
temperature, 8 hours in refrigerator. These periods of time are valid for 50 mg/ml 
concentration (Kanmaz, 2010). 
6.4.34 Metronidazole 
Uses: Reserved for treatment of meningitis, ventriculitis, and endocarditis caused by 
Bacteroides fragilis and other anaerobes resistant to penicillin; treatment of serious intra-
abdominal infections; and treatment of infections caused by Trichomonas vaginalis. 
Treatment of C. difficile colitis. 
Dose: Loading dose: 15 mg/kg PO or IV infusion by syringe pump over 60 minutes 
Maintenance dose: 7.5 mg/kg per dose PO or IV infusion over 60 minutes. Begin one dosing 
interval after initial dose. Adverse Effects: Seizures and sensory polyneuropathy have been 
reported in a few adult patients receiving high doses over a prolonged period. Drug 
metabolites may cause brownish discoloration of the urine (Young & Mangum, 2010). 
6.4.35 Phenobarbital 
It is a long-term effective MSS depressant. For sedation: infants and children; 2-3 
mg/kg/day PO every 8-12 hours. For sleep: infants and children; 2-3 mg/kg/dose PO, if IM 
required it is repeated after 12-24 hours (Eroğlu, 2002). 
Dose: 20 mg/kg IV, given slowly over 10 to 15 minutes. Refractory seizures: Additional 5 
mg/kg doses, up to a total of 40 mg/kg. 
Neonatal Abstinence Syndrome: 16 mg’kg PO on day 1. 
Uses: Epilepsy, seizures primarily large, so called and grand mal seizures, which cover only 
part of the brain. Seizures in newborns. 
Adverse Effects: Respiration and respiratory depression (Kanmaz, 2010). > 1 / 100  
Drowsiness. Disturbances in attention. Irritability, especially in young children.  The 
difficulty of concentration of vision. The difficulty in coordinating movements. Changes in 
the blood picture. Rash. Confusion, especially in older patients. 1/1000  The risk of mucous 
membrane of the mouth and teeth, especially during prolonged treatment.  <1/1000 – 
Anemia (Young & Mangum, 2010). 
 Follow: The therapeutic concentration is 15-30 mcg/ml. Respiratory depression is observed 
in concentration exceeding 60 mcg/ml. The serum half-life is longer in the first 1-2 weeks. 
The serum half-life differs in patients taking phenytoin and valproate (Kanmaz, 2010). 
Administration and Storage Conditions: The ampoules should be used within 30 minutes after 
opening (Kanmaz, 2010). 
Incompatible Drugs: Fat emulsions, Hydralazine, Hydrocortisone, Insulin, Clindamycin, 
Methadone, Midazolam, Morphine, Pancuronium, Ranitidine, Vancomycin (Kanmaz, 2010). 
6.4.36 Phenytoin 
Uses: Anticonvulsant often used to treat seizures refractory to phenobarbital. 
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Dose: 15 to 20 mg/kg IV infusion over at least 30 minutes, after that 4 to 8 mg/kg Q24 hours 
IV or PO. Max 0.5 mg/kg/minute. 
Adverse Effects: Due to the central nervous system: Nystagmus, slurred speech, impaired 
motor coordination, may rarely occur: dizziness, insomnia, irritability, involuntary muscle 
spasms, headache, in very rare cases you may experience dyskinesia.  
Due to the gastrointestinal tract: most - nausea, vomiting, constipation, in rare cases can lead 
to hepatotoxicity.  
On the part of the skin: various forms of skin rashes, systemic lupus erythematous, Stevens - 
Johnson syndrome, toxic epidermolysis.  
On the part of the hematopoietic system: in rare cases there may be abnormal blood cell 
production - thrombocytopenia, leukopenia, granulocytopenia, and anemia Megaloblastic 
makrocytosis (equivalent of treatment with folic acid) (Young & Mangum, 2010). 
Administration Type: Loading dose IV 30 minutes infusion, Maintenance dose IV slow. 
Preparation: The maximum concentration should be 10 mg/ml when it is diluted with SF. 5 
mg/ml concentration is obtained diluting 50 mg/ml with 9 ml SF. 
Miscible Serums: SF. Stability is ruined with most of the IV liquids. 
Drugs to be confronted at the end point: Fluconazole, Sodium bicarbonate 
Incompatible Drugs: 5% Dex, 5% with Dextrose, Dex/Amino acid, Lipid emulsions, 
Aminophylline, Amicasin, Dobutamine, Fentanyl, Heparin, Potassium chloride, Vitamin K1. 
Storage Conditions: Unopened ampoules should be protected against light under room 
temperature. Opened ampoules should not be delayed. 
6.4.37 Potassium chloride 
Uses: Potassium deficiency. Prevention of excessive potassium smothering as a result of 
taking diuretics, diabetes, long-term diarrhea. 
Dose: 0.5 to 1 mEq/kg per day divided an administered with feedings. 1g KCl = 13.4 mEq 
K+ 
Adverse Effects: Confusion, anxiety, feeling like you might pass out; uneven heartbeat; 
extreme thirst, increased urination; leg discomfort; muscle weakness or limp feeling; 
numbness or tingly feeling in your hands or feet, or around your mouth; severe stomach 
pain, ongoing diarrhea or vomiting; black, bloody, or tarry stools; or coughing up blood or 
vomit that looks like coffee grounds (Young & Mangum, 2010). 
Administration: IV infusion 
Preparation: Maximum concentration via peripheral line is 40 mEq/L. and 80 mEq/L. 
through central vein. The desired amount is added to total solution. 
Miscible Serums: Compatible with all standard IV solutions. 





temperature, 18 hours in refrigerator; diluted with 5% Dex for 1 hour under room 
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Drowsiness. Disturbances in attention. Irritability, especially in young children.  The 
difficulty of concentration of vision. The difficulty in coordinating movements. Changes in 
the blood picture. Rash. Confusion, especially in older patients. 1/1000  The risk of mucous 
membrane of the mouth and teeth, especially during prolonged treatment.  <1/1000 – 
Anemia (Young & Mangum, 2010). 
 Follow: The therapeutic concentration is 15-30 mcg/ml. Respiratory depression is observed 
in concentration exceeding 60 mcg/ml. The serum half-life is longer in the first 1-2 weeks. 
The serum half-life differs in patients taking phenytoin and valproate (Kanmaz, 2010). 
Administration and Storage Conditions: The ampoules should be used within 30 minutes after 
opening (Kanmaz, 2010). 
Incompatible Drugs: Fat emulsions, Hydralazine, Hydrocortisone, Insulin, Clindamycin, 
Methadone, Midazolam, Morphine, Pancuronium, Ranitidine, Vancomycin (Kanmaz, 2010). 
6.4.36 Phenytoin 
Uses: Anticonvulsant often used to treat seizures refractory to phenobarbital. 
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Dose: 15 to 20 mg/kg IV infusion over at least 30 minutes, after that 4 to 8 mg/kg Q24 hours 
IV or PO. Max 0.5 mg/kg/minute. 
Adverse Effects: Due to the central nervous system: Nystagmus, slurred speech, impaired 
motor coordination, may rarely occur: dizziness, insomnia, irritability, involuntary muscle 
spasms, headache, in very rare cases you may experience dyskinesia.  
Due to the gastrointestinal tract: most - nausea, vomiting, constipation, in rare cases can lead 
to hepatotoxicity.  
On the part of the skin: various forms of skin rashes, systemic lupus erythematous, Stevens - 
Johnson syndrome, toxic epidermolysis.  
On the part of the hematopoietic system: in rare cases there may be abnormal blood cell 
production - thrombocytopenia, leukopenia, granulocytopenia, and anemia Megaloblastic 
makrocytosis (equivalent of treatment with folic acid) (Young & Mangum, 2010). 
Administration Type: Loading dose IV 30 minutes infusion, Maintenance dose IV slow. 
Preparation: The maximum concentration should be 10 mg/ml when it is diluted with SF. 5 
mg/ml concentration is obtained diluting 50 mg/ml with 9 ml SF. 
Miscible Serums: SF. Stability is ruined with most of the IV liquids. 
Drugs to be confronted at the end point: Fluconazole, Sodium bicarbonate 
Incompatible Drugs: 5% Dex, 5% with Dextrose, Dex/Amino acid, Lipid emulsions, 
Aminophylline, Amicasin, Dobutamine, Fentanyl, Heparin, Potassium chloride, Vitamin K1. 
Storage Conditions: Unopened ampoules should be protected against light under room 
temperature. Opened ampoules should not be delayed. 
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Uses: Potassium deficiency. Prevention of excessive potassium smothering as a result of 
taking diuretics, diabetes, long-term diarrhea. 
Dose: 0.5 to 1 mEq/kg per day divided an administered with feedings. 1g KCl = 13.4 mEq 
K+ 
Adverse Effects: Confusion, anxiety, feeling like you might pass out; uneven heartbeat; 
extreme thirst, increased urination; leg discomfort; muscle weakness or limp feeling; 
numbness or tingly feeling in your hands or feet, or around your mouth; severe stomach 
pain, ongoing diarrhea or vomiting; black, bloody, or tarry stools; or coughing up blood or 
vomit that looks like coffee grounds (Young & Mangum, 2010). 
Administration: IV infusion 
Preparation: Maximum concentration via peripheral line is 40 mEq/L. and 80 mEq/L. 
through central vein. The desired amount is added to total solution. 
Miscible Serums: Compatible with all standard IV solutions. 





6.4.38 Sodium bicarbonicum 8.4% 
Uses: Treatment of normal anion gap metabolic acidosis caused by renal or GI losses. 
Sodium bicarbonate is not a recommended therapy in neonatal resuscitation guidelines. 
Administration during brief CPR may be determinal. 
Dose: 1 to 2 mEq/kg IV over at least 30 minutes 
Adverse Effects: Excess sodium in the body, which can manifest itself in the body of water 
retention, swelling, weakness, anxiety, swollen tongue, dizziness and headaches, fever, 
decrease in saliva and urine, pressure drop, rapid heart rate, apnea (Young & Mangum, 
2010). 
6.4.39 Ranitidine 
Dose: PO: 2 mg/kg per dose Q8 hours. IV: 1.5 mg/kg per dose Q8 hours.  
Uses: Prevention and treatment of stress ulcers and GI hemorrhage aggravated by gastric 
acid secretion.  
Adverse Effects: 1/100 Fatigue. Diarrhea, rash, dizziness. 1/1000 Allergic reactions such as 
swelling of the skin rash, fever, seizures or asthma. Changes in the blood picture and liver 
function. Jaundice. Depression, hallucinations, disorientation, especially in debilitated and 
elderly patients. Seeing the fog. Pain in muscles and joints (Young & Mangum, 2010). 
6.4.40 Steroids 
Steroids are used as anti-inflammatory, immunosuppressive or in rheumatic diseases in 
order to increase sensitivity against beta adrenergic, chronic ulcerative colitis, nephrotic 
syndrome, tuberculosis meningitis and asthma. 
Dose: 
Hydrocortisone  10-20 IV, IM, Oral 
Methylprednisolone  0.4-2 IV, IM, Oral 
Prednisone  1-2 Oral 
The drug can be administered 1-2 times a day by oral route. Hydrocortisone should be 
administered deeply IM and delta frame should not be performed. Steroids should be 
administered by SC route as they cause sterile abscess and pseudoatrophy. The duration of 
therapy may differ from 3-5 days to weeks or months depending on the diagnosis of child. 
The drug is metabolized in liver and discharged from body via urinary system. 
Side Effects: Edema, hypertension, headache, convulsion, acne, skin atrophy, hypokalemia, 
alkalosis, Cushing syndrome, hyperglycemia, peptic ulcer, nausea, vomiting, cataract, 
glaucoma and muscle weakness are observed side effects (Kavakl et al, 1998). 
The things to be considered by nurse applying the drug: The recommendation of manufacturer on 
the route of administration should be taken into consideration. Nurse should administer the 
drug slowly by IV route. In oral administration it should be administered at meal intervals 
or after meals to decrease gastric irritation of drug. Salt is limited in foods. If possible diets 
rich in potassium and protein are prepared. The blood pressure and other vital signs, input-
output, sleeping condition and daily weight check of child is observed in recorded. Oral and 
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hygienic care is provided at frequent intervals. Steroid can cause hyperkalemia when used 
with certain diuretics. Phenobarbiturates decrease the effect of steroids. Urinary and blood 
glucose investigations should be carried out especially in children with diabetics. It may be 
necessary to increase insulin dose. As it is a drug decreasing hypophyseal stimulation for a 
long-term it may cause adrenal insufficiency, in which cases such symptoms as loss of 
appetite, nausea, anorexia, pain, fever and painful urination may appear in children. The 
drug should be administered carefully in patients with previous psychological problems. 
The behaviors, emotional status, sleeping order and psychomotor activity changes of child 
should be monitored and notified to doctor especially on long-term treatments. The 
treatment should be ceased by gradually decreasing dose. Long-term applications should be 
avoided in that it has many side effects. Unless otherwise stated by manufacturer nurse 
should protect drug against light and frost (Kavakl et al, 1998). 
6.4.41 Surfactant 
Uses: Prophylaxis of infants at high risk for RDS (those < 29 weeks gestation). 
Mode of Action: Preparation obtained from the lungs of beef. Lowers the surface tension of 
pulmonary alveoli, allowing easy opening of the alveoli and facilitates the process of 
respiration (Young & Mangum, 2010). 
6.4.42 Tracutil 
Administration: It is added to TPN solution in order to meet daily trace element need. IV 
infusion: Infusion should not be less than 6 and less than 24 hours. Contains Iron, Zinc, 
Manganese, Copper and Selenium. 
Dose: 0.2 cc/kg in first week and then 0.5 cc/kg 
Preparation: It can be used by being added to parenteral nutrition solutions. 
Miscible Serums: 5% Dex, 10% Dex, SF, Ringer lactate, Amino acid solution. 
Incompatibility: Sodium bicarbonate 
Storing Conditions: Unopened ampoules are stored at room temperature under 25°C. 
6.4.43 Vecuronium 
Uses: Loosening the muscles before surgery.  
Dose: 0.1. Mg/kg IV 
Adverse Effects: The preparation is generally well tolerated. <1/1000- Allergic reactions. 
Allergic shock. Irritation at the injection site (Young & Mangum, 2010). 
6.4.44 Vitamin K 
Uses: Prophylaxis and therapy on hemorrhagic disease of the newborn. Treatment of 
hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin K.  
Dose: Preterm infants, 32 weeks gestation: BW > 1000 grams: 0.5 mg/kg IM. BW < 1000 
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Uses: Treatment of normal anion gap metabolic acidosis caused by renal or GI losses. 
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Steroids are used as anti-inflammatory, immunosuppressive or in rheumatic diseases in 
order to increase sensitivity against beta adrenergic, chronic ulcerative colitis, nephrotic 
syndrome, tuberculosis meningitis and asthma. 
Dose: 
Hydrocortisone  10-20 IV, IM, Oral 
Methylprednisolone  0.4-2 IV, IM, Oral 
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hygienic care is provided at frequent intervals. Steroid can cause hyperkalemia when used 
with certain diuretics. Phenobarbiturates decrease the effect of steroids. Urinary and blood 
glucose investigations should be carried out especially in children with diabetics. It may be 
necessary to increase insulin dose. As it is a drug decreasing hypophyseal stimulation for a 
long-term it may cause adrenal insufficiency, in which cases such symptoms as loss of 
appetite, nausea, anorexia, pain, fever and painful urination may appear in children. The 
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The behaviors, emotional status, sleeping order and psychomotor activity changes of child 
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treatment should be ceased by gradually decreasing dose. Long-term applications should be 
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respiration (Young & Mangum, 2010). 
6.4.42 Tracutil 
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7. Drug management in pediatric nursing 
Many drugs can be stored under room temperature (5-25°C). And some drugs need to be 
protected against sunlight. The list of drugs to be stored and not to be stored in refrigerator 
should be attached on the refrigerator in service. No IV drug including the diluted ones with 
more than 24-hour preservation period should be kept more than 24 hours. Preservation 
period for oral drugs explicitly written at the prospectuses are acceptable. If there is no 
period stated they are discharged after 30 days. That is why the first opening and discharge 
dates are always noted on the oral drugs (Çavuşoğlu, 2000). 
Vital signs and clinical findings should be carefully evaluated. Therapeutic and toxic drug 
effects should be closely monitored. Kidney functions should be evaluated by monitoring 
the input-output liquid. The track of serum levels on drugs with limited therapeutic 
boundary should be ensured. The volume of the administered drug should be continuously 
monitored. With drugs requiring special safety measures those measures should be 
followed to the letter. The drugs which are not risky to administer on infants should be 
tagged with catchy titles and be kept away from the preparation area. One should be careful 
against potential side effects of the drugs which are underutilized and have limited reported 
experience on infants (Çetinkaya &Tengir, 2006). In terms of dose, some drugs are 
readjusted for infants by breaking the tablet, opening capsules, mixing with different 
liquids, or weighing the raw drug. Whether the drug was given at desired dose or if its bio-
availability and microbial stabilities were variable cannot be determined when this method 
is used. Therefore, it is recommended not to resort to these methods unless otherwise is 
strictly required (Young & Mangum, 2010). 
When a drug is administered the aim is to get the desired effects while keeping undesired 
ones at minimum. Pediatric nurse evaluates the response of the infant to drug and is the one 
to interfere if necessary. The knowledge of medication principles for newborns ensures a 
reliable drug administration (Çetinkaya &Tengir, 2006). 
The following information should be obtained from parents before administering any  
drugs: 
• Is the newborn allergic to any drugs? 
• How does the newborn response to drug treatment? 
• What are the names, doses, schedules and taking reasons of previously administered 
drugs? 
• If newborn is breastfed, it should be found that whether the mother uses any drug or 
not. 
• Does the infant or family know the reason why the drug has been prescribed or what 
are its desired effects (as well as potential side effects)?  
Drug effectiveness and the tolerance of infants can be determined by the help of these 
questions. Besides, infant’s development level, the needle size and suitable gauge for 
injection, how and when infants should be prepared can also be found out. 
To avoid mistakes and to ensure safe, reliable drug administration, the principle called 
“eight corrects” is of a significant importance: 
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1. Correct Drug: The nurse should know the name and commercial name of the drug given 
by its first manufacturer. Name and dose should be checked three times before the use 
(Çavuşoğlu, 2000; Çetinkaya &Tengir, 2006). 
2. Correct Dose: The dose should be calculated according to the  body weight (kg) and its 
surface area (m2). It is highly important to measure all the drugs properly (Çavuşoğlu, 
2000; Çetinkaya &Tengir, 2006; Oval 2002). 
3. Correct Route: The recommended route is checked along with the availability of that 
route and the condition of infant for that route (Çetinkaya &Tengir, 2006; Eroğlu 2002). 
4. Correct Patient (infant): Each hospital has its own way of patient identification and 
recognition. There may be ID cards attached to the wrists or ankles for these purposes. 
Name of the child should be double-checked to avoid any confusion (Çavuşoğlu, 2000; 
Çetinkaya &Tengir, 2006). 
5. Correct Timing: It takes longer time to administer drug to infants than administering it to 
adult patients. In this sense, timing of the previous administration should be checked 
carefully; and if it was not timely made, a new time-schedule should be arranged 
accordingly (Çetinkaya &Tengir, 2006; McKinney et al, 2000). 
6. Correct Approach: During drug administration to infants, their fears, weaknesses and 
their ways for dealing with them are taken into account with regards to their 
development levels (Çavuşoğlu, 2000; Çetinkaya &Tengir, 2006). 
7. Correct Information: The child and family should be informed about the purpose and 
duration of the drug treatment along with its desired effects and potential side effects. 
By this way, the recommended drugs can be used more safely (Çavuşoğlu, 2000; 
Çetinkaya &Tengir, 2006). 
8. Correct Record: Prior to administration the nurse writes down the name of the drug, its 
dose, administration hour, and administration route on the observation form. The nurse 
performing this administration signs up the observation form with his / her name 
(Çetinkaya &Tengir, 2006; McKinney et al, 2000). 
Pediatric drug doses are calculated according to body weight and body surface. Body 
surface area of the infants in proportion to their weight is much larger than that of the 
children and adults. This is why the dose for infants calculated with body surface is much 
higher than that calculated with body weight. Therefore, during the premature term and 
infancy periods body surface area is not used for dose calculation purposes (Çetinkaya 
&Tengir, 2006). 
Generally, pediatric drug doses are described as gram or milligram per kilogram of body 
weight. Safe dose amounts differ according to infant’s age and his/her ability to metabolize 
the drug. Before any drug is administered the recommended dose is checked and rechecked 
whether it should have been calculated properly. So there should be a drug guide in each 
pediatric unit (Çetinkaya &Tengir, 2006). 
Since the pediatric doses are relatively fewer than adult ones, any mistake in the amount 
may have serious consequences. The biggest responsibility in drug administration falls onto 
nurses. The nurse should be well aware of the pharmacokinetic and pharmacodynamic 
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For premature infants, newborns and early infants the immatureness of their body systems 
affects the drug administration. Among the factors accompanying toxicity of drugs are an 
immature enzyme system in the liver, decrease of the protein fields that drugs bind, and 
immature kidney system. Likewise, drugs leading to acid-base imbalance also affect toxicity. 
For example, overdose of salicylates can easily lead to metabolic acidosis in infants. The 
drug level in serum, its side effects and urinary excretion should be evaluated to avoid drug 
toxicity (Çetinkaya &Tengir, 2006). 
The electrolyte - fluid balance is closely monitored during drug treatment. Newborns have 
limited ability to concentrate urine, so they should be provided with adequate liquid to 
discharge both drugs and metabolites. Dehydration may increase the drug toxicity risk. An 
immature blood - brain barrier also serves for drug toxicity. The immature myelination of 
the central nervous system increases the permeability of blood - brain barrier. The 
myelination forming this barrier is not fully mature until the infant is 2 years old. As the 
permeability of blood - brain barrier increases during the diseases like meningitis and brain 
tumor, side effects of the drugs administered into central nervous system should be 
monitored closely (Çetinkaya &Tengir, 2006). 
The skin absorption rate of the topical drugs is significant. Infants have a thin layer of 
dermis and epidermis, hence their absorption rate would be greater compared to adults. 
Besides, greater body surface in proportion to weight is an important factor when drug is 
administered on wide skin surface. Infants, therefore, should be monitored for their 
sensitiveness to the drugs applied on skin surface (Çetinkaya &Tengir, 2006). 
If the patients taking numerous drugs together yield different findings than the anticipated 
results in the light of laboratory findings, drug interactions should be taken into 
consideration. Some drugs affect the absorption of other drugs through the gastrointestinal 
system (GIS). This interaction or behavior results from changes in pH, changes in flora, and 
drug binding to intestine lumen. For example, antacids do not only cause intestinal pH to 
change; but also inactivate the drugs by binding to them (Çetinkaya &Tengir, 2006). 
The period of drug use differs from 1 week to 5 weeks before any symptom appears; 
following the next dose the symptoms reappear instantly. Redness, fever, joint pain and 
inflammation, lymphadenopathy, eosinophilic leukopathy can be observed (Çetinkaya 
&Tengir, 2006). 
Drug Mistakes Caused by Nurse: Administration of drugs prior to a non-official request, 
administration of drugs without a physician’s request, administration of wrong drug 
because of misspelling or resemblance in appearance, miscalculation of drug dose or 
administration at wrong dose, inattention to information provided on the drug container or 
package, forgetting the administration (Çetinkaya &Tengir, 2006). 
Medical mistakes have a potential of becoming 8 times more harmful at the newborn 
intensive care units. One of those mistakes is the administration of the similar drugs at 
different concentrations given in different doses, whereas other mistakes could be system-
related. 
These are the most common mistakes made on newborns regarding drug administration: 
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• Administration of wrong dose because of the resemblance between Adult Vitamin K (10 
mg/ml) and Neonatal Vitamin K (1 mg/0.5 ml) ampoules 
• To confuse Vancomycin and Heparin vials 
• Though not exactly a drug administration, vaccination at wrong doses through 
mistaking adult and infant versions of Diphtheria-Tetanus vaccine. Moreover, the 
administration of DTaP and Hib combination vaccine on inappropriate age groups in 
terms of their effectiveness on infants (although pentaxim or infanrix can be received 
under 1 year of age, combination vaccines, in general, has low effectiveness on such 
infants). 
• To confuse Vecuronium (1mg/ml) (preparation: 0.25 mg/0.25 ml) and Cisatracurium (2 
mg/ml) (preparation: 0.5 mg/0.25 ml (Used for avoiding muscle paralysis. Sedation 
effective) (Sauberan et al, 2010). 
In this sense, the physician requests should be re-checked, any questions in mind should be 
asked to physician and be well understood, and the medication should be carried out on 
time and be recorded appropriately; by this way, any medical or legal danger caused by the 
drug mistakes either by nurses or physicians can be avoided. Since the pediatric doses are 
relatively fewer than those for adults, any quantitative mistake may lead to serious 
consequences (Çetinkaya &Tengir, 2006). 
The factors leading to inadequate adaptation to prescribed drugs: 
• Not obtaining the prescription, or not having it at the pharmacy 
• Unclearness of the purpose regarding drug use 
• Surmising the ineffectiveness of the drug 
• Occurrence of actual side effect, or the thought of side effects appearing 
• Unclearness of the instructions regarding drug intake 
• Physical difficulty during the administration (handling small tablets, or unpacking drug 
container) 
• Repelling formulations (e.g. unpleasant taste) (Kayaalp, 2001). 
It is noteworthy again that the pediatric nurse to administer drug on patients should find 
out first that if the dose and route of the administration asked by physician is appropriate or 
not. The nurse should be careful for potential drug interactions. Infant’s developmental 
characteristics affect the techniques and approaches used in drug administration. The infant 
and parents should be prepared besides with the drug. Attentive observation should be 
performed in and after the process. Observations about administration should be recorded. 
Patient should be kept well-monitored against undesired effects prior to administration. It is 
important to provide information and consultation services to the patient and/or family 
about drugs. 
In conclusion, any mistake in drug amount for infants may have serious consequences. 
Nurse should be well informed about the preparation and administration of the drugs. 
Nurse should know about his/her legal responsibilities that might require in the process, 
and the pharmacologic properties of drugs. Nurse should also know about the generic and 
commercial names of drugs, and remain utmost careful during the administration. Pediatric 
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c : Compatible (can be given together or can be mixed) 
x : Incompatible ( cannot be mixed, cannot be administered consecutively through the same path) 
? : Unknown 
Table 1. Compatibility Chart of Some of the Most Frequently Used Drugs in Pediatrics 
(Katzung, 1998; Loeb, 1990; Trissel, 1992; Wong et al, 1992; Young & Magnum, 2008). 
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